data_1ctl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ctl _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.628 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 t -122.42 103.2 38.64 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -167.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -59.13 -15.2 27.16 Favored 'Trans proline' 0 N--CA 1.485 1.025 0 C-N-CA 122.704 2.269 . . . . 0.0 113.557 171.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.491 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -82.3 -65.87 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.459 -167.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.7 p -87.49 -14.57 40.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.517 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.94 18.41 61.3 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.534 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.51 161.17 13.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 110.272 167.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.517 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -119.81 148.61 43.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.277 169.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.517 HG23 ' CD2' ' A' ' 32' ' ' HIS . 4.4 t -109.81 144.1 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.025 -166.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.73 -45.44 2.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.445 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.02 -11.69 9.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.315 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.47 ' CA ' HG13 ' A' ' 18' ' ' VAL . . . 61.73 92.54 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.31 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.18 27.81 8.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.702 164.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.17 130.2 37.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.29 -162.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.468 ' CG2' ' HB2' ' A' ' 31' ' ' TRP . 2.3 m -107.04 -168.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.003 161.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -154.56 155.55 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.435 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' A' ' 52' ' ' ASP . . . -161.57 128.67 1.95 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 168.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.54 -82.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.289 -172.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.39 21.13 0.83 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -85.29 168.63 14.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.395 170.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.99 142.33 32.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.295 168.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.468 ' HB2' ' CG2' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -135.39 176.47 8.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.091 -169.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.517 ' CD2' HG23 ' A' ' 18' ' ' VAL . 16.9 m80 -84.63 164.58 18.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.083 165.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 tttp -60.95 -24.88 66.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.508 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -129.42 31.21 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.33 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -119.5 -10.35 9.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.823 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.439 ' CE2' ' CG2' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -61.67 107.19 0.77 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.333 -172.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.46 100.54 7.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.366 -166.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 25.2 t -62.82 117.37 6.25 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.532 167.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.66 41.77 1.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.39 169.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -131.47 -48.35 0.98 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.436 -176.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.2 p -97.12 -11.85 23.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.099 162.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.3 17.68 58.54 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.372 167.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -107.96 147.03 31.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.069 0.462 . . . . 0.0 110.353 -164.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 m -68.77 136.59 53.02 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.53 159.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -100.84 -163.63 1.04 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.913 -158.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HB2' ' CG2' ' A' ' 49' ' ' THR . 7.3 mt-10 -117.16 -178.17 3.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.926 165.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -57.17 5.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.343 -166.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.8 t -118.82 44.48 2.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.405 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.459 ' CG2' ' HB2' ' A' ' 46' ' ' GLU . 11.8 t -141.68 68.39 1.33 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.324 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.512 ' N ' ' HB2' ' A' ' 60' ' ' LYS . 2.2 pp -149.11 170.5 18.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.37 -164.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -158.14 115.22 2.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.35 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.506 ' HA ' HG21 ' A' ' 57' ' ' ILE . 3.0 p30 -91.82 162.08 14.59 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.353 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 13.0 tptt -169.14 135.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.323 168.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.86 -95.49 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.477 175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.29 16.57 1.69 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -127.58 -177.98 4.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 167.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.506 HG21 ' HA ' ' A' ' 52' ' ' ASP . 27.2 pt -157.27 136.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.538 -159.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.54 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 3.6 p90 -126.57 177.94 6.2 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 155.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.541 ' HB2' HD23 ' A' ' 45' ' ' LEU 0.255 12.2 p -110.74 148.09 33.03 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.099 0.476 . . . . 0.0 111.793 -150.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.512 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -73.58 -6.47 46.82 Favored 'General case' 0 C--N 1.347 0.466 0 O-C-N 120.162 -1.586 . . . . 0.0 109.993 167.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.81 -3.02 26.16 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.609 159.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.8 -48.69 2.01 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -167.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -59.91 -12.87 8.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.334 162.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.67 -69.25 0.7 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.347 166.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.78 -32.53 71.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.447 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.414 170.91 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.526 0.748 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 9.3 t -123.29 106.68 32.98 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -162.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 8.6 Cg_endo -58.47 -15.3 24.24 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 C-N-CA 122.917 2.411 . . . . 0.0 113.61 167.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -67.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.377 -166.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.7 p -88.73 -22.75 23.18 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.618 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.6 -18.26 38.22 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -66.42 171.6 4.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.295 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -143.59 143.37 31.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.191 169.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.519 HG23 ' CD2' ' A' ' 32' ' ' HIS . 2.4 t -96.01 158.64 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.451 -162.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -94.55 38.89 1.1 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.475 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.84 67.87 0.73 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.077 -167.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.492 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -129.12 -64.41 0.91 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.483 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.512 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 3.0 mt-10 -129.38 16.71 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.185 -166.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.58 158.68 15.58 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.018 -166.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -158.92 173.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.724 -147.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.43 140.79 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.51 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.8 134.83 4.18 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 167.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.75 -83.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.275 -0.462 . . . . 0.0 110.459 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.14 48.18 0.52 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 172.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.89 148.66 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.4 -170.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.09 144.28 35.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.27 168.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -147.93 172.6 13.94 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.782 -170.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.519 ' CD2' HG23 ' A' ' 18' ' ' VAL . 43.3 m80 -92.96 156.18 17.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.855 162.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.512 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 13.7 ptmt -62.59 -14.18 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.456 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.49 17.73 18.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.547 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.1 m -125.73 23.51 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.243 167.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.513 ' CE1' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -118.3 82.97 1.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.177 -168.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -119.91 129.25 54.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.255 -166.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 13.0 t -60.01 105.59 0.41 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.271 163.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.46 -19.48 64.76 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.571 170.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -65.08 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.59 -164.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.3 p -88.0 -24.92 23.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.615 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.96 18.76 30.86 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -99.03 132.19 44.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.396 169.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -81.72 134.98 35.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.332 168.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 59' ' ' CYS . 1.1 pp -157.78 -173.07 4.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.361 177.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -139.01 -179.27 5.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.073 -162.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.521 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -66.44 169.08 7.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.365 -165.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.08 13.17 4.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.344 -167.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.524 ' HA ' ' HB3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -168.6 30.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.57 -174.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 47' ' ' SER . 4.0 pp -153.03 175.11 13.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.498 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.67 107.97 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.3 -169.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.525 ' HB3' HG23 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -90.63 161.13 15.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.418 176.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.508 ' HD2' ' CE1' ' A' ' 58' ' ' TYR . 8.4 ptmm? -166.29 109.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.429 -171.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 60.78 18.36 8.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.471 164.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.4 -28.16 8.86 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -104.93 168.58 8.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.525 HG23 ' HB3' ' A' ' 52' ' ' ASP . 32.3 pt -150.11 131.22 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.443 -158.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.508 ' CE1' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -124.71 -175.27 3.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.747 161.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.526 ' HB2' HD12 ' A' ' 45' ' ' LEU . 14.2 p -111.11 157.39 20.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.327 0.584 . . . . 0.0 110.927 -153.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 49' ' ' THR . 6.2 ttmm -71.89 -13.86 61.78 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.824 169.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.22 -10.41 41.1 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.151 165.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.15 -46.86 2.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -164.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -17.1 41.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.364 165.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.13 -58.31 2.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.289 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -20.52 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.401 -167.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.309 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 t -125.01 108.66 27.82 Favored Pre-proline 0 C--O 1.244 0.799 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -164.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -57.56 -16.4 23.94 Favored 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 122.854 2.369 . . . . 0.0 113.578 166.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.82 -68.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.392 -167.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.1 p -90.1 -13.16 36.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.5 -175.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.75 18.74 67.3 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 175.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.89 164.44 13.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.378 168.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.534 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -120.32 143.2 48.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.089 167.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 22' ' ' GLU . 3.5 t -108.14 140.6 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.864 -164.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -103.52 136.03 44.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.437 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.57 19.77 10.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.425 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.94 110.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.286 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.54 ' HB3' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -117.85 20.35 13.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.55 166.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -102.96 168.06 9.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.421 -158.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.513 HG22 ' CE2' ' A' ' 36' ' ' PHE . 1.2 m -115.51 -171.69 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.148 167.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -163.6 146.62 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.412 166.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.467 ' N ' HG13 ' A' ' 25' ' ' ILE . . . -171.44 141.07 6.2 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -170.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.38 -82.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.248 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.46 21.08 0.93 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 168.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -122.17 128.55 51.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.374 -169.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.48 144.14 26.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.34 167.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -139.51 -163.22 1.45 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.892 -177.122 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 18.6 m80 -103.9 163.55 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.136 164.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -73.92 -11.56 60.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.396 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.0 23.33 11.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.431 177.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 1.8 m -121.32 -20.35 6.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.457 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.513 ' CE2' HG22 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -61.42 104.62 0.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.298 -171.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 ptm85 -115.59 102.35 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.312 -164.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 29.8 t -62.53 116.35 5.05 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.477 163.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 41.99 1.1 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.371 168.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -129.93 -53.57 1.13 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.555 -178.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.6 p -92.63 -11.23 34.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.005 163.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.62 18.2 60.57 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.434 167.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -108.06 147.88 30.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.943 0.401 . . . . 0.0 110.34 -164.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.82 138.71 52.85 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.633 158.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -103.62 -163.51 0.99 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.919 -157.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.71 -159.26 0.68 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.095 168.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.0 p -92.52 -58.2 2.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.365 -168.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -110.62 41.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.453 -169.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 28.2 p -151.27 78.68 1.28 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.523 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.507 ' N ' ' HB2' ' A' ' 60' ' ' LYS . 2.7 pp -151.96 167.18 29.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.496 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.07 114.37 6.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.255 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.514 ' HA ' HG21 ' A' ' 57' ' ' ILE . 3.0 p30 -85.53 160.87 19.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.434 171.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.71 97.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.408 -169.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 61.03 17.82 8.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.464 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.9 -23.63 25.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 170.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -103.72 165.09 11.25 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 167.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.514 HG21 ' HA ' ' A' ' 52' ' ' ASP . 31.9 pt -147.98 137.6 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.376 -157.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 1.9 p90 -125.86 176.22 7.11 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.538 156.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.522 ' HB2' HD23 ' A' ' 45' ' ' LEU 0.25 12.4 p -110.15 148.76 31.17 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.302 0.573 . . . . 0.0 111.814 -149.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.507 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -71.71 -9.63 58.56 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 120.587 -1.32 . . . . 0.0 109.873 168.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.02 -4.74 22.91 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.457 162.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.4 -49.26 2.16 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -166.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -13.6 12.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.367 163.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.48 -64.24 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.331 166.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -12.07 9.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.421 -166.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.478 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.9 t -129.65 102.42 18.1 Favored Pre-proline 0 C--O 1.242 0.692 0 CA-C-O 121.285 0.564 . . . . 0.0 109.5 -162.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -58.36 -15.06 22.6 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.79 2.327 . . . . 0.0 113.504 170.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -63.76 1.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.463 -167.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -89.04 -34.85 16.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.554 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.7 -31.15 3.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.47 168.99 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.373 -169.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -126.56 145.87 50.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.215 168.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.517 HG23 ' CD2' ' A' ' 32' ' ' HIS . 3.8 t -109.15 148.91 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.907 -165.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -125.56 -45.46 1.79 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.516 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.95 -11.0 6.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.355 170.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.46 ' CA ' HG13 ' A' ' 18' ' ' VAL . . . 61.76 93.1 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.347 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -107.68 34.36 3.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.764 164.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 124.1 31.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.345 -162.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.463 ' CG2' ' HB2' ' A' ' 31' ' ' TRP . 2.6 m -97.15 176.33 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.889 160.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -145.94 143.49 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.364 167.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.91 127.56 1.23 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 169.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 36.78 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.385 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.21 -20.27 48.74 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -86.6 130.44 34.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.382 -173.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.4 t -103.82 117.25 33.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.209 166.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.484 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -113.1 -173.43 2.25 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.029 -167.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.517 ' CD2' HG23 ' A' ' 18' ' ' VAL . 19.2 m80 -96.07 157.17 16.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.039 163.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -15.98 30.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.603 168.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.8 p -106.9 -27.13 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.353 -171.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -88.03 -17.38 31.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.384 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.449 ' CD2' HG22 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -60.6 95.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.431 171.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 18.9 ptt85 -133.11 126.73 32.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.316 -169.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 14.3 t -60.26 111.78 1.67 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.125 163.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.0 41.01 1.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.406 167.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.57 -41.26 1.53 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.539 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.2 p -108.5 -27.35 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.485 166.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.49 18.61 25.4 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -98.07 145.98 26.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.377 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 3.9 m -80.77 145.14 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.396 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 59' ' ' CYS . 1.4 pp -168.53 179.11 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.151 167.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.507 ' HA ' HD21 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -171.47 -159.34 0.15 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.107 -178.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.91 -86.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.594 167.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 t -138.15 42.0 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.367 -166.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.532 ' HA ' ' HB3' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -168.09 40.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.471 -177.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 46' ' ' GLU . 1.9 pp -133.45 167.78 19.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.409 -174.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.57 103.53 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.262 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.537 ' HA ' HG21 ' A' ' 57' ' ' ILE . 6.6 p-10 -75.62 168.83 19.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.335 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.47 100.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.482 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 60.88 19.46 9.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.444 165.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.58 -32.0 5.36 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.92 164.55 11.62 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.537 HG21 ' HA ' ' A' ' 52' ' ' ASP . 32.9 pt -148.64 129.99 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.363 -157.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.67 -175.66 3.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.768 162.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 13.7 p -111.61 155.16 23.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 111.166 -153.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 49' ' ' THR . 17.8 tptp -71.16 -14.01 62.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.733 169.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.16 -8.63 31.1 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.111 164.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.56 -46.57 2.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -165.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -14.88 20.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.423 165.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.46 -68.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.398 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -61.11 -25.95 67.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.402 -166.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.469 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.5 t -123.69 102.15 35.81 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -162.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.18 -14.12 27.35 Favored 'Trans proline' 0 N--CA 1.485 1.015 0 C-N-CA 122.778 2.319 . . . . 0.0 113.486 167.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.511 ' HD3' ' CZ3' ' A' ' 31' ' ' TRP . 4.8 tpt180 -79.39 -63.26 1.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.341 -167.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.2 p -91.78 -24.11 19.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.512 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.12 -29.55 5.05 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -172.64 1.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.293 -0.454 . . . . 0.0 110.331 -172.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.541 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -146.86 152.23 38.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.189 166.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG23 ' CD2' ' A' ' 32' ' ' HIS . 2.6 t -106.46 166.61 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.556 -166.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -101.39 68.41 1.2 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.467 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.14 16.75 7.46 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.524 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB1' HG13 ' A' ' 18' ' ' VAL . . . -91.81 -70.45 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.359 -165.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HG2' ' HB2' ' A' ' 21' ' ' ALA . 3.3 mm-40 -106.27 17.12 23.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.123 -167.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.09 106.07 16.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.342 -163.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.518 HG22 ' CE2' ' A' ' 36' ' ' PHE . 15.7 m -86.84 -167.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.015 161.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 tt -154.68 150.54 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.428 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.1 -142.01 3.71 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 168.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.1 87.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.274 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.78 23.11 60.69 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -113.31 154.59 26.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.4 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.63 120.24 10.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.246 168.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.514 ' CZ2' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -115.38 166.3 12.03 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.858 -164.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.52 ' CD2' HG23 ' A' ' 18' ' ' VAL . 39.5 m80 -80.45 156.23 26.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.004 162.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -60.85 -12.31 10.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.486 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.1 p -115.93 18.3 15.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.412 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.78 11.89 6.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.413 -171.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.518 ' CE2' HG22 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -89.38 89.4 7.86 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.268 177.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HD2' ' NH2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -109.11 108.62 19.36 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.456 -173.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 32.2 t -62.91 116.81 5.62 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.399 163.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.63 40.26 1.14 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.387 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -129.27 -49.21 1.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.462 -176.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -96.07 -12.19 25.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.081 162.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.81 18.38 56.44 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.378 168.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -106.5 145.14 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.341 -163.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.8 m -69.61 126.28 29.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.668 159.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -90.55 -164.64 1.2 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.736 -158.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.45 88.59 2.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.173 -166.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 64.95 -86.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.483 165.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 p -146.61 67.37 1.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.405 -168.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 2.4 p -152.7 75.02 1.08 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.354 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 0.6 OUTLIER -145.43 -177.35 5.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.376 -166.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.48 104.61 2.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.259 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.539 ' HA ' HG23 ' A' ' 57' ' ' ILE . 2.3 p30 -87.54 154.35 20.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.363 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 178.81 140.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.425 168.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.34 18.34 9.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.394 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.87 -29.31 10.98 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 168.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -113.11 177.95 4.45 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.93 -0.635 . . . . 0.0 109.966 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.539 HG23 ' HA ' ' A' ' 52' ' ' ASP . 35.5 pt -148.25 141.06 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.323 -159.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.488 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 4.2 p90 -130.5 173.7 10.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.333 156.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.539 ' HB2' HD23 ' A' ' 45' ' ' LEU 0.252 11.8 p -109.62 148.22 31.69 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.283 0.563 . . . . 0.0 111.86 -149.257 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.517 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 14.2 tttt -72.49 -9.03 58.04 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 120.387 -1.445 . . . . 0.0 109.853 167.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.7 -4.45 19.54 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.457 161.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.89 -51.51 2.02 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -166.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -14.21 16.92 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.479 166.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.86 -66.0 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.322 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -11.68 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.508 -166.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.378 179.49 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.6 t -128.68 104.18 19.18 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -164.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.97 -12.32 22.03 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.792 2.328 . . . . 0.0 113.629 171.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -85.26 -65.58 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.368 -167.272 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -85.46 -27.66 25.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.481 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.72 -31.34 5.77 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.3 150.78 38.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.376 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.539 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -115.49 140.62 48.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.114 166.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.514 HG23 ' CD2' ' A' ' 32' ' ' HIS . 3.6 t -102.3 140.17 21.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.942 -162.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -121.07 -39.07 2.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.435 175.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -11.47 8.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.376 168.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.465 ' CA ' HG13 ' A' ' 18' ' ' VAL . . . 61.56 95.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.307 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.515 ' HG3' ' HD2' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -117.67 27.72 8.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.613 165.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 130.1 36.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.355 -160.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.476 HG22 ' CD1' ' A' ' 31' ' ' TRP . 11.1 m -95.93 -176.31 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.546 158.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.516 HD12 ' N ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -144.52 152.41 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.44 167.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.65 137.78 3.91 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' A' ' 52' ' ' ASP . . . 61.55 14.37 5.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.296 174.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.58 -32.93 6.54 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.516 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -61.87 165.66 5.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.245 -0.477 . . . . 0.0 110.422 -170.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.88 124.37 20.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.228 165.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.516 ' CZ3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -117.69 159.64 22.64 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.658 -166.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.514 ' CD2' HG23 ' A' ' 18' ' ' VAL . 36.6 m80 -80.54 156.66 26.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.497 154.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HD2' ' HG3' ' A' ' 22' ' ' GLU . 12.4 ptmt -60.15 -12.81 9.45 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.569 170.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 t -122.47 18.29 10.5 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.481 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 79.7 m -129.14 34.16 4.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.042 163.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.511 ' CE1' HD13 ' A' ' 57' ' ' ILE . 8.8 t80 -126.04 96.23 4.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.692 -164.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 21.6 ttp180 -127.98 126.63 41.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.228 -164.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 12.2 t -59.29 111.56 1.41 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.411 163.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.43 -24.14 65.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.216 -1.357 . . . . 0.0 110.708 171.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -75.02 0.13 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.308 -173.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p -86.94 -17.14 33.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.585 -170.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.83 19.75 50.05 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.33 129.07 45.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.449 -0.376 . . . . 0.0 110.407 171.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 53.9 p -78.65 121.79 25.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.262 167.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 59' ' ' CYS . 1.1 pp -147.14 -174.18 4.44 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.475 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.04 71.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.778 167.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.458 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -95.02 -165.27 1.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.46 -171.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.52 HG21 ' HG3' ' A' ' 60' ' ' LYS . 12.5 t -68.48 -12.84 61.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.635 -169.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -139.62 136.3 34.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.518 -173.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.41 163.32 32.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.193 162.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.3 75.58 1.63 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.294 -173.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.53 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 2.0 p30 -69.04 151.15 46.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.387 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.57 135.41 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.415 168.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 p30 61.06 22.11 12.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.554 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.01 -37.99 3.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -103.91 -171.31 1.91 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.968 -0.616 . . . . 0.0 110.043 -177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.516 HD12 ' CZ3' ' A' ' 31' ' ' TRP . 27.5 pt -149.62 165.19 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.181 -160.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.72 170.06 16.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.696 162.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 14.5 p -104.88 155.9 18.51 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.253 0.549 . . . . 0.0 111.097 -152.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HG3' HG21 ' A' ' 48' ' ' THR . 1.0 OUTLIER -61.42 -22.68 65.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.022 166.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.49 -5.89 38.79 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.538 174.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -118.43 -45.4 2.62 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -165.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.5 -15.0 22.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.309 165.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.7 -70.49 0.71 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.387 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -61.05 -12.58 12.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.338 -165.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.379 177.503 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.2 t -123.95 100.55 36.75 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -167.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -60.3 -13.27 23.58 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.82 2.347 . . . . 0.0 113.539 171.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HD3' ' HB3' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -83.79 -63.24 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.444 -165.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -85.0 -26.08 27.32 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.504 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.41 -23.43 6.78 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 172.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.39 176.34 9.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.361 -171.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -130.67 155.55 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.227 167.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.517 HG23 ' CD2' ' A' ' 32' ' ' HIS . 6.9 t -110.16 142.13 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.226 -167.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.56 -30.91 3.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.417 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.52 17.94 10.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.456 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.481 ' N ' HG13 ' A' ' 18' ' ' VAL . . . 61.19 94.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.301 165.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.442 ' N ' HG12 ' A' ' 18' ' ' VAL . 2.8 mt-10 -122.68 26.93 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.712 163.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.88 112.56 24.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.285 -162.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.507 HG22 ' CE2' ' A' ' 36' ' ' PHE . 10.8 m -80.95 -172.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.862 160.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -142.22 144.45 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.5 171.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.41 ' N ' HG13 ' A' ' 25' ' ' ILE . . . -136.55 96.33 0.25 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 -82.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.982 -0.609 . . . . 0.0 110.379 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.63 39.52 1.78 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 168.47 13.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.384 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.97 131.77 19.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.293 168.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.506 ' CZ2' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -129.05 159.45 35.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.061 -165.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.517 ' CD2' HG23 ' A' ' 18' ' ' VAL . 25.9 m80 -71.55 147.66 47.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.05 165.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.53 69.05 1.2 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.659 159.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.3 -42.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.913 -171.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.523 ' HB3' ' HD3' ' A' ' 13' ' ' ARG . 61.3 m -94.38 17.07 13.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.269 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.507 ' CE2' HG22 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -100.68 72.55 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.096 -164.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 16.1 mtt180 -93.28 117.04 29.6 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.376 -171.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 13.4 t -60.21 109.43 0.98 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.192 165.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.83 -22.64 65.14 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.424 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HD3' ' HB3' ' A' ' 58' ' ' TYR . 1.3 ttpp -71.25 -66.18 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.562 -167.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.7 p -89.77 -29.33 18.75 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.682 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.18 -25.5 6.68 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.8 129.36 39.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.354 -169.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 77.7 p -87.17 105.88 17.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.367 169.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.466 ' CD1' ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -126.09 -171.14 2.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.263 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -131.45 -173.47 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.051 -161.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.461 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -64.25 170.29 3.88 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.281 -172.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.8 p 59.07 13.43 2.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.972 -175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.454 ' HA ' ' CB ' ' A' ' 60' ' ' LYS . 10.4 p -155.29 43.13 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.48 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 2.5 pp -129.98 174.21 9.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.332 -173.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.51 119.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.313 169.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -98.68 169.07 9.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.326 -172.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? 178.39 131.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.45 167.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 60.78 19.72 9.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.39 164.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.01 -19.94 52.83 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -105.06 168.09 9.29 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 169.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.506 HG23 ' CZ2' ' A' ' 31' ' ' TRP . 29.7 pt -141.93 142.33 28.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.521 -158.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.526 ' HB3' ' HD3' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -133.18 -175.26 3.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.56 158.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 14.1 p -111.01 162.04 15.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.175 0.512 . . . . 0.0 110.727 -153.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -77.21 -12.71 59.98 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.927 169.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.89 -10.14 37.48 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.15 164.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.26 -50.52 2.56 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -164.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -59.88 -17.67 38.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.543 166.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.24 -66.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.289 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -60.85 -12.65 11.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.438 -166.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.425 -178.252 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.525 0.707 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 7.1 t -130.0 109.01 16.77 Favored Pre-proline 0 C--O 1.246 0.897 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -160.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 7.2 Cg_endo -58.13 -19.29 40.64 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.975 2.45 . . . . 0.0 113.598 165.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.453 ' HA ' ' HD2' ' A' ' 13' ' ' ARG . 11.5 tpt180 -80.51 -73.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.403 -170.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.21 -11.76 48.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.601 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.6 18.17 76.15 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.36 -169.99 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.181 166.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.523 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -152.55 146.57 25.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.212 165.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.532 HG23 ' HG3' ' A' ' 22' ' ' GLU . 2.4 t -101.47 178.11 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.295 -164.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.422 ' N ' HG13 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -91.7 46.79 1.31 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.551 172.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.62 29.97 18.41 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.291 -174.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.504 ' HB2' HG12 ' A' ' 18' ' ' VAL . . . -93.99 -70.84 0.69 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.377 -159.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 32' ' ' HIS . 0.0 OUTLIER -94.32 -9.75 34.92 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.907 -151.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -58.89 124.77 20.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.495 -146.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.512 HG22 ' CE2' ' A' ' 36' ' ' PHE . 10.0 m -93.08 175.03 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.721 158.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.473 HG21 ' N ' ' A' ' 26' ' ' GLY . 4.4 mp -142.3 153.15 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.382 166.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.473 ' N ' HG21 ' A' ' 25' ' ' ILE . . . -154.02 135.58 4.84 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 169.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.57 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.99 -0.605 . . . . 0.0 110.291 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.61 20.43 1.84 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -103.65 168.31 9.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.392 -171.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.0 t -143.52 149.99 38.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.229 167.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -143.88 176.3 9.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.906 -168.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.541 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 67.3 m80 -90.57 164.21 14.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.507 160.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -30.12 63.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.429 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -81.44 -18.31 45.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.428 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.49 -15.2 43.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.446 -170.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CE2' HD21 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -68.85 110.11 4.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.327 -171.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.63 99.79 7.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.344 -170.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 29.7 t -63.35 116.48 5.55 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.381 165.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.84 42.76 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.341 168.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.465 ' HD3' ' CB ' ' A' ' 58' ' ' TYR . 20.9 tttm -129.22 -46.95 1.21 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.491 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.3 p -96.57 -13.32 23.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.893 161.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.89 18.24 54.71 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.498 167.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.33 148.76 30.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.005 0.431 . . . . 0.0 110.404 -164.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -68.98 138.24 54.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.636 158.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.528 HD23 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -102.37 -164.88 1.13 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.776 -158.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -123.27 170.7 10.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.077 -170.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.2 p -60.89 -13.31 14.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.397 167.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.8 p -60.89 -177.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.486 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.446 ' HB ' ' CB ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -83.54 -174.12 5.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.441 -168.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.52 HD21 ' CE2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -154.45 -171.06 3.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.397 -170.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.06 104.12 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.225 170.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.531 ' HA ' HG21 ' A' ' 57' ' ' ILE . 3.1 p30 -79.38 157.24 27.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.371 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -179.94 112.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.517 -171.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 p30 61.27 20.45 11.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.615 170.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.73 -24.62 30.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 168.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -99.04 -174.75 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 168.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.531 HG21 ' HA ' ' A' ' 52' ' ' ASP . 16.9 pt -157.1 139.68 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.255 -160.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.465 ' CB ' ' HD3' ' A' ' 40' ' ' LYS . 25.1 p90 -130.68 176.48 8.15 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.817 159.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.528 ' HB2' HD23 ' A' ' 45' ' ' LEU 0.251 11.9 p -110.76 148.2 32.82 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 111.795 -150.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.446 ' CB ' ' HB ' ' A' ' 49' ' ' THR . 4.4 tttm -72.0 -9.38 58.3 Favored 'General case' 0 C--N 1.345 0.375 0 O-C-N 120.403 -1.436 . . . . 0.0 109.883 167.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.26 -3.54 18.96 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.501 161.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -122.42 -49.93 2.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -167.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -59.96 -12.36 7.75 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.339 165.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.76 -61.22 1.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.369 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -60.95 -14.56 23.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.318 -166.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.444 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.527 0.793 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -136.31 112.03 10.08 Favored Pre-proline 0 C--O 1.245 0.848 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -158.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -55.67 -17.2 16.96 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 C-N-CA 122.99 2.46 . . . . 0.0 113.53 164.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.451 ' HD3' ' CE3' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -89.27 -70.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.466 -166.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 p -88.57 -26.06 22.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.577 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.7 44.83 4.76 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -124.7 144.01 50.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.985 -0.607 . . . . 0.0 110.29 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.539 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -96.23 142.05 28.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.183 167.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.426 HG23 ' NE2' ' A' ' 32' ' ' HIS . 6.1 t -108.22 135.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.144 -164.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -61.48 -76.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.405 -166.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.03 -83.18 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.168 168.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.4 126.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.155 166.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.481 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 1.5 mm-40 -114.41 17.67 17.31 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.455 164.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.41 170.59 8.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.091 -159.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 31' ' ' TRP . 1.1 p -164.33 156.6 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.608 -148.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 tp -139.8 118.28 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.442 -168.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.458 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -99.09 171.3 24.42 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 160.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.37 -13.31 18.78 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.001 0.429 . . . . 0.0 110.619 -167.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.461 ' N ' ' HA2' ' A' ' 55' ' ' GLY . . . -128.04 -18.7 1.87 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -140.59 158.41 44.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.378 -162.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.78 146.38 47.12 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.026 164.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.483 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -146.6 177.47 9.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.915 -163.501 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.426 ' NE2' HG23 ' A' ' 18' ' ' VAL . 13.7 m80 -85.84 158.35 19.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.898 161.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.481 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -60.33 -26.51 66.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.474 165.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.8 p -116.71 18.44 14.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.469 -171.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.7 m -120.23 14.33 12.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.184 163.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.513 ' CZ ' HD23 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -92.71 108.19 19.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.276 -166.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -126.78 125.62 42.03 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.231 -165.065 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.5 t -57.52 107.6 0.46 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.755 162.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.11 -24.77 68.05 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.546 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.504 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -79.26 -76.38 0.21 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.522 -175.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.9 p -79.21 -18.0 53.77 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.431 -163.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.07 13.84 58.43 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -90.34 108.46 19.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.243 -0.478 . . . . 0.0 110.401 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 47.1 m -74.33 107.44 6.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.227 167.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -138.22 -172.86 3.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.306 -177.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -119.54 -177.37 3.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.068 -160.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.54 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 2.0 m -61.11 -46.36 90.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.457 -168.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.4 m -60.9 -13.64 17.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.457 -171.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 60' ' ' LYS . 6.9 m -145.12 41.49 1.27 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.374 -175.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.54 ' HG ' ' HA ' ' A' ' 47' ' ' SER . 2.0 pp -137.8 -175.46 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.375 170.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.448 ' N ' ' CD1' ' A' ' 50' ' ' LEU . . . -159.16 146.38 17.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.268 168.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.458 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 10.2 p-10 -89.55 143.8 26.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.383 169.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.48 99.83 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.392 -168.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 60.99 26.63 16.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.4 165.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.461 ' HA2' ' N ' ' A' ' 28' ' ' GLY . . . 103.75 -26.86 21.97 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 170.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -104.88 172.2 6.91 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.443 ' CD1' ' CH2' ' A' ' 31' ' ' TRP . 30.1 pt -130.71 158.82 43.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.307 -159.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.504 ' CE2' ' HG3' ' A' ' 40' ' ' LYS . 1.9 t80 -179.15 144.34 0.23 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.97 -159.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 38' ' ' CYS 0.252 9.6 p -101.46 157.15 17.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.314 0.578 . . . . 0.0 111.283 -148.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.515 ' HB3' HG21 ' A' ' 49' ' ' THR . 0.0 OUTLIER -74.83 -14.77 60.72 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.703 169.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.18 -9.43 29.29 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.072 166.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -118.22 -46.79 2.59 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -165.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.94 -10.03 3.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.486 167.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.43 -66.33 0.93 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.52 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -59.83 -31.9 70.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.056 -158.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.393 175.55 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.595 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 t -123.84 101.51 36.01 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -167.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -59.95 -14.1 26.18 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 122.885 2.39 . . . . 0.0 113.47 167.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -80.07 -62.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.436 -167.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -91.26 -25.53 19.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.499 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.8 18.62 17.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -101.23 171.33 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.323 168.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.521 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -130.21 147.67 51.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.171 167.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.518 HG23 ' CD2' ' A' ' 32' ' ' HIS . 4.5 t -106.04 141.51 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.136 -165.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -124.86 -31.97 3.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.374 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.95 18.81 9.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.33 170.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.17 97.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.286 166.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HB2' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -125.74 23.79 7.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.623 163.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 117.75 30.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.316 -161.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.515 HG22 ' CE2' ' A' ' 36' ' ' PHE . 9.2 m -81.97 -176.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.707 159.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 pt -142.98 138.22 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.485 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 52' ' ' ASP . . . -126.5 -139.27 5.01 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 168.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.79 83.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.271 -169.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.57 19.4 54.13 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -170.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.77 167.89 9.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.932 0.396 . . . . 0.0 110.338 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.9 147.73 29.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.131 166.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.503 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -143.82 158.06 43.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.833 -164.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.518 ' CD2' HG23 ' A' ' 18' ' ' VAL . 44.1 m80 -78.41 154.96 30.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.988 161.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -23.05 64.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.505 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -84.45 -29.19 26.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.347 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.1 m -95.14 15.95 17.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.453 -167.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.515 ' CE2' HG22 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -100.59 101.7 12.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.412 -166.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 8.1 mtp180 -124.94 125.03 43.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.295 -168.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.9 t -64.44 109.77 2.06 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.502 170.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.94 67.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.448 171.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -74.5 -74.27 0.2 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.332 -170.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -87.3 -11.13 50.45 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.645 -169.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.69 17.19 79.19 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.426 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -92.74 113.8 26.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.315 167.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 54.3 p -83.6 115.25 22.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.074 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.475 ' CD1' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -129.63 -171.18 2.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.86 -171.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -172.88 176.46 3.07 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 112.672 -2.058 . . . . 0.0 109.946 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.1 t 66.73 -61.98 0.3 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.458 170.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -177.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.368 166.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -92.17 -177.51 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.475 -164.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.448 HD23 ' CE2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -148.77 -166.24 2.5 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.334 -171.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.38 94.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.327 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 8.7 p-10 -65.37 161.95 18.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.442 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 tttt 179.92 124.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.358 168.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 70.34 -92.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.395 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.83 18.34 3.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.16 -171.53 3.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.263 -0.469 . . . . 0.0 109.884 -170.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.504 HD11 ' CE1' ' A' ' 36' ' ' PHE . 32.6 pt -150.46 157.64 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.243 -160.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.468 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -141.72 170.03 16.49 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.388 161.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 14.5 p -104.5 168.61 8.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.196 0.522 . . . . 0.0 110.84 -151.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 2.5 tptp -80.67 -14.82 57.81 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.086 168.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.37 -9.75 32.04 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.999 166.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.1 m -118.6 -48.83 2.47 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -164.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -59.6 -17.11 30.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.513 164.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.63 -57.64 3.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.336 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -11.32 10.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.491 -173.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.433 173.826 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.3 t -127.66 109.25 20.66 Favored Pre-proline 0 C--O 1.246 0.9 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -164.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -65.06 -15.72 51.81 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.701 2.267 . . . . 0.0 113.707 171.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HD2' ' CE3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -77.0 -76.21 0.18 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.411 -178.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 p -85.63 -15.81 41.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.498 -166.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.12 22.67 31.86 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 171.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.42 156.04 19.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.983 -0.609 . . . . 0.0 110.399 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -113.51 142.99 45.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.191 167.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.515 HG23 ' NE2' ' A' ' 32' ' ' HIS . 3.5 t -105.22 136.31 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.932 -164.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.47 121.51 45.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.059 168.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.73 98.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.844 -160.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.465 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . . . -60.04 123.85 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.4 -160.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.54 15.95 23.39 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.444 165.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -100.02 -178.27 3.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.126 -160.592 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 31' ' ' TRP . 3.7 p -164.91 179.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.973 -147.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.5 pt -140.05 142.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.404 -172.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.51 117.3 0.78 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 167.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 52' ' ' ASP . . . 61.89 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.395 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.39 -18.93 1.25 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -88.76 149.35 23.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.433 -0.383 . . . . 0.0 110.338 -168.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.8 m -105.71 144.76 32.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.168 166.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.521 ' CE3' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -144.64 -170.91 3.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.818 -168.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 41.5 m80 -102.51 161.83 13.4 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.652 163.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HG2' ' HB3' ' A' ' 47' ' ' SER . 0.1 OUTLIER -62.64 129.72 41.82 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.671 154.604 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.6 p 69.11 13.06 8.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.475 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 1.1 m -99.79 -20.87 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.537 156.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.474 ' CZ ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -61.9 104.45 0.45 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.307 174.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.511 ' HG3' ' NH1' ' A' ' 13' ' ' ARG . 4.3 mmt180 -113.03 100.43 8.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.371 -167.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 27.0 t -62.91 116.28 5.14 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.499 164.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.11 42.8 1.08 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.413 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.74 -51.55 1.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.49 -177.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.5 p -93.18 -13.02 28.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.04 161.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.92 18.18 56.6 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.408 167.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -109.05 148.93 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.024 0.44 . . . . 0.0 110.446 -164.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.5 p -70.13 139.11 52.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.631 159.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.521 HD12 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -103.46 -163.65 1.0 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.027 -157.371 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -104.78 -162.24 0.87 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.126 169.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.531 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -94.34 -35.44 12.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.362 -168.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.5 t -139.67 37.71 2.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.4 -168.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.469 ' CB ' ' HB3' ' A' ' 60' ' ' LYS . 1.2 p -142.08 83.53 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.549 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.474 HD12 ' CZ ' ' A' ' 36' ' ' PHE . 2.8 pp -153.22 165.06 36.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.386 -171.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.61 115.97 7.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.314 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -94.06 161.05 14.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.416 -178.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.79 115.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.34 -174.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.18 14.74 6.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.511 169.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.06 -18.36 56.83 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -104.62 171.55 7.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.3 pt -148.97 137.42 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.349 -158.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -126.21 172.81 9.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.478 156.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.521 ' HB2' HD12 ' A' ' 45' ' ' LEU . 12.5 p -108.77 147.17 32.44 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.339 0.59 . . . . 0.0 111.759 -148.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -69.61 -9.84 55.74 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.319 -1.488 . . . . 0.0 109.803 167.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.11 -2.47 25.21 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.59 163.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -122.59 -50.06 1.99 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -167.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -60.21 -12.45 8.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.376 165.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.56 -65.64 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.376 169.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -25.85 67.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.439 -165.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.624 -179.716 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 N--CA 1.465 0.607 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 t -125.89 99.7 31.7 Favored Pre-proline 0 C--O 1.244 0.781 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -162.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.95 -13.78 24.63 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 122.864 2.376 . . . . 0.0 113.443 164.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -59.33 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.462 -165.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.5 p -93.0 -39.97 10.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.503 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.23 -45.23 0.87 Allowed Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.512 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -171.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.321 -167.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.534 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -151.03 149.55 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.231 165.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 23' ' ' LYS . 2.1 t -123.17 142.97 37.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.019 -165.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -125.26 12.87 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.518 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.14 -38.89 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.407 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.47 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -60.75 -79.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.368 -158.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.459 ' HB3' ' CG ' ' A' ' 33' ' ' LYS . 13.4 mm-40 -135.97 11.78 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.484 -157.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.531 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -79.78 155.23 28.0 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.118 -164.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -154.47 175.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.551 -151.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.448 HG21 HD11 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -149.0 141.89 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.539 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.39 107.76 0.4 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 165.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.75 -82.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.173 -0.513 . . . . 0.0 110.32 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.03 21.56 3.15 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -168.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.27 154.34 37.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.255 -0.473 . . . . 0.0 110.41 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -119.71 139.26 52.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.397 168.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.514 ' CZ3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -145.68 160.43 41.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.791 -170.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.52 ' CD2' HG22 ' A' ' 18' ' ' VAL . 51.2 m80 -80.49 161.44 24.85 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.361 158.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.459 ' CG ' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.73 133.39 43.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.784 154.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 72.33 9.52 5.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.583 -160.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 3.4 m -113.78 -29.59 7.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 155.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.507 ' CD1' HD13 ' A' ' 57' ' ' ILE . 0.9 OUTLIER -60.04 110.47 1.21 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.611 174.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.462 ' CD ' ' HB3' ' A' ' 44' ' ' SER . 1.6 mtt180 -124.93 125.12 43.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.216 -169.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 8.5 t -61.51 112.81 2.36 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.632 166.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.11 18.95 7.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.541 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' HB2' ' CD2' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -96.2 -76.3 0.51 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.286 161.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -85.04 -22.65 28.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.576 -165.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.06 32.34 6.49 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.38 122.05 46.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.417 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.462 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 24.9 p -78.89 112.14 15.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.394 165.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER -149.62 -168.81 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.554 -174.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -170.29 -82.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.907 162.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.6 p 67.23 -67.11 0.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.069 169.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.2 -87.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.404 -167.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -87.17 117.63 26.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.458 -166.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.443 ' CD2' ' CE2' ' A' ' 36' ' ' PHE . 3.5 pp -125.22 154.53 41.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.143 173.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -142.87 97.9 3.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.331 -164.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.3 153.07 21.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.313 -176.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.61 136.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.342 168.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.84 35.6 13.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.385 171.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.97 -18.33 57.55 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.75 -170.81 2.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -167.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.514 HD12 ' CZ3' ' A' ' 31' ' ' TRP . 15.6 pt -149.82 158.82 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.093 -158.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -139.46 173.46 11.52 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.166 164.149 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.54 ' HB2' HD23 ' A' ' 45' ' ' LEU . 14.4 p -107.67 158.07 17.57 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.14 0.495 . . . . 0.0 111.134 -154.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -60.11 -26.96 66.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.295 164.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 60' ' ' LYS . . . -65.92 -5.75 27.38 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.331 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -118.79 -45.04 2.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -165.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.48 -18.8 53.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.368 163.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.75 -45.53 7.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.282 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . 3.9 tmmm? -61.21 -29.35 69.77 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.452 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.402 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.533 1.2 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 6.6 t -142.35 106.37 5.58 Favored Pre-proline 0 C--O 1.248 0.977 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -150.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.18 -14.32 23.43 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 C-N-CA 122.959 2.439 . . . . 0.0 113.403 165.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.528 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -82.69 -64.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.449 -167.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.59 -27.76 18.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.672 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.31 18.51 35.96 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -95.86 -168.97 1.85 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.203 167.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -164.72 147.63 8.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.167 164.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 21' ' ' ALA . 62.8 t -146.35 141.02 21.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 -156.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.31 -18.59 10.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.448 168.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.75 39.37 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.111 -162.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.54 ' HB2' HG12 ' A' ' 18' ' ' VAL . . . -137.19 -78.95 0.39 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.418 162.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 0.4 OUTLIER -126.96 6.65 6.6 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.869 -165.028 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 124.89 22.33 Favored 'General case' 0 C--O 1.231 0.093 0 O-C-N 121.228 -0.92 . . . . 0.0 110.443 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 31' ' ' TRP . 2.7 m -109.56 -179.8 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.971 161.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 tt -148.77 144.6 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.355 164.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.18 107.56 0.32 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.22 30.16 19.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.348 -0.426 . . . . 0.0 110.319 168.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.08 -37.24 3.81 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -72.91 160.77 31.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.301 -0.45 . . . . 0.0 110.32 -170.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -132.44 134.26 44.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.373 168.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.519 ' CZ3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -133.27 179.22 6.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.551 -169.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 39.5 m80 -118.81 160.75 21.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.296 156.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HB3' ' HG2' ' A' ' 46' ' ' GLU . 17.5 mtmt -61.53 -45.77 92.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.424 -172.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.428 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -61.08 -35.43 76.96 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.512 176.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.528 ' HB3' ' HG2' ' A' ' 13' ' ' ARG . 76.9 m -77.66 -16.62 58.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.639 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.498 ' CE2' HD23 ' A' ' 50' ' ' LEU . 1.9 t80 -67.11 104.34 1.4 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.365 -168.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HG2' ' HB2' ' A' ' 44' ' ' SER . 9.6 mtp180 -116.79 121.63 42.11 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.307 -166.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.2 t -58.44 118.17 5.28 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.768 168.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.21 28.89 2.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.451 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -114.15 -73.82 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.258 159.348 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 22.5 p -79.28 -7.43 58.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.656 -168.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.2 17.71 68.41 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.456 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.455 ' HD2' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -85.56 110.45 19.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.278 166.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.53 ' HB2' ' HG2' ' A' ' 37' ' ' ARG . 40.4 t -79.41 103.03 9.06 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.181 171.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.465 ' CD1' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -116.87 -168.39 1.45 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.562 -175.363 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HG2' ' HB3' ' A' ' 33' ' ' LYS . 1.7 tt0 -172.23 156.52 3.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 113.146 -1.843 . . . . 0.0 110.098 -161.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.513 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 21.9 p 60.66 10.81 2.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.492 166.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 p -138.85 163.68 31.62 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.216 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -62.36 172.21 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.514 -165.027 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.498 HD23 ' CE2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -153.54 -163.51 1.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.299 -172.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -174.36 97.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.25 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 3.6 p30 -85.94 131.98 34.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.363 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -153.76 147.51 25.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.325 166.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 61.12 30.04 19.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.302 168.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.99 -25.06 29.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -120.35 -171.76 2.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.245 -0.477 . . . . 0.0 109.972 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.519 HD12 ' CZ3' ' A' ' 31' ' ' TRP . 35.2 pt -142.86 178.7 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.465 -157.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 62' ' ' CYS . 87.8 t80 -170.05 143.76 2.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.21 -174.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 13.8 p -97.49 167.15 11.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.149 0.5 . . . . 0.0 111.023 -146.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.489 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 1.6 tttp -77.69 -16.98 58.12 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.025 168.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.22 -9.1 40.31 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.324 170.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 58' ' ' TYR . 1.2 m -119.03 -49.35 2.41 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -165.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -60.02 -13.81 13.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.366 166.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.08 -70.19 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.416 168.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -32.69 72.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.418 -165.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.2 t30 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.406 -169.455 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.633 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.1 t -124.56 108.98 28.7 Favored Pre-proline 0 C--O 1.246 0.887 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -167.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -59.14 -15.35 27.9 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 122.808 2.338 . . . . 0.0 113.592 168.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.413 ' HA ' ' HD2' ' A' ' 13' ' ' ARG . 4.1 tpt180 -84.8 -69.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.469 -168.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -89.8 -16.14 30.83 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.547 -173.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.82 18.15 70.92 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -96.97 138.92 33.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 110.245 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.525 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -102.63 142.84 33.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.25 175.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.535 HG13 ' HA ' ' A' ' 21' ' ' ALA . 3.3 t -105.77 136.14 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.967 -164.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -99.09 -72.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.183 172.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.8 97.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.978 162.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.535 ' HA ' HG13 ' A' ' 18' ' ' VAL . . . -60.09 113.27 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.451 -160.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 33' ' ' LYS . 3.9 tp10 -112.99 26.53 10.41 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.607 174.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -100.05 164.38 12.01 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.034 -161.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 1.1 p -156.08 172.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.7 -148.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 mt -145.96 145.16 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.631 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.87 111.89 0.5 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.97 -82.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.35 -170.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.45 13.61 1.4 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -170.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -106.77 148.22 28.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.365 176.607 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.91 142.18 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.317 169.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.489 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -150.45 -176.7 5.59 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.686 -168.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.511 ' CD2' HG23 ' A' ' 18' ' ' VAL . 18.8 m80 -93.17 163.84 13.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.121 169.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.534 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 1.4 mmtp -62.86 -16.18 57.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.557 170.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -126.97 23.14 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.424 -172.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.3 m -120.68 -11.96 8.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.515 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.518 ' CE2' HD23 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -61.18 108.63 0.93 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.313 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -111.7 103.26 11.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.378 -167.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 31.8 t -63.14 116.66 5.6 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.389 163.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.93 42.65 1.08 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.462 168.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.54 -52.72 1.08 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.517 -177.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.7 p -91.87 -11.13 37.25 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.985 161.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.32 18.65 62.05 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.479 167.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.25 149.53 30.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.127 0.489 . . . . 0.0 110.436 -164.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -68.15 138.88 56.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.736 160.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -102.83 -164.89 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.711 -159.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -144.95 -165.42 2.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.031 -168.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.2 p -76.64 -17.81 58.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.394 -170.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 p -61.06 143.6 55.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.362 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.67 -164.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.458 -170.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.518 HD23 ' CE2' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -155.9 -170.55 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.333 -173.523 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.31 79.18 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.325 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.526 ' HA ' HG21 ' A' ' 57' ' ' ILE . 4.6 p30 -73.6 156.39 38.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.401 174.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 179.67 136.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.445 168.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.1 t70 61.57 19.96 10.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.367 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.97 17.91 60.48 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 171.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.1 178.05 7.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 166.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.526 HG21 ' HA ' ' A' ' 52' ' ' ASP . 33.8 pt -154.13 135.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.426 -159.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -130.19 175.48 8.88 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.741 160.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.527 ' HB2' HD23 ' A' ' 45' ' ' LEU 0.254 11.7 p -110.34 147.88 33.05 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.381 0.61 . . . . 0.0 111.857 -149.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.29 -9.76 58.65 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 120.441 -1.412 . . . . 0.0 109.856 168.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.86 -4.92 22.67 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.468 162.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.46 -48.07 2.2 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -166.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -60.09 -10.37 4.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.461 165.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.01 -45.13 5.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.491 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.8 20.28 6.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.462 -172.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.3 165.578 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.527 0.793 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.5 t -132.38 101.71 14.52 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -160.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.93 -14.12 26.15 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 122.697 2.265 . . . . 0.0 113.483 167.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -81.22 -62.25 1.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.412 -166.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -88.8 -17.76 29.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.484 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.37 -13.83 54.69 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -79.45 175.51 10.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.396 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -131.84 172.92 11.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.987 163.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 21' ' ' ALA . 2.6 t -119.67 158.74 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.811 -172.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -94.96 38.33 1.13 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.428 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . . . 61.88 68.05 0.72 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.079 -167.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -129.13 -63.72 0.94 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.444 -174.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 33' ' ' LYS . 16.9 mm-40 -117.9 27.61 8.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.081 -173.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HG2' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -87.32 112.92 22.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.297 -167.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.476 HG22 ' CD2' ' A' ' 36' ' ' PHE . 15.5 m -97.99 -178.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.154 165.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 pp -139.87 159.96 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.481 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.84 87.1 0.16 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.252 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.05 -18.91 10.66 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HB3' ' NE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -72.42 159.6 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.431 -0.384 . . . . 0.0 110.349 -169.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 98.8 p -147.86 123.53 10.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.157 167.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.51 ' NE1' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -122.66 178.48 4.99 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.799 -165.414 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 20.0 m80 -94.04 162.15 14.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.875 160.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.8 mttp -60.38 -42.45 95.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.449 167.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -95.78 21.14 8.84 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.69 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 16.6 m -120.68 -19.55 7.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.382 167.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CD2' HG22 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -60.57 113.02 2.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.329 175.018 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -138.67 127.03 22.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.282 -172.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 14.0 t -58.56 112.81 1.73 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.631 165.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.2 23.01 3.49 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.631 171.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.97 -75.7 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.491 170.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.1 p -75.67 -21.54 57.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.562 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.15 -17.82 40.35 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.459 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.85 128.91 36.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.162 0.506 . . . . 0.0 110.388 -170.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -64.94 140.02 58.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.08 164.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 59' ' ' CYS . 0.8 OUTLIER -163.62 -176.25 4.57 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.16 165.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HA ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -172.32 -157.63 0.11 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.381 -160.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.71 -87.29 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.74 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.38 15.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.241 -174.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -118.19 45.19 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.331 -171.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 46' ' ' GLU . 3.9 pp -142.8 168.79 18.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.452 -177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.71 125.97 12.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.357 173.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.531 ' HA ' HG21 ' A' ' 57' ' ' ILE . 3.6 p-10 -124.64 146.65 48.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.427 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.66 156.32 0.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.449 167.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 61.27 19.76 10.42 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.554 172.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.83 -27.4 20.38 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 166.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.23 178.62 4.3 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.044 -0.578 . . . . 0.0 109.899 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.531 HG21 ' HA ' ' A' ' 52' ' ' ASP . 35.0 pt -156.2 135.83 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.446 -160.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -134.02 177.73 7.51 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 156.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.538 ' HB2' HD12 ' A' ' 45' ' ' LEU 0.258 12.4 p -113.92 152.29 31.01 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.992 0.901 . . . . 0.0 113.17 -143.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -84.91 -0.29 53.66 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 119.476 -2.015 . . . . 0.0 110.352 166.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.47 ' HA3' ' CD2' ' A' ' 45' ' ' LEU . . . -58.09 -15.25 20.94 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 151.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 -51.78 2.43 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -157.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -60.08 -14.85 18.76 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.474 167.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.5 -66.12 0.95 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.39 167.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -41.23 94.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.493 -164.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.352 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 t -124.41 113.34 27.63 Favored Pre-proline 0 C--O 1.244 0.789 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -157.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -63.4 -7.04 11.35 Favored 'Trans proline' 0 N--CA 1.484 0.916 0 C-N-CA 122.686 2.258 . . . . 0.0 113.696 171.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.535 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -92.09 -70.27 0.7 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.407 -174.102 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.4 p -91.22 -29.99 16.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.63 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 48.35 2.72 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.52 157.42 33.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.399 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.523 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -113.88 137.74 51.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.171 168.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG13 ' CA ' ' A' ' 21' ' ' ALA . 3.2 t -113.41 134.48 56.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.865 -163.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -94.2 -69.44 0.75 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.382 -167.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 -10.33 5.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.4 167.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.46 ' CA ' HG13 ' A' ' 18' ' ' VAL . . . 61.74 111.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.329 -178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -114.4 31.55 6.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.535 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.511 ' NZ ' ' HB3' ' A' ' 23' ' ' LYS . 4.5 mtpm? -106.48 -175.14 2.71 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.171 -160.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 36' ' ' PHE . 2.1 p -169.05 161.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.768 -148.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -141.21 144.74 25.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.45 -171.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 52' ' ' ASP . . . -163.99 135.65 3.88 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 167.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.55 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.334 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.89 16.87 0.82 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -173.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.12 140.33 52.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.375 -168.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.501 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -104.67 145.59 30.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.305 168.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.515 ' CZ2' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -149.71 163.94 36.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.595 -170.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 17.9 m80 -74.26 144.66 44.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.734 158.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . 4.1 mttm -60.27 -21.54 62.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.487 169.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -111.21 18.16 19.59 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.51 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.535 ' HB3' ' HG2' ' A' ' 13' ' ' ARG . 21.3 m -119.79 16.38 12.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.215 166.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -98.11 110.64 23.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.263 -163.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 7.7 ttp-105 -122.61 120.62 34.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.278 -164.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.1 t -58.42 111.83 1.37 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.728 164.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.47 -24.6 67.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.681 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.52 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -75.99 -78.82 0.11 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.26 -176.32 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.7 p -84.75 -9.12 58.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.783 -163.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.78 15.69 74.8 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.614 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 8.6 tptm -88.78 103.07 15.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.415 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 14.3 t -71.15 92.38 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.105 166.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -128.12 -175.17 3.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.555 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.535 ' HG3' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -171.64 -45.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.789 -163.32 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -60.94 -61.29 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.369 -173.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 49.8 p -65.63 133.05 50.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.124 163.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.531 HG23 ' HG2' ' A' ' 60' ' ' LYS . 6.3 t -62.6 -176.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.335 -166.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 2.3 pp -119.81 177.42 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.335 -167.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -163.41 108.84 1.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.292 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.483 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 4.4 p-10 -94.99 145.34 25.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.3 -168.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.49 -174.49 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.394 165.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.63 92.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.424 -169.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.04 -22.95 37.88 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.34 -174.08 3.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.046 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.515 HG22 ' CZ2' ' A' ' 31' ' ' TRP . 35.6 pt -148.37 175.8 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.333 -161.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.52 ' CE2' ' HG3' ' A' ' 40' ' ' LYS . 13.6 t80 -178.29 141.45 0.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.162 -160.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 10.1 p -100.67 168.97 9.35 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.898 -148.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' HG2' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -85.23 -12.84 51.62 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.123 169.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.75 -10.35 37.62 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.038 166.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.516 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 1.3 m -119.0 -46.85 2.52 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -164.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -60.19 -16.4 32.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.444 163.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 -43.41 12.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.287 168.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.495 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -60.79 -11.72 8.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.523 177.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.307 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.527 0.818 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 t -136.16 111.33 10.07 Favored Pre-proline 0 C--O 1.247 0.94 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -158.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -53.9 -20.24 17.38 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.99 2.46 . . . . 0.0 113.642 166.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.23 -72.44 0.51 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.429 -167.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 p -86.62 -18.15 32.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.61 -172.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.87 18.75 64.74 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.77 168.09 11.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.328 170.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.535 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -122.49 145.03 48.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.168 168.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.446 HG23 ' NE2' ' A' ' 32' ' ' HIS . 4.8 t -101.56 135.2 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.19 -164.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -73.83 -77.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.423 -166.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.61 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.135 167.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.86 133.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.091 165.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.0 17.51 6.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.389 161.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' CD ' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -103.49 160.59 14.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.91 -159.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 31' ' ' TRP . 2.3 p -150.97 178.02 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.575 -147.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.91 147.58 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.541 -175.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.3 139.36 5.63 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.64 -82.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.046 -0.577 . . . . 0.0 110.397 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -153.74 27.95 0.75 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 170.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.62 153.85 31.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.399 -0.401 . . . . 0.0 110.359 -170.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 t -110.43 143.42 40.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.2 168.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.519 ' CH2' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -148.38 170.98 16.78 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.952 -172.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.446 ' NE2' HG23 ' A' ' 18' ' ' VAL . 15.2 m80 -86.31 147.38 26.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.519 -1.218 . . . . 0.0 110.084 162.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -60.67 -13.31 13.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.489 171.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -101.55 -36.08 8.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.417 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 39.8 m -72.93 -17.29 61.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.453 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -61.19 85.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.267 177.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 17.5 mtm180 -121.65 127.12 50.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.196 -167.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 12.4 t -59.33 107.08 0.51 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.477 164.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.51 -20.99 66.07 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.573 170.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -77.45 -67.37 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.541 -165.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p -88.55 -27.16 21.59 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.65 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.95 22.37 6.96 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.6 tppp? -110.03 110.7 21.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.265 -0.468 . . . . 0.0 110.401 -168.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -65.15 112.43 3.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.358 167.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 59' ' ' CYS . 1.2 pp -147.19 176.64 9.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.399 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HA ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -172.36 -32.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.917 -173.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -67.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.54 -165.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -61.44 -75.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.358 -173.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.537 HG21 ' HG2' ' A' ' 60' ' ' LYS . 14.8 t -178.77 -169.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.366 164.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -168.66 -171.52 1.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.236 -169.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.34 82.64 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.368 -167.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.534 ' HA ' HG23 ' A' ' 57' ' ' ILE . 3.0 p30 -69.6 147.35 50.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.356 170.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.33 149.31 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.42 169.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.19 -96.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.459 -170.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.24 23.59 0.98 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.29 173.82 12.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 171.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.534 HG23 ' HA ' ' A' ' 52' ' ' ASP . 39.3 pt -141.3 152.74 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.194 -158.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -134.13 174.58 10.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.679 157.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 14.2 p -106.79 159.14 16.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.179 0.514 . . . . 0.0 110.847 -152.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.537 ' HG2' HG21 ' A' ' 49' ' ' THR . 11.8 tptt -72.33 -14.7 61.8 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.848 168.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.7 -10.26 43.49 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.196 166.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.43 -48.54 2.7 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -164.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -60.38 -13.62 14.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.258 165.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.57 -65.37 1.02 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.522 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -61.26 -16.53 46.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.567 -165.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.256 167.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.533 1.179 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.521 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 8.1 t -140.32 107.02 6.64 Favored Pre-proline 0 C--O 1.249 1.049 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -149.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.74 -16.98 33.63 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 C-N-CA 122.762 2.308 . . . . 0.0 113.625 171.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -84.08 -67.03 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.593 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 p -87.94 -29.96 20.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.602 -170.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.09 18.62 36.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -93.64 -169.03 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 164.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -165.59 145.26 6.55 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.262 164.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.463 HG12 ' CB ' ' A' ' 21' ' ' ALA . 64.7 t -143.57 137.77 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.444 -155.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -109.32 -19.04 13.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.446 169.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.57 -56.57 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.257 -167.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.463 ' CB ' HG12 ' A' ' 18' ' ' VAL . . . -61.38 -74.54 0.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.412 -162.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.518 ' HB2' ' CD2' ' A' ' 32' ' ' HIS . 4.2 mm-40 -117.34 7.64 12.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.792 -164.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -60.9 122.11 14.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -161.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.516 HG22 ' CD2' ' A' ' 36' ' ' PHE . 3.5 m -122.13 169.27 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.249 167.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.7 mt -145.94 139.99 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.424 168.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.46 120.27 0.93 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -170.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.68 16.31 7.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.332 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.62 -22.92 25.39 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 134.64 36.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.437 -172.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.7 m -102.33 119.35 38.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.396 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.486 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -124.31 174.58 7.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.602 -172.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.521 ' CE1' ' HB2' ' A' ' 11' ' ' CYS . 44.2 m80 -105.29 153.99 20.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.1 157.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HD3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -61.11 -27.12 68.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.4 178.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 t -84.52 -23.77 29.64 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.486 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.3 m -95.81 25.09 4.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.347 171.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.516 ' CD2' HG22 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -113.14 89.31 3.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.269 -171.066 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 1.1 ppt_? -112.02 130.39 55.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.282 -166.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.9 t -65.28 110.92 2.77 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.446 168.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.511 ' HB1' ' NH1' ' A' ' 37' ' ' ARG . . . -92.51 18.62 8.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.616 170.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.73 -75.34 0.48 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.379 165.195 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.5 p -83.4 -22.65 32.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.494 -173.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.35 -28.35 6.31 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 165.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.515 ' HD2' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -82.61 145.22 29.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.307 -0.447 . . . . 0.0 110.385 -168.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 15.0 m -92.14 137.35 32.43 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.328 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -140.88 -168.47 2.6 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.841 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.522 ' HB2' ' HD3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -171.88 -69.73 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.946 -1.934 . . . . 0.0 110.254 -171.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.5 p -61.84 -22.06 65.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.391 -166.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -96.02 156.97 16.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.412 170.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -60.91 -173.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.355 -168.081 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.449 ' CD2' ' CE2' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -148.34 -175.89 5.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.419 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.46 77.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.312 -169.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.523 ' HA ' HG23 ' A' ' 57' ' ' ILE . 4.9 p-10 -67.45 90.91 0.25 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.361 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.25 169.66 17.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.368 170.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -61.07 89.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.434 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.74 -19.19 14.32 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -155.33 -171.73 3.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.003 -169.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.523 HG23 ' HA ' ' A' ' 52' ' ' ASP . 38.1 pt -148.77 140.15 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.381 -161.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 1.5 m-85 -132.93 -175.94 3.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.938 163.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.541 ' HB2' HD23 ' A' ' 45' ' ' LEU . 14.6 p -110.54 159.85 17.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.466 0.65 . . . . 0.0 111.185 -153.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.511 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 6.7 tmtt? -74.46 -13.32 60.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.866 169.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.66 -9.64 39.72 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.21 164.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.91 -45.34 2.77 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -164.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -60.51 -13.25 12.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.224 162.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.67 -51.1 5.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.393 172.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.02 -13.58 17.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.375 -168.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 . . . . . 0 N--CA 1.455 -0.18 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.458 -178.917 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptt? . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 121.107 0.48 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.31 154.26 22.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.304 171.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 64.55 146.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.347 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.11 149.37 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.411 -169.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.5 p 60.12 39.41 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.045 174.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.26 143.0 6.95 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.451 -1.059 . . . . 0.0 110.451 170.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.95 97.56 2.41 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.8 t 65.81 116.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.437 -0.382 . . . . 0.0 110.3 -168.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.97 117.71 3.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.295 -168.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -108.35 170.66 15.15 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -164.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 t -122.42 103.2 38.64 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -167.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -59.13 -15.2 27.16 Favored 'Trans proline' 0 N--CA 1.485 1.025 0 C-N-CA 122.704 2.269 . . . . 0.0 113.557 171.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.491 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -82.3 -65.87 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.459 -167.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.7 p -87.49 -14.57 40.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.517 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.94 18.41 61.3 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.534 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.51 161.17 13.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 110.272 167.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.517 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -119.81 148.61 43.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.277 169.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.517 HG23 ' CD2' ' A' ' 32' ' ' HIS . 4.4 t -109.81 144.1 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.025 -166.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.73 -45.44 2.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.445 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.02 -11.69 9.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.315 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.47 ' CA ' HG13 ' A' ' 18' ' ' VAL . . . 61.73 92.54 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.31 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.18 27.81 8.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.702 164.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.17 130.2 37.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.29 -162.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.468 ' CG2' ' HB2' ' A' ' 31' ' ' TRP . 2.3 m -107.04 -168.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.003 161.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -154.56 155.55 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.435 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' A' ' 52' ' ' ASP . . . -161.57 128.67 1.95 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 168.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.54 -82.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.289 -172.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.39 21.13 0.83 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -85.29 168.63 14.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.395 170.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.99 142.33 32.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.295 168.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.468 ' HB2' ' CG2' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -135.39 176.47 8.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.091 -169.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.517 ' CD2' HG23 ' A' ' 18' ' ' VAL . 16.9 m80 -84.63 164.58 18.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.083 165.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 tttp -60.95 -24.88 66.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.508 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -129.42 31.21 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.33 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -119.5 -10.35 9.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.823 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.439 ' CE2' ' CG2' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -61.67 107.19 0.77 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.333 -172.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.46 100.54 7.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.366 -166.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 25.2 t -62.82 117.37 6.25 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.532 167.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.66 41.77 1.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.39 169.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.54 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -131.47 -48.35 0.98 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.436 -176.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.2 p -97.12 -11.85 23.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.099 162.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.3 17.68 58.54 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.372 167.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -107.96 147.03 31.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.069 0.462 . . . . 0.0 110.353 -164.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 m -68.77 136.59 53.02 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.53 159.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -100.84 -163.63 1.04 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.913 -158.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' HB2' ' CG2' ' A' ' 49' ' ' THR . 7.3 mt-10 -117.16 -178.17 3.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.926 165.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -57.17 5.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.343 -166.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.8 t -118.82 44.48 2.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.405 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.459 ' CG2' ' HB2' ' A' ' 46' ' ' GLU . 11.8 t -141.68 68.39 1.33 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.324 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.512 ' N ' ' HB2' ' A' ' 60' ' ' LYS . 2.2 pp -149.11 170.5 18.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.37 -164.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -158.14 115.22 2.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.35 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.506 ' HA ' HG21 ' A' ' 57' ' ' ILE . 3.0 p30 -91.82 162.08 14.59 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.353 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 13.0 tptt -169.14 135.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.323 168.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.86 -95.49 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.477 175.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.29 16.57 1.69 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -127.58 -177.98 4.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 167.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.506 HG21 ' HA ' ' A' ' 52' ' ' ASP . 27.2 pt -157.27 136.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.538 -159.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.54 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 3.6 p90 -126.57 177.94 6.2 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 155.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.541 ' HB2' HD23 ' A' ' 45' ' ' LEU 0.255 12.2 p -110.74 148.09 33.03 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.099 0.476 . . . . 0.0 111.793 -150.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.512 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -73.58 -6.47 46.82 Favored 'General case' 0 C--N 1.347 0.466 0 O-C-N 120.162 -1.586 . . . . 0.0 109.993 167.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.81 -3.02 26.16 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.609 159.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.8 -48.69 2.01 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -167.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -59.91 -12.87 8.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.334 162.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.67 -69.25 0.7 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.347 166.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.78 -32.53 71.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.447 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -117.85 62.27 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.414 170.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -61.82 -22.29 65.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.313 -176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.7 87.84 0.13 Allowed Glycine 0 CA--C 1.543 1.802 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -173.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.44 146.72 50.7 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 122.514 2.143 . . . . 0.0 113.443 171.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 tptp 179.98 -76.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.442 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.04 153.57 11.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -168.21 124.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.371 -0.414 . . . . 0.0 110.345 170.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.2 44.72 0.03 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 170.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 70.02 -78.44 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.384 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.53 158.22 50.14 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -85.66 -63.57 1.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.113 -0.543 . . . . 0.0 110.363 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.99 -39.25 1.81 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -170.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.93 94.71 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.236 169.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.51 -79.77 0.93 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -166.09 35.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.363 -0.418 . . . . 0.0 110.259 -169.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.4 pp -77.14 -43.06 35.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.497 169.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.0 tp 58.54 61.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.608 171.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 m80 69.68 -80.58 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.432 170.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.66 -28.03 36.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.381 -168.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 . . . . . 0 C--O 1.241 0.616 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.393 -169.682 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HE1' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 121.137 0.494 . . . . 0.0 109.846 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.94 157.16 23.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.234 172.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -85.82 151.16 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.303 169.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 128.6 36.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.381 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 m -111.23 142.78 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.377 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.19 162.7 22.59 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 169.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.94 -111.92 2.97 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -170.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.452 ' HB3' ' N ' ' A' ' 20' ' ' ALA . 44.9 t -139.94 -72.73 0.37 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.418 -169.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.5 ' HB3' ' HD3' ' A' ' 23' ' ' LYS . 7.3 t0 -153.75 124.79 7.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.121 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -111.43 -179.36 20.12 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -158.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 9.3 t -123.29 106.68 32.98 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -162.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 8.6 Cg_endo -58.47 -15.3 24.24 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 C-N-CA 122.917 2.411 . . . . 0.0 113.61 167.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -67.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.377 -166.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.7 p -88.73 -22.75 23.18 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.618 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.6 -18.26 38.22 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -66.42 171.6 4.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.295 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -143.59 143.37 31.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.191 169.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.519 HG23 ' CD2' ' A' ' 32' ' ' HIS . 2.4 t -96.01 158.64 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.451 -162.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -94.55 38.89 1.1 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.475 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.452 ' N ' ' HB3' ' A' ' 8' ' ' SER . . . 61.84 67.87 0.73 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.077 -167.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.492 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -129.12 -64.41 0.91 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.483 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.512 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 3.0 mt-10 -129.38 16.71 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.185 -166.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.5 ' HD3' ' HB3' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -93.58 158.68 15.58 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.018 -166.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -158.92 173.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.724 -147.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.43 140.79 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.51 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.8 134.83 4.18 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 167.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.75 -83.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.275 -0.462 . . . . 0.0 110.459 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.14 48.18 0.52 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 172.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.89 148.66 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.4 -170.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.09 144.28 35.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.27 168.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.481 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -147.93 172.6 13.94 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.782 -170.138 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.519 ' CD2' HG23 ' A' ' 18' ' ' VAL . 43.3 m80 -92.96 156.18 17.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.855 162.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.512 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 13.7 ptmt -62.59 -14.18 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.456 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.49 17.73 18.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.547 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.1 m -125.73 23.51 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.243 167.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.513 ' CE1' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -118.3 82.97 1.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.177 -168.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.522 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -119.91 129.25 54.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.255 -166.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 13.0 t -60.01 105.59 0.41 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.271 163.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.46 -19.48 64.76 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.571 170.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -65.08 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.59 -164.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.3 p -88.0 -24.92 23.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.615 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.96 18.76 30.86 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -99.03 132.19 44.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.396 169.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -81.72 134.98 35.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.332 168.115 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.526 HD12 ' HB2' ' A' ' 59' ' ' CYS . 1.1 pp -157.78 -173.07 4.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.361 177.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -139.01 -179.27 5.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.073 -162.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.521 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -66.44 169.08 7.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.365 -165.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.08 13.17 4.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.344 -167.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.524 ' HA ' ' HB3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -168.6 30.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.57 -174.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 47' ' ' SER . 4.0 pp -153.03 175.11 13.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.498 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.67 107.97 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.3 -169.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.525 ' HB3' HG23 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -90.63 161.13 15.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.418 176.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.508 ' HD2' ' CE1' ' A' ' 58' ' ' TYR . 8.4 ptmm? -166.29 109.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.429 -171.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 60.78 18.36 8.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.471 164.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.4 -28.16 8.86 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -104.93 168.58 8.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.525 HG23 ' HB3' ' A' ' 52' ' ' ASP . 32.3 pt -150.11 131.22 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.443 -158.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.508 ' CE1' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -124.71 -175.27 3.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.747 161.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.526 ' HB2' HD12 ' A' ' 45' ' ' LEU . 14.2 p -111.11 157.39 20.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.327 0.584 . . . . 0.0 110.927 -153.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 49' ' ' THR . 6.2 ttmm -71.89 -13.86 61.78 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.824 169.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.22 -10.41 41.1 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.151 165.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.15 -46.86 2.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -164.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -17.1 41.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.364 165.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.13 -58.31 2.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.289 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -20.52 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.401 -167.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.07 38.05 3.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.309 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.88 -42.11 13.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.335 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.9 102.24 2.4 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -171.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -58.79 91.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.605 2.203 . . . . 0.0 113.517 -173.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.38 -169.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.461 169.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.03 -99.47 2.56 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -168.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -96.68 175.89 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.426 -168.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.84 174.79 28.21 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 169.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -128.83 -22.45 3.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.411 -0.394 . . . . 0.0 110.313 -169.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.22 -38.58 3.1 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -166.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 69.9 -76.0 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.33 167.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.19 177.21 15.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -167.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.41 -162.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.425 -0.388 . . . . 0.0 110.221 -168.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.21 -166.39 39.66 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 169.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.12 155.87 44.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.353 -0.424 . . . . 0.0 110.29 -170.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mt 60.16 -79.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.626 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.9 -32.44 6.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.441 -169.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 21.1 m170 71.58 -80.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.451 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 80.8 p 61.22 96.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.617 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.522 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.396 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' HE3' ' HA3' ' A' ' 10' ' ' GLY . 92.5 mtp . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.29 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.408 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.7 27.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.358 -169.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.468 ' HA ' ' CE ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -114.36 -174.48 2.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.398 -178.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 m 59.61 40.38 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.224 174.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.31 -179.22 37.57 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.97 85.19 1.21 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 169.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.09 -163.65 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.069 0.461 . . . . 0.0 110.375 -168.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -147.0 -171.53 3.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.133 169.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -153.15 170.04 32.07 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -170.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 t -125.01 108.66 27.82 Favored Pre-proline 0 C--O 1.244 0.799 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -164.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -57.56 -16.4 23.94 Favored 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 122.854 2.369 . . . . 0.0 113.578 166.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.82 -68.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.392 -167.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.1 p -90.1 -13.16 36.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.5 -175.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.75 18.74 67.3 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 175.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.89 164.44 13.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.378 168.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.534 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -120.32 143.2 48.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.089 167.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.54 HG12 ' HB3' ' A' ' 22' ' ' GLU . 3.5 t -108.14 140.6 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.864 -164.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -103.52 136.03 44.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.437 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.57 19.77 10.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.425 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.94 110.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.286 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.54 ' HB3' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -117.85 20.35 13.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.55 166.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -102.96 168.06 9.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.421 -158.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.513 HG22 ' CE2' ' A' ' 36' ' ' PHE . 1.2 m -115.51 -171.69 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.148 167.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -163.6 146.62 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.412 166.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.467 ' N ' HG13 ' A' ' 25' ' ' ILE . . . -171.44 141.07 6.2 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -170.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.38 -82.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.248 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.46 21.08 0.93 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 168.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -122.17 128.55 51.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.374 -169.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.48 144.14 26.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.34 167.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -139.51 -163.22 1.45 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.892 -177.122 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 18.6 m80 -103.9 163.55 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.136 164.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -73.92 -11.56 60.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.396 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.0 23.33 11.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.431 177.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 1.8 m -121.32 -20.35 6.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.457 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.513 ' CE2' HG22 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -61.42 104.62 0.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.298 -171.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 ptm85 -115.59 102.35 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.312 -164.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 29.8 t -62.53 116.35 5.05 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.477 163.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 41.99 1.1 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.371 168.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -129.93 -53.57 1.13 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.555 -178.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.6 p -92.63 -11.23 34.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.005 163.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.62 18.2 60.57 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.434 167.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -108.06 147.88 30.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.943 0.401 . . . . 0.0 110.34 -164.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.82 138.71 52.85 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.633 158.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -103.62 -163.51 0.99 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.919 -157.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.71 -159.26 0.68 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.095 168.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.0 p -92.52 -58.2 2.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.365 -168.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -110.62 41.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.453 -169.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 28.2 p -151.27 78.68 1.28 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.523 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.507 ' N ' ' HB2' ' A' ' 60' ' ' LYS . 2.7 pp -151.96 167.18 29.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.496 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.07 114.37 6.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.255 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' HA ' HG21 ' A' ' 57' ' ' ILE . 3.0 p30 -85.53 160.87 19.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.434 171.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.71 97.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.408 -169.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 61.03 17.82 8.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.464 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.9 -23.63 25.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 170.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -103.72 165.09 11.25 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 167.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.514 HG21 ' HA ' ' A' ' 52' ' ' ASP . 31.9 pt -147.98 137.6 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.376 -157.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 1.9 p90 -125.86 176.22 7.11 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.538 156.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.522 ' HB2' HD23 ' A' ' 45' ' ' LEU 0.25 12.4 p -110.15 148.76 31.17 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.302 0.573 . . . . 0.0 111.814 -149.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.507 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -71.71 -9.63 58.56 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 120.587 -1.32 . . . . 0.0 109.873 168.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.02 -4.74 22.91 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.457 162.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.4 -49.26 2.16 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -166.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -13.6 12.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.367 163.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.48 -64.24 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.331 166.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -12.07 9.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.421 -166.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.97 -20.19 59.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.478 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -156.16 111.24 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.408 -175.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.44 ' N ' ' CD ' ' A' ' 69' ' ' PRO . . . 165.78 -54.43 0.26 Allowed Glycine 0 CA--C 1.543 1.831 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -173.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 68' ' ' GLY . 15.5 Cg_exo -52.38 91.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.532 2.155 . . . . 0.0 113.583 -171.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.22 -77.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.512 171.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.14 153.77 6.12 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -169.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.3 130.22 23.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.317 -0.441 . . . . 0.0 110.328 170.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.88 -103.34 0.17 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -170.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.26 -175.95 3.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.332 170.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.26 -71.58 0.27 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 170.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.37 -176.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.448 170.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.35 158.78 46.07 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -170.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.75 133.01 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.395 -0.402 . . . . 0.0 110.235 169.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.21 -44.71 0.04 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -169.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.23 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.329 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.36 99.84 8.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.388 -169.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 tp -97.95 -15.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.46 170.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 72.05 -80.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.433 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.27 -166.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.43 -170.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.241 0.655 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.324 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ptm . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.139 0.495 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.44 -171.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.311 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.4 126.94 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.312 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.95 -45.97 2.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.399 -170.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.433 HG21 ' N ' ' A' ' 6' ' ' GLY . 15.5 m -90.9 -48.75 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.426 -170.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.433 ' N ' HG21 ' A' ' 5' ' ' VAL . . . 120.27 177.16 15.93 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -170.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.0 -64.97 0.36 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -138.66 175.28 9.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.405 -0.398 . . . . 0.0 110.398 -169.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.514 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 7.8 t0 -130.97 123.57 29.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.169 169.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -117.92 177.36 16.52 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -161.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.9 t -129.65 102.42 18.1 Favored Pre-proline 0 C--O 1.242 0.692 0 CA-C-O 121.285 0.564 . . . . 0.0 109.5 -162.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -58.36 -15.06 22.6 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.79 2.327 . . . . 0.0 113.504 170.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -63.76 1.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.463 -167.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -89.04 -34.85 16.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.554 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.7 -31.15 3.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.47 168.99 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.373 -169.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -126.56 145.87 50.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.215 168.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.517 HG23 ' CD2' ' A' ' 32' ' ' HIS . 3.8 t -109.15 148.91 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.907 -165.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -125.56 -45.46 1.79 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.516 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.95 -11.0 6.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.355 170.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.46 ' CA ' HG13 ' A' ' 18' ' ' VAL . . . 61.76 93.1 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.347 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -107.68 34.36 3.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.764 164.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HD2' ' HB3' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -85.7 124.1 31.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.345 -162.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.463 ' CG2' ' HB2' ' A' ' 31' ' ' TRP . 2.6 m -97.15 176.33 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.889 160.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -145.94 143.49 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.364 167.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.91 127.56 1.23 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 169.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 36.78 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.385 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.21 -20.27 48.74 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -86.6 130.44 34.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.382 -173.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.4 t -103.82 117.25 33.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.209 166.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.484 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -113.1 -173.43 2.25 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.029 -167.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.517 ' CD2' HG23 ' A' ' 18' ' ' VAL . 19.2 m80 -96.07 157.17 16.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.039 163.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -15.98 30.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.603 168.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.8 p -106.9 -27.13 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.353 -171.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -88.03 -17.38 31.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.384 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.449 ' CD2' HG22 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -60.6 95.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.431 171.306 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 18.9 ptt85 -133.11 126.73 32.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.316 -169.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 14.3 t -60.26 111.78 1.67 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.125 163.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.0 41.01 1.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.406 167.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.57 -41.26 1.53 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.539 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.2 p -108.5 -27.35 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.485 166.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.49 18.61 25.4 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -98.07 145.98 26.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.377 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 3.9 m -80.77 145.14 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.396 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 59' ' ' CYS . 1.4 pp -168.53 179.11 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.151 167.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.507 ' HA ' HD21 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -171.47 -159.34 0.15 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.107 -178.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.91 -86.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.594 167.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 t -138.15 42.0 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.367 -166.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.532 ' HA ' ' HB3' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -168.09 40.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.471 -177.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 46' ' ' GLU . 1.9 pp -133.45 167.78 19.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.409 -174.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.57 103.53 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.262 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.537 ' HA ' HG21 ' A' ' 57' ' ' ILE . 6.6 p-10 -75.62 168.83 19.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.335 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.47 100.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.482 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 60.88 19.46 9.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.444 165.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.58 -32.0 5.36 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.92 164.55 11.62 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.537 HG21 ' HA ' ' A' ' 52' ' ' ASP . 32.9 pt -148.64 129.99 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.363 -157.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.67 -175.66 3.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.768 162.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 13.7 p -111.61 155.16 23.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 111.166 -153.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 49' ' ' THR . 17.8 tptp -71.16 -14.01 62.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.733 169.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.16 -8.63 31.1 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.111 164.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.56 -46.57 2.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -165.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -14.88 20.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.423 165.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.46 -68.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.398 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -61.11 -25.95 67.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.402 -166.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.08 -19.16 22.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.469 -169.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -115.13 29.62 7.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.279 -169.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -122.89 67.51 0.48 Allowed Glycine 0 CA--C 1.543 1.843 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.32 106.31 0.18 Allowed 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 122.522 2.148 . . . . 0.0 113.537 171.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 86.82 5.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.469 -167.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.74 -127.85 41.98 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 171.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.52 141.27 20.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.337 175.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.33 50.26 1.87 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -169.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -132.44 98.7 4.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.33 -0.435 . . . . 0.0 110.365 169.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.27 -154.19 7.96 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 69.3 98.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.343 170.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -162.89 19.9 0.16 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -170.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -113.06 -46.97 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.276 169.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.97 120.75 6.29 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' A' ' 82' ' ' ILE . . . -68.75 154.84 41.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.194 -169.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.51 -18.48 28.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.515 169.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.513 HG21 ' HB2' ' A' ' 80' ' ' ALA . 4.0 pt 57.69 51.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.864 168.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -86.87 -73.64 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.398 168.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.69 -83.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.37 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 . . . . . 0 C--O 1.24 0.567 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.316 -170.622 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 121.222 0.534 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.18 -162.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.239 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.89 120.83 26.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.462 169.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.03 -169.95 2.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.372 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 p -101.23 30.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.349 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.27 87.79 1.1 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.66 -173.93 13.14 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -170.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.72 -56.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.452 -169.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.88 122.72 5.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.147 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -109.26 177.4 20.18 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -160.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.5 t -123.69 102.15 35.81 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -162.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.18 -14.12 27.35 Favored 'Trans proline' 0 N--CA 1.485 1.015 0 C-N-CA 122.778 2.319 . . . . 0.0 113.486 167.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.511 ' HD3' ' CZ3' ' A' ' 31' ' ' TRP . 4.8 tpt180 -79.39 -63.26 1.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.341 -167.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.2 p -91.78 -24.11 19.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.512 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.12 -29.55 5.05 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -172.64 1.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.293 -0.454 . . . . 0.0 110.331 -172.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.541 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -146.86 152.23 38.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.189 166.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG23 ' CD2' ' A' ' 32' ' ' HIS . 2.6 t -106.46 166.61 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.556 -166.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -101.39 68.41 1.2 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.467 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.14 16.75 7.46 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.524 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB1' HG13 ' A' ' 18' ' ' VAL . . . -91.81 -70.45 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.359 -165.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HG2' ' HB2' ' A' ' 21' ' ' ALA . 3.3 mm-40 -106.27 17.12 23.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.123 -167.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.09 106.07 16.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.342 -163.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.518 HG22 ' CE2' ' A' ' 36' ' ' PHE . 15.7 m -86.84 -167.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.015 161.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 tt -154.68 150.54 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.428 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.1 -142.01 3.71 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 168.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.1 87.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.274 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.78 23.11 60.69 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -113.31 154.59 26.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.4 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.63 120.24 10.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.246 168.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.514 ' CZ2' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -115.38 166.3 12.03 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.858 -164.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.52 ' CD2' HG23 ' A' ' 18' ' ' VAL . 39.5 m80 -80.45 156.23 26.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.004 162.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -60.85 -12.31 10.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.486 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.1 p -115.93 18.3 15.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.412 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.78 11.89 6.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.413 -171.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.518 ' CE2' HG22 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -89.38 89.4 7.86 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.268 177.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HD2' ' NH2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -109.11 108.62 19.36 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.456 -173.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 32.2 t -62.91 116.81 5.62 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.399 163.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.63 40.26 1.14 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.387 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -129.27 -49.21 1.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.462 -176.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -96.07 -12.19 25.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.081 162.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.81 18.38 56.44 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.378 168.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -106.5 145.14 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.341 -163.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.8 m -69.61 126.28 29.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.668 159.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -90.55 -164.64 1.2 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.736 -158.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.45 88.59 2.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.173 -166.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 64.95 -86.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.483 165.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 p -146.61 67.37 1.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.405 -168.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 2.4 p -152.7 75.02 1.08 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.354 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 0.6 OUTLIER -145.43 -177.35 5.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.376 -166.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.48 104.61 2.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.259 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.539 ' HA ' HG23 ' A' ' 57' ' ' ILE . 2.3 p30 -87.54 154.35 20.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.363 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 178.81 140.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.425 168.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.34 18.34 9.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.394 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.87 -29.31 10.98 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 168.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -113.11 177.95 4.45 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.93 -0.635 . . . . 0.0 109.966 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.539 HG23 ' HA ' ' A' ' 52' ' ' ASP . 35.5 pt -148.25 141.06 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.323 -159.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.488 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 4.2 p90 -130.5 173.7 10.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.333 156.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.539 ' HB2' HD23 ' A' ' 45' ' ' LEU 0.252 11.8 p -109.62 148.22 31.69 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.283 0.563 . . . . 0.0 111.86 -149.257 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.517 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 14.2 tttt -72.49 -9.03 58.04 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 120.387 -1.445 . . . . 0.0 109.853 167.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.7 -4.45 19.54 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.457 161.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.89 -51.51 2.02 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -166.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -14.21 16.92 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.479 166.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.86 -66.0 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.322 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -11.68 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.508 -166.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -146.08 51.49 1.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.378 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -87.9 -45.67 10.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.325 167.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -114.45 -65.7 0.43 Allowed Glycine 0 CA--C 1.542 1.78 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.31 141.99 94.77 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 122.353 2.035 . . . . 0.0 113.542 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -117.44 155.53 29.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.435 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.46 138.55 15.0 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 169.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -74.9 -79.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.334 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.73 166.04 32.03 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -113.62 -172.74 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.284 170.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.7 -145.06 0.14 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -170.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -174.37 -66.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.412 -170.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.3 149.43 5.66 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -174.54 168.47 3.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.225 -169.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.92 62.18 0.41 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -172.01 100.42 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.338 -0.431 . . . . 0.0 110.257 169.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.57 169.53 6.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.428 169.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.28 116.52 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.332 170.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -162.59 152.68 16.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.463 169.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.8 m -86.87 -77.84 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.398 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.579 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.339 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 121.208 0.527 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.44 173.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.297 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -76.7 98.07 4.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.423 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -178.63 162.91 1.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.434 169.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 t 65.51 19.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.295 170.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.43 -176.88 25.52 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 170.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 60.96 -102.83 0.44 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -169.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 p -63.41 157.17 23.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.954 0.407 . . . . 0.0 110.318 167.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.86 154.69 18.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.179 175.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -122.27 173.44 15.93 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -160.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.6 t -128.68 104.18 19.18 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -164.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -60.97 -12.32 22.03 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.792 2.328 . . . . 0.0 113.629 171.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -85.26 -65.58 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.368 -167.272 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -85.46 -27.66 25.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.481 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.72 -31.34 5.77 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.3 150.78 38.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.376 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.539 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -115.49 140.62 48.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.114 166.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.514 HG23 ' CD2' ' A' ' 32' ' ' HIS . 3.6 t -102.3 140.17 21.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.942 -162.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -121.07 -39.07 2.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.435 175.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -11.47 8.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.376 168.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.465 ' CA ' HG13 ' A' ' 18' ' ' VAL . . . 61.56 95.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.307 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.515 ' HG3' ' HD2' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -117.67 27.72 8.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.613 165.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 130.1 36.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.355 -160.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.476 HG22 ' CD1' ' A' ' 31' ' ' TRP . 11.1 m -95.93 -176.31 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.546 158.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.516 HD12 ' N ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -144.52 152.41 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.44 167.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.65 137.78 3.91 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' A' ' 52' ' ' ASP . . . 61.55 14.37 5.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.296 174.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.58 -32.93 6.54 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.516 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -61.87 165.66 5.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.245 -0.477 . . . . 0.0 110.422 -170.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.88 124.37 20.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.228 165.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.516 ' CZ3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -117.69 159.64 22.64 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.658 -166.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.514 ' CD2' HG23 ' A' ' 18' ' ' VAL . 36.6 m80 -80.54 156.66 26.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.497 154.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HD2' ' HG3' ' A' ' 22' ' ' GLU . 12.4 ptmt -60.15 -12.81 9.45 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.569 170.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 t -122.47 18.29 10.5 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.481 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HB3' ' CG ' ' A' ' 13' ' ' ARG . 79.7 m -129.14 34.16 4.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.042 163.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.511 ' CE1' HD13 ' A' ' 57' ' ' ILE . 8.8 t80 -126.04 96.23 4.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.692 -164.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 21.6 ttp180 -127.98 126.63 41.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.228 -164.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.542 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 12.2 t -59.29 111.56 1.41 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.411 163.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.43 -24.14 65.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.216 -1.357 . . . . 0.0 110.708 171.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -75.02 0.13 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.308 -173.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p -86.94 -17.14 33.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.585 -170.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.83 19.75 50.05 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.33 129.07 45.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.449 -0.376 . . . . 0.0 110.407 171.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 53.9 p -78.65 121.79 25.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.262 167.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 59' ' ' CYS . 1.1 pp -147.14 -174.18 4.44 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.475 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.04 71.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.778 167.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.458 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -95.02 -165.27 1.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.46 -171.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.52 HG21 ' HG3' ' A' ' 60' ' ' LYS . 12.5 t -68.48 -12.84 61.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.635 -169.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -139.62 136.3 34.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.518 -173.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.41 163.32 32.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.193 162.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.3 75.58 1.63 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.294 -173.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.53 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 2.0 p30 -69.04 151.15 46.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.387 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.57 135.41 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.415 168.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 p30 61.06 22.11 12.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.554 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.01 -37.99 3.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -103.91 -171.31 1.91 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.968 -0.616 . . . . 0.0 110.043 -177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.516 HD12 ' CZ3' ' A' ' 31' ' ' TRP . 27.5 pt -149.62 165.19 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.181 -160.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.72 170.06 16.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.696 162.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 14.5 p -104.88 155.9 18.51 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.253 0.549 . . . . 0.0 111.097 -152.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HG3' HG21 ' A' ' 48' ' ' THR . 1.0 OUTLIER -61.42 -22.68 65.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.022 166.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.49 -5.89 38.79 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.538 174.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -118.43 -45.4 2.62 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -165.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.5 -15.0 22.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.309 165.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.7 -70.49 0.71 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.387 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -61.05 -12.58 12.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.338 -165.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -61.2 -52.09 66.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.379 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 64.86 -80.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.388 171.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.87 68.84 0.01 OUTLIER Glycine 0 CA--C 1.543 1.834 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.78 -41.02 49.33 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 C-N-CA 122.596 2.198 . . . . 0.0 113.605 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.56 140.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.311 -167.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.1 176.35 19.9 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -169.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -146.39 -44.6 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.39 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.53 136.99 9.59 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -113.23 29.53 7.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.343 170.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.85 80.56 0.45 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 69.82 132.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.377 -0.411 . . . . 0.0 110.339 170.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 124.72 135.54 4.42 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -170.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.78 96.22 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.358 -0.421 . . . . 0.0 110.224 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.69 170.46 19.91 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 169.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.08 -162.87 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.253 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 mt -134.46 -91.68 0.33 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.407 169.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.4 mm -139.8 -60.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.378 -169.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -132.9 -76.91 0.49 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.379 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.57 156.98 16.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.406 -169.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 . . . . . 0 C--O 1.24 0.559 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.392 177.778 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.155 0.503 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.22 -162.91 0.82 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.253 171.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.87 177.06 3.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.372 169.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 tttp 64.38 103.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.357 -170.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.0 p -128.96 138.72 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.32 -170.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.26 -122.34 3.85 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -169.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.08 -30.0 29.68 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -169.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.2 t -61.03 156.73 17.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.341 -0.43 . . . . 0.0 110.354 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.531 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -156.46 128.87 7.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.225 169.107 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -109.81 171.56 15.11 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -162.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.2 t -123.95 100.55 36.75 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -167.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -60.3 -13.27 23.58 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.82 2.347 . . . . 0.0 113.539 171.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.523 ' HD3' ' HB3' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -83.79 -63.24 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.444 -165.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -85.0 -26.08 27.32 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.504 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.41 -23.43 6.78 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 172.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.39 176.34 9.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.361 -171.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -130.67 155.55 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.227 167.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.517 HG23 ' CD2' ' A' ' 32' ' ' HIS . 6.9 t -110.16 142.13 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.226 -167.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.56 -30.91 3.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.417 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.52 17.94 10.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.456 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.481 ' N ' HG13 ' A' ' 18' ' ' VAL . . . 61.19 94.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.301 165.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.442 ' N ' HG12 ' A' ' 18' ' ' VAL . 2.8 mt-10 -122.68 26.93 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.712 163.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.531 ' HG2' ' HB2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -93.88 112.56 24.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.285 -162.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.507 HG22 ' CE2' ' A' ' 36' ' ' PHE . 10.8 m -80.95 -172.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.862 160.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -142.22 144.45 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.5 171.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.41 ' N ' HG13 ' A' ' 25' ' ' ILE . . . -136.55 96.33 0.25 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 -82.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.982 -0.609 . . . . 0.0 110.379 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.63 39.52 1.78 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 168.47 13.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.384 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.97 131.77 19.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.293 168.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.506 ' CZ2' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -129.05 159.45 35.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.061 -165.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.517 ' CD2' HG23 ' A' ' 18' ' ' VAL . 25.9 m80 -71.55 147.66 47.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.05 165.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.53 69.05 1.2 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.659 159.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.3 -42.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.913 -171.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.523 ' HB3' ' HD3' ' A' ' 13' ' ' ARG . 61.3 m -94.38 17.07 13.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.269 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.507 ' CE2' HG22 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -100.68 72.55 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.096 -164.64 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 16.1 mtt180 -93.28 117.04 29.6 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.376 -171.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 13.4 t -60.21 109.43 0.98 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.192 165.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.83 -22.64 65.14 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.424 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HD3' ' HB3' ' A' ' 58' ' ' TYR . 1.3 ttpp -71.25 -66.18 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.562 -167.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.7 p -89.77 -29.33 18.75 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.682 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.18 -25.5 6.68 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.8 129.36 39.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.354 -169.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 77.7 p -87.17 105.88 17.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.367 169.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.466 ' CD1' ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -126.09 -171.14 2.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.263 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -131.45 -173.47 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.051 -161.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.461 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -64.25 170.29 3.88 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.281 -172.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.8 p 59.07 13.43 2.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.972 -175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.454 ' HA ' ' CB ' ' A' ' 60' ' ' LYS . 10.4 p -155.29 43.13 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.48 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 2.5 pp -129.98 174.21 9.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.332 -173.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.51 119.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.313 169.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -98.68 169.07 9.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.326 -172.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? 178.39 131.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.45 167.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 60.78 19.72 9.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.39 164.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.01 -19.94 52.83 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -105.06 168.09 9.29 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 169.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.506 HG23 ' CZ2' ' A' ' 31' ' ' TRP . 29.7 pt -141.93 142.33 28.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.521 -158.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.526 ' HB3' ' HD3' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -133.18 -175.26 3.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.56 158.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 14.1 p -111.01 162.04 15.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.175 0.512 . . . . 0.0 110.727 -153.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -77.21 -12.71 59.98 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.927 169.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.89 -10.14 37.48 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.15 164.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.26 -50.52 2.56 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -164.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -59.88 -17.67 38.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.543 166.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.24 -66.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.289 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -60.85 -12.65 11.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.438 -166.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -141.65 47.32 1.66 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.425 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -81.28 124.62 29.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.361 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.06 100.65 0.01 OUTLIER Glycine 0 CA--C 1.544 1.846 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.82 167.32 2.31 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.473 2.115 . . . . 0.0 113.517 171.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -122.5 153.97 38.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.404 169.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.34 -80.11 1.02 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -170.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -113.08 158.71 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.335 -0.432 . . . . 0.0 110.37 169.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.08 -134.08 4.68 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -148.61 131.46 16.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.372 170.09 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.34 102.68 0.22 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 170.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -98.24 129.94 44.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.382 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 145.9 69.17 0.01 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -169.75 128.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.269 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.8 150.4 10.77 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -169.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.6 -163.01 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.977 -0.611 . . . . 0.0 110.284 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 tt 60.1 107.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.52 -170.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -127.74 134.21 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.412 170.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -96.94 -43.12 7.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.394 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.94 152.01 35.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.376 169.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.564 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.349 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.187 0.517 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.46 -19.72 62.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.28 171.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.94 -84.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.38 -169.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -162.67 123.98 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.351 170.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.7 153.48 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.327 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.31 -107.94 1.39 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.77 -170.27 17.66 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -176.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.516 ' HB3' ' N ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -73.98 -65.42 0.84 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.004 -0.598 . . . . 0.0 110.401 179.033 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.514 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . 68.7 m-20 -138.45 108.64 6.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.007 165.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -112.29 -179.64 19.68 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -159.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 7.1 t -130.0 109.01 16.77 Favored Pre-proline 0 C--O 1.246 0.897 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -160.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 7.2 Cg_endo -58.13 -19.29 40.64 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.975 2.45 . . . . 0.0 113.598 165.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.453 ' HA ' ' HD2' ' A' ' 13' ' ' ARG . 11.5 tpt180 -80.51 -73.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.403 -170.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.21 -11.76 48.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.601 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.6 18.17 76.15 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.36 -169.99 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.181 166.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.523 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -152.55 146.57 25.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.212 165.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.532 HG23 ' HG3' ' A' ' 22' ' ' GLU . 2.4 t -101.47 178.11 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.295 -164.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.422 ' N ' HG13 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -91.7 46.79 1.31 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.551 172.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' N ' ' HB3' ' A' ' 8' ' ' SER . . . 61.62 29.97 18.41 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.291 -174.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.504 ' HB2' HG12 ' A' ' 18' ' ' VAL . . . -93.99 -70.84 0.69 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.377 -159.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 32' ' ' HIS . 0.0 OUTLIER -94.32 -9.75 34.92 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.907 -151.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.513 ' HD3' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -58.89 124.77 20.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.495 -146.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.512 HG22 ' CE2' ' A' ' 36' ' ' PHE . 10.0 m -93.08 175.03 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.721 158.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.473 HG21 ' N ' ' A' ' 26' ' ' GLY . 4.4 mp -142.3 153.15 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.382 166.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.473 ' N ' HG21 ' A' ' 25' ' ' ILE . . . -154.02 135.58 4.84 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 169.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.57 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.99 -0.605 . . . . 0.0 110.291 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.61 20.43 1.84 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -103.65 168.31 9.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.392 -171.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.0 t -143.52 149.99 38.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.229 167.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -143.88 176.3 9.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.906 -168.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.541 ' HA ' ' HG2' ' A' ' 22' ' ' GLU . 67.3 m80 -90.57 164.21 14.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.507 160.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -30.12 63.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.429 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -81.44 -18.31 45.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.428 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.49 -15.2 43.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.446 -170.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CE2' HD21 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -68.85 110.11 4.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.327 -171.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.63 99.79 7.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.344 -170.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 29.7 t -63.35 116.48 5.55 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.381 165.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.84 42.76 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.341 168.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.465 ' HD3' ' CB ' ' A' ' 58' ' ' TYR . 20.9 tttm -129.22 -46.95 1.21 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.491 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.3 p -96.57 -13.32 23.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.893 161.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.89 18.24 54.71 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.498 167.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.33 148.76 30.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.005 0.431 . . . . 0.0 110.404 -164.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -68.98 138.24 54.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.636 158.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.528 HD23 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -102.37 -164.88 1.13 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.776 -158.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -123.27 170.7 10.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.077 -170.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.2 p -60.89 -13.31 14.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.397 167.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.8 p -60.89 -177.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.486 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.446 ' HB ' ' CB ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -83.54 -174.12 5.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.441 -168.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.52 HD21 ' CE2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -154.45 -171.06 3.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.397 -170.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.06 104.12 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.225 170.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.531 ' HA ' HG21 ' A' ' 57' ' ' ILE . 3.1 p30 -79.38 157.24 27.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.371 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -179.94 112.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.517 -171.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 p30 61.27 20.45 11.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.615 170.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.73 -24.62 30.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 168.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -99.04 -174.75 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 168.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.531 HG21 ' HA ' ' A' ' 52' ' ' ASP . 16.9 pt -157.1 139.68 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.255 -160.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.465 ' CB ' ' HD3' ' A' ' 40' ' ' LYS . 25.1 p90 -130.68 176.48 8.15 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.817 159.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.528 ' HB2' HD23 ' A' ' 45' ' ' LEU 0.251 11.9 p -110.76 148.2 32.82 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 111.795 -150.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.446 ' CB ' ' HB ' ' A' ' 49' ' ' THR . 4.4 tttm -72.0 -9.38 58.3 Favored 'General case' 0 C--N 1.345 0.375 0 O-C-N 120.403 -1.436 . . . . 0.0 109.883 167.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.26 -3.54 18.96 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.501 161.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -122.42 -49.93 2.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -167.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -59.96 -12.36 7.75 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.339 165.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.76 -61.22 1.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.369 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -60.95 -14.56 23.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.318 -166.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.53 60.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.444 169.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -72.1 172.69 9.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.441 171.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.46 141.35 15.47 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -170.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -61.75 -24.11 77.06 Favored 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 122.608 2.205 . . . . 0.0 113.675 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.54 26.82 13.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.429 173.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.14 60.57 0.23 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -122.88 -53.57 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.305 169.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.99 18.91 55.84 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 169.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 66.43 167.29 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.198 -0.501 . . . . 0.0 110.396 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.94 28.42 4.38 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -170.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -137.37 87.53 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.376 170.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -143.23 154.04 25.18 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.94 139.71 53.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.317 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -150.22 23.47 1.11 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -117.91 -82.3 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.395 -0.403 . . . . 0.0 110.243 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.468 ' CD2' HG21 ' A' ' 82' ' ' ILE . 1.3 tt -124.6 -60.63 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.335 169.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.468 HG21 ' CD2' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -171.94 106.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.365 169.013 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -159.26 121.53 3.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.261 -169.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.52 103.17 12.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.356 -170.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 . . . . . 0 C--O 1.241 0.626 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.401 170.218 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptt? . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 121.134 0.493 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.44 -173.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.268 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -86.99 150.8 23.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.38 169.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.68 122.99 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.38 -170.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 p -159.74 115.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.386 169.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.03 88.68 0.07 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.47 -77.32 0.23 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 170.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.31 -176.5 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.37 -0.415 . . . . 0.0 110.372 170.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.535 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . 25.3 m-20 -102.89 -168.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.168 167.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -174.81 173.74 46.32 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 166.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -136.31 112.03 10.08 Favored Pre-proline 0 C--O 1.245 0.848 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -158.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -55.67 -17.2 16.96 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 C-N-CA 122.99 2.46 . . . . 0.0 113.53 164.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' HD3' ' CE3' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -89.27 -70.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.466 -166.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 p -88.57 -26.06 22.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.577 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.7 44.83 4.76 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -124.7 144.01 50.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.985 -0.607 . . . . 0.0 110.29 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.539 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -96.23 142.05 28.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.183 167.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 9' ' ' ASP . 6.1 t -108.22 135.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.144 -164.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -61.48 -76.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.405 -166.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.03 -83.18 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.168 168.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.4 126.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.155 166.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.481 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 1.5 mm-40 -114.41 17.67 17.31 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.455 164.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' HG3' ' HB3' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -97.41 170.59 8.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.091 -159.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 31' ' ' TRP . 1.1 p -164.33 156.6 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.608 -148.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 tp -139.8 118.28 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.442 -168.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.458 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -99.09 171.3 24.42 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 160.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.37 -13.31 18.78 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.001 0.429 . . . . 0.0 110.619 -167.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.461 ' N ' ' HA2' ' A' ' 55' ' ' GLY . . . -128.04 -18.7 1.87 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -140.59 158.41 44.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.378 -162.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -121.78 146.38 47.12 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.026 164.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.483 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -146.6 177.47 9.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.915 -163.501 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.426 ' NE2' HG23 ' A' ' 18' ' ' VAL . 13.7 m80 -85.84 158.35 19.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.898 161.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.481 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -60.33 -26.51 66.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.474 165.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.8 p -116.71 18.44 14.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.469 -171.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.7 m -120.23 14.33 12.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.184 163.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.513 ' CZ ' HD23 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -92.71 108.19 19.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.276 -166.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -126.78 125.62 42.03 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.231 -165.065 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.5 t -57.52 107.6 0.46 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.755 162.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.11 -24.77 68.05 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.546 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.504 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -79.26 -76.38 0.21 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.522 -175.534 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.9 p -79.21 -18.0 53.77 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.431 -163.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.07 13.84 58.43 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -90.34 108.46 19.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.243 -0.478 . . . . 0.0 110.401 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 47.1 m -74.33 107.44 6.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.227 167.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.524 HD23 ' HB2' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -138.22 -172.86 3.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.306 -177.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -119.54 -177.37 3.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.068 -160.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.54 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 2.0 m -61.11 -46.36 90.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.457 -168.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.4 m -60.9 -13.64 17.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.457 -171.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 60' ' ' LYS . 6.9 m -145.12 41.49 1.27 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.374 -175.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.54 ' HG ' ' HA ' ' A' ' 47' ' ' SER . 2.0 pp -137.8 -175.46 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.375 170.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.448 ' N ' ' CD1' ' A' ' 50' ' ' LEU . . . -159.16 146.38 17.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.268 168.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.458 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 10.2 p-10 -89.55 143.8 26.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.383 169.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.48 99.83 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.392 -168.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 60.99 26.63 16.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.4 165.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.461 ' HA2' ' N ' ' A' ' 28' ' ' GLY . . . 103.75 -26.86 21.97 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 170.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -104.88 172.2 6.91 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.443 ' CD1' ' CH2' ' A' ' 31' ' ' TRP . 30.1 pt -130.71 158.82 43.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.307 -159.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.504 ' CE2' ' HG3' ' A' ' 40' ' ' LYS . 1.9 t80 -179.15 144.34 0.23 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.97 -159.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 38' ' ' CYS 0.252 9.6 p -101.46 157.15 17.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.314 0.578 . . . . 0.0 111.283 -148.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.515 ' HB3' HG21 ' A' ' 49' ' ' THR . 0.0 OUTLIER -74.83 -14.77 60.72 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.703 169.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.18 -9.43 29.29 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.072 166.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -118.22 -46.79 2.59 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -165.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.94 -10.03 3.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.486 167.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.43 -66.33 0.93 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.52 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -59.83 -31.9 70.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.056 -158.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -144.59 16.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.393 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.77 12.23 3.64 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.423 -172.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 173.6 -144.65 7.81 Favored Glycine 0 CA--C 1.544 1.879 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -172.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -62.16 149.28 91.11 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 122.611 2.208 . . . . 0.0 113.573 -169.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.82 105.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.352 167.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.68 135.7 5.42 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -166.93 -38.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.325 -0.438 . . . . 0.0 110.309 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.73 -74.12 0.05 OUTLIER Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.13 -57.49 0.86 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.109 -0.545 . . . . 0.0 110.361 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.98 70.79 0.01 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -103.32 116.23 32.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.394 169.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.15 -65.25 0.56 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -169.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.75 109.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.341 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.76 158.15 8.02 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 169.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.8 27.46 16.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.369 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -131.61 61.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.404 167.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -71.94 84.34 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.364 -169.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -130.11 106.43 8.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.36 169.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -98.16 -165.44 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.368 -169.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.626 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.347 -170.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 121.13 0.49 . . . . 0.0 109.831 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.46 174.39 6.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.268 172.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -61.57 93.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.417 169.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -61.87 -42.9 99.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.341 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.93 18.38 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.417 -170.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.94 17.28 50.7 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 168.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.74 36.21 0.19 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -169.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.53 162.78 38.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.383 169.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -156.69 136.85 12.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.203 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -116.42 171.31 13.71 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -162.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 t -123.84 101.51 36.01 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -167.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -59.95 -14.1 26.18 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 122.885 2.39 . . . . 0.0 113.47 167.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -80.07 -62.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.436 -167.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -91.26 -25.53 19.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.499 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.8 18.62 17.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -101.23 171.33 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.323 168.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.521 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -130.21 147.67 51.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.171 167.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.518 HG23 ' CD2' ' A' ' 32' ' ' HIS . 4.5 t -106.04 141.51 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.136 -165.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -124.86 -31.97 3.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.374 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.95 18.81 9.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.33 170.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.17 97.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.286 166.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HB2' HG12 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -125.74 23.79 7.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.623 163.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' HG2' ' HB2' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -94.25 117.75 30.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.316 -161.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.515 HG22 ' CE2' ' A' ' 36' ' ' PHE . 9.2 m -81.97 -176.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.707 159.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 pt -142.98 138.22 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.485 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 52' ' ' ASP . . . -126.5 -139.27 5.01 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 168.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.79 83.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.271 -169.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.57 19.4 54.13 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -170.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.77 167.89 9.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.932 0.396 . . . . 0.0 110.338 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.9 147.73 29.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.131 166.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.503 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -143.82 158.06 43.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.833 -164.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.518 ' CD2' HG23 ' A' ' 18' ' ' VAL . 44.1 m80 -78.41 154.96 30.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.988 161.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -23.05 64.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.505 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -84.45 -29.19 26.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.347 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.1 m -95.14 15.95 17.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.453 -167.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.515 ' CE2' HG22 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -100.59 101.7 12.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.412 -166.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 8.1 mtp180 -124.94 125.03 43.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.295 -168.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.9 t -64.44 109.77 2.06 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.502 170.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.94 67.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.448 171.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -74.5 -74.27 0.2 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.332 -170.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -87.3 -11.13 50.45 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.645 -169.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.69 17.19 79.19 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.426 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -92.74 113.8 26.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.315 167.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 54.3 p -83.6 115.25 22.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.074 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.475 ' CD1' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -129.63 -171.18 2.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.86 -171.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -172.88 176.46 3.07 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 112.672 -2.058 . . . . 0.0 109.946 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.1 t 66.73 -61.98 0.3 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.458 170.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -177.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.368 166.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -92.17 -177.51 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.475 -164.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.448 HD23 ' CE2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -148.77 -166.24 2.5 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.334 -171.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.38 94.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.327 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 8.7 p-10 -65.37 161.95 18.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.442 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 tttt 179.92 124.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.358 168.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 70.34 -92.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.395 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.83 18.34 3.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.16 -171.53 3.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.263 -0.469 . . . . 0.0 109.884 -170.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.504 HD11 ' CE1' ' A' ' 36' ' ' PHE . 32.6 pt -150.46 157.64 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.243 -160.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.468 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -141.72 170.03 16.49 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.388 161.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 14.5 p -104.5 168.61 8.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.196 0.522 . . . . 0.0 110.84 -151.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 2.5 tptp -80.67 -14.82 57.81 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.086 168.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.37 -9.75 32.04 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.999 166.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.1 m -118.6 -48.83 2.47 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -164.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -59.6 -17.11 30.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.513 164.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.63 -57.64 3.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.336 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -11.32 10.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.491 -173.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -153.46 65.78 0.75 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.433 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.72 104.75 0.47 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.396 177.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.87 93.13 0.05 OUTLIER Glycine 0 CA--C 1.543 1.816 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -50.36 113.5 1.05 Allowed 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 122.537 2.158 . . . . 0.0 113.611 -173.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.9 101.43 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.499 172.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.85 167.47 12.83 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 67.54 104.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.293 -0.453 . . . . 0.0 110.439 -169.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.42 -177.37 47.14 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -170.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -102.55 98.41 8.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.356 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.03 -81.09 0.45 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 170.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -133.2 115.78 15.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.121 -0.539 . . . . 0.0 110.382 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.01 -160.67 2.97 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.47 -81.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.183 -0.509 . . . . 0.0 110.372 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.69 -164.37 16.47 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -169.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.21 -48.04 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.273 -169.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.4 mt -95.48 16.09 17.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.393 -169.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.51 124.67 24.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.439 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.5 m170 62.03 19.36 10.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.388 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.75 77.01 1.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.319 169.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 . . . . . 0 C--O 1.24 0.562 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.364 -169.22 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 121.17 0.509 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.38 -39.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.26 -171.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.3 -165.44 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.344 -169.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.34 148.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.376 -169.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.15 153.07 5.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.311 -169.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.2 -41.12 0.31 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 -170.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.18 -111.04 2.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 p 67.94 104.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.393 0.616 . . . . 0.0 110.848 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.537 ' HB3' ' HD3' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -174.6 151.83 1.56 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.266 -177.06 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -122.39 170.96 15.27 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -162.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.3 t -127.66 109.25 20.66 Favored Pre-proline 0 C--O 1.246 0.9 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -164.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -65.06 -15.72 51.81 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.701 2.267 . . . . 0.0 113.707 171.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HD2' ' CE3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -77.0 -76.21 0.18 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.411 -178.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 p -85.63 -15.81 41.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.498 -166.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.12 22.67 31.86 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 171.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.42 156.04 19.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.983 -0.609 . . . . 0.0 110.399 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -113.51 142.99 45.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.191 167.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.515 HG23 ' NE2' ' A' ' 32' ' ' HIS . 3.5 t -105.22 136.31 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.932 -164.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.47 121.51 45.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.059 168.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.73 98.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.844 -160.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.465 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . . . -60.04 123.85 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.4 -160.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.54 15.95 23.39 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.444 165.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -100.02 -178.27 3.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.126 -160.592 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 31' ' ' TRP . 3.7 p -164.91 179.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.973 -147.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.5 pt -140.05 142.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.404 -172.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.51 117.3 0.78 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 167.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.431 ' CB ' ' HB2' ' A' ' 52' ' ' ASP . . . 61.89 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.395 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.39 -18.93 1.25 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -88.76 149.35 23.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.433 -0.383 . . . . 0.0 110.338 -168.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.8 m -105.71 144.76 32.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.168 166.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.521 ' CE3' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -144.64 -170.91 3.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.818 -168.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 41.5 m80 -102.51 161.83 13.4 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.652 163.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HG2' ' HB3' ' A' ' 47' ' ' SER . 0.1 OUTLIER -62.64 129.72 41.82 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.671 154.604 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.6 p 69.11 13.06 8.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.475 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 1.1 m -99.79 -20.87 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.537 156.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.474 ' CZ ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -61.9 104.45 0.45 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.307 174.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.511 ' HG3' ' NH1' ' A' ' 13' ' ' ARG . 4.3 mmt180 -113.03 100.43 8.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.371 -167.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 27.0 t -62.91 116.28 5.14 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.499 164.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.11 42.8 1.08 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.413 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.74 -51.55 1.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.49 -177.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.5 p -93.18 -13.02 28.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.04 161.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.92 18.18 56.6 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.408 167.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -109.05 148.93 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.024 0.44 . . . . 0.0 110.446 -164.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.5 p -70.13 139.11 52.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.631 159.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.521 HD12 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -103.46 -163.65 1.0 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.027 -157.371 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -104.78 -162.24 0.87 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.126 169.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.531 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -94.34 -35.44 12.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.362 -168.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.5 t -139.67 37.71 2.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.4 -168.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.469 ' CB ' ' HB3' ' A' ' 60' ' ' LYS . 1.2 p -142.08 83.53 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.549 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.474 HD12 ' CZ ' ' A' ' 36' ' ' PHE . 2.8 pp -153.22 165.06 36.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.386 -171.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.61 115.97 7.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.314 -177.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -94.06 161.05 14.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.416 -178.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.79 115.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.34 -174.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.18 14.74 6.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.511 169.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.06 -18.36 56.83 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -104.62 171.55 7.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.3 pt -148.97 137.42 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.349 -158.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -126.21 172.81 9.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.478 156.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.521 ' HB2' HD12 ' A' ' 45' ' ' LEU . 12.5 p -108.77 147.17 32.44 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.339 0.59 . . . . 0.0 111.759 -148.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -69.61 -9.84 55.74 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.319 -1.488 . . . . 0.0 109.803 167.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.11 -2.47 25.21 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.59 163.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -122.59 -50.06 1.99 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -167.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.522 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 7.2 t80 -60.21 -12.45 8.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.376 165.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.56 -65.64 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.376 169.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -25.85 67.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.439 -165.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -122.16 17.54 10.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.624 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 60.81 18.56 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.497 167.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 63' ' ' TYR . . . 110.24 -72.91 0.21 Allowed Glycine 0 CA--C 1.543 1.787 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 173.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -53.77 172.45 0.25 Allowed 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 122.632 2.222 . . . . 0.0 113.557 -171.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.79 -54.72 3.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.339 -169.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.67 169.68 13.05 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -170.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.71 163.06 15.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.325 170.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.38 -114.99 2.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 170.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -89.44 -13.73 36.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.376 -0.412 . . . . 0.0 110.406 169.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.84 -126.14 1.67 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -100.26 96.41 7.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.3 -0.45 . . . . 0.0 110.363 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.57 -121.2 0.56 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -170.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.66 28.68 17.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.315 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.71 129.1 0.06 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -174.25 39.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.324 -0.438 . . . . 0.0 110.276 169.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.1 pp -112.71 -178.56 3.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.39 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -165.04 69.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.444 169.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -136.62 -61.66 0.67 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.343 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 85.1 p -139.87 -164.23 1.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.299 170.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 C--O 1.241 0.632 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.362 170.077 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mmm . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 121.19 0.519 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.31 113.4 19.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.209 -172.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -110.45 14.32 22.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.401 -169.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.68 101.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.351 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.71 136.81 43.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.366 168.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.87 -179.68 26.35 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 174.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.78 172.47 36.02 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -169.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.52 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 0.3 OUTLIER 63.02 -165.78 0.23 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.969 -0.616 . . . . 0.0 110.216 179.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 76.79 170.22 0.24 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.344 171.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -109.62 -177.74 21.2 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -153.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 t -125.89 99.7 31.7 Favored Pre-proline 0 C--O 1.244 0.781 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -162.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.95 -13.78 24.63 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 122.864 2.376 . . . . 0.0 113.443 164.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -59.33 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.462 -165.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.5 p -93.0 -39.97 10.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.503 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.23 -45.23 0.87 Allowed Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.512 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -171.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.321 -167.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.534 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -151.03 149.55 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.231 165.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 23' ' ' LYS . 2.1 t -123.17 142.97 37.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.019 -165.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -125.26 12.87 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.518 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.14 -38.89 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.407 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.47 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -60.75 -79.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.368 -158.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.459 ' HB3' ' CG ' ' A' ' 33' ' ' LYS . 13.4 mm-40 -135.97 11.78 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.484 -157.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.531 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -79.78 155.23 28.0 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.118 -164.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -154.47 175.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.551 -151.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.448 HG21 HD11 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -149.0 141.89 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.539 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.39 107.76 0.4 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 165.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.75 -82.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.173 -0.513 . . . . 0.0 110.32 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.03 21.56 3.15 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -168.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.27 154.34 37.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.255 -0.473 . . . . 0.0 110.41 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -119.71 139.26 52.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.397 168.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.514 ' CZ3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -145.68 160.43 41.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.791 -170.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.52 ' CD2' HG22 ' A' ' 18' ' ' VAL . 51.2 m80 -80.49 161.44 24.85 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.361 158.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.459 ' CG ' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.73 133.39 43.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.784 154.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 72.33 9.52 5.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.583 -160.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 3.4 m -113.78 -29.59 7.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 155.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.507 ' CD1' HD13 ' A' ' 57' ' ' ILE . 0.9 OUTLIER -60.04 110.47 1.21 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.611 174.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.462 ' CD ' ' HB3' ' A' ' 44' ' ' SER . 1.6 mtt180 -124.93 125.12 43.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.216 -169.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 8.5 t -61.51 112.81 2.36 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.632 166.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.11 18.95 7.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.541 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' HB2' ' CD2' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -96.2 -76.3 0.51 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.286 161.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -85.04 -22.65 28.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.576 -165.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.06 32.34 6.49 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.38 122.05 46.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.417 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.462 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 24.9 p -78.89 112.14 15.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.394 165.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER -149.62 -168.81 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.554 -174.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -170.29 -82.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.907 162.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.6 p 67.23 -67.11 0.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.069 169.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.2 -87.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.404 -167.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.519 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -87.17 117.63 26.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.458 -166.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.443 ' CD2' ' CE2' ' A' ' 36' ' ' PHE . 3.5 pp -125.22 154.53 41.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.143 173.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -142.87 97.9 3.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.331 -164.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.3 153.07 21.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.313 -176.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.61 136.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.342 168.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.84 35.6 13.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.385 171.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.97 -18.33 57.55 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.75 -170.81 2.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -167.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.514 HD12 ' CZ3' ' A' ' 31' ' ' TRP . 15.6 pt -149.82 158.82 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.093 -158.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -139.46 173.46 11.52 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.166 164.149 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.54 ' HB2' HD23 ' A' ' 45' ' ' LEU . 14.4 p -107.67 158.07 17.57 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.14 0.495 . . . . 0.0 111.134 -154.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.519 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -60.11 -26.96 66.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.295 164.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 60' ' ' LYS . . . -65.92 -5.75 27.38 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.331 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -118.79 -45.04 2.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -165.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.48 -18.8 53.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.368 163.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.75 -45.53 7.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.282 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . 3.9 tmmm? -61.21 -29.35 69.77 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.452 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.01 32.36 3.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.402 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.76 115.25 0.86 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.428 169.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.441 ' N ' ' CD ' ' A' ' 69' ' ' PRO . . . 138.54 -54.02 0.7 Allowed Glycine 0 CA--C 1.543 1.811 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 68' ' ' GLY . 14.9 Cg_exo -52.06 151.08 17.22 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.572 2.181 . . . . 0.0 113.609 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -65.8 175.91 1.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.37 -169.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.9 156.52 51.72 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -170.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.82 -179.12 0.18 Allowed 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.418 -175.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.13 -86.04 1.75 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -158.7 92.1 1.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.015 -0.593 . . . . 0.0 110.361 -178.416 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.55 44.6 1.73 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -169.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 179.64 92.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.345 -0.427 . . . . 0.0 110.351 170.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.14 -108.31 2.46 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 170.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.63 143.31 32.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.258 -169.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.94 -107.55 3.07 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.23 86.56 4.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.439 -0.381 . . . . 0.0 110.264 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.22 161.15 15.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.419 -176.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.6 tt -90.31 129.7 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.384 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -61.11 -52.37 65.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.377 -169.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 p -84.97 179.07 7.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.359 -170.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 . . . . . 0 C--O 1.241 0.635 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.284 -170.047 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 mtp . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 121.132 0.491 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.38 142.93 0.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.281 -171.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -66.65 -19.1 65.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.4 tttt 64.0 142.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.357 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.6 t 61.85 37.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.32 -170.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.69 -64.82 1.59 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -170.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.25 -101.45 0.17 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.517 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 0.6 OUTLIER -65.72 -163.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.411 -169.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.15 107.44 18.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.022 167.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -114.05 -167.91 16.26 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -162.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 6.6 t -142.35 106.37 5.58 Favored Pre-proline 0 C--O 1.248 0.977 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -150.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.18 -14.32 23.43 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 C-N-CA 122.959 2.439 . . . . 0.0 113.403 165.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.528 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -82.69 -64.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.449 -167.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.59 -27.76 18.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.672 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.31 18.51 35.96 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -95.86 -168.97 1.85 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.203 167.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -164.72 147.63 8.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.167 164.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 21' ' ' ALA . 62.8 t -146.35 141.02 21.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 -156.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.517 ' CD1' ' HA ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -116.31 -18.59 10.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.448 168.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.75 39.37 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.111 -162.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.54 ' HB2' HG12 ' A' ' 18' ' ' VAL . . . -137.19 -78.95 0.39 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.418 162.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 32' ' ' HIS . 0.4 OUTLIER -126.96 6.65 6.6 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.869 -165.028 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 124.89 22.33 Favored 'General case' 0 C--O 1.231 0.093 0 O-C-N 121.228 -0.92 . . . . 0.0 110.443 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 31' ' ' TRP . 2.7 m -109.56 -179.8 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.971 161.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 tt -148.77 144.6 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.355 164.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.18 107.56 0.32 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.22 30.16 19.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.348 -0.426 . . . . 0.0 110.319 168.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.08 -37.24 3.81 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -72.91 160.77 31.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.301 -0.45 . . . . 0.0 110.32 -170.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -132.44 134.26 44.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.373 168.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.519 ' CZ3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -133.27 179.22 6.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.551 -169.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 39.5 m80 -118.81 160.75 21.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.296 156.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HB3' ' HG2' ' A' ' 46' ' ' GLU . 17.5 mtmt -61.53 -45.77 92.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.424 -172.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.428 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -61.08 -35.43 76.96 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.512 176.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.528 ' HB3' ' HG2' ' A' ' 13' ' ' ARG . 76.9 m -77.66 -16.62 58.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.639 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.498 ' CE2' HD23 ' A' ' 50' ' ' LEU . 1.9 t80 -67.11 104.34 1.4 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.365 -168.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.53 ' HG2' ' HB2' ' A' ' 44' ' ' SER . 9.6 mtp180 -116.79 121.63 42.11 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.307 -166.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.2 t -58.44 118.17 5.28 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.768 168.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.21 28.89 2.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.451 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -114.15 -73.82 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.258 159.348 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 22.5 p -79.28 -7.43 58.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.656 -168.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.2 17.71 68.41 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.456 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.455 ' HD2' ' CD2' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -85.56 110.45 19.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.278 166.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.53 ' HB2' ' HG2' ' A' ' 37' ' ' ARG . 40.4 t -79.41 103.03 9.06 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.181 171.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.465 ' CD1' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -116.87 -168.39 1.45 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.562 -175.363 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HG2' ' HB3' ' A' ' 33' ' ' LYS . 1.7 tt0 -172.23 156.52 3.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 113.146 -1.843 . . . . 0.0 110.098 -161.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.513 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 21.9 p 60.66 10.81 2.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.492 166.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 p -138.85 163.68 31.62 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.216 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -62.36 172.21 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.514 -165.027 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.498 HD23 ' CE2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -153.54 -163.51 1.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.299 -172.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -174.36 97.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.25 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 3.6 p30 -85.94 131.98 34.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.363 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -153.76 147.51 25.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.325 166.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 61.12 30.04 19.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.302 168.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.99 -25.06 29.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -120.35 -171.76 2.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.245 -0.477 . . . . 0.0 109.972 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.519 HD12 ' CZ3' ' A' ' 31' ' ' TRP . 35.2 pt -142.86 178.7 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.465 -157.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 62' ' ' CYS . 87.8 t80 -170.05 143.76 2.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.21 -174.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 13.8 p -97.49 167.15 11.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.149 0.5 . . . . 0.0 111.023 -146.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.489 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 1.6 tttp -77.69 -16.98 58.12 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.025 168.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.22 -9.1 40.31 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.324 170.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 58' ' ' TYR . 1.2 m -119.03 -49.35 2.41 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -165.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -60.02 -13.81 13.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.366 166.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.08 -70.19 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.416 168.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -32.69 72.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.418 -165.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -60.85 -17.89 52.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.406 -169.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.17 101.79 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.367 -169.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.11 169.06 13.26 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 176.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -52.11 149.33 21.8 Favored 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 122.467 2.112 . . . . 0.0 113.575 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.39 103.22 13.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.361 169.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.77 -89.51 0.08 OUTLIER Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.425 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 2.4 m-85 -70.42 140.22 51.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.41 169.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.03 25.88 17.19 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.425 ' CD2' ' HB3' ' A' ' 72' ' ' PHE . 10.6 m-85 -98.11 -25.21 15.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.083 -0.559 . . . . 0.0 110.34 -177.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.93 48.08 83.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -169.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.94 -176.19 0.1 Allowed 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.122 -0.634 . . . . 0.0 110.899 177.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.73 175.96 15.91 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -169.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.28 -18.07 56.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.403 -0.399 . . . . 0.0 110.197 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.67 75.26 1.16 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 169.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -175.64 -82.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.282 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 mt -88.54 -157.97 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.356 -169.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.3 mm -129.34 44.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.39 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.34 19.62 17.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.426 169.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.67 119.88 11.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.336 -171.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--O 1.239 0.552 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.324 170.084 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 tpt . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.093 0.473 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.12 -43.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.329 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 52.17 -91.17 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.731 0.812 . . . . 0.0 112.159 167.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.03 -169.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.481 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.3 p -101.07 -19.22 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.312 167.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.53 107.26 0.2 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -113.81 54.62 0.55 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -169.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.61 -80.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.413 -0.393 . . . . 0.0 110.401 -172.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.458 ' CB ' ' HE2' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -174.08 -171.39 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.261 167.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -152.99 172.25 31.99 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -169.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.1 t -124.56 108.98 28.7 Favored Pre-proline 0 C--O 1.246 0.887 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -167.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -59.14 -15.35 27.9 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 122.808 2.338 . . . . 0.0 113.592 168.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.413 ' HA ' ' HD2' ' A' ' 13' ' ' ARG . 4.1 tpt180 -84.8 -69.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.469 -168.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -89.8 -16.14 30.83 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.547 -173.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.82 18.15 70.92 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -96.97 138.92 33.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 110.245 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.525 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -102.63 142.84 33.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.25 175.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.535 HG13 ' HA ' ' A' ' 21' ' ' ALA . 3.3 t -105.77 136.14 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.967 -164.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -99.09 -72.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.183 172.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.8 97.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.978 162.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.535 ' HA ' HG13 ' A' ' 18' ' ' VAL . . . -60.09 113.27 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.451 -160.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 33' ' ' LYS . 3.9 tp10 -112.99 26.53 10.41 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.607 174.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -100.05 164.38 12.01 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.034 -161.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 1.1 p -156.08 172.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.7 -148.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 mt -145.96 145.16 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.631 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.87 111.89 0.5 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.97 -82.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.35 -170.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.45 13.61 1.4 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -170.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -106.77 148.22 28.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.365 176.607 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.91 142.18 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.317 169.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.489 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -150.45 -176.7 5.59 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.686 -168.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.511 ' CD2' HG23 ' A' ' 18' ' ' VAL . 18.8 m80 -93.17 163.84 13.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.121 169.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.534 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 1.4 mmtp -62.86 -16.18 57.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.557 170.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -126.97 23.14 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.424 -172.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.3 m -120.68 -11.96 8.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.515 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.518 ' CE2' HD23 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -61.18 108.63 0.93 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.313 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -111.7 103.26 11.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.378 -167.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 31.8 t -63.14 116.66 5.6 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.389 163.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.93 42.65 1.08 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.462 168.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.54 -52.72 1.08 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.517 -177.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.7 p -91.87 -11.13 37.25 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.985 161.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.32 18.65 62.05 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.479 167.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.25 149.53 30.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.127 0.489 . . . . 0.0 110.436 -164.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -68.15 138.88 56.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.736 160.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -102.83 -164.89 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.711 -159.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -144.95 -165.42 2.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.031 -168.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.2 p -76.64 -17.81 58.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.394 -170.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 p -61.06 143.6 55.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.362 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.67 -164.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.458 -170.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.518 HD23 ' CE2' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -155.9 -170.55 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.333 -173.523 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.31 79.18 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.325 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.526 ' HA ' HG21 ' A' ' 57' ' ' ILE . 4.6 p30 -73.6 156.39 38.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.401 174.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 179.67 136.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.445 168.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.1 t70 61.57 19.96 10.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.367 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.97 17.91 60.48 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 171.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.1 178.05 7.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 166.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.526 HG21 ' HA ' ' A' ' 52' ' ' ASP . 33.8 pt -154.13 135.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.426 -159.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -130.19 175.48 8.88 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.741 160.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.527 ' HB2' HD23 ' A' ' 45' ' ' LEU 0.254 11.7 p -110.34 147.88 33.05 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.381 0.61 . . . . 0.0 111.857 -149.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.29 -9.76 58.65 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 120.441 -1.412 . . . . 0.0 109.856 168.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.86 -4.92 22.67 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.468 162.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.46 -48.07 2.2 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -166.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -60.09 -10.37 4.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.461 165.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.01 -45.13 5.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.491 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.8 20.28 6.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.462 -172.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -103.76 -22.15 13.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.3 165.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.71 -80.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.377 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.38 97.15 0.16 Allowed Glycine 0 CA--C 1.543 1.839 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -173.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -54.98 -40.36 86.21 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 122.454 2.103 . . . . 0.0 113.468 -171.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.87 173.9 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.391 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.8 131.16 2.76 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 170.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -158.66 149.91 20.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.353 170.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.53 -18.94 13.06 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -118.62 114.92 23.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.313 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.44 56.03 0.51 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 68.9 127.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.311 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.69 147.3 0.18 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 168.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -175.59 128.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.282 169.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.65 -34.35 0.41 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.38 139.7 35.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.394 . . . . 0.0 110.28 -169.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 mp 60.05 19.07 8.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.599 -170.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.8 mm -105.8 80.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.353 169.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.13 122.91 16.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.352 -168.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -175.32 134.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.32 170.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--O 1.24 0.6 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.387 -170.041 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 tpt . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 121.146 0.498 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.34 -44.17 0.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.219 -172.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 70.02 -77.48 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.354 169.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.87 -77.22 0.59 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.49 170.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 m -163.75 80.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.324 -174.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.29 -69.86 0.09 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.87 -87.06 0.55 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -169.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -61.17 -167.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.292 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 23' ' ' LYS . 2.8 m-20 -132.26 99.71 4.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.104 167.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -108.21 -179.52 21.85 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -163.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.5 t -132.38 101.71 14.52 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -160.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.93 -14.12 26.15 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 122.697 2.265 . . . . 0.0 113.483 167.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -81.22 -62.25 1.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.412 -166.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -88.8 -17.76 29.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.484 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.37 -13.83 54.69 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -79.45 175.51 10.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.396 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -131.84 172.92 11.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.987 163.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 21' ' ' ALA . 2.6 t -119.67 158.74 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.811 -172.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -94.96 38.33 1.13 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.428 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . . . 61.88 68.05 0.72 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.079 -167.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' N ' HG13 ' A' ' 18' ' ' VAL . . . -129.13 -63.72 0.94 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.444 -174.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 33' ' ' LYS . 16.9 mm-40 -117.9 27.61 8.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.081 -173.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HG2' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -87.32 112.92 22.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.297 -167.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.476 HG22 ' CD2' ' A' ' 36' ' ' PHE . 15.5 m -97.99 -178.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.154 165.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 pp -139.87 159.96 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.481 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.84 87.1 0.16 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.252 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.05 -18.91 10.66 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HB3' ' NE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -72.42 159.6 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.431 -0.384 . . . . 0.0 110.349 -169.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 98.8 p -147.86 123.53 10.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.157 167.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.51 ' NE1' ' HB3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -122.66 178.48 4.99 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.799 -165.414 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 20.0 m80 -94.04 162.15 14.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.875 160.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.8 mttp -60.38 -42.45 95.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.449 167.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -95.78 21.14 8.84 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.69 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 16.6 m -120.68 -19.55 7.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.382 167.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CD2' HG22 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -60.57 113.02 2.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.329 175.018 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -138.67 127.03 22.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.282 -172.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 14.0 t -58.56 112.81 1.73 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.631 165.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.2 23.01 3.49 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.631 171.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.97 -75.7 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.491 170.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.1 p -75.67 -21.54 57.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.562 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.15 -17.82 40.35 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.459 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.85 128.91 36.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.162 0.506 . . . . 0.0 110.388 -170.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -64.94 140.02 58.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.08 164.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.538 HD12 ' HB2' ' A' ' 59' ' ' CYS . 0.8 OUTLIER -163.62 -176.25 4.57 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.16 165.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.423 ' HA ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -172.32 -157.63 0.11 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.381 -160.749 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.71 -87.29 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.74 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.38 15.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.241 -174.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -118.19 45.19 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.331 -171.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 46' ' ' GLU . 3.9 pp -142.8 168.79 18.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.452 -177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.71 125.97 12.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.357 173.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.531 ' HA ' HG21 ' A' ' 57' ' ' ILE . 3.6 p-10 -124.64 146.65 48.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.427 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.66 156.32 0.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.449 167.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 61.27 19.76 10.42 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.554 172.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.83 -27.4 20.38 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 166.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.23 178.62 4.3 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.044 -0.578 . . . . 0.0 109.899 178.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.531 HG21 ' HA ' ' A' ' 52' ' ' ASP . 35.0 pt -156.2 135.83 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.446 -160.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -134.02 177.73 7.51 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 156.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.538 ' HB2' HD12 ' A' ' 45' ' ' LEU 0.258 12.4 p -113.92 152.29 31.01 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.992 0.901 . . . . 0.0 113.17 -143.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.521 ' HB3' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -84.91 -0.29 53.66 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 119.476 -2.015 . . . . 0.0 110.352 166.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.47 ' HA3' ' CD2' ' A' ' 45' ' ' LEU . . . -58.09 -15.25 20.94 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 151.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 -51.78 2.43 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -157.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -60.08 -14.85 18.76 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.474 167.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.5 -66.12 0.95 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.39 167.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -41.23 94.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.493 -164.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.12 28.83 3.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.352 -175.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -125.46 80.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.346 167.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.66 -83.37 0.18 Allowed Glycine 0 CA--C 1.543 1.784 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.96 -179.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 122.403 2.069 . . . . 0.0 113.474 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.517 ' HG2' ' N ' ' A' ' 71' ' ' GLY . 8.4 tttt -105.86 163.83 12.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.332 170.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.517 ' N ' ' HG2' ' A' ' 70' ' ' LYS . . . -137.05 -179.62 16.98 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 169.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -64.73 -76.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.345 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.94 -117.31 1.63 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -169.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -114.41 -37.93 4.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.106 -0.547 . . . . 0.0 110.364 -176.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.01 -175.75 23.7 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -170.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -119.78 107.96 13.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.343 -0.429 . . . . 0.0 110.322 -170.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.76 167.36 42.9 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 170.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.94 -65.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.299 -169.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.31 168.7 23.56 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.53 106.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.363 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.6 tp -146.42 -82.13 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.398 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.1 pt 57.6 42.2 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.91 173.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 71.32 -79.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.312 -172.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.36 169.13 11.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.315 -170.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 . . . . . 0 C--O 1.24 0.595 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.308 -170.036 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtt . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 121.05 0.452 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.66 -46.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.224 172.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.31 135.68 49.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.351 -169.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.5 tptt 65.01 -77.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.452 172.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 m -104.49 100.27 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.315 -170.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.19 -49.58 0.04 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -169.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.75 73.62 0.27 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 173.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m 65.9 173.67 0.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.338 166.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.516 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 31.7 p30 -116.48 132.52 56.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.0 167.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -120.7 174.41 15.73 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -160.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 t -124.41 113.34 27.63 Favored Pre-proline 0 C--O 1.244 0.789 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -157.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -63.4 -7.04 11.35 Favored 'Trans proline' 0 N--CA 1.484 0.916 0 C-N-CA 122.686 2.258 . . . . 0.0 113.696 171.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.535 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -92.09 -70.27 0.7 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.407 -174.102 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.4 p -91.22 -29.99 16.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.63 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 48.35 2.72 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.52 157.42 33.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.399 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.523 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -113.88 137.74 51.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.171 168.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG13 ' CA ' ' A' ' 21' ' ' ALA . 3.2 t -113.41 134.48 56.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.865 -163.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -94.2 -69.44 0.75 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.382 -167.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 -10.33 5.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.4 167.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.46 ' CA ' HG13 ' A' ' 18' ' ' VAL . . . 61.74 111.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.329 -178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -114.4 31.55 6.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.535 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' NZ ' ' HB2' ' A' ' 9' ' ' ASP . 4.5 mtpm? -106.48 -175.14 2.71 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.171 -160.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 36' ' ' PHE . 2.1 p -169.05 161.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.768 -148.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -141.21 144.74 25.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.45 -171.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 52' ' ' ASP . . . -163.99 135.65 3.88 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 167.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.55 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.334 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.89 16.87 0.82 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -173.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.12 140.33 52.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.375 -168.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.501 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -104.67 145.59 30.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.305 168.675 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.515 ' CZ2' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -149.71 163.94 36.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.595 -170.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 17.9 m80 -74.26 144.66 44.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.734 158.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' HG3' ' A' ' 46' ' ' GLU . 4.1 mttm -60.27 -21.54 62.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.487 169.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -111.21 18.16 19.59 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.51 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.535 ' HB3' ' HG2' ' A' ' 13' ' ' ARG . 21.3 m -119.79 16.38 12.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.215 166.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.498 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -98.11 110.64 23.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.263 -163.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 7.7 ttp-105 -122.61 120.62 34.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.278 -164.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.1 t -58.42 111.83 1.37 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.728 164.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.47 -24.6 67.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.681 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.52 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -75.99 -78.82 0.11 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.26 -176.32 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.7 p -84.75 -9.12 58.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.783 -163.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.78 15.69 74.8 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.614 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 8.6 tptm -88.78 103.07 15.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.415 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 14.3 t -71.15 92.38 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.105 166.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -128.12 -175.17 3.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.555 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.535 ' HG3' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -171.64 -45.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.789 -163.32 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -60.94 -61.29 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.369 -173.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 49.8 p -65.63 133.05 50.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.124 163.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.531 HG23 ' HG2' ' A' ' 60' ' ' LYS . 6.3 t -62.6 -176.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.335 -166.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 2.3 pp -119.81 177.42 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.335 -167.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -163.41 108.84 1.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.292 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.483 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 4.4 p-10 -94.99 145.34 25.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.3 -168.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.49 -174.49 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.394 165.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.63 92.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.424 -169.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.04 -22.95 37.88 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.34 -174.08 3.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.046 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.515 HG22 ' CZ2' ' A' ' 31' ' ' TRP . 35.6 pt -148.37 175.8 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.333 -161.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.52 ' CE2' ' HG3' ' A' ' 40' ' ' LYS . 13.6 t80 -178.29 141.45 0.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.162 -160.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 10.1 p -100.67 168.97 9.35 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.898 -148.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' HG2' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -85.23 -12.84 51.62 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.123 169.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.75 -10.35 37.62 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.038 166.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.516 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 1.3 m -119.0 -46.85 2.52 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -164.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -60.19 -16.4 32.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.444 163.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 -43.41 12.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.287 168.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.495 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -60.79 -11.72 8.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.523 177.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.9 37.82 1.77 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.307 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -79.06 -27.4 43.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.398 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.87 89.75 2.06 Favored Glycine 0 CA--C 1.543 1.795 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 171.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.69 119.02 5.87 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 122.493 2.129 . . . . 0.0 113.466 171.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.11 -19.38 15.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.395 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.44 80.67 1.05 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -170.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.51 105.19 9.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.389 -0.405 . . . . 0.0 110.346 -169.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.48 -101.62 2.79 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -100.9 135.53 42.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.447 -0.376 . . . . 0.0 110.338 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.46 61.18 2.83 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -70.98 -23.84 62.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.082 -0.559 . . . . 0.0 110.427 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.53 165.09 38.58 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.68 163.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.23 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.16 174.29 33.85 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -170.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -119.16 99.94 7.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.283 -169.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 2.0 mm? -84.27 67.93 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.323 169.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.493 HG21 ' N ' ' A' ' 83' ' ' HIS . 42.1 mt 66.12 166.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.355 -169.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.493 ' N ' HG21 ' A' ' 82' ' ' ILE . 3.0 m80 -61.06 93.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.338 -169.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.9 t -112.45 -79.81 0.58 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.379 -170.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 . . . . . 0 C--O 1.24 0.568 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.367 170.079 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.0 ttm . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.137 0.494 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.46 -82.02 0.31 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.298 -172.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 57.53 96.87 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.481 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -61.34 -26.31 67.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.42 -177.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.446 HG21 ' N ' ' A' ' 6' ' ' GLY . 35.0 m -152.71 -35.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.424 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.446 ' N ' HG21 ' A' ' 5' ' ' VAL . . . 121.29 -116.9 3.28 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.71 -89.48 0.6 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -172.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -61.11 -171.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.386 -0.407 . . . . 0.0 110.313 167.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.498 ' HB3' ' HE3' ' A' ' 23' ' ' LYS . 18.5 m-20 -125.48 -162.16 1.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.221 166.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -174.31 178.73 46.03 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 165.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 t -136.16 111.33 10.07 Favored Pre-proline 0 C--O 1.247 0.94 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -158.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -53.9 -20.24 17.38 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.99 2.46 . . . . 0.0 113.642 166.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.23 -72.44 0.51 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.429 -167.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 p -86.62 -18.15 32.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.61 -172.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.87 18.75 64.74 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.77 168.09 11.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.328 170.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.535 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -122.49 145.03 48.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.168 168.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.446 HG23 ' NE2' ' A' ' 32' ' ' HIS . 4.8 t -101.56 135.2 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.19 -164.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -73.83 -77.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.423 -166.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.61 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.135 167.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.86 133.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.091 165.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.0 17.51 6.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.389 161.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -103.49 160.59 14.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.91 -159.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 31' ' ' TRP . 2.3 p -150.97 178.02 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.575 -147.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.91 147.58 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.541 -175.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.3 139.36 5.63 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.64 -82.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.046 -0.577 . . . . 0.0 110.397 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -153.74 27.95 0.75 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 170.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.62 153.85 31.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.399 -0.401 . . . . 0.0 110.359 -170.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 t -110.43 143.42 40.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.2 168.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.519 ' CH2' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -148.38 170.98 16.78 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.952 -172.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.446 ' NE2' HG23 ' A' ' 18' ' ' VAL . 15.2 m80 -86.31 147.38 26.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.519 -1.218 . . . . 0.0 110.084 162.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -60.67 -13.31 13.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.489 171.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -101.55 -36.08 8.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.417 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 39.8 m -72.93 -17.29 61.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.453 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.515 ' CE1' HD11 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -61.19 85.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.267 177.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 17.5 mtm180 -121.65 127.12 50.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.196 -167.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 12.4 t -59.33 107.08 0.51 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.477 164.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.51 -20.99 66.07 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.573 170.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.403 ' HA ' ' HE3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -77.45 -67.37 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.541 -165.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p -88.55 -27.16 21.59 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.65 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.95 22.37 6.96 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.6 tppp? -110.03 110.7 21.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.265 -0.468 . . . . 0.0 110.401 -168.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -65.15 112.43 3.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.358 167.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 59' ' ' CYS . 1.2 pp -147.19 176.64 9.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.399 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HA ' HD22 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -172.36 -32.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.917 -173.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -67.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.54 -165.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -61.44 -75.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.358 -173.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.537 HG21 ' HG2' ' A' ' 60' ' ' LYS . 14.8 t -178.77 -169.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.366 164.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -168.66 -171.52 1.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.236 -169.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.34 82.64 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.368 -167.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.534 ' HA ' HG23 ' A' ' 57' ' ' ILE . 3.0 p30 -69.6 147.35 50.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.356 170.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.33 149.31 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.42 169.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.19 -96.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.459 -170.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.24 23.59 0.98 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.29 173.82 12.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 171.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.534 HG23 ' HA ' ' A' ' 52' ' ' ASP . 39.3 pt -141.3 152.74 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.194 -158.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -134.13 174.58 10.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.679 157.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 38' ' ' CYS . 14.2 p -106.79 159.14 16.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.179 0.514 . . . . 0.0 110.847 -152.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.537 ' HG2' HG21 ' A' ' 49' ' ' THR . 11.8 tptt -72.33 -14.7 61.8 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.848 168.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.7 -10.26 43.49 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.196 166.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.43 -48.54 2.7 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -164.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -60.38 -13.62 14.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.258 165.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.57 -65.37 1.02 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.522 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -61.26 -16.53 46.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.567 -165.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.04 -56.59 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.256 167.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 t80 60.77 13.93 4.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.508 -175.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.85 -142.8 3.6 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -168.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.98 -88.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.058 0 C-N-CA 122.612 2.208 . . . . 0.0 113.511 -167.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.68 -34.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.394 -167.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.47 96.9 0.1 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -164.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.5 t80 179.28 110.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.403 -0.398 . . . . 0.0 110.288 166.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.43 130.6 3.02 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -169.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.3 t80 68.18 156.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.435 -0.382 . . . . 0.0 110.364 168.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.23 159.14 9.22 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 70.24 -71.36 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.439 169.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.96 -86.36 0.04 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.68 110.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.35 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.3 128.64 0.01 OUTLIER Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -161.61 -70.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.37 -0.415 . . . . 0.0 110.286 -169.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 81' ' ' LEU . 14.8 mt -64.93 -91.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.437 -168.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.6 mm -100.23 168.41 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.457 -169.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -122.03 103.78 9.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.337 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.0 t 66.05 119.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.36 169.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.534 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.408 169.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtt . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 121.106 0.479 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.53 -78.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.266 172.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 62.9 77.7 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.473 -169.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -104.93 102.16 11.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.362 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 t -102.99 109.51 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.335 -169.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.42 98.75 0.26 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.66 118.77 6.26 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 1.9 m -96.32 -164.42 1.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.406 170.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.464 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 45.7 m-20 -85.04 104.72 15.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.013 170.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -110.93 -168.13 19.05 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -162.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.521 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 8.1 t -140.32 107.02 6.64 Favored Pre-proline 0 C--O 1.249 1.049 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -149.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.74 -16.98 33.63 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 C-N-CA 122.762 2.308 . . . . 0.0 113.625 171.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -84.08 -67.03 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.593 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 p -87.94 -29.96 20.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.602 -170.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.09 18.62 36.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -93.64 -169.03 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 164.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -165.59 145.26 6.55 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.262 164.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.463 HG12 ' CB ' ' A' ' 21' ' ' ALA . 64.7 t -143.57 137.77 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.444 -155.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 50.5 t80 -109.32 -19.04 13.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.446 169.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.57 -56.57 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.257 -167.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.463 ' CB ' HG12 ' A' ' 18' ' ' VAL . . . -61.38 -74.54 0.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.412 -162.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.518 ' HB2' ' CD2' ' A' ' 32' ' ' HIS . 4.2 mm-40 -117.34 7.64 12.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.792 -164.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' CG ' ' HB2' ' A' ' 9' ' ' ASP . 3.4 ttpt -60.9 122.11 14.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -161.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.516 HG22 ' CD2' ' A' ' 36' ' ' PHE . 3.5 m -122.13 169.27 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.249 167.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.7 mt -145.94 139.99 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.424 168.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.46 120.27 0.93 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -170.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.68 16.31 7.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.332 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.62 -22.92 25.39 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.64 134.64 36.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.437 -172.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.7 m -102.33 119.35 38.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.396 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.486 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -124.31 174.58 7.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.602 -172.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.521 ' CE1' ' HB2' ' A' ' 11' ' ' CYS . 44.2 m80 -105.29 153.99 20.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.1 157.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HD3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -61.11 -27.12 68.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.4 178.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 t -84.52 -23.77 29.64 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.486 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.3 m -95.81 25.09 4.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.347 171.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.516 ' CD2' HG22 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -113.14 89.31 3.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.269 -171.066 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 1.1 ppt_? -112.02 130.39 55.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.282 -166.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.9 t -65.28 110.92 2.77 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.446 168.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.511 ' HB1' ' NH1' ' A' ' 37' ' ' ARG . . . -92.51 18.62 8.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.616 170.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.73 -75.34 0.48 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.379 165.195 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.5 p -83.4 -22.65 32.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.494 -173.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.35 -28.35 6.31 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 165.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.515 ' HD2' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -82.61 145.22 29.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.307 -0.447 . . . . 0.0 110.385 -168.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 15.0 m -92.14 137.35 32.43 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.328 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -140.88 -168.47 2.6 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.841 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.522 ' HB2' ' HD3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -171.88 -69.73 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.946 -1.934 . . . . 0.0 110.254 -171.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.5 p -61.84 -22.06 65.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.391 -166.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -96.02 156.97 16.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.412 170.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -60.91 -173.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.355 -168.081 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.449 ' CD2' ' CE2' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -148.34 -175.89 5.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.419 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.46 77.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.312 -169.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.523 ' HA ' HG23 ' A' ' 57' ' ' ILE . 4.9 p-10 -67.45 90.91 0.25 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.361 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.25 169.66 17.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.368 170.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -61.07 89.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.434 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.74 -19.19 14.32 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -155.33 -171.73 3.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.003 -169.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.523 HG23 ' HA ' ' A' ' 52' ' ' ASP . 38.1 pt -148.77 140.15 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.381 -161.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.515 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 1.5 m-85 -132.93 -175.94 3.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.938 163.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.541 ' HB2' HD23 ' A' ' 45' ' ' LEU . 14.6 p -110.54 159.85 17.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.466 0.65 . . . . 0.0 111.185 -153.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.511 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 6.7 tmtt? -74.46 -13.32 60.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.866 169.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.66 -9.64 39.72 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.21 164.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.91 -45.34 2.77 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -164.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -60.51 -13.25 12.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.224 162.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.67 -51.1 5.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.393 172.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.02 -13.58 17.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.375 -168.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -61.51 -18.52 59.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.458 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -75.47 -33.68 60.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.332 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -118.37 105.79 1.25 Allowed Glycine 0 CA--C 1.542 1.762 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -170.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -51.82 -34.85 56.85 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.651 2.234 . . . . 0.0 113.515 173.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -63.91 147.67 51.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.358 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.17 -114.99 0.63 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -170.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -95.82 177.74 5.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.34 169.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.16 132.48 6.13 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 170.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -92.02 101.86 14.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.413 -0.393 . . . . 0.0 110.311 169.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.74 72.31 0.33 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -170.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -144.34 18.14 1.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.382 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.04 179.67 30.08 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -170.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -175.25 -60.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.273 169.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.62 100.32 1.54 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -161.96 107.24 1.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.026 -0.587 . . . . 0.0 110.356 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 mt 60.04 96.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.59 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 18.5 mm -74.23 167.93 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.353 -170.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -87.12 121.33 29.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.386 170.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 p -159.13 -77.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.402 170.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.24 0.594 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.289 -170.07 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.628 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 t -122.42 103.2 38.64 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -167.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 30' ' ' SER . 10.3 Cg_endo -59.13 -15.2 27.16 Favored 'Trans proline' 0 N--CA 1.485 1.025 0 C-N-CA 122.704 2.269 . . . . 0.0 113.557 171.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -82.3 -65.87 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.459 -167.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.7 p -87.49 -14.57 40.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.517 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.94 18.41 61.3 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.534 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.51 161.17 13.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 110.272 167.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -119.81 148.61 43.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.277 169.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.892 HG11 ' H ' ' A' ' 22' ' ' GLU . 4.4 t -109.81 144.1 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.025 -166.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.73 -45.44 2.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.445 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.02 -11.69 9.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.315 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.595 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 61.73 92.54 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.31 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.892 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -106.18 27.81 8.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.702 164.327 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.17 130.2 37.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.29 -162.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.636 HG21 ' CD2' ' A' ' 36' ' ' PHE . 2.3 m -107.04 -168.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.003 161.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -154.56 155.55 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.435 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 52' ' ' ASP . . . -161.57 128.67 1.95 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 168.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.54 -82.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.289 -172.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.39 21.13 0.83 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -85.29 168.63 14.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.395 170.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -141.99 142.33 32.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.295 168.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.793 ' CH2' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -135.39 176.47 8.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.091 -169.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.647 ' NE2' HG22 ' A' ' 18' ' ' VAL . 16.9 m80 -84.63 164.58 18.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.083 165.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.452 ' H ' ' HG2' ' A' ' 22' ' ' GLU . 16.0 tttp -60.95 -24.88 66.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.508 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -129.42 31.21 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.33 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -119.5 -10.35 9.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.823 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.733 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -61.67 107.19 0.77 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.333 -172.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.46 100.54 7.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.366 -166.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 25.2 t -62.82 117.37 6.25 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.532 167.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.66 41.77 1.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.39 169.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -131.47 -48.35 0.98 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.436 -176.102 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.2 p -97.12 -11.85 23.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.099 162.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.3 17.68 58.54 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.372 167.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -107.96 147.03 31.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.069 0.462 . . . . 0.0 110.353 -164.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 m -68.77 136.59 53.02 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.53 159.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.764 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -100.84 -163.63 1.04 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.913 -158.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.818 ' HB2' HG22 ' A' ' 49' ' ' THR . 7.3 mt-10 -117.16 -178.17 3.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.926 165.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -57.17 5.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.343 -166.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.8 t -118.82 44.48 2.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.405 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.818 HG22 ' HB2' ' A' ' 46' ' ' GLU . 11.8 t -141.68 68.39 1.33 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.324 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.733 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 2.2 pp -149.11 170.5 18.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.37 -164.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -158.14 115.22 2.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.35 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.672 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.0 p30 -91.82 162.08 14.59 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.353 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 13.0 tptt -169.14 135.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.323 168.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.86 -95.49 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.477 175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.29 16.57 1.69 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -127.58 -177.98 4.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 167.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.793 HD13 ' CH2' ' A' ' 31' ' ' TRP . 27.2 pt -157.27 136.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.538 -159.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 3.6 p90 -126.57 177.94 6.2 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 155.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.764 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.255 12.2 p -110.74 148.09 33.03 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.099 0.476 . . . . 0.0 111.793 -150.196 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -73.58 -6.47 46.82 Favored 'General case' 0 C--N 1.347 0.466 0 O-C-N 120.162 -1.586 . . . . 0.0 109.993 167.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.81 -3.02 26.16 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.609 159.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.8 -48.69 2.01 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -167.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -59.91 -12.87 8.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.334 162.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.67 -69.25 0.7 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.347 166.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.78 -32.53 71.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.447 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.414 170.91 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.526 0.748 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 9.3 t -123.29 106.68 32.98 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -162.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 30' ' ' SER . 8.6 Cg_endo -58.47 -15.3 24.24 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 C-N-CA 122.917 2.411 . . . . 0.0 113.61 167.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -67.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.377 -166.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.7 p -88.73 -22.75 23.18 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.618 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.6 -18.26 38.22 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -66.42 171.6 4.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.295 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -143.59 143.37 31.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.191 169.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.852 ' CG1' ' HB3' ' A' ' 21' ' ' ALA . 2.4 t -96.01 158.64 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.451 -162.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 9.9 t80 -94.55 38.89 1.1 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.475 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 19' ' ' TYR . . . 61.84 67.87 0.73 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.077 -167.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.852 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -129.12 -64.41 0.91 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.483 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.82 ' H ' HG11 ' A' ' 18' ' ' VAL . 3.0 mt-10 -129.38 16.71 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.185 -166.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.58 158.68 15.58 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.018 -166.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -158.92 173.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.724 -147.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.43 140.79 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.51 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.8 134.83 4.18 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 167.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.75 -83.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.275 -0.462 . . . . 0.0 110.459 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.14 48.18 0.52 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 172.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.89 148.66 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.4 -170.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.42 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -108.09 144.28 35.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.27 168.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.757 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -147.93 172.6 13.94 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.782 -170.138 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.821 ' NE2' HG22 ' A' ' 18' ' ' VAL . 43.3 m80 -92.96 156.18 17.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.855 162.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.544 ' CD ' ' HB3' ' A' ' 22' ' ' GLU . 13.7 ptmt -62.59 -14.18 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.456 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.49 17.73 18.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.547 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.1 m -125.73 23.51 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.243 167.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -118.3 82.97 1.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.177 -168.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -119.91 129.25 54.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.255 -166.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 13.0 t -60.01 105.59 0.41 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.271 163.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.46 -19.48 64.76 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.571 170.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -65.08 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.59 -164.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.3 p -88.0 -24.92 23.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.615 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.96 18.76 30.86 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -99.03 132.19 44.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.396 169.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -81.72 134.98 35.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.332 168.115 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.689 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.1 pp -157.78 -173.07 4.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.361 177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.719 ' C ' HD23 ' A' ' 50' ' ' LEU . 1.3 pt-20 -139.01 -179.27 5.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.073 -162.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.491 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -66.44 169.08 7.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.365 -165.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 49' ' ' THR . 0.3 OUTLIER 61.08 13.17 4.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.344 -167.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -168.6 30.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.57 -174.294 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.719 HD23 ' C ' ' A' ' 46' ' ' GLU . 4.0 pp -153.03 175.11 13.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.498 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.67 107.97 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.3 -169.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.753 ' CB ' HG22 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -90.63 161.13 15.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.418 176.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.501 ' HD2' ' CE1' ' A' ' 58' ' ' TYR . 8.4 ptmm? -166.29 109.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.429 -171.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 60.78 18.36 8.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.471 164.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.4 -28.16 8.86 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -104.93 168.58 8.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.753 HG22 ' CB ' ' A' ' 52' ' ' ASP . 32.3 pt -150.11 131.22 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.443 -158.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.517 ' H ' ' HD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -124.71 -175.27 3.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.747 161.039 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.689 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.2 p -111.11 157.39 20.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.327 0.584 . . . . 0.0 110.927 -153.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 49' ' ' THR . 6.2 ttmm -71.89 -13.86 61.78 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.824 169.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.22 -10.41 41.1 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.151 165.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.15 -46.86 2.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -164.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -17.1 41.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.364 165.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.13 -58.31 2.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.289 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -20.52 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.401 -167.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.309 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 t -125.01 108.66 27.82 Favored Pre-proline 0 C--O 1.244 0.799 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -164.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 30' ' ' SER . 7.7 Cg_exo -57.56 -16.4 23.94 Favored 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 122.854 2.369 . . . . 0.0 113.578 166.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.82 -68.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.392 -167.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.1 p -90.1 -13.16 36.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.5 -175.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.75 18.74 67.3 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 175.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.89 164.44 13.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.378 168.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -120.32 143.2 48.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.089 167.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.781 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.5 t -108.14 140.6 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.864 -164.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -103.52 136.03 44.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.437 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.57 19.77 10.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.425 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.94 110.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.286 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.781 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -117.85 20.35 13.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.55 166.263 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -102.96 168.06 9.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.421 -158.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.982 HG21 ' CD2' ' A' ' 36' ' ' PHE . 1.2 m -115.51 -171.69 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.148 167.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -163.6 146.62 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.412 166.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.459 ' N ' HG13 ' A' ' 25' ' ' ILE . . . -171.44 141.07 6.2 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -170.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.38 -82.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.248 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.46 21.08 0.93 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 168.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -122.17 128.55 51.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.374 -169.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.435 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -96.48 144.14 26.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.34 167.469 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -139.51 -163.22 1.45 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.892 -177.122 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.623 ' NE2' HG22 ' A' ' 18' ' ' VAL . 18.6 m80 -103.9 163.55 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.136 164.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -73.92 -11.56 60.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.396 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -120.0 23.33 11.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.431 177.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 1.8 m -121.32 -20.35 6.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.457 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.982 ' CD2' HG21 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -61.42 104.62 0.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.298 -171.018 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 ptm85 -115.59 102.35 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.312 -164.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 29.8 t -62.53 116.35 5.05 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.477 163.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 41.99 1.1 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.371 168.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -129.93 -53.57 1.13 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.555 -178.608 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.6 p -92.63 -11.23 34.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.005 163.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.62 18.2 60.57 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.434 167.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -108.06 147.88 30.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.943 0.401 . . . . 0.0 110.34 -164.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.82 138.71 52.85 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.633 158.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -103.62 -163.51 0.99 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.919 -157.155 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.71 -159.26 0.68 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.095 168.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.0 p -92.52 -58.2 2.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.365 -168.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -110.62 41.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.453 -169.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 28.2 p -151.27 78.68 1.28 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.523 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.735 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 2.7 pp -151.96 167.18 29.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.496 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 58' ' ' TYR . . . -146.07 114.37 6.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.255 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.954 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.0 p30 -85.53 160.87 19.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.434 171.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.71 97.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.408 -169.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 61.03 17.82 8.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.464 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.9 -23.63 25.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 170.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -103.72 165.09 11.25 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 167.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.954 HG22 ' HA ' ' A' ' 52' ' ' ASP . 31.9 pt -147.98 137.6 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.376 -157.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 1.9 p90 -125.86 176.22 7.11 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.538 156.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.793 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.25 12.4 p -110.15 148.76 31.17 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.302 0.573 . . . . 0.0 111.814 -149.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -71.71 -9.63 58.56 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 120.587 -1.32 . . . . 0.0 109.873 168.092 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.02 -4.74 22.91 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.457 162.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.4 -49.26 2.16 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -166.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -13.6 12.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.367 163.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.48 -64.24 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.331 166.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -12.07 9.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.421 -166.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.478 178.379 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.9 t -129.65 102.42 18.1 Favored Pre-proline 0 C--O 1.242 0.692 0 CA-C-O 121.285 0.564 . . . . 0.0 109.5 -162.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 30' ' ' SER . 2.6 Cg_endo -58.36 -15.06 22.6 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.79 2.327 . . . . 0.0 113.504 170.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -63.76 1.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.463 -167.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -89.04 -34.85 16.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.554 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.7 -31.15 3.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.47 168.99 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.373 -169.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -126.56 145.87 50.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.215 168.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.885 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.8 t -109.15 148.91 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.907 -165.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -125.56 -45.46 1.79 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.516 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.95 -11.0 6.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.355 170.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.6 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 61.76 93.1 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.347 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.885 ' H ' HG11 ' A' ' 18' ' ' VAL . 4.0 mm-40 -107.68 34.36 3.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.764 164.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 124.1 31.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.345 -162.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.883 HG21 ' CD2' ' A' ' 36' ' ' PHE . 2.6 m -97.15 176.33 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.889 160.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.589 ' N ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -145.94 143.49 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.364 167.691 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.91 127.56 1.23 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 169.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 36.78 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.385 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.21 -20.27 48.74 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -86.6 130.44 34.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.382 -173.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 32.4 t -103.82 117.25 33.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.209 166.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.561 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -113.1 -173.43 2.25 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.029 -167.371 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.66 ' NE2' HG22 ' A' ' 18' ' ' VAL . 19.2 m80 -96.07 157.17 16.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.039 163.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -15.98 30.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.603 168.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.8 p -106.9 -27.13 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.353 -171.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -88.03 -17.38 31.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.384 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.94 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -60.6 95.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.431 171.306 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 18.9 ptt85 -133.11 126.73 32.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.316 -169.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 14.3 t -60.26 111.78 1.67 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.125 163.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.0 41.01 1.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.406 167.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.57 -41.26 1.53 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.539 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.2 p -108.5 -27.35 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.485 166.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.49 18.61 25.4 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -98.07 145.98 26.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.377 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 3.9 m -80.77 145.14 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.396 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 59' ' ' CYS . 1.4 pp -168.53 179.11 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.151 167.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.47 -159.34 0.15 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.107 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.91 -86.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.594 167.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 49' ' ' THR . 15.0 t -138.15 42.0 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.367 -166.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.527 ' HA ' ' HB3' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -168.09 40.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.471 -177.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.94 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 1.9 pp -133.45 167.78 19.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.409 -174.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.57 103.53 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.262 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.849 ' HA ' HG22 ' A' ' 57' ' ' ILE . 6.6 p-10 -75.62 168.83 19.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.335 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.47 100.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.482 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 60.88 19.46 9.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.444 165.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.58 -32.0 5.36 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.92 164.55 11.62 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.849 HG22 ' HA ' ' A' ' 52' ' ' ASP . 32.9 pt -148.64 129.99 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.363 -157.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.67 -175.66 3.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.768 162.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.633 ' HB2' HD11 ' A' ' 45' ' ' LEU . 13.7 p -111.61 155.16 23.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 111.166 -153.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 49' ' ' THR . 17.8 tptp -71.16 -14.01 62.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.733 169.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.16 -8.63 31.1 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.111 164.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.56 -46.57 2.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -165.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -14.88 20.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.423 165.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.46 -68.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.398 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -61.11 -25.95 67.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.402 -166.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.469 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.5 t -123.69 102.15 35.81 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -162.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 30' ' ' SER . 2.0 Cg_endo -60.18 -14.12 27.35 Favored 'Trans proline' 0 N--CA 1.485 1.015 0 C-N-CA 122.778 2.319 . . . . 0.0 113.486 167.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.51 ' HD3' ' CZ3' ' A' ' 31' ' ' TRP . 4.8 tpt180 -79.39 -63.26 1.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.341 -167.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.2 p -91.78 -24.11 19.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.512 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.12 -29.55 5.05 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -172.64 1.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.293 -0.454 . . . . 0.0 110.331 -172.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.544 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -146.86 152.23 38.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.189 166.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.791 HG11 ' H ' ' A' ' 22' ' ' GLU . 2.6 t -106.46 166.61 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.556 -166.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -101.39 68.41 1.2 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.467 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.14 16.75 7.46 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.524 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.758 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -91.81 -70.45 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.359 -165.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.791 ' H ' HG11 ' A' ' 18' ' ' VAL . 3.3 mm-40 -106.27 17.12 23.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.123 -167.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.09 106.07 16.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.342 -163.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 36' ' ' PHE . 15.7 m -86.84 -167.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.015 161.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 tt -154.68 150.54 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.428 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.1 -142.01 3.71 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 168.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.419 ' HB3' ' H ' ' A' ' 55' ' ' GLY . . . -71.1 87.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.274 -173.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.78 23.11 60.69 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -113.31 154.59 26.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.4 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.459 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -144.63 120.24 10.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.246 168.368 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.644 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -115.38 166.3 12.03 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.858 -164.602 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.727 ' NE2' HG22 ' A' ' 18' ' ' VAL . 39.5 m80 -80.45 156.23 26.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.004 162.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -60.85 -12.31 10.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.486 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.1 p -115.93 18.3 15.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.412 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.78 11.89 6.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.413 -171.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.757 ' CE1' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -89.38 89.4 7.86 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.268 177.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.11 108.62 19.36 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.456 -173.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 32.2 t -62.91 116.81 5.62 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.399 163.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.63 40.26 1.14 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.387 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -129.27 -49.21 1.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.462 -176.441 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -96.07 -12.19 25.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.081 162.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.81 18.38 56.44 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.378 168.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -106.5 145.14 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.341 -163.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.8 m -69.61 126.28 29.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.668 159.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -90.55 -164.64 1.2 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.736 -158.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.45 88.59 2.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.173 -166.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 64.95 -86.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.483 165.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 p -146.61 67.37 1.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.405 -168.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 2.4 p -152.7 75.02 1.08 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.354 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.757 HD13 ' CE1' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -145.43 -177.35 5.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.376 -166.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.48 104.61 2.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.259 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.584 ' HA ' HG22 ' A' ' 57' ' ' ILE . 2.3 p30 -87.54 154.35 20.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.363 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER 178.81 140.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.425 168.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.34 18.34 9.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.394 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 27' ' ' ALA . . . 106.87 -29.31 10.98 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 168.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -113.11 177.95 4.45 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.93 -0.635 . . . . 0.0 109.966 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 52' ' ' ASP . 35.5 pt -148.25 141.06 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.323 -159.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.508 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 4.2 p90 -130.5 173.7 10.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.333 156.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.792 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.252 11.8 p -109.62 148.22 31.69 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.283 0.563 . . . . 0.0 111.86 -149.257 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.536 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 14.2 tttt -72.49 -9.03 58.04 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 120.387 -1.445 . . . . 0.0 109.853 167.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.7 -4.45 19.54 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.457 161.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.89 -51.51 2.02 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -166.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -14.21 16.92 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.479 166.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.86 -66.0 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.322 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -11.68 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.508 -166.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.378 179.49 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.6 t -128.68 104.18 19.18 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -164.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' A' ' 30' ' ' SER . 5.8 Cg_exo -60.97 -12.32 22.03 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.792 2.328 . . . . 0.0 113.629 171.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.47 ' CB ' ' HB3' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -85.26 -65.58 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.368 -167.272 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -85.46 -27.66 25.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.481 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.72 -31.34 5.77 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.3 150.78 38.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.376 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.537 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -115.49 140.62 48.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.114 166.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.884 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.6 t -102.3 140.17 21.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.942 -162.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -121.07 -39.07 2.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.435 175.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -11.47 8.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.376 168.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.555 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 61.56 95.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.307 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.884 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -117.67 27.72 8.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.613 165.571 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 130.1 36.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.355 -160.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.803 HG23 ' CD1' ' A' ' 31' ' ' TRP . 11.1 m -95.93 -176.31 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.546 158.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.536 ' N ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -144.52 152.41 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.44 167.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.65 137.78 3.91 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . . . 61.55 14.37 5.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.296 174.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.58 -32.93 6.54 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.516 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -61.87 165.66 5.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.245 -0.477 . . . . 0.0 110.422 -170.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.451 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -137.88 124.37 20.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.228 165.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.803 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -117.69 159.64 22.64 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.658 -166.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.686 ' NE2' HG22 ' A' ' 18' ' ' VAL . 36.6 m80 -80.54 156.66 26.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.497 154.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HD2' ' HG3' ' A' ' 22' ' ' GLU . 12.4 ptmt -60.15 -12.81 9.45 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.569 170.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 t -122.47 18.29 10.5 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.481 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.47 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 79.7 m -129.14 34.16 4.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.042 163.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.764 ' HD2' HG21 ' A' ' 24' ' ' VAL . 8.8 t80 -126.04 96.23 4.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.692 -164.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 21.6 ttp180 -127.98 126.63 41.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.228 -164.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 12.2 t -59.29 111.56 1.41 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.411 163.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.43 -24.14 65.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.216 -1.357 . . . . 0.0 110.708 171.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -75.02 0.13 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.308 -173.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p -86.94 -17.14 33.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.585 -170.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.83 19.75 50.05 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.33 129.07 45.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.449 -0.376 . . . . 0.0 110.407 171.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 53.9 p -78.65 121.79 25.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.262 167.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.686 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.1 pp -147.14 -174.18 4.44 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.475 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.04 71.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.778 167.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -95.02 -165.27 1.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.46 -171.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.477 HG23 ' OG1' ' A' ' 49' ' ' THR . 12.5 t -68.48 -12.84 61.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.635 -169.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.477 ' OG1' HG23 ' A' ' 48' ' ' THR . 0.2 OUTLIER -139.62 136.3 34.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.518 -173.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.592 HD22 ' HZ ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -138.41 163.32 32.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.193 162.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB3' ' HD1' ' A' ' 58' ' ' TYR . . . -128.3 75.58 1.63 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.294 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 2.0 p30 -69.04 151.15 46.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.387 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.57 135.41 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.415 168.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 p30 61.06 22.11 12.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.554 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.01 -37.99 3.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -103.91 -171.31 1.91 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.968 -0.616 . . . . 0.0 110.043 -177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.781 HD13 ' CH2' ' A' ' 31' ' ' TRP . 27.5 pt -149.62 165.19 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.181 -160.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HD1' ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -133.72 170.06 16.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.696 162.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.686 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.5 p -104.88 155.9 18.51 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.253 0.549 . . . . 0.0 111.097 -152.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 1.0 OUTLIER -61.42 -22.68 65.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.022 166.487 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.49 -5.89 38.79 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.538 174.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -118.43 -45.4 2.62 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -165.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.5 -15.0 22.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.309 165.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.7 -70.49 0.71 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.387 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -61.05 -12.58 12.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.338 -165.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.379 177.503 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.2 t -123.95 100.55 36.75 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -167.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 30' ' ' SER . 2.8 Cg_exo -60.3 -13.27 23.58 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.82 2.347 . . . . 0.0 113.539 171.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.54 ' HD3' ' HB3' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -83.79 -63.24 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.444 -165.806 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -85.0 -26.08 27.32 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.504 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.41 -23.43 6.78 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 172.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.39 176.34 9.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.361 -171.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -130.67 155.55 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.227 167.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.839 HG11 ' H ' ' A' ' 22' ' ' GLU . 6.9 t -110.16 142.13 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.226 -167.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.56 -30.91 3.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.417 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.52 17.94 10.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.456 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' N ' HG12 ' A' ' 18' ' ' VAL . . . 61.19 94.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.301 165.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.839 ' H ' HG11 ' A' ' 18' ' ' VAL . 2.8 mt-10 -122.68 26.93 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.712 163.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.88 112.56 24.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.285 -162.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.875 HG21 ' CD2' ' A' ' 36' ' ' PHE . 10.8 m -80.95 -172.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.862 160.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -142.22 144.45 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.5 171.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.4 ' N ' HG13 ' A' ' 25' ' ' ILE . . . -136.55 96.33 0.25 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 -82.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.982 -0.609 . . . . 0.0 110.379 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.63 39.52 1.78 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 168.47 13.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.384 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.456 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -145.97 131.77 19.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.293 168.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.595 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -129.05 159.45 35.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.061 -165.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.734 ' NE2' HG22 ' A' ' 18' ' ' VAL . 25.9 m80 -71.55 147.66 47.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.05 165.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HG3' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.53 69.05 1.2 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.659 159.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.3 -42.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.913 -171.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.54 ' HB3' ' HD3' ' A' ' 13' ' ' ARG . 61.3 m -94.38 17.07 13.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.269 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.946 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -100.68 72.55 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.096 -164.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 16.1 mtt180 -93.28 117.04 29.6 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.376 -171.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 13.4 t -60.21 109.43 0.98 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.192 165.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.83 -22.64 65.14 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.424 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HD3' ' HB3' ' A' ' 58' ' ' TYR . 1.3 ttpp -71.25 -66.18 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.562 -167.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.7 p -89.77 -29.33 18.75 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.682 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.18 -25.5 6.68 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.8 129.36 39.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.354 -169.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 77.7 p -87.17 105.88 17.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.367 169.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.688 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -126.09 -171.14 2.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.263 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -131.45 -173.47 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.051 -161.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.856 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -64.25 170.29 3.88 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.281 -172.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 49' ' ' THR . 15.8 p 59.07 13.43 2.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.972 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 48' ' ' THR . 10.4 p -155.29 43.13 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.48 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.946 HD22 ' CE2' ' A' ' 36' ' ' PHE . 2.5 pp -129.98 174.21 9.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.332 -173.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.51 119.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.313 169.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -98.68 169.07 9.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.326 -172.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? 178.39 131.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.45 167.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 60.78 19.72 9.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.39 164.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.01 -19.94 52.83 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -105.06 168.09 9.29 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 169.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.583 HD12 ' CD1' ' A' ' 36' ' ' PHE . 29.7 pt -141.93 142.33 28.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.521 -158.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.524 ' HB3' ' HD3' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -133.18 -175.26 3.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.56 158.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.688 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.1 p -111.01 162.04 15.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.175 0.512 . . . . 0.0 110.727 -153.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -77.21 -12.71 59.98 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.927 169.273 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.89 -10.14 37.48 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.15 164.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.26 -50.52 2.56 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -164.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -59.88 -17.67 38.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.543 166.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.24 -66.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.289 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -60.85 -12.65 11.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.438 -166.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.425 -178.252 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.525 0.707 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 7.1 t -130.0 109.01 16.77 Favored Pre-proline 0 C--O 1.246 0.897 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -160.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 7.2 Cg_endo -58.13 -19.29 40.64 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.975 2.45 . . . . 0.0 113.598 165.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.437 ' HD2' ' HA ' ' A' ' 13' ' ' ARG . 11.5 tpt180 -80.51 -73.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.403 -170.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.21 -11.76 48.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.601 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.6 18.17 76.15 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.36 -169.99 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.181 166.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -152.55 146.57 25.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.212 165.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.842 HG22 ' HE2' ' A' ' 32' ' ' HIS . 2.4 t -101.47 178.11 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.295 -164.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.667 ' H ' HG12 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -91.7 46.79 1.31 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.551 172.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 19' ' ' TYR . . . 61.62 29.97 18.41 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.291 -174.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.841 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -93.99 -70.84 0.69 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.377 -159.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.838 ' CD ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -94.32 -9.75 34.92 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.907 -151.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.52 ' H ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -58.89 124.77 20.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.495 -146.136 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.86 HG21 ' CD2' ' A' ' 36' ' ' PHE . 10.0 m -93.08 175.03 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.721 158.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 29' ' ' LYS . 4.4 mp -142.3 153.15 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.382 166.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.02 135.58 4.84 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 169.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.57 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.99 -0.605 . . . . 0.0 110.291 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.61 20.43 1.84 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.624 ' O ' HG23 ' A' ' 25' ' ' ILE . 25.8 mmtm -103.65 168.31 9.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.392 -171.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.406 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 39.0 t -143.52 149.99 38.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.229 167.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.67 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -143.88 176.3 9.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.906 -168.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.842 ' HE2' HG22 ' A' ' 18' ' ' VAL . 67.3 m80 -90.57 164.21 14.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.507 160.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -30.12 63.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.429 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -81.44 -18.31 45.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.428 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.49 -15.2 43.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.446 -170.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.903 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -68.85 110.11 4.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.327 -171.141 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.63 99.79 7.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.344 -170.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 29.7 t -63.35 116.48 5.55 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.381 165.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.84 42.76 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.341 168.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.468 ' HD3' ' CB ' ' A' ' 58' ' ' TYR . 20.9 tttm -129.22 -46.95 1.21 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.491 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.3 p -96.57 -13.32 23.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.893 161.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.89 18.24 54.71 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.498 167.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.33 148.76 30.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.005 0.431 . . . . 0.0 110.404 -164.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -68.98 138.24 54.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.636 158.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.779 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -102.37 -164.88 1.13 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.776 -158.475 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -123.27 170.7 10.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.077 -170.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.2 p -60.89 -13.31 14.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.397 167.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.8 p -60.89 -177.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.486 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.629 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -83.54 -174.12 5.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.441 -168.525 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.903 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -154.45 -171.06 3.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.397 -170.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.06 104.12 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.225 170.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.513 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.1 p30 -79.38 157.24 27.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.371 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -179.94 112.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.517 -171.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 p30 61.27 20.45 11.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.615 170.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.73 -24.62 30.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 168.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 11.4 pt-20 -99.04 -174.75 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 168.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.788 HD12 ' CD1' ' A' ' 36' ' ' PHE . 16.9 pt -157.1 139.68 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.255 -160.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CB ' ' HD3' ' A' ' 40' ' ' LYS . 25.1 p90 -130.68 176.48 8.15 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.817 159.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.779 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.251 11.9 p -110.76 148.2 32.82 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 111.795 -150.413 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 4.4 tttm -72.0 -9.38 58.3 Favored 'General case' 0 C--N 1.345 0.375 0 O-C-N 120.403 -1.436 . . . . 0.0 109.883 167.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.26 -3.54 18.96 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.501 161.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -122.42 -49.93 2.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -167.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -59.96 -12.36 7.75 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.339 165.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.76 -61.22 1.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.369 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -60.95 -14.56 23.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.318 -166.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.444 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.527 0.793 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -136.31 112.03 10.08 Favored Pre-proline 0 C--O 1.245 0.848 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -158.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 30' ' ' SER . 8.8 Cg_exo -55.67 -17.2 16.96 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 C-N-CA 122.99 2.46 . . . . 0.0 113.53 164.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HD3' ' CE3' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -89.27 -70.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.466 -166.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 p -88.57 -26.06 22.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.577 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.7 44.83 4.76 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -124.7 144.01 50.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.985 -0.607 . . . . 0.0 110.29 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.536 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -96.23 142.05 28.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.183 167.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.883 HG11 ' H ' ' A' ' 22' ' ' GLU . 6.1 t -108.22 135.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.144 -164.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -61.48 -76.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.405 -166.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.03 -83.18 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.168 168.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.4 126.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.155 166.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.883 ' H ' HG11 ' A' ' 18' ' ' VAL . 1.5 mm-40 -114.41 17.67 17.31 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.455 164.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.54 ' HD2' ' H ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -97.41 170.59 8.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.091 -159.268 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 31' ' ' TRP . 1.1 p -164.33 156.6 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.608 -148.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 25' ' ' ILE . 3.0 tp -139.8 118.28 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.442 -168.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.46 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -99.09 171.3 24.42 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 160.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.647 ' HB3' ' H ' ' A' ' 55' ' ' GLY . . . -61.37 -13.31 18.78 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.001 0.429 . . . . 0.0 110.619 -167.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.449 ' N ' ' HA2' ' A' ' 55' ' ' GLY . . . -128.04 -18.7 1.87 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -140.59 158.41 44.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.378 -162.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.421 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -121.78 146.38 47.12 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.026 164.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.784 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -146.6 177.47 9.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.915 -163.501 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.564 ' NE2' HG22 ' A' ' 18' ' ' VAL . 13.7 m80 -85.84 158.35 19.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.898 161.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -60.33 -26.51 66.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.474 165.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.487 ' H ' ' HB3' ' A' ' 32' ' ' HIS . 59.8 p -116.71 18.44 14.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.469 -171.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.7 m -120.23 14.33 12.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.184 163.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CD1' HD22 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -92.71 108.19 19.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.276 -166.288 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -126.78 125.62 42.03 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.231 -165.065 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.5 t -57.52 107.6 0.46 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.755 162.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.11 -24.77 68.05 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.546 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.533 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -79.26 -76.38 0.21 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.522 -175.534 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.9 p -79.21 -18.0 53.77 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.431 -163.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.07 13.84 58.43 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -90.34 108.46 19.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.243 -0.478 . . . . 0.0 110.401 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 47.1 m -74.33 107.44 6.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.227 167.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.662 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -138.22 -172.86 3.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.306 -177.647 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.648 ' C ' HD23 ' A' ' 50' ' ' LEU . 1.7 mp0 -119.54 -177.37 3.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.068 -160.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.511 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 2.0 m -61.11 -46.36 90.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.457 -168.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.4 m -60.9 -13.64 17.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.457 -171.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 60' ' ' LYS . 6.9 m -145.12 41.49 1.27 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.374 -175.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.771 HD12 ' N ' ' A' ' 51' ' ' ALA . 2.0 pp -137.8 -175.46 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.375 170.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.771 ' N ' HD12 ' A' ' 50' ' ' LEU . . . -159.16 146.38 17.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.268 168.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.46 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 10.2 p-10 -89.55 143.8 26.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.383 169.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.48 99.83 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.392 -168.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 60.99 26.63 16.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.4 165.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.647 ' H ' ' HB3' ' A' ' 27' ' ' ALA . . . 103.75 -26.86 21.97 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 170.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -104.88 172.2 6.91 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.726 HD13 ' CH2' ' A' ' 31' ' ' TRP . 30.1 pt -130.71 158.82 43.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.307 -159.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.533 ' CE2' ' HG3' ' A' ' 40' ' ' LYS . 1.9 t80 -179.15 144.34 0.23 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.97 -159.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.662 ' SG ' HD21 ' A' ' 45' ' ' LEU 0.252 9.6 p -101.46 157.15 17.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.314 0.578 . . . . 0.0 111.283 -148.585 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.514 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -74.83 -14.77 60.72 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.703 169.224 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.18 -9.43 29.29 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.072 166.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -118.22 -46.79 2.59 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -165.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.94 -10.03 3.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.486 167.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.43 -66.33 0.93 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.52 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -59.83 -31.9 70.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.056 -158.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.393 175.55 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.595 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 t -123.84 101.51 36.01 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -167.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' A' ' 30' ' ' SER . 3.5 Cg_exo -59.95 -14.1 26.18 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 122.885 2.39 . . . . 0.0 113.47 167.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -80.07 -62.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.436 -167.145 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -91.26 -25.53 19.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.499 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.8 18.62 17.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -101.23 171.33 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.323 168.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -130.21 147.67 51.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.171 167.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.855 HG11 ' H ' ' A' ' 22' ' ' GLU . 4.5 t -106.04 141.51 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.136 -165.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -124.86 -31.97 3.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.374 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.95 18.81 9.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.33 170.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.17 97.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.286 166.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.855 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -125.74 23.79 7.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.623 163.552 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 117.75 30.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.316 -161.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.847 HG21 ' CE2' ' A' ' 36' ' ' PHE . 9.2 m -81.97 -176.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.707 159.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 pt -142.98 138.22 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.485 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 52' ' ' ASP . . . -126.5 -139.27 5.01 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 168.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.79 83.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.271 -169.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.57 19.4 54.13 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -170.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.77 167.89 9.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.932 0.396 . . . . 0.0 110.338 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -148.9 147.73 29.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.131 166.236 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.723 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -143.82 158.06 43.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.833 -164.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.713 ' NE2' HG22 ' A' ' 18' ' ' VAL . 44.1 m80 -78.41 154.96 30.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.988 161.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -23.05 64.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.505 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -84.45 -29.19 26.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.347 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.1 m -95.14 15.95 17.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.453 -167.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.913 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -100.59 101.7 12.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.412 -166.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.623 ' O ' HD11 ' A' ' 57' ' ' ILE . 8.1 mtp180 -124.94 125.03 43.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.295 -168.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.9 t -64.44 109.77 2.06 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.502 170.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.94 67.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.448 171.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -74.5 -74.27 0.2 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.332 -170.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -87.3 -11.13 50.45 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.645 -169.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.69 17.19 79.19 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.426 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -92.74 113.8 26.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.315 167.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 54.3 p -83.6 115.25 22.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.074 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.654 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -129.63 -171.18 2.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.86 -171.364 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -172.88 176.46 3.07 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 112.672 -2.058 . . . . 0.0 109.946 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.1 t 66.73 -61.98 0.3 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.458 170.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -177.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.368 166.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -92.17 -177.51 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.475 -164.405 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.913 HD22 ' CE2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -148.77 -166.24 2.5 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.334 -171.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.38 94.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.327 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.542 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 8.7 p-10 -65.37 161.95 18.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.442 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 tttt 179.92 124.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.358 168.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 70.34 -92.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.395 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.83 18.34 3.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.16 -171.53 3.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.263 -0.469 . . . . 0.0 109.884 -170.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.788 HD12 ' CD1' ' A' ' 36' ' ' PHE . 32.6 pt -150.46 157.64 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.243 -160.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -141.72 170.03 16.49 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.388 161.608 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.654 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.5 p -104.5 168.61 8.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.196 0.522 . . . . 0.0 110.84 -151.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 2.5 tptp -80.67 -14.82 57.81 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.086 168.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.37 -9.75 32.04 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.999 166.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.1 m -118.6 -48.83 2.47 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -164.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -59.6 -17.11 30.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.513 164.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.63 -57.64 3.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.336 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -11.32 10.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.491 -173.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.433 173.826 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.3 t -127.66 109.25 20.66 Favored Pre-proline 0 C--O 1.246 0.9 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -164.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 30' ' ' SER . 7.3 Cg_exo -65.06 -15.72 51.81 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.701 2.267 . . . . 0.0 113.707 171.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HD2' ' CE3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -77.0 -76.21 0.18 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.411 -178.813 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 p -85.63 -15.81 41.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.498 -166.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.12 22.67 31.86 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 171.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.42 156.04 19.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.983 -0.609 . . . . 0.0 110.399 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.533 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -113.51 142.99 45.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.191 167.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.892 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.5 t -105.22 136.31 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.932 -164.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.47 121.51 45.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.059 168.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.73 98.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.844 -160.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.625 ' HB1' ' HG3' ' A' ' 23' ' ' LYS . . . -60.04 123.85 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.4 -160.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.892 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -98.54 15.95 23.39 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.444 165.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HG3' ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -100.02 -178.27 3.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.126 -160.592 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 25' ' ' ILE . 3.7 p -164.91 179.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.973 -147.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.578 ' H ' HG22 ' A' ' 24' ' ' VAL . 12.5 pt -140.05 142.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.404 -172.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.51 117.3 0.78 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 167.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.896 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . . . 61.89 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.395 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.39 -18.93 1.25 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -88.76 149.35 23.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.433 -0.383 . . . . 0.0 110.338 -168.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.435 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 39.8 m -105.71 144.76 32.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.168 166.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.531 ' CE3' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -144.64 -170.91 3.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.818 -168.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.644 ' NE2' HG22 ' A' ' 18' ' ' VAL . 41.5 m80 -102.51 161.83 13.4 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.652 163.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HG2' ' HB3' ' A' ' 47' ' ' SER . 0.1 OUTLIER -62.64 129.72 41.82 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.671 154.604 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.6 p 69.11 13.06 8.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.475 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 1.1 m -99.79 -20.87 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.537 156.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.762 ' CE1' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -61.9 104.45 0.45 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.307 174.575 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.506 ' HG3' ' NH1' ' A' ' 13' ' ' ARG . 4.3 mmt180 -113.03 100.43 8.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.371 -167.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 27.0 t -62.91 116.28 5.14 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.499 164.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.11 42.8 1.08 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.413 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -130.74 -51.55 1.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.49 -177.451 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.5 p -93.18 -13.02 28.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.04 161.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.92 18.18 56.6 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.408 167.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -109.05 148.93 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.024 0.44 . . . . 0.0 110.446 -164.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.5 p -70.13 139.11 52.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.631 159.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.795 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -103.46 -163.65 1.0 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.027 -157.371 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -104.78 -162.24 0.87 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.126 169.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -94.34 -35.44 12.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.362 -168.658 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.5 t -139.67 37.71 2.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.4 -168.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.472 ' CB ' ' HB3' ' A' ' 60' ' ' LYS . 1.2 p -142.08 83.53 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.549 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.762 HD13 ' CE1' ' A' ' 36' ' ' PHE . 2.8 pp -153.22 165.06 36.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.386 -171.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 58' ' ' TYR . . . -146.61 115.97 7.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.314 -177.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.896 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -94.06 161.05 14.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.416 -178.182 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.79 115.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.34 -174.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.18 14.74 6.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.511 169.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.06 -18.36 56.83 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -104.62 171.55 7.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.725 HD12 ' HD1' ' A' ' 36' ' ' PHE . 17.3 pt -148.97 137.42 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.349 -158.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 3.5 p90 -126.21 172.81 9.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.478 156.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.795 ' HB2' HD11 ' A' ' 45' ' ' LEU . 12.5 p -108.77 147.17 32.44 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.339 0.59 . . . . 0.0 111.759 -148.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.487 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -69.61 -9.84 55.74 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.319 -1.488 . . . . 0.0 109.803 167.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.11 -2.47 25.21 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.59 163.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -122.59 -50.06 1.99 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -167.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -60.21 -12.45 8.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.376 165.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.56 -65.64 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.376 169.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -25.85 67.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.439 -165.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.624 -179.716 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 N--CA 1.465 0.607 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 t -125.89 99.7 31.7 Favored Pre-proline 0 C--O 1.244 0.781 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -162.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' O ' ' A' ' 30' ' ' SER . 1.1 Cg_endo -59.95 -13.78 24.63 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 122.864 2.376 . . . . 0.0 113.443 164.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -59.33 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.462 -165.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.5 p -93.0 -39.97 10.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.503 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.23 -45.23 0.87 Allowed Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.512 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -171.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.321 -167.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -151.03 149.55 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.231 165.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.796 HG11 ' H ' ' A' ' 22' ' ' GLU . 2.1 t -123.17 142.97 37.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.019 -165.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -125.26 12.87 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.518 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.44 ' H ' HG12 ' A' ' 18' ' ' VAL . . . -175.14 -38.89 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.407 176.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.776 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -60.75 -79.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.368 -158.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.796 ' H ' HG11 ' A' ' 18' ' ' VAL . 13.4 mm-40 -135.97 11.78 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.484 -157.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -79.78 155.23 28.0 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.118 -164.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -154.47 175.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.551 -151.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.566 ' N ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -149.0 141.89 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.539 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.4 ' CA ' ' HB3' ' A' ' 52' ' ' ASP . . . -147.39 107.76 0.4 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 165.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.75 -82.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.173 -0.513 . . . . 0.0 110.32 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.03 21.56 3.15 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -168.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.27 154.34 37.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.255 -0.473 . . . . 0.0 110.41 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 4.1 p -119.71 139.26 52.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.397 168.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.755 ' CH2' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -145.68 160.43 41.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.791 -170.594 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.651 ' CD2' HG21 ' A' ' 18' ' ' VAL . 51.2 m80 -80.49 161.44 24.85 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.361 158.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.597 ' CG ' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.73 133.39 43.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.784 154.532 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 72.33 9.52 5.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.583 -160.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 3.4 m -113.78 -29.59 7.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 155.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.941 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -60.04 110.47 1.21 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.611 174.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.57 ' O ' HD11 ' A' ' 57' ' ' ILE . 1.6 mtt180 -124.93 125.12 43.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.216 -169.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 8.5 t -61.51 112.81 2.36 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.632 166.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.11 18.95 7.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.541 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HB2' ' CD2' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -96.2 -76.3 0.51 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.286 161.654 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -85.04 -22.65 28.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.576 -165.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.06 32.34 6.49 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.38 122.05 46.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.417 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.463 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 24.9 p -78.89 112.14 15.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.394 165.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.672 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.7 OUTLIER -149.62 -168.81 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.554 -174.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -170.29 -82.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.907 162.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.6 p 67.23 -67.11 0.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.069 169.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.2 -87.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.404 -167.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.469 ' CB ' ' HB3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -87.17 117.63 26.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.458 -166.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.941 HD22 ' CE2' ' A' ' 36' ' ' PHE . 3.5 pp -125.22 154.53 41.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.143 173.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -142.87 97.9 3.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.331 -164.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HB3' ' CA ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER -89.3 153.07 21.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.313 -176.541 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.61 136.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.342 168.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.84 35.6 13.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.385 171.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.97 -18.33 57.55 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.75 -170.81 2.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -167.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.922 HD12 ' CD1' ' A' ' 36' ' ' PHE . 15.6 pt -149.82 158.82 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.093 -158.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -139.46 173.46 11.52 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.166 164.149 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.672 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.4 p -107.67 158.07 17.57 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.14 0.495 . . . . 0.0 111.134 -154.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -60.11 -26.96 66.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.295 164.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.431 ' N ' ' CD ' ' A' ' 60' ' ' LYS . . . -65.92 -5.75 27.38 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.331 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -118.79 -45.04 2.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -165.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.48 -18.8 53.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.368 163.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.75 -45.53 7.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.282 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . 3.9 tmmm? -61.21 -29.35 69.77 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.452 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.402 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.533 1.2 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.524 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 6.6 t -142.35 106.37 5.58 Favored Pre-proline 0 C--O 1.248 0.977 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -150.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.18 -14.32 23.43 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 C-N-CA 122.959 2.439 . . . . 0.0 113.403 165.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.51 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -82.69 -64.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.449 -167.251 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.59 -27.76 18.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.672 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.31 18.51 35.96 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -95.86 -168.97 1.85 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.203 167.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.523 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -164.72 147.63 8.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.167 164.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.861 HG11 ' H ' ' A' ' 22' ' ' GLU . 62.8 t -146.35 141.02 21.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 -156.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.31 -18.59 10.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.448 168.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.75 39.37 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.111 -162.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.575 ' H ' ' CG1' ' A' ' 18' ' ' VAL . . . -137.19 -78.95 0.39 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.418 162.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.861 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -126.96 6.65 6.6 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.869 -165.028 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 124.89 22.33 Favored 'General case' 0 C--O 1.231 0.093 0 O-C-N 121.228 -0.92 . . . . 0.0 110.443 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.709 HG21 ' CD2' ' A' ' 36' ' ' PHE . 2.7 m -109.56 -179.8 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.971 161.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 tt -148.77 144.6 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.355 164.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.18 107.56 0.32 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.22 30.16 19.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.348 -0.426 . . . . 0.0 110.319 168.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.08 -37.24 3.81 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -72.91 160.77 31.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.301 -0.45 . . . . 0.0 110.32 -170.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -132.44 134.26 44.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.373 168.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.714 ' CZ3' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -133.27 179.22 6.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.551 -169.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.661 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 39.5 m80 -118.81 160.75 21.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.296 156.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HB3' ' HG2' ' A' ' 46' ' ' GLU . 17.5 mtmt -61.53 -45.77 92.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.424 -172.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.429 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -61.08 -35.43 76.96 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.512 176.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.51 ' HB3' ' HG2' ' A' ' 13' ' ' ARG . 76.9 m -77.66 -16.62 58.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.639 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.884 ' CD1' HD12 ' A' ' 57' ' ' ILE . 1.9 t80 -67.11 104.34 1.4 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.365 -168.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.583 ' O ' HD11 ' A' ' 57' ' ' ILE . 9.6 mtp180 -116.79 121.63 42.11 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.307 -166.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.2 t -58.44 118.17 5.28 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.768 168.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.21 28.89 2.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.451 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -114.15 -73.82 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.258 159.348 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 22.5 p -79.28 -7.43 58.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.656 -168.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.2 17.71 68.41 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.456 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.809 ' HD2' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -85.56 110.45 19.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.278 166.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.507 ' HB2' ' HG2' ' A' ' 37' ' ' ARG . 40.4 t -79.41 103.03 9.06 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.181 171.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.809 HD23 ' HD2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -116.87 -168.39 1.45 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.562 -175.363 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.58 ' HG2' ' HB3' ' A' ' 33' ' ' LYS . 1.7 tt0 -172.23 156.52 3.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 113.146 -1.843 . . . . 0.0 110.098 -161.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.46 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 21.9 p 60.66 10.81 2.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.492 166.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 p -138.85 163.68 31.62 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.216 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.468 ' CA ' ' HB2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -62.36 172.21 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.514 -165.027 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.869 HD22 ' CE2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -153.54 -163.51 1.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.299 -172.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -174.36 97.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.25 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 3.6 p30 -85.94 131.98 34.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.363 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -153.76 147.51 25.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.325 166.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 61.12 30.04 19.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.302 168.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.99 -25.06 29.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -120.35 -171.76 2.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.245 -0.477 . . . . 0.0 109.972 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.884 HD12 ' CD1' ' A' ' 36' ' ' PHE . 35.2 pt -142.86 178.7 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.465 -157.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 62' ' ' CYS . 87.8 t80 -170.05 143.76 2.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.21 -174.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.661 ' SG ' HD21 ' A' ' 45' ' ' LEU . 13.8 p -97.49 167.15 11.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.149 0.5 . . . . 0.0 111.023 -146.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.468 ' HB2' ' CA ' ' A' ' 49' ' ' THR . 1.6 tttp -77.69 -16.98 58.12 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.025 168.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.22 -9.1 40.31 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.324 170.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 58' ' ' TYR . 1.2 m -119.03 -49.35 2.41 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -165.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -60.02 -13.81 13.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.366 166.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.08 -70.19 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.416 168.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -32.69 72.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.418 -165.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.2 t30 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.406 -169.455 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.633 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.1 t -124.56 108.98 28.7 Favored Pre-proline 0 C--O 1.246 0.887 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -167.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 30' ' ' SER . 8.1 Cg_exo -59.14 -15.35 27.9 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 122.808 2.338 . . . . 0.0 113.592 168.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -84.8 -69.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.469 -168.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -89.8 -16.14 30.83 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.547 -173.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.82 18.15 70.92 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -96.97 138.92 33.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 110.245 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -102.63 142.84 33.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.25 175.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.917 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.3 t -105.77 136.14 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.967 -164.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -99.09 -72.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.183 172.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 18' ' ' VAL . . . -61.8 97.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.978 162.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 113.27 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.451 -160.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.917 ' H ' HG11 ' A' ' 18' ' ' VAL . 3.9 tp10 -112.99 26.53 10.41 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.607 174.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.687 ' HD2' ' H ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -100.05 164.38 12.01 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.034 -161.644 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 31' ' ' TRP . 1.1 p -156.08 172.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.7 -148.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 mt -145.96 145.16 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.631 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.87 111.89 0.5 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . . . 61.97 -82.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.35 -170.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.45 13.61 1.4 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -170.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -106.77 148.22 28.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.365 176.607 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.424 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -110.91 142.18 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.317 169.089 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.746 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -150.45 -176.7 5.59 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.686 -168.409 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.676 ' NE2' HG22 ' A' ' 18' ' ' VAL . 18.8 m80 -93.17 163.84 13.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.121 169.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.527 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 1.4 mmtp -62.86 -16.18 57.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.557 170.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -126.97 23.14 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.424 -172.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.425 ' HB2' ' H ' ' A' ' 32' ' ' HIS . 8.3 m -120.68 -11.96 8.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.515 175.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.564 ' CD1' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -61.18 108.63 0.93 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.313 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -111.7 103.26 11.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.378 -167.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 31.8 t -63.14 116.66 5.6 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.389 163.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.93 42.65 1.08 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.462 168.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.54 -52.72 1.08 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.517 -177.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.7 p -91.87 -11.13 37.25 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.985 161.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.32 18.65 62.05 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.479 167.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.25 149.53 30.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.127 0.489 . . . . 0.0 110.436 -164.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -68.15 138.88 56.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.736 160.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.784 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -102.83 -164.89 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.711 -159.585 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -144.95 -165.42 2.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.031 -168.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.2 p -76.64 -17.81 58.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.394 -170.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 p -61.06 143.6 55.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.362 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.67 -164.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.458 -170.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.511 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -155.9 -170.55 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.333 -173.523 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.31 79.18 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.325 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.594 ' CB ' HG22 ' A' ' 57' ' ' ILE . 4.6 p30 -73.6 156.39 38.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.401 174.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 179.67 136.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.445 168.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.1 t70 61.57 19.96 10.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.367 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.97 17.91 60.48 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 171.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.1 178.05 7.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 166.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.594 HG22 ' CB ' ' A' ' 52' ' ' ASP . 33.8 pt -154.13 135.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.426 -159.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -130.19 175.48 8.88 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.741 160.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.784 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.254 11.7 p -110.34 147.88 33.05 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.381 0.61 . . . . 0.0 111.857 -149.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.29 -9.76 58.65 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 120.441 -1.412 . . . . 0.0 109.856 168.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.86 -4.92 22.67 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.468 162.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.46 -48.07 2.2 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -166.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -60.09 -10.37 4.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.461 165.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.01 -45.13 5.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.491 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.8 20.28 6.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.462 -172.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.3 165.578 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.527 0.793 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.5 t -132.38 101.71 14.52 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -160.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 30' ' ' SER . 1.4 Cg_endo -59.93 -14.12 26.15 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 122.697 2.265 . . . . 0.0 113.483 167.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -81.22 -62.25 1.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.412 -166.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -88.8 -17.76 29.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.484 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.37 -13.83 54.69 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -79.45 175.51 10.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.396 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.518 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -131.84 172.92 11.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.987 163.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.882 HG11 ' H ' ' A' ' 22' ' ' GLU . 2.6 t -119.67 158.74 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.811 -172.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.433 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.5 m-85 -94.96 38.33 1.13 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.428 177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.51 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . . . 61.88 68.05 0.72 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.079 -167.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.844 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -129.13 -63.72 0.94 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.444 -174.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.882 ' H ' HG11 ' A' ' 18' ' ' VAL . 16.9 mm-40 -117.9 27.61 8.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.081 -173.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -87.32 112.92 22.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.297 -167.06 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.944 HG21 ' CD2' ' A' ' 36' ' ' PHE . 15.5 m -97.99 -178.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.154 165.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 pp -139.87 159.96 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.481 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.84 87.1 0.16 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.252 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.05 -18.91 10.66 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.524 ' HB3' ' NE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -72.42 159.6 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.431 -0.384 . . . . 0.0 110.349 -169.596 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 98.8 p -147.86 123.53 10.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.157 167.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.799 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -122.66 178.48 4.99 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.799 -165.414 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.79 ' NE2' HG22 ' A' ' 18' ' ' VAL . 20.0 m80 -94.04 162.15 14.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.875 160.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.8 mttp -60.38 -42.45 95.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.449 167.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -95.78 21.14 8.84 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.69 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 16.6 m -120.68 -19.55 7.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.382 167.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.944 ' CD2' HG21 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -60.57 113.02 2.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.329 175.018 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.802 ' CZ ' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -138.67 127.03 22.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.282 -172.178 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 14.0 t -58.56 112.81 1.73 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.631 165.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.802 ' HB2' ' CZ ' ' A' ' 37' ' ' ARG . . . -91.2 23.01 3.49 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.631 171.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.97 -75.7 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.491 170.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.1 p -75.67 -21.54 57.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.562 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.15 -17.82 40.35 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.459 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.85 128.91 36.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.162 0.506 . . . . 0.0 110.388 -170.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -64.94 140.02 58.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.08 164.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.821 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.8 OUTLIER -163.62 -176.25 4.57 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.16 165.542 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.566 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -172.32 -157.63 0.11 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.381 -160.749 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.71 -87.29 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.74 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.38 15.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.241 -174.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.723 HG22 ' C ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -118.19 45.19 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.331 -171.6 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 46' ' ' GLU . 3.9 pp -142.8 168.79 18.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.452 -177.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.71 125.97 12.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.357 173.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.708 ' CB ' HG22 ' A' ' 57' ' ' ILE . 3.6 p-10 -124.64 146.65 48.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.427 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.66 156.32 0.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.449 167.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 61.27 19.76 10.42 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.554 172.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.83 -27.4 20.38 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 166.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.443 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -117.23 178.62 4.3 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.044 -0.578 . . . . 0.0 109.899 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.708 HG22 ' CB ' ' A' ' 52' ' ' ASP . 35.0 pt -156.2 135.83 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.446 -160.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -134.02 177.73 7.51 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 156.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.821 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.258 12.4 p -113.92 152.29 31.01 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.992 0.901 . . . . 0.0 113.17 -143.386 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.723 ' C ' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -84.91 -0.29 53.66 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 119.476 -2.015 . . . . 0.0 110.352 166.158 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.525 ' N ' HG22 ' A' ' 49' ' ' THR . . . -58.09 -15.25 20.94 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 151.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 -51.78 2.43 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -157.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -60.08 -14.85 18.76 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.474 167.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.5 -66.12 0.95 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.39 167.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -41.23 94.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.493 -164.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.352 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 t -124.41 113.34 27.63 Favored Pre-proline 0 C--O 1.244 0.789 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -157.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.429 ' HG2' ' O ' ' A' ' 30' ' ' SER . 6.8 Cg_endo -63.4 -7.04 11.35 Favored 'Trans proline' 0 N--CA 1.484 0.916 0 C-N-CA 122.686 2.258 . . . . 0.0 113.696 171.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.512 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -92.09 -70.27 0.7 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.407 -174.102 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.4 p -91.22 -29.99 16.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.63 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 48.35 2.72 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.52 157.42 33.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.399 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -113.88 137.74 51.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.171 168.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.909 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.2 t -113.41 134.48 56.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.865 -163.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -94.2 -69.44 0.75 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.382 -167.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 -10.33 5.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.4 167.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.74 111.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.329 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.909 ' H ' HG11 ' A' ' 18' ' ' VAL . 9.0 tt0 -114.4 31.55 6.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.535 172.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.52 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 4.5 mtpm? -106.48 -175.14 2.71 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.171 -160.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 31' ' ' TRP . 2.1 p -169.05 161.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.768 -148.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -141.21 144.74 25.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.45 -171.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.512 ' HA3' ' HB3' ' A' ' 52' ' ' ASP . . . -163.99 135.65 3.88 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 167.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 53' ' ' LYS . . . 61.55 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.334 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.89 16.87 0.82 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -173.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.12 140.33 52.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.375 -168.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.51 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -104.67 145.59 30.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.305 168.675 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.771 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -149.71 163.94 36.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.595 -170.539 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 17.9 m80 -74.26 144.66 44.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.734 158.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 4.1 mttm -60.27 -21.54 62.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.487 169.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -111.21 18.16 19.59 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.51 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 21.3 m -119.79 16.38 12.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.215 166.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.957 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -98.11 110.64 23.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.263 -163.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.529 ' O ' HD11 ' A' ' 57' ' ' ILE . 7.7 ttp-105 -122.61 120.62 34.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.278 -164.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.1 t -58.42 111.83 1.37 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.728 164.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.47 -24.6 67.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.681 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.551 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -75.99 -78.82 0.11 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.26 -176.32 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.7 p -84.75 -9.12 58.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.783 -163.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.78 15.69 74.8 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.929 ' HG2' HD23 ' A' ' 45' ' ' LEU . 8.6 tptm -88.78 103.07 15.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.415 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 14.3 t -71.15 92.38 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.105 166.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.929 HD23 ' HG2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -128.12 -175.17 3.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.555 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -171.64 -45.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.789 -163.32 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -60.94 -61.29 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.369 -173.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.8 p -65.63 133.05 50.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.124 163.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.58 HG22 ' HG2' ' A' ' 60' ' ' LYS . 6.3 t -62.6 -176.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.335 -166.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.957 HD22 ' CE2' ' A' ' 36' ' ' PHE . 2.3 pp -119.81 177.42 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.335 -167.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -163.41 108.84 1.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.292 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.512 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 4.4 p-10 -94.99 145.34 25.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.3 -168.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -130.49 -174.49 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.394 165.78 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.63 92.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.424 -169.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.04 -22.95 37.88 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.34 -174.08 3.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.046 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.873 HD12 ' CD1' ' A' ' 36' ' ' PHE . 35.6 pt -148.37 175.8 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.333 -161.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.551 ' CE2' ' HG3' ' A' ' 40' ' ' LYS . 13.6 t80 -178.29 141.45 0.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.162 -160.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.721 ' HB2' HD11 ' A' ' 45' ' ' LEU . 10.1 p -100.67 168.97 9.35 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.898 -148.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.58 ' HG2' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -85.23 -12.84 51.62 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.123 169.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.75 -10.35 37.62 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.038 166.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.526 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 1.3 m -119.0 -46.85 2.52 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -164.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -60.19 -16.4 32.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.444 163.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 -43.41 12.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.287 168.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -60.79 -11.72 8.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.523 177.472 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.307 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.527 0.818 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 t -136.16 111.33 10.07 Favored Pre-proline 0 C--O 1.247 0.94 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -158.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 30' ' ' SER . 15.1 Cg_exo -53.9 -20.24 17.38 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.99 2.46 . . . . 0.0 113.642 166.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.23 -72.44 0.51 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.429 -167.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 p -86.62 -18.15 32.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.61 -172.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.87 18.75 64.74 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.77 168.09 11.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.328 170.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -122.49 145.03 48.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.168 168.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.92 HG11 ' H ' ' A' ' 22' ' ' GLU . 4.8 t -101.56 135.2 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.19 -164.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -73.83 -77.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.423 -166.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.61 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.135 167.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.86 133.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.091 165.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.92 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -129.0 17.51 6.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.389 161.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' CD ' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -103.49 160.59 14.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.91 -159.609 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 31' ' ' TRP . 2.3 p -150.97 178.02 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.575 -147.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.468 ' H ' HG22 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -144.91 147.58 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.541 -175.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.3 139.36 5.63 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.64 -82.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.046 -0.577 . . . . 0.0 110.397 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -153.74 27.95 0.75 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 170.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.62 153.85 31.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.399 -0.401 . . . . 0.0 110.359 -170.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.408 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 14.9 t -110.43 143.42 40.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.2 168.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.779 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -148.38 170.98 16.78 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.952 -172.228 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.725 ' NE2' HG22 ' A' ' 18' ' ' VAL . 15.2 m80 -86.31 147.38 26.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.519 -1.218 . . . . 0.0 110.084 162.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -60.67 -13.31 13.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.489 171.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -101.55 -36.08 8.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.417 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 39.8 m -72.93 -17.29 61.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.453 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.619 ' CE1' HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -61.19 85.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.267 177.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 17.5 mtm180 -121.65 127.12 50.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.196 -167.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 12.4 t -59.33 107.08 0.51 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.477 164.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.51 -20.99 66.07 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.573 170.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -67.37 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.541 -165.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p -88.55 -27.16 21.59 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.65 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.95 22.37 6.96 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.6 tppp? -110.03 110.7 21.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.265 -0.468 . . . . 0.0 110.401 -168.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -65.15 112.43 3.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.358 167.433 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.692 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.2 pp -147.19 176.64 9.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.399 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.36 -32.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.917 -173.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -67.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.54 -165.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -61.44 -75.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.358 -173.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.673 HG23 ' HB2' ' A' ' 60' ' ' LYS . 14.8 t -178.77 -169.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.366 164.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.619 HD13 ' CE1' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -168.66 -171.52 1.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.236 -169.159 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.34 82.64 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.368 -167.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.907 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.0 p30 -69.6 147.35 50.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.356 170.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.33 149.31 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.42 169.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.19 -96.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.459 -170.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.24 23.59 0.98 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.29 173.82 12.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 171.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.907 HG22 ' HA ' ' A' ' 52' ' ' ASP . 39.3 pt -141.3 152.74 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.194 -158.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -134.13 174.58 10.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.679 157.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.692 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.2 p -106.79 159.14 16.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.179 0.514 . . . . 0.0 110.847 -152.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.673 ' HB2' HG23 ' A' ' 49' ' ' THR . 11.8 tptt -72.33 -14.7 61.8 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.848 168.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.7 -10.26 43.49 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.196 166.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.43 -48.54 2.7 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -164.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -60.38 -13.62 14.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.258 165.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.57 -65.37 1.02 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.522 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -61.26 -16.53 46.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.567 -165.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.256 167.24 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.533 1.179 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 8.1 t -140.32 107.02 6.64 Favored Pre-proline 0 C--O 1.249 1.049 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -149.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.74 -16.98 33.63 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 C-N-CA 122.762 2.308 . . . . 0.0 113.625 171.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -84.08 -67.03 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.593 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 p -87.94 -29.96 20.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.602 -170.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.09 18.62 36.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -93.64 -169.03 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 164.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -165.59 145.26 6.55 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.262 164.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.874 HG11 ' H ' ' A' ' 22' ' ' GLU . 64.7 t -143.57 137.77 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.444 -155.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -109.32 -19.04 13.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.446 169.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.57 -56.57 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.257 -167.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.801 ' HB1' ' OE2' ' A' ' 22' ' ' GLU . . . -61.38 -74.54 0.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.412 -162.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.874 ' H ' HG11 ' A' ' 18' ' ' VAL . 4.2 mm-40 -117.34 7.64 12.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.792 -164.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -60.9 122.11 14.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -161.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.637 HG21 ' CD2' ' A' ' 36' ' ' PHE . 3.5 m -122.13 169.27 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.249 167.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.7 mt -145.94 139.99 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.424 168.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.46 120.27 0.93 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -170.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.68 16.31 7.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.332 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.62 -22.92 25.39 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -79.64 134.64 36.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.437 -172.504 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.7 m -102.33 119.35 38.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.396 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.486 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -124.31 174.58 7.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.602 -172.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.532 ' CE1' ' HB2' ' A' ' 11' ' ' CYS . 44.2 m80 -105.29 153.99 20.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.1 157.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HD3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -61.11 -27.12 68.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.4 178.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 t -84.52 -23.77 29.64 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.486 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.3 m -95.81 25.09 4.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.347 171.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.884 ' HZ ' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -113.14 89.31 3.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.269 -171.066 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.892 ' NH1' ' HB2' ' A' ' 39' ' ' ALA . 1.1 ppt_? -112.02 130.39 55.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.282 -166.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.9 t -65.28 110.92 2.77 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.446 168.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.892 ' HB2' ' NH1' ' A' ' 37' ' ' ARG . . . -92.51 18.62 8.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.616 170.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.498 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.73 -75.34 0.48 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.379 165.195 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.5 p -83.4 -22.65 32.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.494 -173.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.35 -28.35 6.31 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 165.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HD2' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -82.61 145.22 29.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.307 -0.447 . . . . 0.0 110.385 -168.61 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 15.0 m -92.14 137.35 32.43 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.328 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.656 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -140.88 -168.47 2.6 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.841 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.506 ' HB2' ' HD3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -171.88 -69.73 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.946 -1.934 . . . . 0.0 110.254 -171.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.5 p -61.84 -22.06 65.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.391 -166.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -96.02 156.97 16.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.412 170.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.683 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -60.91 -173.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.355 -168.081 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.884 HD13 ' HZ ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -148.34 -175.89 5.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.419 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.46 77.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.312 -169.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.615 ' HA ' HG22 ' A' ' 57' ' ' ILE . 4.9 p-10 -67.45 90.91 0.25 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.361 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.25 169.66 17.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.368 170.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -61.07 89.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.434 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.74 -19.19 14.32 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -155.33 -171.73 3.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.003 -169.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.783 HD12 ' CE1' ' A' ' 36' ' ' PHE . 38.1 pt -148.77 140.15 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.381 -161.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.498 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 1.5 m-85 -132.93 -175.94 3.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.938 163.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.6 p -110.54 159.85 17.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.466 0.65 . . . . 0.0 111.185 -153.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 6.7 tmtt? -74.46 -13.32 60.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.866 169.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.66 -9.64 39.72 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.21 164.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.91 -45.34 2.77 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -164.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -60.51 -13.25 12.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.224 162.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.67 -51.1 5.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.393 172.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.02 -13.58 17.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.375 -168.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 . . . . . 0 N--CA 1.455 -0.18 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.458 -178.917 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptt? . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 121.107 0.48 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.31 154.26 22.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.304 171.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 64.55 146.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.347 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.495 ' O ' HG12 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -127.11 149.37 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.411 -169.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 4' ' ' LYS . 5.5 p 60.12 39.41 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.045 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.26 143.0 6.95 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.451 -1.059 . . . . 0.0 110.451 170.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.95 97.56 2.41 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.8 t 65.81 116.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.437 -0.382 . . . . 0.0 110.3 -168.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.97 117.71 3.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.295 -168.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -108.35 170.66 15.15 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -164.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 t -122.42 103.2 38.64 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -167.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 30' ' ' SER . 10.3 Cg_endo -59.13 -15.2 27.16 Favored 'Trans proline' 0 N--CA 1.485 1.025 0 C-N-CA 122.704 2.269 . . . . 0.0 113.557 171.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -82.3 -65.87 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.459 -167.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.7 p -87.49 -14.57 40.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.517 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.94 18.41 61.3 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.534 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.51 161.17 13.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 110.272 167.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -119.81 148.61 43.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.277 169.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.892 HG11 ' H ' ' A' ' 22' ' ' GLU . 4.4 t -109.81 144.1 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.025 -166.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.73 -45.44 2.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.445 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.02 -11.69 9.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.315 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.595 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 61.73 92.54 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.31 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.892 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -106.18 27.81 8.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.702 164.327 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.17 130.2 37.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.29 -162.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.636 HG21 ' CD2' ' A' ' 36' ' ' PHE . 2.3 m -107.04 -168.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.003 161.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -154.56 155.55 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.435 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 52' ' ' ASP . . . -161.57 128.67 1.95 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 168.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.54 -82.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.289 -172.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.39 21.13 0.83 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -85.29 168.63 14.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.395 170.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -141.99 142.33 32.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.295 168.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.793 ' CH2' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -135.39 176.47 8.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.091 -169.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.647 ' NE2' HG22 ' A' ' 18' ' ' VAL . 16.9 m80 -84.63 164.58 18.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.083 165.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.452 ' H ' ' HG2' ' A' ' 22' ' ' GLU . 16.0 tttp -60.95 -24.88 66.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.508 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -129.42 31.21 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.33 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -119.5 -10.35 9.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.823 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.733 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -61.67 107.19 0.77 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.333 -172.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.46 100.54 7.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.366 -166.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 25.2 t -62.82 117.37 6.25 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.532 167.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.66 41.77 1.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.39 169.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -131.47 -48.35 0.98 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.436 -176.102 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.2 p -97.12 -11.85 23.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.099 162.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.3 17.68 58.54 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.372 167.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -107.96 147.03 31.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.069 0.462 . . . . 0.0 110.353 -164.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 m -68.77 136.59 53.02 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.53 159.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.764 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -100.84 -163.63 1.04 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.913 -158.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.818 ' HB2' HG22 ' A' ' 49' ' ' THR . 7.3 mt-10 -117.16 -178.17 3.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.926 165.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -57.17 5.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.343 -166.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.8 t -118.82 44.48 2.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.405 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.818 HG22 ' HB2' ' A' ' 46' ' ' GLU . 11.8 t -141.68 68.39 1.33 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.324 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.733 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 2.2 pp -149.11 170.5 18.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.37 -164.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -158.14 115.22 2.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.35 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.672 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.0 p30 -91.82 162.08 14.59 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.353 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 13.0 tptt -169.14 135.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.323 168.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.86 -95.49 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.477 175.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.29 16.57 1.69 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -127.58 -177.98 4.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 167.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.793 HD13 ' CH2' ' A' ' 31' ' ' TRP . 27.2 pt -157.27 136.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.538 -159.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 3.6 p90 -126.57 177.94 6.2 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 155.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.764 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.255 12.2 p -110.74 148.09 33.03 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.099 0.476 . . . . 0.0 111.793 -150.196 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -73.58 -6.47 46.82 Favored 'General case' 0 C--N 1.347 0.466 0 O-C-N 120.162 -1.586 . . . . 0.0 109.993 167.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.81 -3.02 26.16 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.609 159.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.8 -48.69 2.01 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -167.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -59.91 -12.87 8.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.334 162.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.67 -69.25 0.7 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.347 166.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.78 -32.53 71.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.447 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -117.85 62.27 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.414 170.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -61.82 -22.29 65.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.313 -176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.7 87.84 0.13 Allowed Glycine 0 CA--C 1.543 1.802 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -173.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.44 146.72 50.7 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 122.514 2.143 . . . . 0.0 113.443 171.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 tptp 179.98 -76.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.442 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.04 153.57 11.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -168.21 124.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.371 -0.414 . . . . 0.0 110.345 170.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.2 44.72 0.03 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 170.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 70.02 -78.44 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.384 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.53 158.22 50.14 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -85.66 -63.57 1.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.113 -0.543 . . . . 0.0 110.363 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.99 -39.25 1.81 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -170.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.93 94.71 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.236 169.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.51 -79.77 0.93 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -166.09 35.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.363 -0.418 . . . . 0.0 110.259 -169.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.431 ' C ' HG22 ' A' ' 82' ' ' ILE . 1.4 pp -77.14 -43.06 35.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.497 169.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.431 HG22 ' C ' ' A' ' 81' ' ' LEU . 9.0 tp 58.54 61.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.608 171.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 m80 69.68 -80.58 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.432 170.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.66 -28.03 36.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.381 -168.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 C--O 1.241 0.616 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.393 -169.682 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 121.137 0.494 . . . . 0.0 109.846 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.94 157.16 23.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.234 172.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -85.82 151.16 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.303 169.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 128.6 36.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.381 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 m -111.23 142.78 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.377 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.19 162.7 22.59 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 169.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.94 -111.92 2.97 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -170.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.67 ' OG ' ' HB2' ' A' ' 20' ' ' ALA . 44.9 t -139.94 -72.73 0.37 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.418 -169.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.512 ' HB3' ' HD3' ' A' ' 23' ' ' LYS . 7.3 t0 -153.75 124.79 7.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.121 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -111.43 -179.36 20.12 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -158.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 9.3 t -123.29 106.68 32.98 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -162.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 30' ' ' SER . 8.6 Cg_endo -58.47 -15.3 24.24 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 C-N-CA 122.917 2.411 . . . . 0.0 113.61 167.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -67.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.377 -166.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.7 p -88.73 -22.75 23.18 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.618 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.6 -18.26 38.22 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -66.42 171.6 4.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.295 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -143.59 143.37 31.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.191 169.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.852 ' CG1' ' HB3' ' A' ' 21' ' ' ALA . 2.4 t -96.01 158.64 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.451 -162.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 9.9 t80 -94.55 38.89 1.1 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.475 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.67 ' HB2' ' OG ' ' A' ' 8' ' ' SER . . . 61.84 67.87 0.73 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.077 -167.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.852 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -129.12 -64.41 0.91 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.483 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.82 ' H ' HG11 ' A' ' 18' ' ' VAL . 3.0 mt-10 -129.38 16.71 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.185 -166.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' HD3' ' HB3' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -93.58 158.68 15.58 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.018 -166.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -158.92 173.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.724 -147.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.43 140.79 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.51 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.8 134.83 4.18 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 167.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.75 -83.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.275 -0.462 . . . . 0.0 110.459 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.14 48.18 0.52 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 172.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.89 148.66 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.4 -170.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.42 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -108.09 144.28 35.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.27 168.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.757 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -147.93 172.6 13.94 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.782 -170.138 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.821 ' NE2' HG22 ' A' ' 18' ' ' VAL . 43.3 m80 -92.96 156.18 17.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.855 162.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.544 ' CD ' ' HB3' ' A' ' 22' ' ' GLU . 13.7 ptmt -62.59 -14.18 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.456 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.49 17.73 18.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.547 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.1 m -125.73 23.51 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.243 167.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -118.3 82.97 1.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.177 -168.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -119.91 129.25 54.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.255 -166.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 13.0 t -60.01 105.59 0.41 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.271 163.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.46 -19.48 64.76 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.571 170.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -65.08 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.59 -164.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.3 p -88.0 -24.92 23.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.615 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.96 18.76 30.86 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -99.03 132.19 44.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.396 169.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -81.72 134.98 35.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.332 168.115 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.689 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.1 pp -157.78 -173.07 4.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.361 177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.719 ' C ' HD23 ' A' ' 50' ' ' LEU . 1.3 pt-20 -139.01 -179.27 5.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.073 -162.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.491 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -66.44 169.08 7.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.365 -165.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 49' ' ' THR . 0.3 OUTLIER 61.08 13.17 4.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.344 -167.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -168.6 30.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.57 -174.294 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.719 HD23 ' C ' ' A' ' 46' ' ' GLU . 4.0 pp -153.03 175.11 13.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.498 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.67 107.97 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.3 -169.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.753 ' CB ' HG22 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -90.63 161.13 15.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.418 176.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.501 ' HD2' ' CE1' ' A' ' 58' ' ' TYR . 8.4 ptmm? -166.29 109.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.429 -171.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 60.78 18.36 8.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.471 164.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.4 -28.16 8.86 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -104.93 168.58 8.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.753 HG22 ' CB ' ' A' ' 52' ' ' ASP . 32.3 pt -150.11 131.22 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.443 -158.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.517 ' H ' ' HD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -124.71 -175.27 3.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.747 161.039 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.689 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.2 p -111.11 157.39 20.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.327 0.584 . . . . 0.0 110.927 -153.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 49' ' ' THR . 6.2 ttmm -71.89 -13.86 61.78 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.824 169.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.22 -10.41 41.1 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.151 165.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.15 -46.86 2.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -164.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -17.1 41.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.364 165.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.13 -58.31 2.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.289 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -20.52 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.401 -167.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.07 38.05 3.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.309 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.451 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -86.88 -42.11 13.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.335 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.9 102.24 2.4 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -171.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 8.0 Cg_exo -58.79 91.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.605 2.203 . . . . 0.0 113.517 -173.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.38 -169.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.461 169.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.03 -99.47 2.56 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -168.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -96.68 175.89 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.426 -168.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.84 174.79 28.21 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 169.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -128.83 -22.45 3.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.411 -0.394 . . . . 0.0 110.313 -169.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.22 -38.58 3.1 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -166.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 69.9 -76.0 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.33 167.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.19 177.21 15.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -167.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.41 -162.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.425 -0.388 . . . . 0.0 110.221 -168.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.21 -166.39 39.66 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 169.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.12 155.87 44.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.353 -0.424 . . . . 0.0 110.29 -170.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mt 60.16 -79.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.626 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.9 -32.44 6.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.441 -169.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 21.1 m170 71.58 -80.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.451 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 80.8 p 61.22 96.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.617 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.522 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.396 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.601 ' HE1' ' HB1' ' A' ' 17' ' ' ALA . 92.5 mtp . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.29 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.408 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.7 27.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.358 -169.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.488 ' O ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -114.36 -174.48 2.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.398 -178.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 4' ' ' LYS . 10.0 m 59.61 40.38 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.224 174.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.31 -179.22 37.57 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.97 85.19 1.21 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 169.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.09 -163.65 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.069 0.461 . . . . 0.0 110.375 -168.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.402 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -147.0 -171.53 3.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.133 169.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -153.15 170.04 32.07 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -170.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 t -125.01 108.66 27.82 Favored Pre-proline 0 C--O 1.244 0.799 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -164.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 30' ' ' SER . 7.7 Cg_exo -57.56 -16.4 23.94 Favored 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 122.854 2.369 . . . . 0.0 113.578 166.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.82 -68.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.392 -167.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.1 p -90.1 -13.16 36.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.5 -175.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.75 18.74 67.3 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 175.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.89 164.44 13.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.378 168.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.601 ' HB1' ' HE1' ' A' ' 1' ' ' MET . . . -120.32 143.2 48.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.089 167.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.781 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.5 t -108.14 140.6 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.864 -164.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -103.52 136.03 44.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.437 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.57 19.77 10.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.425 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.94 110.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.286 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.781 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -117.85 20.35 13.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.55 166.263 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -102.96 168.06 9.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.421 -158.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.982 HG21 ' CD2' ' A' ' 36' ' ' PHE . 1.2 m -115.51 -171.69 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.148 167.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -163.6 146.62 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.412 166.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.459 ' N ' HG13 ' A' ' 25' ' ' ILE . . . -171.44 141.07 6.2 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -170.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.38 -82.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.248 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.46 21.08 0.93 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 168.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -122.17 128.55 51.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.374 -169.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.435 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -96.48 144.14 26.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.34 167.469 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -139.51 -163.22 1.45 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.892 -177.122 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.664 ' HE2' HG22 ' A' ' 18' ' ' VAL . 18.6 m80 -103.9 163.55 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.136 164.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -73.92 -11.56 60.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.396 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -120.0 23.33 11.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.431 177.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 1.8 m -121.32 -20.35 6.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.457 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.982 ' CD2' HG21 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -61.42 104.62 0.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.298 -171.018 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 ptm85 -115.59 102.35 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.312 -164.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 29.8 t -62.53 116.35 5.05 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.477 163.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 41.99 1.1 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.371 168.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -129.93 -53.57 1.13 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.555 -178.608 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.6 p -92.63 -11.23 34.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.005 163.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.62 18.2 60.57 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.434 167.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -108.06 147.88 30.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.943 0.401 . . . . 0.0 110.34 -164.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.82 138.71 52.85 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.633 158.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -103.62 -163.51 0.99 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.919 -157.155 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.71 -159.26 0.68 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.095 168.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.0 p -92.52 -58.2 2.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.365 -168.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -110.62 41.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.453 -169.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 28.2 p -151.27 78.68 1.28 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.523 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.735 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 2.7 pp -151.96 167.18 29.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.496 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 58' ' ' TYR . . . -146.07 114.37 6.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.255 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.954 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.0 p30 -85.53 160.87 19.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.434 171.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.71 97.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.408 -169.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 61.03 17.82 8.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.464 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.9 -23.63 25.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 170.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -103.72 165.09 11.25 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 167.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.954 HG22 ' HA ' ' A' ' 52' ' ' ASP . 31.9 pt -147.98 137.6 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.376 -157.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 1.9 p90 -125.86 176.22 7.11 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.538 156.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.793 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.25 12.4 p -110.15 148.76 31.17 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.302 0.573 . . . . 0.0 111.814 -149.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -71.71 -9.63 58.56 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 120.587 -1.32 . . . . 0.0 109.873 168.092 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.02 -4.74 22.91 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.457 162.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.4 -49.26 2.16 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -166.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -13.6 12.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.367 163.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.48 -64.24 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.331 166.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -12.07 9.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.421 -166.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -74.97 -20.19 59.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.478 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -156.16 111.24 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.408 -175.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.44 ' N ' ' CD ' ' A' ' 69' ' ' PRO . . . 165.78 -54.43 0.26 Allowed Glycine 0 CA--C 1.543 1.831 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -173.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 68' ' ' GLY . 15.5 Cg_exo -52.38 91.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.532 2.155 . . . . 0.0 113.583 -171.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.22 -77.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.512 171.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.14 153.77 6.12 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -169.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.3 130.22 23.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.317 -0.441 . . . . 0.0 110.328 170.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.88 -103.34 0.17 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -170.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.26 -175.95 3.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.332 170.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.26 -71.58 0.27 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 170.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.37 -176.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.448 170.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.35 158.78 46.07 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -170.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.75 133.01 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.395 -0.402 . . . . 0.0 110.235 169.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.21 -44.71 0.04 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -169.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.23 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.329 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.36 99.84 8.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.388 -169.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 tp -97.95 -15.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.46 170.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 72.05 -80.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.433 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.27 -166.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.43 -170.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.241 0.655 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.324 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ptm . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.139 0.495 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.44 -171.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.311 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.4 126.94 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.312 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.95 -45.97 2.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.399 -170.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 m -90.9 -48.75 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.426 -170.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.27 177.16 15.93 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -170.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.0 -64.97 0.36 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -138.66 175.28 9.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.405 -0.398 . . . . 0.0 110.398 -169.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.52 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 7.8 t0 -130.97 123.57 29.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.169 169.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -117.92 177.36 16.52 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -161.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.9 t -129.65 102.42 18.1 Favored Pre-proline 0 C--O 1.242 0.692 0 CA-C-O 121.285 0.564 . . . . 0.0 109.5 -162.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 30' ' ' SER . 2.6 Cg_endo -58.36 -15.06 22.6 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.79 2.327 . . . . 0.0 113.504 170.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -63.76 1.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.463 -167.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -89.04 -34.85 16.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.554 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.7 -31.15 3.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.47 168.99 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.373 -169.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -126.56 145.87 50.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.215 168.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.885 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.8 t -109.15 148.91 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.907 -165.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -125.56 -45.46 1.79 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.516 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.95 -11.0 6.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.355 170.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.6 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 61.76 93.1 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.347 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.885 ' H ' HG11 ' A' ' 18' ' ' VAL . 4.0 mm-40 -107.68 34.36 3.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.764 164.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.52 ' HD2' ' HB3' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -85.7 124.1 31.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.345 -162.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.883 HG21 ' CD2' ' A' ' 36' ' ' PHE . 2.6 m -97.15 176.33 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.889 160.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.589 ' N ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -145.94 143.49 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.364 167.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.91 127.56 1.23 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 169.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 36.78 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.385 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.21 -20.27 48.74 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -86.6 130.44 34.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.382 -173.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 32.4 t -103.82 117.25 33.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.209 166.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.561 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -113.1 -173.43 2.25 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.029 -167.371 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.735 ' HE2' HG22 ' A' ' 18' ' ' VAL . 19.2 m80 -96.07 157.17 16.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.039 163.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -15.98 30.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.603 168.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.8 p -106.9 -27.13 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.353 -171.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -88.03 -17.38 31.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.384 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.94 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -60.6 95.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.431 171.306 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 18.9 ptt85 -133.11 126.73 32.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.316 -169.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 14.3 t -60.26 111.78 1.67 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.125 163.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.0 41.01 1.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.406 167.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.57 -41.26 1.53 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.539 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.2 p -108.5 -27.35 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.485 166.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.49 18.61 25.4 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -98.07 145.98 26.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.377 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 3.9 m -80.77 145.14 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.396 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 59' ' ' CYS . 1.4 pp -168.53 179.11 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.151 167.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.47 -159.34 0.15 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.107 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.91 -86.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.594 167.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 49' ' ' THR . 15.0 t -138.15 42.0 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.367 -166.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.527 ' HA ' ' HB3' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -168.09 40.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.471 -177.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.94 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 1.9 pp -133.45 167.78 19.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.409 -174.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.57 103.53 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.262 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.849 ' HA ' HG22 ' A' ' 57' ' ' ILE . 6.6 p-10 -75.62 168.83 19.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.335 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.47 100.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.482 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 60.88 19.46 9.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.444 165.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.58 -32.0 5.36 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.92 164.55 11.62 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.849 HG22 ' HA ' ' A' ' 52' ' ' ASP . 32.9 pt -148.64 129.99 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.363 -157.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.67 -175.66 3.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.768 162.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.633 ' HB2' HD11 ' A' ' 45' ' ' LEU . 13.7 p -111.61 155.16 23.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 111.166 -153.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 49' ' ' THR . 17.8 tptp -71.16 -14.01 62.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.733 169.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.16 -8.63 31.1 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.111 164.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.56 -46.57 2.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -165.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -14.88 20.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.423 165.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.46 -68.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.398 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -61.11 -25.95 67.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.402 -166.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.08 -19.16 22.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.469 -169.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -115.13 29.62 7.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.279 -169.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -122.89 67.51 0.48 Allowed Glycine 0 CA--C 1.543 1.843 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.32 106.31 0.18 Allowed 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 122.522 2.148 . . . . 0.0 113.537 171.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 86.82 5.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.469 -167.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.74 -127.85 41.98 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 171.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.52 141.27 20.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.337 175.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.33 50.26 1.87 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -169.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -132.44 98.7 4.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.33 -0.435 . . . . 0.0 110.365 169.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.27 -154.19 7.96 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 69.3 98.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.343 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -162.89 19.9 0.16 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -170.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -113.06 -46.97 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.276 169.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.97 120.75 6.29 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.75 154.84 41.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.194 -169.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.51 -18.48 28.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.515 169.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.0 pt 57.69 51.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.864 168.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -86.87 -73.64 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.398 168.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.69 -83.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.37 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 . . . . . 0 C--O 1.24 0.567 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.316 -170.622 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 121.222 0.534 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.18 -162.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.239 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.89 120.83 26.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.462 169.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.03 -169.95 2.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.372 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 p -101.23 30.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.349 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.27 87.79 1.1 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.66 -173.93 13.14 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -170.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -123.72 -56.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.452 -169.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.88 122.72 5.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.147 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -109.26 177.4 20.18 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -160.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.5 t -123.69 102.15 35.81 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -162.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 30' ' ' SER . 2.0 Cg_endo -60.18 -14.12 27.35 Favored 'Trans proline' 0 N--CA 1.485 1.015 0 C-N-CA 122.778 2.319 . . . . 0.0 113.486 167.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.51 ' HD3' ' CZ3' ' A' ' 31' ' ' TRP . 4.8 tpt180 -79.39 -63.26 1.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.341 -167.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.2 p -91.78 -24.11 19.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.512 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.12 -29.55 5.05 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -172.64 1.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.293 -0.454 . . . . 0.0 110.331 -172.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.544 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -146.86 152.23 38.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.189 166.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.791 HG11 ' H ' ' A' ' 22' ' ' GLU . 2.6 t -106.46 166.61 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.556 -166.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -101.39 68.41 1.2 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.467 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.492 ' HB2' ' OG ' ' A' ' 8' ' ' SER . . . 61.14 16.75 7.46 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.524 174.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.758 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -91.81 -70.45 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.359 -165.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.791 ' H ' HG11 ' A' ' 18' ' ' VAL . 3.3 mm-40 -106.27 17.12 23.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.123 -167.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.09 106.07 16.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.342 -163.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 36' ' ' PHE . 15.7 m -86.84 -167.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.015 161.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 tt -154.68 150.54 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.428 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.1 -142.01 3.71 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 168.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.419 ' HB3' ' H ' ' A' ' 55' ' ' GLY . . . -71.1 87.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.274 -173.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.78 23.11 60.69 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -113.31 154.59 26.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.4 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.459 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -144.63 120.24 10.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.246 168.368 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.644 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -115.38 166.3 12.03 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.858 -164.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.727 ' NE2' HG22 ' A' ' 18' ' ' VAL . 39.5 m80 -80.45 156.23 26.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.004 162.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -60.85 -12.31 10.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.486 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.1 p -115.93 18.3 15.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.412 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.78 11.89 6.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.413 -171.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.757 ' CE1' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -89.38 89.4 7.86 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.268 177.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.11 108.62 19.36 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.456 -173.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 32.2 t -62.91 116.81 5.62 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.399 163.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.63 40.26 1.14 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.387 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -129.27 -49.21 1.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.462 -176.441 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -96.07 -12.19 25.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.081 162.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.81 18.38 56.44 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.378 168.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -106.5 145.14 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.341 -163.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.8 m -69.61 126.28 29.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.668 159.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -90.55 -164.64 1.2 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.736 -158.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.45 88.59 2.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.173 -166.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 64.95 -86.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.483 165.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 p -146.61 67.37 1.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.405 -168.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 2.4 p -152.7 75.02 1.08 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.354 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.757 HD13 ' CE1' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -145.43 -177.35 5.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.376 -166.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.48 104.61 2.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.259 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.584 ' HA ' HG22 ' A' ' 57' ' ' ILE . 2.3 p30 -87.54 154.35 20.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.363 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER 178.81 140.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.425 168.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.34 18.34 9.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.394 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 27' ' ' ALA . . . 106.87 -29.31 10.98 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 168.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -113.11 177.95 4.45 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.93 -0.635 . . . . 0.0 109.966 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 52' ' ' ASP . 35.5 pt -148.25 141.06 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.323 -159.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.508 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 4.2 p90 -130.5 173.7 10.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.333 156.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.792 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.252 11.8 p -109.62 148.22 31.69 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.283 0.563 . . . . 0.0 111.86 -149.257 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.536 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 14.2 tttt -72.49 -9.03 58.04 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 120.387 -1.445 . . . . 0.0 109.853 167.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.7 -4.45 19.54 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.457 161.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.89 -51.51 2.02 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -166.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -14.21 16.92 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.479 166.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.86 -66.0 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.322 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -11.68 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.508 -166.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -146.08 51.49 1.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.378 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -87.9 -45.67 10.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.325 167.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.482 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . -114.45 -65.7 0.43 Allowed Glycine 0 CA--C 1.542 1.78 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -174.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.482 ' HD2' ' H ' ' A' ' 68' ' ' GLY . 1.6 Cg_endo -57.31 141.99 94.77 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 122.353 2.035 . . . . 0.0 113.542 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -117.44 155.53 29.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.435 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.46 138.55 15.0 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 169.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -74.9 -79.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.334 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.73 166.04 32.03 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -113.62 -172.74 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.284 170.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.7 -145.06 0.14 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -170.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -174.37 -66.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.412 -170.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.3 149.43 5.66 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -174.54 168.47 3.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.225 -169.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.92 62.18 0.41 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -172.01 100.42 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.338 -0.431 . . . . 0.0 110.257 169.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.57 169.53 6.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.428 169.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.28 116.52 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.332 170.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -162.59 152.68 16.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.463 169.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.8 m -86.87 -77.84 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.398 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.579 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.339 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 121.208 0.527 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.44 173.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.297 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -76.7 98.07 4.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.423 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.65 ' HB3' HG23 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -178.63 162.91 1.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.434 169.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.65 HG23 ' HB3' ' A' ' 4' ' ' LYS . 11.4 t 65.51 19.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.295 170.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.43 -176.88 25.52 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 170.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 60.96 -102.83 0.44 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -169.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 p -63.41 157.17 23.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.954 0.407 . . . . 0.0 110.318 167.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.86 154.69 18.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.179 175.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -122.27 173.44 15.93 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -160.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.6 t -128.68 104.18 19.18 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -164.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' A' ' 30' ' ' SER . 5.8 Cg_exo -60.97 -12.32 22.03 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.792 2.328 . . . . 0.0 113.629 171.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.47 ' CB ' ' HB3' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -85.26 -65.58 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.368 -167.272 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -85.46 -27.66 25.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.481 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.72 -31.34 5.77 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.3 150.78 38.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.376 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.537 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -115.49 140.62 48.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.114 166.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.884 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.6 t -102.3 140.17 21.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.942 -162.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -121.07 -39.07 2.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.435 175.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -11.47 8.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.376 168.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.555 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 61.56 95.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.307 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.884 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -117.67 27.72 8.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.613 165.571 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 130.1 36.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.355 -160.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.803 HG23 ' CD1' ' A' ' 31' ' ' TRP . 11.1 m -95.93 -176.31 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.546 158.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.536 ' N ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -144.52 152.41 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.44 167.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.65 137.78 3.91 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . . . 61.55 14.37 5.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.296 174.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.58 -32.93 6.54 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.516 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -61.87 165.66 5.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.245 -0.477 . . . . 0.0 110.422 -170.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.451 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -137.88 124.37 20.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.228 165.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.803 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -117.69 159.64 22.64 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.658 -166.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.696 ' HE2' HG22 ' A' ' 18' ' ' VAL . 36.6 m80 -80.54 156.66 26.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.497 154.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HD2' ' HG3' ' A' ' 22' ' ' GLU . 12.4 ptmt -60.15 -12.81 9.45 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.569 170.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 t -122.47 18.29 10.5 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.481 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.47 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 79.7 m -129.14 34.16 4.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.042 163.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.764 ' HD2' HG21 ' A' ' 24' ' ' VAL . 8.8 t80 -126.04 96.23 4.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.692 -164.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 21.6 ttp180 -127.98 126.63 41.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.228 -164.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 12.2 t -59.29 111.56 1.41 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.411 163.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.43 -24.14 65.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.216 -1.357 . . . . 0.0 110.708 171.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -75.02 0.13 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.308 -173.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p -86.94 -17.14 33.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.585 -170.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.83 19.75 50.05 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.33 129.07 45.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.449 -0.376 . . . . 0.0 110.407 171.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 53.9 p -78.65 121.79 25.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.262 167.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.686 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.1 pp -147.14 -174.18 4.44 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.475 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.04 71.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.778 167.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -95.02 -165.27 1.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.46 -171.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.477 HG23 ' OG1' ' A' ' 49' ' ' THR . 12.5 t -68.48 -12.84 61.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.635 -169.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.477 ' OG1' HG23 ' A' ' 48' ' ' THR . 0.2 OUTLIER -139.62 136.3 34.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.518 -173.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.592 HD22 ' HZ ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -138.41 163.32 32.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.193 162.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB3' ' HD1' ' A' ' 58' ' ' TYR . . . -128.3 75.58 1.63 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.294 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 2.0 p30 -69.04 151.15 46.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.387 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.57 135.41 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.415 168.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 p30 61.06 22.11 12.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.554 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.01 -37.99 3.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -103.91 -171.31 1.91 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.968 -0.616 . . . . 0.0 110.043 -177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.781 HD13 ' CH2' ' A' ' 31' ' ' TRP . 27.5 pt -149.62 165.19 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.181 -160.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HD1' ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -133.72 170.06 16.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.696 162.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.686 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.5 p -104.88 155.9 18.51 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.253 0.549 . . . . 0.0 111.097 -152.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 1.0 OUTLIER -61.42 -22.68 65.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.022 166.487 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.49 -5.89 38.79 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.538 174.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -118.43 -45.4 2.62 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -165.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.5 -15.0 22.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.309 165.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.7 -70.49 0.71 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.387 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -61.05 -12.58 12.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.338 -165.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 31.8 t-20 -61.2 -52.09 66.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.379 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 64.86 -80.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.388 171.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.87 68.84 0.01 OUTLIER Glycine 0 CA--C 1.543 1.834 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 66' ' ' ASN . 9.6 Cg_endo -60.78 -41.02 49.33 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 C-N-CA 122.596 2.198 . . . . 0.0 113.605 -171.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.56 140.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.311 -167.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.1 176.35 19.9 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -169.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -146.39 -44.6 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.39 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.53 136.99 9.59 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -113.23 29.53 7.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.343 170.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.85 80.56 0.45 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 69.82 132.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.377 -0.411 . . . . 0.0 110.339 170.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 124.72 135.54 4.42 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -170.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.78 96.22 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.358 -0.421 . . . . 0.0 110.224 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.69 170.46 19.91 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 169.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.08 -162.87 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.253 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 mt -134.46 -91.68 0.33 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.407 169.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.4 mm -139.8 -60.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.378 -169.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -132.9 -76.91 0.49 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.379 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.57 156.98 16.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.406 -169.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 . . . . . 0 C--O 1.24 0.559 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.392 177.778 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.155 0.503 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.22 -162.91 0.82 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.253 171.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.87 177.06 3.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.372 169.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 tttp 64.38 103.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.357 -170.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.0 p -128.96 138.72 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.32 -170.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.26 -122.34 3.85 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -169.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.08 -30.0 29.68 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -169.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.2 t -61.03 156.73 17.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.341 -0.43 . . . . 0.0 110.354 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.536 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -156.46 128.87 7.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.225 169.107 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -109.81 171.56 15.11 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -162.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.2 t -123.95 100.55 36.75 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -167.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 30' ' ' SER . 2.8 Cg_exo -60.3 -13.27 23.58 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.82 2.347 . . . . 0.0 113.539 171.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.54 ' HD3' ' HB3' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -83.79 -63.24 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.444 -165.806 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -85.0 -26.08 27.32 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.504 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.41 -23.43 6.78 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 172.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.39 176.34 9.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.361 -171.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -130.67 155.55 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.227 167.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.839 HG11 ' H ' ' A' ' 22' ' ' GLU . 6.9 t -110.16 142.13 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.226 -167.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.56 -30.91 3.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.417 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.52 17.94 10.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.456 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' N ' HG12 ' A' ' 18' ' ' VAL . . . 61.19 94.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.301 165.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.839 ' H ' HG11 ' A' ' 18' ' ' VAL . 2.8 mt-10 -122.68 26.93 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.712 163.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HG2' ' HB2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -93.88 112.56 24.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.285 -162.432 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.875 HG21 ' CD2' ' A' ' 36' ' ' PHE . 10.8 m -80.95 -172.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.862 160.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -142.22 144.45 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.5 171.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.4 ' N ' HG13 ' A' ' 25' ' ' ILE . . . -136.55 96.33 0.25 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 -82.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.982 -0.609 . . . . 0.0 110.379 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.63 39.52 1.78 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 168.47 13.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.384 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.456 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -145.97 131.77 19.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.293 168.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.595 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -129.05 159.45 35.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.061 -165.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.734 ' NE2' HG22 ' A' ' 18' ' ' VAL . 25.9 m80 -71.55 147.66 47.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.05 165.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HG3' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.53 69.05 1.2 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.659 159.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.3 -42.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.913 -171.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.54 ' HB3' ' HD3' ' A' ' 13' ' ' ARG . 61.3 m -94.38 17.07 13.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.269 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.946 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -100.68 72.55 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.096 -164.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 16.1 mtt180 -93.28 117.04 29.6 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.376 -171.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 13.4 t -60.21 109.43 0.98 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.192 165.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.83 -22.64 65.14 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.424 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HD3' ' HB3' ' A' ' 58' ' ' TYR . 1.3 ttpp -71.25 -66.18 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.562 -167.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.7 p -89.77 -29.33 18.75 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.682 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.18 -25.5 6.68 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.8 129.36 39.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.354 -169.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 77.7 p -87.17 105.88 17.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.367 169.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.688 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -126.09 -171.14 2.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.263 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -131.45 -173.47 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.051 -161.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.856 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -64.25 170.29 3.88 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.281 -172.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 49' ' ' THR . 15.8 p 59.07 13.43 2.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.972 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 48' ' ' THR . 10.4 p -155.29 43.13 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.48 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.946 HD22 ' CE2' ' A' ' 36' ' ' PHE . 2.5 pp -129.98 174.21 9.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.332 -173.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.51 119.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.313 169.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -98.68 169.07 9.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.326 -172.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? 178.39 131.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.45 167.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 60.78 19.72 9.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.39 164.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.01 -19.94 52.83 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -105.06 168.09 9.29 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 169.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.583 HD12 ' CD1' ' A' ' 36' ' ' PHE . 29.7 pt -141.93 142.33 28.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.521 -158.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.524 ' HB3' ' HD3' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -133.18 -175.26 3.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.56 158.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.688 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.1 p -111.01 162.04 15.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.175 0.512 . . . . 0.0 110.727 -153.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -77.21 -12.71 59.98 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.927 169.273 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.89 -10.14 37.48 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.15 164.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.26 -50.52 2.56 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -164.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -59.88 -17.67 38.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.543 166.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.24 -66.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.289 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -60.85 -12.65 11.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.438 -166.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -141.65 47.32 1.66 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.425 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -81.28 124.62 29.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.361 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.06 100.65 0.01 OUTLIER Glycine 0 CA--C 1.544 1.846 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.82 167.32 2.31 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.473 2.115 . . . . 0.0 113.517 171.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -122.5 153.97 38.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.404 169.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.34 -80.11 1.02 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -170.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -113.08 158.71 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.335 -0.432 . . . . 0.0 110.37 169.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.08 -134.08 4.68 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -148.61 131.46 16.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.372 170.09 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.34 102.68 0.22 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 170.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -98.24 129.94 44.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.382 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 145.9 69.17 0.01 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -169.75 128.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.269 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.8 150.4 10.77 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -169.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.6 -163.01 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.977 -0.611 . . . . 0.0 110.284 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 tt 60.1 107.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.52 -170.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -127.74 134.21 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.412 170.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -96.94 -43.12 7.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.394 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.94 152.01 35.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.376 169.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.564 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.349 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.187 0.517 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.46 -19.72 62.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.28 171.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.94 -84.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.38 -169.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -162.67 123.98 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.351 170.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.7 153.48 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.327 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.31 -107.94 1.39 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.77 -170.27 17.66 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -176.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -73.98 -65.42 0.84 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.004 -0.598 . . . . 0.0 110.401 179.033 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . 68.7 m-20 -138.45 108.64 6.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.007 165.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -112.29 -179.64 19.68 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -159.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 7.1 t -130.0 109.01 16.77 Favored Pre-proline 0 C--O 1.246 0.897 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -160.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 7.2 Cg_endo -58.13 -19.29 40.64 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.975 2.45 . . . . 0.0 113.598 165.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.437 ' HD2' ' HA ' ' A' ' 13' ' ' ARG . 11.5 tpt180 -80.51 -73.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.403 -170.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.21 -11.76 48.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.601 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.6 18.17 76.15 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.36 -169.99 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.181 166.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -152.55 146.57 25.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.212 165.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.842 HG22 ' HE2' ' A' ' 32' ' ' HIS . 2.4 t -101.47 178.11 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.295 -164.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.667 ' H ' HG12 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -91.7 46.79 1.31 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.551 172.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.646 ' HB2' ' HB3' ' A' ' 8' ' ' SER . . . 61.62 29.97 18.41 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.291 -174.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.841 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -93.99 -70.84 0.69 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.377 -159.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.838 ' CD ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -94.32 -9.75 34.92 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.907 -151.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.52 ' H ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -58.89 124.77 20.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.495 -146.136 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.86 HG21 ' CD2' ' A' ' 36' ' ' PHE . 10.0 m -93.08 175.03 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.721 158.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 29' ' ' LYS . 4.4 mp -142.3 153.15 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.382 166.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.02 135.58 4.84 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 169.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.57 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.99 -0.605 . . . . 0.0 110.291 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.61 20.43 1.84 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.624 ' O ' HG23 ' A' ' 25' ' ' ILE . 25.8 mmtm -103.65 168.31 9.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.392 -171.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.406 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 39.0 t -143.52 149.99 38.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.229 167.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.67 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -143.88 176.3 9.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.906 -168.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.842 ' HE2' HG22 ' A' ' 18' ' ' VAL . 67.3 m80 -90.57 164.21 14.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.507 160.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -30.12 63.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.429 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -81.44 -18.31 45.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.428 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.49 -15.2 43.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.446 -170.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.903 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -68.85 110.11 4.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.327 -171.141 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.63 99.79 7.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.344 -170.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 29.7 t -63.35 116.48 5.55 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.381 165.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.84 42.76 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.341 168.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.468 ' HD3' ' CB ' ' A' ' 58' ' ' TYR . 20.9 tttm -129.22 -46.95 1.21 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.491 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.3 p -96.57 -13.32 23.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.893 161.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.89 18.24 54.71 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.498 167.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.33 148.76 30.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.005 0.431 . . . . 0.0 110.404 -164.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -68.98 138.24 54.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.636 158.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.779 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -102.37 -164.88 1.13 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.776 -158.475 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -123.27 170.7 10.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.077 -170.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.2 p -60.89 -13.31 14.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.397 167.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.8 p -60.89 -177.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.486 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.629 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -83.54 -174.12 5.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.441 -168.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.903 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -154.45 -171.06 3.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.397 -170.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.06 104.12 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.225 170.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.1 p30 -79.38 157.24 27.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.371 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -179.94 112.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.517 -171.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 p30 61.27 20.45 11.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.615 170.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.73 -24.62 30.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 168.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 11.4 pt-20 -99.04 -174.75 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 168.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.788 HD12 ' CD1' ' A' ' 36' ' ' PHE . 16.9 pt -157.1 139.68 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.255 -160.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CB ' ' HD3' ' A' ' 40' ' ' LYS . 25.1 p90 -130.68 176.48 8.15 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.817 159.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.779 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.251 11.9 p -110.76 148.2 32.82 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 111.795 -150.413 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 4.4 tttm -72.0 -9.38 58.3 Favored 'General case' 0 C--N 1.345 0.375 0 O-C-N 120.403 -1.436 . . . . 0.0 109.883 167.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.26 -3.54 18.96 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.501 161.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -122.42 -49.93 2.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -167.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -59.96 -12.36 7.75 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.339 165.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.76 -61.22 1.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.369 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -60.95 -14.56 23.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.318 -166.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.53 60.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.444 169.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -72.1 172.69 9.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.441 171.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.46 141.35 15.47 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -170.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -61.75 -24.11 77.06 Favored 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 122.608 2.205 . . . . 0.0 113.675 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.54 26.82 13.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.429 173.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.14 60.57 0.23 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -122.88 -53.57 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.305 169.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.99 18.91 55.84 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 169.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 66.43 167.29 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.198 -0.501 . . . . 0.0 110.396 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.94 28.42 4.38 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -170.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -137.37 87.53 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.376 170.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -143.23 154.04 25.18 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.94 139.71 53.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.317 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -150.22 23.47 1.11 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -117.91 -82.3 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.395 -0.403 . . . . 0.0 110.243 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.758 HD23 HG22 ' A' ' 82' ' ' ILE . 1.3 tt -124.6 -60.63 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.335 169.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.758 HG22 HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -171.94 106.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.365 169.013 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -159.26 121.53 3.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.261 -169.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.52 103.17 12.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.356 -170.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 . . . . . 0 C--O 1.241 0.626 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.401 170.218 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptt? . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 121.134 0.493 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.44 -173.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.268 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -86.99 150.8 23.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.38 169.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.68 122.99 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.38 -170.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 p -159.74 115.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.386 169.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.03 88.68 0.07 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.47 -77.32 0.23 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 170.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.31 -176.5 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.37 -0.415 . . . . 0.0 110.372 170.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.539 ' OD2' ' HB1' ' A' ' 21' ' ' ALA . 25.3 m-20 -102.89 -168.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.168 167.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -174.81 173.74 46.32 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 166.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -136.31 112.03 10.08 Favored Pre-proline 0 C--O 1.245 0.848 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -158.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 30' ' ' SER . 8.8 Cg_exo -55.67 -17.2 16.96 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 C-N-CA 122.99 2.46 . . . . 0.0 113.53 164.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HD3' ' CE3' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -89.27 -70.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.466 -166.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 p -88.57 -26.06 22.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.577 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.7 44.83 4.76 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -124.7 144.01 50.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.985 -0.607 . . . . 0.0 110.29 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.536 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -96.23 142.05 28.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.183 167.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.883 HG11 ' H ' ' A' ' 22' ' ' GLU . 6.1 t -108.22 135.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.144 -164.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -61.48 -76.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.405 -166.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.03 -83.18 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.168 168.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HB1' ' OD2' ' A' ' 9' ' ' ASP . . . -176.4 126.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.155 166.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.883 ' H ' HG11 ' A' ' 18' ' ' VAL . 1.5 mm-40 -114.41 17.67 17.31 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.455 164.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.54 ' HD2' ' H ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -97.41 170.59 8.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.091 -159.268 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 31' ' ' TRP . 1.1 p -164.33 156.6 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.608 -148.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 25' ' ' ILE . 3.0 tp -139.8 118.28 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.442 -168.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.46 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -99.09 171.3 24.42 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 160.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.647 ' HB3' ' H ' ' A' ' 55' ' ' GLY . . . -61.37 -13.31 18.78 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.001 0.429 . . . . 0.0 110.619 -167.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.449 ' N ' ' HA2' ' A' ' 55' ' ' GLY . . . -128.04 -18.7 1.87 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -140.59 158.41 44.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.378 -162.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.421 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -121.78 146.38 47.12 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.026 164.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.784 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -146.6 177.47 9.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.915 -163.501 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.784 ' HE2' HG22 ' A' ' 18' ' ' VAL . 13.7 m80 -85.84 158.35 19.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.898 161.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -60.33 -26.51 66.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.474 165.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.487 ' H ' ' HB3' ' A' ' 32' ' ' HIS . 59.8 p -116.71 18.44 14.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.469 -171.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.7 m -120.23 14.33 12.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.184 163.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CD1' HD22 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -92.71 108.19 19.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.276 -166.288 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -126.78 125.62 42.03 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.231 -165.065 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.5 t -57.52 107.6 0.46 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.755 162.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.11 -24.77 68.05 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.546 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.533 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -79.26 -76.38 0.21 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.522 -175.534 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.9 p -79.21 -18.0 53.77 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.431 -163.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.07 13.84 58.43 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -90.34 108.46 19.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.243 -0.478 . . . . 0.0 110.401 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 47.1 m -74.33 107.44 6.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.227 167.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.662 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -138.22 -172.86 3.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.306 -177.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.648 ' C ' HD23 ' A' ' 50' ' ' LEU . 1.7 mp0 -119.54 -177.37 3.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.068 -160.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.511 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 2.0 m -61.11 -46.36 90.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.457 -168.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.4 m -60.9 -13.64 17.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.457 -171.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 60' ' ' LYS . 6.9 m -145.12 41.49 1.27 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.374 -175.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.771 HD12 ' N ' ' A' ' 51' ' ' ALA . 2.0 pp -137.8 -175.46 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.375 170.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.771 ' N ' HD12 ' A' ' 50' ' ' LEU . . . -159.16 146.38 17.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.268 168.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 10.2 p-10 -89.55 143.8 26.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.383 169.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.48 99.83 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.392 -168.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 60.99 26.63 16.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.4 165.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.647 ' H ' ' HB3' ' A' ' 27' ' ' ALA . . . 103.75 -26.86 21.97 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 170.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -104.88 172.2 6.91 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.726 HD13 ' CH2' ' A' ' 31' ' ' TRP . 30.1 pt -130.71 158.82 43.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.307 -159.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.533 ' CE2' ' HG3' ' A' ' 40' ' ' LYS . 1.9 t80 -179.15 144.34 0.23 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.97 -159.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.662 ' SG ' HD21 ' A' ' 45' ' ' LEU 0.252 9.6 p -101.46 157.15 17.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.314 0.578 . . . . 0.0 111.283 -148.585 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.514 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -74.83 -14.77 60.72 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.703 169.224 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.18 -9.43 29.29 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.072 166.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -118.22 -46.79 2.59 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -165.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.94 -10.03 3.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.486 167.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.43 -66.33 0.93 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.52 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -59.83 -31.9 70.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.056 -158.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -144.59 16.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.393 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.77 12.23 3.64 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.423 -172.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 173.6 -144.65 7.81 Favored Glycine 0 CA--C 1.544 1.879 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -172.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -62.16 149.28 91.11 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 122.611 2.208 . . . . 0.0 113.573 -169.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.82 105.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.352 167.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.68 135.7 5.42 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -166.93 -38.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.325 -0.438 . . . . 0.0 110.309 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.73 -74.12 0.05 OUTLIER Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.13 -57.49 0.86 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.109 -0.545 . . . . 0.0 110.361 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.98 70.79 0.01 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -103.32 116.23 32.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.394 169.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.15 -65.25 0.56 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -169.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.75 109.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.341 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.76 158.15 8.02 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 169.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.768 ' C ' HD22 ' A' ' 81' ' ' LEU . . . 61.8 27.46 16.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.369 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.768 HD22 ' C ' ' A' ' 80' ' ' ALA . 3.4 mm? -131.61 61.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.404 167.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 82' ' ' ILE . 0.7 OUTLIER -71.94 84.34 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.364 -169.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -130.11 106.43 8.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.36 169.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -98.16 -165.44 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.368 -169.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.626 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.347 -170.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 121.13 0.49 . . . . 0.0 109.831 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.46 174.39 6.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.268 172.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -61.57 93.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.417 169.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -61.87 -42.9 99.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.341 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.93 18.38 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.417 -170.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.94 17.28 50.7 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 168.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.74 36.21 0.19 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -169.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.53 162.78 38.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.383 169.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.534 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -156.69 136.85 12.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.203 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -116.42 171.31 13.71 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -162.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 t -123.84 101.51 36.01 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -167.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' A' ' 30' ' ' SER . 3.5 Cg_exo -59.95 -14.1 26.18 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 122.885 2.39 . . . . 0.0 113.47 167.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -80.07 -62.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.436 -167.145 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -91.26 -25.53 19.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.499 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.8 18.62 17.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -101.23 171.33 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.323 168.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -130.21 147.67 51.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.171 167.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.855 HG11 ' H ' ' A' ' 22' ' ' GLU . 4.5 t -106.04 141.51 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.136 -165.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -124.86 -31.97 3.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.374 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.95 18.81 9.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.33 170.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.17 97.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.286 166.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.855 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -125.74 23.79 7.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.623 163.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' HG2' ' HB2' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -94.25 117.75 30.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.316 -161.522 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.847 HG21 ' CE2' ' A' ' 36' ' ' PHE . 9.2 m -81.97 -176.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.707 159.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 pt -142.98 138.22 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.485 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 52' ' ' ASP . . . -126.5 -139.27 5.01 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 168.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.79 83.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.271 -169.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.57 19.4 54.13 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -170.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.77 167.89 9.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.932 0.396 . . . . 0.0 110.338 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -148.9 147.73 29.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.131 166.236 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.723 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -143.82 158.06 43.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.833 -164.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.764 ' HE2' HG22 ' A' ' 18' ' ' VAL . 44.1 m80 -78.41 154.96 30.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.988 161.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -23.05 64.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.505 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -84.45 -29.19 26.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.347 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.1 m -95.14 15.95 17.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.453 -167.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.913 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -100.59 101.7 12.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.412 -166.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.623 ' O ' HD11 ' A' ' 57' ' ' ILE . 8.1 mtp180 -124.94 125.03 43.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.295 -168.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.9 t -64.44 109.77 2.06 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.502 170.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.94 67.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.448 171.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -74.5 -74.27 0.2 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.332 -170.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -87.3 -11.13 50.45 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.645 -169.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.69 17.19 79.19 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.426 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -92.74 113.8 26.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.315 167.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 54.3 p -83.6 115.25 22.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.074 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.654 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -129.63 -171.18 2.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.86 -171.364 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -172.88 176.46 3.07 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 112.672 -2.058 . . . . 0.0 109.946 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.1 t 66.73 -61.98 0.3 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.458 170.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -177.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.368 166.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -92.17 -177.51 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.475 -164.405 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.913 HD22 ' CE2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -148.77 -166.24 2.5 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.334 -171.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.38 94.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.327 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.542 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 8.7 p-10 -65.37 161.95 18.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.442 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 tttt 179.92 124.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.358 168.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 70.34 -92.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.395 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.83 18.34 3.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.16 -171.53 3.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.263 -0.469 . . . . 0.0 109.884 -170.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.788 HD12 ' CD1' ' A' ' 36' ' ' PHE . 32.6 pt -150.46 157.64 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.243 -160.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -141.72 170.03 16.49 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.388 161.608 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.654 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.5 p -104.5 168.61 8.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.196 0.522 . . . . 0.0 110.84 -151.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 2.5 tptp -80.67 -14.82 57.81 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.086 168.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.37 -9.75 32.04 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.999 166.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.1 m -118.6 -48.83 2.47 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -164.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 67' ' ' PHE . 10.3 t80 -59.6 -17.11 30.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.513 164.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.63 -57.64 3.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.336 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -11.32 10.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.491 -173.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -153.46 65.78 0.75 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.433 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -61.72 104.75 0.47 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.396 177.031 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.87 93.13 0.05 OUTLIER Glycine 0 CA--C 1.543 1.816 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -50.36 113.5 1.05 Allowed 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 122.537 2.158 . . . . 0.0 113.611 -173.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.9 101.43 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.499 172.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.85 167.47 12.83 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 67.54 104.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.293 -0.453 . . . . 0.0 110.439 -169.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.42 -177.37 47.14 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -170.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -102.55 98.41 8.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.356 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.03 -81.09 0.45 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 170.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -133.2 115.78 15.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.121 -0.539 . . . . 0.0 110.382 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.01 -160.67 2.97 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.47 -81.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.183 -0.509 . . . . 0.0 110.372 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.69 -164.37 16.47 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -169.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.21 -48.04 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.273 -169.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.4 mt -95.48 16.09 17.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.393 -169.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.51 124.67 24.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.439 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.5 m170 62.03 19.36 10.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.388 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.75 77.01 1.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.319 169.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 . . . . . 0 C--O 1.24 0.562 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.364 -169.22 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 121.17 0.509 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.38 -39.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.26 -171.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.3 -165.44 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.344 -169.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.34 148.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.376 -169.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.15 153.07 5.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.311 -169.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.2 -41.12 0.31 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 -170.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.18 -111.04 2.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 p 67.94 104.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.393 0.616 . . . . 0.0 110.848 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB3' ' HD3' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -174.6 151.83 1.56 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.266 -177.06 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -122.39 170.96 15.27 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -162.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.3 t -127.66 109.25 20.66 Favored Pre-proline 0 C--O 1.246 0.9 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -164.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 30' ' ' SER . 7.3 Cg_exo -65.06 -15.72 51.81 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.701 2.267 . . . . 0.0 113.707 171.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HD2' ' CE3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -77.0 -76.21 0.18 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.411 -178.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 p -85.63 -15.81 41.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.498 -166.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.12 22.67 31.86 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 171.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.42 156.04 19.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.983 -0.609 . . . . 0.0 110.399 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.533 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -113.51 142.99 45.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.191 167.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.892 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.5 t -105.22 136.31 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.932 -164.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.47 121.51 45.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.059 168.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.73 98.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.844 -160.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.625 ' HB1' ' HG3' ' A' ' 23' ' ' LYS . . . -60.04 123.85 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.4 -160.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.892 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -98.54 15.95 23.39 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.444 165.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HG3' ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -100.02 -178.27 3.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.126 -160.592 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 25' ' ' ILE . 3.7 p -164.91 179.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.973 -147.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.578 ' H ' HG22 ' A' ' 24' ' ' VAL . 12.5 pt -140.05 142.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.404 -172.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.51 117.3 0.78 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 167.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.896 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . . . 61.89 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.395 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.39 -18.93 1.25 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -88.76 149.35 23.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.433 -0.383 . . . . 0.0 110.338 -168.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.435 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 39.8 m -105.71 144.76 32.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.168 166.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.531 ' CE3' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -144.64 -170.91 3.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.818 -168.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.792 ' HE2' HG22 ' A' ' 18' ' ' VAL . 41.5 m80 -102.51 161.83 13.4 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.652 163.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HG2' ' HB3' ' A' ' 47' ' ' SER . 0.1 OUTLIER -62.64 129.72 41.82 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.671 154.604 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.6 p 69.11 13.06 8.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.475 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 1.1 m -99.79 -20.87 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.537 156.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.762 ' CE1' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -61.9 104.45 0.45 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.307 174.575 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.506 ' HG3' ' NH1' ' A' ' 13' ' ' ARG . 4.3 mmt180 -113.03 100.43 8.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.371 -167.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 27.0 t -62.91 116.28 5.14 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.499 164.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.11 42.8 1.08 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.413 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -130.74 -51.55 1.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.49 -177.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.5 p -93.18 -13.02 28.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.04 161.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.92 18.18 56.6 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.408 167.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -109.05 148.93 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.024 0.44 . . . . 0.0 110.446 -164.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.5 p -70.13 139.11 52.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.631 159.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.795 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -103.46 -163.65 1.0 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.027 -157.371 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -104.78 -162.24 0.87 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.126 169.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -94.34 -35.44 12.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.362 -168.658 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.5 t -139.67 37.71 2.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.4 -168.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.472 ' CB ' ' HB3' ' A' ' 60' ' ' LYS . 1.2 p -142.08 83.53 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.549 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.762 HD13 ' CE1' ' A' ' 36' ' ' PHE . 2.8 pp -153.22 165.06 36.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.386 -171.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 58' ' ' TYR . . . -146.61 115.97 7.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.314 -177.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.896 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -94.06 161.05 14.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.416 -178.182 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.79 115.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.34 -174.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.18 14.74 6.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.511 169.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.06 -18.36 56.83 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -104.62 171.55 7.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.725 HD12 ' HD1' ' A' ' 36' ' ' PHE . 17.3 pt -148.97 137.42 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.349 -158.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 3.5 p90 -126.21 172.81 9.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.478 156.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.795 ' HB2' HD11 ' A' ' 45' ' ' LEU . 12.5 p -108.77 147.17 32.44 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.339 0.59 . . . . 0.0 111.759 -148.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.487 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -69.61 -9.84 55.74 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.319 -1.488 . . . . 0.0 109.803 167.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.11 -2.47 25.21 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.59 163.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -122.59 -50.06 1.99 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -167.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.507 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 7.2 t80 -60.21 -12.45 8.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.376 165.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.56 -65.64 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.376 169.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -25.85 67.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.439 -165.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -122.16 17.54 10.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.624 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 60.81 18.56 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.497 167.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 63' ' ' TYR . . . 110.24 -72.91 0.21 Allowed Glycine 0 CA--C 1.543 1.787 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 173.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -53.77 172.45 0.25 Allowed 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 122.632 2.222 . . . . 0.0 113.557 -171.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.79 -54.72 3.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.339 -169.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.67 169.68 13.05 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -170.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.71 163.06 15.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.325 170.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.38 -114.99 2.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 170.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -89.44 -13.73 36.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.376 -0.412 . . . . 0.0 110.406 169.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.84 -126.14 1.67 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -100.26 96.41 7.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.3 -0.45 . . . . 0.0 110.363 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.57 -121.2 0.56 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -170.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.66 28.68 17.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.315 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.71 129.1 0.06 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -174.25 39.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.324 -0.438 . . . . 0.0 110.276 169.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.1 pp -112.71 -178.56 3.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.39 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 82' ' ' ILE . 0.6 OUTLIER -165.04 69.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.444 169.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -136.62 -61.66 0.67 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.343 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 85.1 p -139.87 -164.23 1.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.299 170.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 C--O 1.241 0.632 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.362 170.077 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mmm . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 121.19 0.519 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.31 113.4 19.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.209 -172.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -110.45 14.32 22.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.401 -169.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.68 101.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.351 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.71 136.81 43.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.366 168.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.87 -179.68 26.35 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 174.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.78 172.47 36.02 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -169.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.608 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER 63.02 -165.78 0.23 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.969 -0.616 . . . . 0.0 110.216 179.465 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 76.79 170.22 0.24 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.344 171.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -109.62 -177.74 21.2 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -153.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 t -125.89 99.7 31.7 Favored Pre-proline 0 C--O 1.244 0.781 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -162.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' O ' ' A' ' 30' ' ' SER . 1.1 Cg_endo -59.95 -13.78 24.63 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 122.864 2.376 . . . . 0.0 113.443 164.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -59.33 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.462 -165.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.5 p -93.0 -39.97 10.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.503 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.23 -45.23 0.87 Allowed Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.512 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -171.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.321 -167.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -151.03 149.55 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.231 165.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.796 HG11 ' H ' ' A' ' 22' ' ' GLU . 2.1 t -123.17 142.97 37.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.019 -165.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -125.26 12.87 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.518 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.44 ' H ' HG12 ' A' ' 18' ' ' VAL . . . -175.14 -38.89 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.407 176.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.776 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -60.75 -79.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.368 -158.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.796 ' H ' HG11 ' A' ' 18' ' ' VAL . 13.4 mm-40 -135.97 11.78 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.484 -157.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.608 ' HD3' ' H ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -79.78 155.23 28.0 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.118 -164.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -154.47 175.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.551 -151.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.566 ' N ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -149.0 141.89 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.539 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.4 ' CA ' ' HB3' ' A' ' 52' ' ' ASP . . . -147.39 107.76 0.4 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 165.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.75 -82.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.173 -0.513 . . . . 0.0 110.32 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.03 21.56 3.15 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -168.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.27 154.34 37.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.255 -0.473 . . . . 0.0 110.41 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 4.1 p -119.71 139.26 52.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.397 168.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.755 ' CH2' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -145.68 160.43 41.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.791 -170.594 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.651 ' CD2' HG21 ' A' ' 18' ' ' VAL . 51.2 m80 -80.49 161.44 24.85 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.361 158.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.597 ' CG ' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.73 133.39 43.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.784 154.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 72.33 9.52 5.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.583 -160.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 3.4 m -113.78 -29.59 7.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 155.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.941 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -60.04 110.47 1.21 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.611 174.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.57 ' O ' HD11 ' A' ' 57' ' ' ILE . 1.6 mtt180 -124.93 125.12 43.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.216 -169.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 8.5 t -61.51 112.81 2.36 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.632 166.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.11 18.95 7.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.541 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HB2' ' CD2' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -96.2 -76.3 0.51 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.286 161.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -85.04 -22.65 28.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.576 -165.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.06 32.34 6.49 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.38 122.05 46.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.417 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.463 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 24.9 p -78.89 112.14 15.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.394 165.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.672 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.7 OUTLIER -149.62 -168.81 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.554 -174.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -170.29 -82.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.907 162.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.6 p 67.23 -67.11 0.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.069 169.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.2 -87.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.404 -167.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.469 ' CB ' ' HB3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -87.17 117.63 26.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.458 -166.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.941 HD22 ' CE2' ' A' ' 36' ' ' PHE . 3.5 pp -125.22 154.53 41.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.143 173.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -142.87 97.9 3.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.331 -164.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HB3' ' CA ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER -89.3 153.07 21.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.313 -176.541 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.61 136.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.342 168.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.84 35.6 13.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.385 171.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.97 -18.33 57.55 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.75 -170.81 2.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -167.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.922 HD12 ' CD1' ' A' ' 36' ' ' PHE . 15.6 pt -149.82 158.82 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.093 -158.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -139.46 173.46 11.52 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.166 164.149 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.672 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.4 p -107.67 158.07 17.57 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.14 0.495 . . . . 0.0 111.134 -154.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -60.11 -26.96 66.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.295 164.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.431 ' N ' ' CD ' ' A' ' 60' ' ' LYS . . . -65.92 -5.75 27.38 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.331 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -118.79 -45.04 2.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -165.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.48 -18.8 53.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.368 163.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.75 -45.53 7.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.282 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . 3.9 tmmm? -61.21 -29.35 69.77 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.452 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.01 32.36 3.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.402 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.76 115.25 0.86 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.428 169.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.441 ' N ' ' CD ' ' A' ' 69' ' ' PRO . . . 138.54 -54.02 0.7 Allowed Glycine 0 CA--C 1.543 1.811 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 68' ' ' GLY . 14.9 Cg_exo -52.06 151.08 17.22 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.572 2.181 . . . . 0.0 113.609 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -65.8 175.91 1.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.37 -169.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.9 156.52 51.72 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -170.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.519 ' H ' ' HD1' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -61.82 -179.12 0.18 Allowed 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.418 -175.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.13 -86.04 1.75 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -158.7 92.1 1.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.015 -0.593 . . . . 0.0 110.361 -178.416 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.55 44.6 1.73 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -169.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 179.64 92.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.345 -0.427 . . . . 0.0 110.351 170.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.14 -108.31 2.46 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 170.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.63 143.31 32.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.258 -169.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.94 -107.55 3.07 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.23 86.56 4.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.439 -0.381 . . . . 0.0 110.264 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -108.22 161.15 15.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.419 -176.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.458 ' H ' HD13 ' A' ' 81' ' ' LEU . 2.6 tt -90.31 129.7 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.384 169.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -61.11 -52.37 65.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.377 -169.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 p -84.97 179.07 7.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.359 -170.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 . . . . . 0 C--O 1.241 0.635 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.284 -170.047 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 mtp . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 121.132 0.491 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.38 142.93 0.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.281 -171.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -66.65 -19.1 65.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.4 tttt 64.0 142.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.357 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.6 t 61.85 37.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.32 -170.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.69 -64.82 1.59 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -170.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.25 -101.45 0.17 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.508 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 0.6 OUTLIER -65.72 -163.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.411 -169.08 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.15 107.44 18.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.022 167.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -114.05 -167.91 16.26 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -162.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.524 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 6.6 t -142.35 106.37 5.58 Favored Pre-proline 0 C--O 1.248 0.977 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -150.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.18 -14.32 23.43 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 C-N-CA 122.959 2.439 . . . . 0.0 113.403 165.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.51 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -82.69 -64.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.449 -167.251 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.59 -27.76 18.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.672 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.31 18.51 35.96 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -95.86 -168.97 1.85 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.203 167.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.523 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -164.72 147.63 8.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.167 164.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.861 HG11 ' H ' ' A' ' 22' ' ' GLU . 62.8 t -146.35 141.02 21.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 -156.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.508 ' CD1' ' HA ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -116.31 -18.59 10.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.448 168.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.75 39.37 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.111 -162.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.575 ' H ' ' CG1' ' A' ' 18' ' ' VAL . . . -137.19 -78.95 0.39 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.418 162.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.861 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -126.96 6.65 6.6 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.869 -165.028 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 124.89 22.33 Favored 'General case' 0 C--O 1.231 0.093 0 O-C-N 121.228 -0.92 . . . . 0.0 110.443 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.709 HG21 ' CD2' ' A' ' 36' ' ' PHE . 2.7 m -109.56 -179.8 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.971 161.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 tt -148.77 144.6 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.355 164.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.18 107.56 0.32 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.22 30.16 19.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.348 -0.426 . . . . 0.0 110.319 168.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.08 -37.24 3.81 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -72.91 160.77 31.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.301 -0.45 . . . . 0.0 110.32 -170.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -132.44 134.26 44.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.373 168.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.714 ' CZ3' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -133.27 179.22 6.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.551 -169.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.661 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 39.5 m80 -118.81 160.75 21.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.296 156.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HB3' ' HG2' ' A' ' 46' ' ' GLU . 17.5 mtmt -61.53 -45.77 92.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.424 -172.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.429 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -61.08 -35.43 76.96 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.512 176.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.51 ' HB3' ' HG2' ' A' ' 13' ' ' ARG . 76.9 m -77.66 -16.62 58.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.639 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.884 ' CD1' HD12 ' A' ' 57' ' ' ILE . 1.9 t80 -67.11 104.34 1.4 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.365 -168.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.583 ' O ' HD11 ' A' ' 57' ' ' ILE . 9.6 mtp180 -116.79 121.63 42.11 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.307 -166.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.2 t -58.44 118.17 5.28 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.768 168.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.21 28.89 2.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.451 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -114.15 -73.82 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.258 159.348 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 22.5 p -79.28 -7.43 58.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.656 -168.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.2 17.71 68.41 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.456 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.809 ' HD2' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -85.56 110.45 19.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.278 166.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.507 ' HB2' ' HG2' ' A' ' 37' ' ' ARG . 40.4 t -79.41 103.03 9.06 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.181 171.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.809 HD23 ' HD2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -116.87 -168.39 1.45 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.562 -175.363 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.58 ' HG2' ' HB3' ' A' ' 33' ' ' LYS . 1.7 tt0 -172.23 156.52 3.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 113.146 -1.843 . . . . 0.0 110.098 -161.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.46 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 21.9 p 60.66 10.81 2.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.492 166.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 p -138.85 163.68 31.62 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.216 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.468 ' CA ' ' HB2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -62.36 172.21 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.514 -165.027 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.869 HD22 ' CE2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -153.54 -163.51 1.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.299 -172.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -174.36 97.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.25 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 3.6 p30 -85.94 131.98 34.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.363 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -153.76 147.51 25.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.325 166.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 61.12 30.04 19.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.302 168.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.99 -25.06 29.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -120.35 -171.76 2.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.245 -0.477 . . . . 0.0 109.972 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.884 HD12 ' CD1' ' A' ' 36' ' ' PHE . 35.2 pt -142.86 178.7 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.465 -157.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 62' ' ' CYS . 87.8 t80 -170.05 143.76 2.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.21 -174.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.661 ' SG ' HD21 ' A' ' 45' ' ' LEU . 13.8 p -97.49 167.15 11.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.149 0.5 . . . . 0.0 111.023 -146.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.468 ' HB2' ' CA ' ' A' ' 49' ' ' THR . 1.6 tttp -77.69 -16.98 58.12 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.025 168.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.22 -9.1 40.31 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.324 170.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 58' ' ' TYR . 1.2 m -119.03 -49.35 2.41 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -165.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -60.02 -13.81 13.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.366 166.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.08 -70.19 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.416 168.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -32.69 72.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.418 -165.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -60.85 -17.89 52.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.406 -169.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.17 101.79 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.367 -169.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.11 169.06 13.26 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 176.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -52.11 149.33 21.8 Favored 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 122.467 2.112 . . . . 0.0 113.575 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.39 103.22 13.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.361 169.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.77 -89.51 0.08 OUTLIER Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.433 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 2.4 m-85 -70.42 140.22 51.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.41 169.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.03 25.88 17.19 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 72' ' ' PHE . 10.6 m-85 -98.11 -25.21 15.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.083 -0.559 . . . . 0.0 110.34 -177.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.93 48.08 83.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -169.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.94 -176.19 0.1 Allowed 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.122 -0.634 . . . . 0.0 110.899 177.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.73 175.96 15.91 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -169.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.28 -18.07 56.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.403 -0.399 . . . . 0.0 110.197 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.67 75.26 1.16 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 169.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -175.64 -82.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.282 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 mt -88.54 -157.97 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.356 -169.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 82' ' ' ILE . 5.3 mm -129.34 44.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.39 -169.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.34 19.62 17.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.426 169.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.67 119.88 11.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.336 -171.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--O 1.239 0.552 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.324 170.084 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 tpt . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.093 0.473 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.12 -43.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.329 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 52.17 -91.17 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.731 0.812 . . . . 0.0 112.159 167.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.03 -169.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.481 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.3 p -101.07 -19.22 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.312 167.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.53 107.26 0.2 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -113.81 54.62 0.55 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -169.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.61 -80.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.413 -0.393 . . . . 0.0 110.401 -172.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.452 ' CB ' ' HE2' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -174.08 -171.39 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.261 167.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -152.99 172.25 31.99 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -169.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.1 t -124.56 108.98 28.7 Favored Pre-proline 0 C--O 1.246 0.887 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -167.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 30' ' ' SER . 8.1 Cg_exo -59.14 -15.35 27.9 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 122.808 2.338 . . . . 0.0 113.592 168.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -84.8 -69.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.469 -168.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -89.8 -16.14 30.83 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.547 -173.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.82 18.15 70.92 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -96.97 138.92 33.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 110.245 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -102.63 142.84 33.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.25 175.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.917 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.3 t -105.77 136.14 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.967 -164.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -99.09 -72.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.183 172.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 18' ' ' VAL . . . -61.8 97.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.978 162.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 113.27 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.451 -160.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.917 ' H ' HG11 ' A' ' 18' ' ' VAL . 3.9 tp10 -112.99 26.53 10.41 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.607 174.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.687 ' HD2' ' H ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -100.05 164.38 12.01 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.034 -161.644 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 31' ' ' TRP . 1.1 p -156.08 172.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.7 -148.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 mt -145.96 145.16 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.631 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.87 111.89 0.5 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . . . 61.97 -82.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.35 -170.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.45 13.61 1.4 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -170.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -106.77 148.22 28.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.365 176.607 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.424 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -110.91 142.18 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.317 169.089 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.746 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -150.45 -176.7 5.59 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.686 -168.409 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.762 ' HE2' HG22 ' A' ' 18' ' ' VAL . 18.8 m80 -93.17 163.84 13.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.121 169.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.527 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 1.4 mmtp -62.86 -16.18 57.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.557 170.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -126.97 23.14 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.424 -172.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' HB2' ' H ' ' A' ' 32' ' ' HIS . 8.3 m -120.68 -11.96 8.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.515 175.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.564 ' CD1' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -61.18 108.63 0.93 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.313 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -111.7 103.26 11.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.378 -167.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 31.8 t -63.14 116.66 5.6 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.389 163.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.93 42.65 1.08 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.462 168.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.54 -52.72 1.08 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.517 -177.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.7 p -91.87 -11.13 37.25 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.985 161.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.32 18.65 62.05 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.479 167.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.25 149.53 30.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.127 0.489 . . . . 0.0 110.436 -164.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -68.15 138.88 56.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.736 160.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.784 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -102.83 -164.89 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.711 -159.585 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -144.95 -165.42 2.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.031 -168.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.2 p -76.64 -17.81 58.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.394 -170.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 p -61.06 143.6 55.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.362 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.67 -164.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.458 -170.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.511 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -155.9 -170.55 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.333 -173.523 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.31 79.18 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.325 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.594 ' CB ' HG22 ' A' ' 57' ' ' ILE . 4.6 p30 -73.6 156.39 38.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.401 174.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 179.67 136.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.445 168.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.1 t70 61.57 19.96 10.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.367 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.97 17.91 60.48 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 171.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.1 178.05 7.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 166.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.594 HG22 ' CB ' ' A' ' 52' ' ' ASP . 33.8 pt -154.13 135.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.426 -159.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -130.19 175.48 8.88 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.741 160.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.784 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.254 11.7 p -110.34 147.88 33.05 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.381 0.61 . . . . 0.0 111.857 -149.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.29 -9.76 58.65 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 120.441 -1.412 . . . . 0.0 109.856 168.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.86 -4.92 22.67 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.468 162.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.46 -48.07 2.2 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -166.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -60.09 -10.37 4.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.461 165.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.01 -45.13 5.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.491 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.8 20.28 6.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.462 -172.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -103.76 -22.15 13.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.3 165.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.71 -80.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.377 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.38 97.15 0.16 Allowed Glycine 0 CA--C 1.543 1.839 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -173.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -54.98 -40.36 86.21 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 122.454 2.103 . . . . 0.0 113.468 -171.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.87 173.9 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.391 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.8 131.16 2.76 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 170.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -158.66 149.91 20.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.353 170.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.53 -18.94 13.06 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -118.62 114.92 23.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.313 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.44 56.03 0.51 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 68.9 127.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.311 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.69 147.3 0.18 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 168.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -175.59 128.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.282 169.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.65 -34.35 0.41 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.38 139.7 35.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.394 . . . . 0.0 110.28 -169.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 mp 60.05 19.07 8.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.599 -170.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.8 mm -105.8 80.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.353 169.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.13 122.91 16.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.352 -168.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -175.32 134.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.32 170.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--O 1.24 0.6 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.387 -170.041 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 tpt . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 121.146 0.498 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.34 -44.17 0.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.219 -172.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 70.02 -77.48 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.354 169.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.583 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -124.87 -77.22 0.59 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.49 170.058 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 4' ' ' LYS . 1.3 m -163.75 80.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.324 -174.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.29 -69.86 0.09 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.87 -87.06 0.55 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -169.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -61.17 -167.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.292 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.458 ' HB2' ' CB ' ' A' ' 23' ' ' LYS . 2.8 m-20 -132.26 99.71 4.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.104 167.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -108.21 -179.52 21.85 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -163.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.5 t -132.38 101.71 14.52 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -160.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 30' ' ' SER . 1.4 Cg_endo -59.93 -14.12 26.15 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 122.697 2.265 . . . . 0.0 113.483 167.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -81.22 -62.25 1.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.412 -166.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -88.8 -17.76 29.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.484 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.37 -13.83 54.69 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -79.45 175.51 10.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.396 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.518 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -131.84 172.92 11.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.987 163.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.882 HG11 ' H ' ' A' ' 22' ' ' GLU . 2.6 t -119.67 158.74 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.811 -172.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.433 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.5 m-85 -94.96 38.33 1.13 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.428 177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.51 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . . . 61.88 68.05 0.72 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.079 -167.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.844 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -129.13 -63.72 0.94 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.444 -174.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.882 ' H ' HG11 ' A' ' 18' ' ' VAL . 16.9 mm-40 -117.9 27.61 8.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.081 -173.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -87.32 112.92 22.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.297 -167.06 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.944 HG21 ' CD2' ' A' ' 36' ' ' PHE . 15.5 m -97.99 -178.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.154 165.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 pp -139.87 159.96 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.481 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.84 87.1 0.16 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.252 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.05 -18.91 10.66 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.524 ' HB3' ' NE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -72.42 159.6 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.431 -0.384 . . . . 0.0 110.349 -169.596 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 98.8 p -147.86 123.53 10.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.157 167.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.799 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -122.66 178.48 4.99 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.799 -165.414 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.79 ' NE2' HG22 ' A' ' 18' ' ' VAL . 20.0 m80 -94.04 162.15 14.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.875 160.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.8 mttp -60.38 -42.45 95.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.449 167.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -95.78 21.14 8.84 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.69 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 16.6 m -120.68 -19.55 7.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.382 167.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.944 ' CD2' HG21 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -60.57 113.02 2.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.329 175.018 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.802 ' CZ ' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -138.67 127.03 22.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.282 -172.178 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 14.0 t -58.56 112.81 1.73 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.631 165.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.802 ' HB2' ' CZ ' ' A' ' 37' ' ' ARG . . . -91.2 23.01 3.49 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.631 171.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.97 -75.7 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.491 170.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.1 p -75.67 -21.54 57.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.562 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.15 -17.82 40.35 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.459 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.85 128.91 36.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.162 0.506 . . . . 0.0 110.388 -170.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -64.94 140.02 58.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.08 164.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.821 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.8 OUTLIER -163.62 -176.25 4.57 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.16 165.542 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.566 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -172.32 -157.63 0.11 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.381 -160.749 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.71 -87.29 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.74 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.38 15.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.241 -174.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.723 HG22 ' C ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -118.19 45.19 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.331 -171.6 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 46' ' ' GLU . 3.9 pp -142.8 168.79 18.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.452 -177.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.71 125.97 12.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.357 173.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.708 ' CB ' HG22 ' A' ' 57' ' ' ILE . 3.6 p-10 -124.64 146.65 48.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.427 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.66 156.32 0.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.449 167.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 61.27 19.76 10.42 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.554 172.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.83 -27.4 20.38 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 166.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.443 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -117.23 178.62 4.3 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.044 -0.578 . . . . 0.0 109.899 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.708 HG22 ' CB ' ' A' ' 52' ' ' ASP . 35.0 pt -156.2 135.83 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.446 -160.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -134.02 177.73 7.51 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 156.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.821 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.258 12.4 p -113.92 152.29 31.01 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.992 0.901 . . . . 0.0 113.17 -143.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.723 ' C ' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -84.91 -0.29 53.66 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 119.476 -2.015 . . . . 0.0 110.352 166.158 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.525 ' N ' HG22 ' A' ' 49' ' ' THR . . . -58.09 -15.25 20.94 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 151.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 -51.78 2.43 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -157.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -60.08 -14.85 18.76 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.474 167.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.5 -66.12 0.95 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.39 167.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -41.23 94.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.493 -164.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.12 28.83 3.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.352 -175.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -125.46 80.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.346 167.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.66 -83.37 0.18 Allowed Glycine 0 CA--C 1.543 1.784 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.96 -179.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 122.403 2.069 . . . . 0.0 113.474 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 71' ' ' GLY . 8.4 tttt -105.86 163.83 12.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.332 170.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.522 ' N ' ' HG2' ' A' ' 70' ' ' LYS . . . -137.05 -179.62 16.98 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 169.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -64.73 -76.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.345 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.94 -117.31 1.63 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -169.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -114.41 -37.93 4.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.106 -0.547 . . . . 0.0 110.364 -176.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.01 -175.75 23.7 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -170.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -119.78 107.96 13.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.343 -0.429 . . . . 0.0 110.322 -170.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.76 167.36 42.9 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 170.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.94 -65.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.299 -169.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.31 168.7 23.56 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.53 106.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.363 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.6 tp -146.42 -82.13 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.398 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.1 pt 57.6 42.2 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.91 173.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 71.32 -79.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.312 -172.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.36 169.13 11.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.315 -170.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 . . . . . 0 C--O 1.24 0.595 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.308 -170.036 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtt . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 121.05 0.452 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.66 -46.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.224 172.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.31 135.68 49.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.351 -169.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.713 ' HG3' HG13 ' A' ' 5' ' ' VAL . 39.5 tptt 65.01 -77.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.452 172.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.713 HG13 ' HG3' ' A' ' 4' ' ' LYS . 11.4 m -104.49 100.27 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.315 -170.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.19 -49.58 0.04 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -169.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.75 73.62 0.27 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 173.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m 65.9 173.67 0.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.338 166.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 31.7 p30 -116.48 132.52 56.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.0 167.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -120.7 174.41 15.73 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -160.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 t -124.41 113.34 27.63 Favored Pre-proline 0 C--O 1.244 0.789 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -157.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.429 ' HG2' ' O ' ' A' ' 30' ' ' SER . 6.8 Cg_endo -63.4 -7.04 11.35 Favored 'Trans proline' 0 N--CA 1.484 0.916 0 C-N-CA 122.686 2.258 . . . . 0.0 113.696 171.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.512 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -92.09 -70.27 0.7 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.407 -174.102 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.4 p -91.22 -29.99 16.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.63 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 48.35 2.72 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.52 157.42 33.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.399 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -113.88 137.74 51.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.171 168.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.909 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.2 t -113.41 134.48 56.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.865 -163.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -94.2 -69.44 0.75 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.382 -167.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 -10.33 5.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.4 167.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.74 111.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.329 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.909 ' H ' HG11 ' A' ' 18' ' ' VAL . 9.0 tt0 -114.4 31.55 6.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.535 172.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.52 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 4.5 mtpm? -106.48 -175.14 2.71 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.171 -160.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 31' ' ' TRP . 2.1 p -169.05 161.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.768 -148.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -141.21 144.74 25.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.45 -171.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.512 ' HA3' ' HB3' ' A' ' 52' ' ' ASP . . . -163.99 135.65 3.88 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 167.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 53' ' ' LYS . . . 61.55 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.334 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.89 16.87 0.82 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -173.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.12 140.33 52.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.375 -168.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.51 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -104.67 145.59 30.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.305 168.675 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.771 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -149.71 163.94 36.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.595 -170.539 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.635 ' HE2' HG22 ' A' ' 18' ' ' VAL . 17.9 m80 -74.26 144.66 44.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.734 158.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 4.1 mttm -60.27 -21.54 62.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.487 169.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -111.21 18.16 19.59 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.51 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 21.3 m -119.79 16.38 12.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.215 166.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.957 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -98.11 110.64 23.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.263 -163.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.529 ' O ' HD11 ' A' ' 57' ' ' ILE . 7.7 ttp-105 -122.61 120.62 34.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.278 -164.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.1 t -58.42 111.83 1.37 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.728 164.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.47 -24.6 67.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.681 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.551 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -75.99 -78.82 0.11 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.26 -176.32 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.7 p -84.75 -9.12 58.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.783 -163.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.78 15.69 74.8 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.929 ' HG2' HD23 ' A' ' 45' ' ' LEU . 8.6 tptm -88.78 103.07 15.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.415 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 14.3 t -71.15 92.38 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.105 166.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.929 HD23 ' HG2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -128.12 -175.17 3.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.555 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -171.64 -45.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.789 -163.32 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -60.94 -61.29 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.369 -173.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.8 p -65.63 133.05 50.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.124 163.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.58 HG22 ' HG2' ' A' ' 60' ' ' LYS . 6.3 t -62.6 -176.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.335 -166.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.957 HD22 ' CE2' ' A' ' 36' ' ' PHE . 2.3 pp -119.81 177.42 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.335 -167.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -163.41 108.84 1.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.292 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.512 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 4.4 p-10 -94.99 145.34 25.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.3 -168.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -130.49 -174.49 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.394 165.78 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.63 92.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.424 -169.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.04 -22.95 37.88 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.34 -174.08 3.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.046 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.873 HD12 ' CD1' ' A' ' 36' ' ' PHE . 35.6 pt -148.37 175.8 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.333 -161.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.551 ' CE2' ' HG3' ' A' ' 40' ' ' LYS . 13.6 t80 -178.29 141.45 0.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.162 -160.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.721 ' HB2' HD11 ' A' ' 45' ' ' LEU . 10.1 p -100.67 168.97 9.35 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.898 -148.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.58 ' HG2' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -85.23 -12.84 51.62 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.123 169.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.75 -10.35 37.62 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.038 166.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.526 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 1.3 m -119.0 -46.85 2.52 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -164.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -60.19 -16.4 32.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.444 163.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 -43.41 12.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.287 168.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -60.79 -11.72 8.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.523 177.472 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.9 37.82 1.77 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.307 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -79.06 -27.4 43.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.398 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.87 89.75 2.06 Favored Glycine 0 CA--C 1.543 1.795 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 171.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.69 119.02 5.87 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 122.493 2.129 . . . . 0.0 113.466 171.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.11 -19.38 15.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.395 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.44 80.67 1.05 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -170.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.51 105.19 9.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.389 -0.405 . . . . 0.0 110.346 -169.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.48 -101.62 2.79 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -100.9 135.53 42.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.447 -0.376 . . . . 0.0 110.338 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.46 61.18 2.83 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -70.98 -23.84 62.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.082 -0.559 . . . . 0.0 110.427 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.53 165.09 38.58 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.68 163.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.23 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.16 174.29 33.85 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -170.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -119.16 99.94 7.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.283 -169.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.685 HD22 ' N ' ' A' ' 81' ' ' LEU . 2.0 mm? -84.27 67.93 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.323 169.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 83' ' ' HIS . 42.1 mt 66.12 166.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.355 -169.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.43 ' N ' HG22 ' A' ' 82' ' ' ILE . 3.0 m80 -61.06 93.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.338 -169.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.9 t -112.45 -79.81 0.58 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.379 -170.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 . . . . . 0 C--O 1.24 0.568 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.367 170.079 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.0 ttm . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.137 0.494 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.46 -82.02 0.31 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.298 -172.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 57.53 96.87 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.481 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HE2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -61.34 -26.31 67.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.42 -177.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.428 HG13 ' HE2' ' A' ' 4' ' ' LYS . 35.0 m -152.71 -35.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.424 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.29 -116.9 3.28 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.71 -89.48 0.6 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -172.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -61.11 -171.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.386 -0.407 . . . . 0.0 110.313 167.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' CB ' ' HB3' ' A' ' 23' ' ' LYS . 18.5 m-20 -125.48 -162.16 1.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.221 166.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -174.31 178.73 46.03 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 165.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 t -136.16 111.33 10.07 Favored Pre-proline 0 C--O 1.247 0.94 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -158.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 30' ' ' SER . 15.1 Cg_exo -53.9 -20.24 17.38 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.99 2.46 . . . . 0.0 113.642 166.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.23 -72.44 0.51 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.429 -167.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 p -86.62 -18.15 32.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.61 -172.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.87 18.75 64.74 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.77 168.09 11.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.328 170.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -122.49 145.03 48.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.168 168.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.92 HG11 ' H ' ' A' ' 22' ' ' GLU . 4.8 t -101.56 135.2 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.19 -164.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -73.83 -77.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.423 -166.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.61 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.135 167.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.406 ' HB1' ' OD2' ' A' ' 9' ' ' ASP . . . -176.86 133.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.091 165.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.92 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -129.0 17.51 6.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.389 161.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -103.49 160.59 14.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.91 -159.609 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 31' ' ' TRP . 2.3 p -150.97 178.02 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.575 -147.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.468 ' H ' HG22 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -144.91 147.58 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.541 -175.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.3 139.36 5.63 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.64 -82.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.046 -0.577 . . . . 0.0 110.397 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -153.74 27.95 0.75 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 170.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.62 153.85 31.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.399 -0.401 . . . . 0.0 110.359 -170.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.408 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 14.9 t -110.43 143.42 40.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.2 168.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.779 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -148.38 170.98 16.78 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.952 -172.228 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.863 ' HE2' HG22 ' A' ' 18' ' ' VAL . 15.2 m80 -86.31 147.38 26.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.519 -1.218 . . . . 0.0 110.084 162.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -60.67 -13.31 13.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.489 171.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -101.55 -36.08 8.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.417 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 39.8 m -72.93 -17.29 61.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.453 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.619 ' CE1' HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -61.19 85.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.267 177.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 17.5 mtm180 -121.65 127.12 50.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.196 -167.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 12.4 t -59.33 107.08 0.51 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.477 164.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.51 -20.99 66.07 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.573 170.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -67.37 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.541 -165.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p -88.55 -27.16 21.59 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.65 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.95 22.37 6.96 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.6 tppp? -110.03 110.7 21.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.265 -0.468 . . . . 0.0 110.401 -168.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -65.15 112.43 3.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.358 167.433 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.692 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.2 pp -147.19 176.64 9.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.399 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.36 -32.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.917 -173.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -67.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.54 -165.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -61.44 -75.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.358 -173.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.673 HG23 ' HB2' ' A' ' 60' ' ' LYS . 14.8 t -178.77 -169.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.366 164.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.619 HD13 ' CE1' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -168.66 -171.52 1.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.236 -169.159 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.34 82.64 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.368 -167.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.907 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.0 p30 -69.6 147.35 50.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.356 170.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.33 149.31 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.42 169.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.19 -96.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.459 -170.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.24 23.59 0.98 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.29 173.82 12.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 171.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.907 HG22 ' HA ' ' A' ' 52' ' ' ASP . 39.3 pt -141.3 152.74 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.194 -158.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -134.13 174.58 10.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.679 157.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.692 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.2 p -106.79 159.14 16.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.179 0.514 . . . . 0.0 110.847 -152.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.673 ' HB2' HG23 ' A' ' 49' ' ' THR . 11.8 tptt -72.33 -14.7 61.8 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.848 168.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.7 -10.26 43.49 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.196 166.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.43 -48.54 2.7 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -164.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -60.38 -13.62 14.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.258 165.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.57 -65.37 1.02 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.522 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -61.26 -16.53 46.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.567 -165.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.04 -56.59 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.256 167.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 t80 60.77 13.93 4.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.508 -175.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.85 -142.8 3.6 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -168.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.98 -88.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.058 0 C-N-CA 122.612 2.208 . . . . 0.0 113.511 -167.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.68 -34.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.394 -167.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.47 96.9 0.1 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -164.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.5 t80 179.28 110.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.403 -0.398 . . . . 0.0 110.288 166.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.43 130.6 3.02 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -169.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.3 t80 68.18 156.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.435 -0.382 . . . . 0.0 110.364 168.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.23 159.14 9.22 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 70.24 -71.36 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.439 169.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.96 -86.36 0.04 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.68 110.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.35 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.3 128.64 0.01 OUTLIER Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -161.61 -70.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.37 -0.415 . . . . 0.0 110.286 -169.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.8 mt -64.93 -91.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.437 -168.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.499 HG22 ' H ' ' A' ' 83' ' ' HIS . 14.6 mm -100.23 168.41 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.457 -169.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.499 ' H ' HG22 ' A' ' 82' ' ' ILE . 4.9 m-70 -122.03 103.78 9.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.337 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.0 t 66.05 119.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.36 169.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.239 0.534 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.408 169.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtt . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 121.106 0.479 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.53 -78.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.266 172.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 62.9 77.7 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.473 -169.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -104.93 102.16 11.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.362 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 t -102.99 109.51 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.335 -169.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.42 98.75 0.26 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.66 118.77 6.26 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 1.9 m -96.32 -164.42 1.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.406 170.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 45.7 m-20 -85.04 104.72 15.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.013 170.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -110.93 -168.13 19.05 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -162.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 8.1 t -140.32 107.02 6.64 Favored Pre-proline 0 C--O 1.249 1.049 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -149.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.74 -16.98 33.63 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 C-N-CA 122.762 2.308 . . . . 0.0 113.625 171.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -84.08 -67.03 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.593 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 p -87.94 -29.96 20.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.602 -170.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.09 18.62 36.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -93.64 -169.03 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 164.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -165.59 145.26 6.55 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.262 164.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.874 HG11 ' H ' ' A' ' 22' ' ' GLU . 64.7 t -143.57 137.77 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.444 -155.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 50.5 t80 -109.32 -19.04 13.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.446 169.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.57 -56.57 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.257 -167.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.801 ' HB1' ' OE2' ' A' ' 22' ' ' GLU . . . -61.38 -74.54 0.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.412 -162.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.874 ' H ' HG11 ' A' ' 18' ' ' VAL . 4.2 mm-40 -117.34 7.64 12.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.792 -164.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' CG ' ' HB2' ' A' ' 9' ' ' ASP . 3.4 ttpt -60.9 122.11 14.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -161.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.637 HG21 ' CD2' ' A' ' 36' ' ' PHE . 3.5 m -122.13 169.27 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.249 167.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.7 mt -145.94 139.99 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.424 168.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.46 120.27 0.93 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -170.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.68 16.31 7.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.332 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.62 -22.92 25.39 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -79.64 134.64 36.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.437 -172.504 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.7 m -102.33 119.35 38.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.396 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.486 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -124.31 174.58 7.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.602 -172.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.532 ' CE1' ' HB2' ' A' ' 11' ' ' CYS . 44.2 m80 -105.29 153.99 20.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.1 157.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HD3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -61.11 -27.12 68.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.4 178.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 t -84.52 -23.77 29.64 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.486 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.3 m -95.81 25.09 4.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.347 171.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.884 ' HZ ' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -113.14 89.31 3.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.269 -171.066 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.892 ' NH1' ' HB2' ' A' ' 39' ' ' ALA . 1.1 ppt_? -112.02 130.39 55.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.282 -166.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.9 t -65.28 110.92 2.77 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.446 168.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.892 ' HB2' ' NH1' ' A' ' 37' ' ' ARG . . . -92.51 18.62 8.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.616 170.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.73 -75.34 0.48 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.379 165.195 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.5 p -83.4 -22.65 32.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.494 -173.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.35 -28.35 6.31 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 165.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HD2' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -82.61 145.22 29.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.307 -0.447 . . . . 0.0 110.385 -168.61 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 15.0 m -92.14 137.35 32.43 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.328 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.656 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -140.88 -168.47 2.6 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.841 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.506 ' HB2' ' HD3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -171.88 -69.73 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.946 -1.934 . . . . 0.0 110.254 -171.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.5 p -61.84 -22.06 65.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.391 -166.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -96.02 156.97 16.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.412 170.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.683 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -60.91 -173.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.355 -168.081 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.884 HD13 ' HZ ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -148.34 -175.89 5.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.419 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.46 77.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.312 -169.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.615 ' HA ' HG22 ' A' ' 57' ' ' ILE . 4.9 p-10 -67.45 90.91 0.25 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.361 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.25 169.66 17.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.368 170.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -61.07 89.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.434 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.74 -19.19 14.32 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -155.33 -171.73 3.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.003 -169.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.783 HD12 ' CE1' ' A' ' 36' ' ' PHE . 38.1 pt -148.77 140.15 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.381 -161.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.498 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 1.5 m-85 -132.93 -175.94 3.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.938 163.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.6 p -110.54 159.85 17.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.466 0.65 . . . . 0.0 111.185 -153.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 6.7 tmtt? -74.46 -13.32 60.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.866 169.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.66 -9.64 39.72 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.21 164.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.91 -45.34 2.77 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -164.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -60.51 -13.25 12.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.224 162.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.67 -51.1 5.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.393 172.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.02 -13.58 17.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.375 -168.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -61.51 -18.52 59.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.458 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -75.47 -33.68 60.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.332 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -118.37 105.79 1.25 Allowed Glycine 0 CA--C 1.542 1.762 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -170.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -51.82 -34.85 56.85 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.651 2.234 . . . . 0.0 113.515 173.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -63.91 147.67 51.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.358 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.17 -114.99 0.63 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -170.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -95.82 177.74 5.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.34 169.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.16 132.48 6.13 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 170.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -92.02 101.86 14.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.413 -0.393 . . . . 0.0 110.311 169.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.74 72.31 0.33 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -170.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -144.34 18.14 1.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.382 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.04 179.67 30.08 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -170.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -175.25 -60.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.273 169.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.62 100.32 1.54 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -161.96 107.24 1.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.026 -0.587 . . . . 0.0 110.356 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 mt 60.04 96.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.59 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 83' ' ' HIS . 18.5 mm -74.23 167.93 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.353 -170.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.432 ' N ' HG22 ' A' ' 82' ' ' ILE . 7.0 t60 -87.12 121.33 29.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.386 170.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 p -159.13 -77.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.402 170.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.24 0.594 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.289 -170.07 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.628 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 t -122.42 103.2 38.64 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -167.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 30' ' ' SER . 10.3 Cg_endo -59.13 -15.2 27.16 Favored 'Trans proline' 0 N--CA 1.485 1.025 0 C-N-CA 122.704 2.269 . . . . 0.0 113.557 171.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -82.3 -65.87 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.459 -167.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.7 p -87.49 -14.57 40.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.517 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.94 18.41 61.3 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.534 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.51 161.17 13.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 110.272 167.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -119.81 148.61 43.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.277 169.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.892 HG11 ' H ' ' A' ' 22' ' ' GLU . 4.4 t -109.81 144.1 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.025 -166.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.73 -45.44 2.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.445 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.02 -11.69 9.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.315 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.595 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 61.73 92.54 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.31 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.892 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -106.18 27.81 8.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.702 164.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.17 130.2 37.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.29 -162.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.636 HG21 ' CD2' ' A' ' 36' ' ' PHE . 2.3 m -107.04 -168.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.003 161.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -154.56 155.55 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.435 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 52' ' ' ASP . . . -161.57 128.67 1.95 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 168.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.54 -82.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.289 -172.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.39 21.13 0.83 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -85.29 168.63 14.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.395 170.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -141.99 142.33 32.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.295 168.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.793 ' CH2' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -135.39 176.47 8.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.091 -169.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.647 ' NE2' HG22 ' A' ' 18' ' ' VAL . 16.9 m80 -84.63 164.58 18.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.083 165.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.452 ' H ' ' HG2' ' A' ' 22' ' ' GLU . 16.0 tttp -60.95 -24.88 66.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.508 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -129.42 31.21 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.33 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -119.5 -10.35 9.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.823 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.733 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -61.67 107.19 0.77 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.333 -172.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.46 100.54 7.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.366 -166.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 25.2 t -62.82 117.37 6.25 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.532 167.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.66 41.77 1.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.39 169.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -131.47 -48.35 0.98 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.436 -176.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.2 p -97.12 -11.85 23.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.099 162.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.3 17.68 58.54 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.372 167.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -107.96 147.03 31.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.069 0.462 . . . . 0.0 110.353 -164.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 m -68.77 136.59 53.02 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.53 159.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.764 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -100.84 -163.63 1.04 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.913 -158.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.818 ' HB2' HG22 ' A' ' 49' ' ' THR . 7.3 mt-10 -117.16 -178.17 3.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.926 165.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -57.17 5.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.343 -166.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.8 t -118.82 44.48 2.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.405 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.818 HG22 ' HB2' ' A' ' 46' ' ' GLU . 11.8 t -141.68 68.39 1.33 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.324 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.733 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 2.2 pp -149.11 170.5 18.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.37 -164.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -158.14 115.22 2.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.35 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.672 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.0 p30 -91.82 162.08 14.59 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.353 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 13.0 tptt -169.14 135.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.323 168.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.86 -95.49 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.477 175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.29 16.57 1.69 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -127.58 -177.98 4.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 167.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.793 HD13 ' CH2' ' A' ' 31' ' ' TRP . 27.2 pt -157.27 136.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.538 -159.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 3.6 p90 -126.57 177.94 6.2 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 155.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.764 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.255 12.2 p -110.74 148.09 33.03 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.099 0.476 . . . . 0.0 111.793 -150.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -73.58 -6.47 46.82 Favored 'General case' 0 C--N 1.347 0.466 0 O-C-N 120.162 -1.586 . . . . 0.0 109.993 167.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.81 -3.02 26.16 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.609 159.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.8 -48.69 2.01 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -167.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -59.91 -12.87 8.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.334 162.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.67 -69.25 0.7 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.347 166.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.78 -32.53 71.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.447 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.414 170.91 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.526 0.748 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 9.3 t -123.29 106.68 32.98 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -162.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 30' ' ' SER . 8.6 Cg_endo -58.47 -15.3 24.24 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 C-N-CA 122.917 2.411 . . . . 0.0 113.61 167.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -67.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.377 -166.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.7 p -88.73 -22.75 23.18 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.618 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.6 -18.26 38.22 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -66.42 171.6 4.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.295 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -143.59 143.37 31.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.191 169.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.852 ' CG1' ' HB3' ' A' ' 21' ' ' ALA . 2.4 t -96.01 158.64 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.451 -162.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 9.9 t80 -94.55 38.89 1.1 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.475 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 19' ' ' TYR . . . 61.84 67.87 0.73 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.077 -167.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.852 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -129.12 -64.41 0.91 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.483 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.82 ' H ' HG11 ' A' ' 18' ' ' VAL . 3.0 mt-10 -129.38 16.71 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.185 -166.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.58 158.68 15.58 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.018 -166.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -158.92 173.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.724 -147.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.43 140.79 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.51 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.8 134.83 4.18 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 167.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.75 -83.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.275 -0.462 . . . . 0.0 110.459 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.14 48.18 0.52 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 172.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.89 148.66 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.4 -170.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.42 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -108.09 144.28 35.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.27 168.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.757 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -147.93 172.6 13.94 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.782 -170.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.821 ' NE2' HG22 ' A' ' 18' ' ' VAL . 43.3 m80 -92.96 156.18 17.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.855 162.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.544 ' CD ' ' HB3' ' A' ' 22' ' ' GLU . 13.7 ptmt -62.59 -14.18 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.456 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.49 17.73 18.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.547 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.1 m -125.73 23.51 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.243 167.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -118.3 82.97 1.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.177 -168.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -119.91 129.25 54.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.255 -166.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 13.0 t -60.01 105.59 0.41 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.271 163.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.46 -19.48 64.76 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.571 170.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -65.08 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.59 -164.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.3 p -88.0 -24.92 23.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.615 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.96 18.76 30.86 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -99.03 132.19 44.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.396 169.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -81.72 134.98 35.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.332 168.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.689 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.1 pp -157.78 -173.07 4.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.361 177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.719 ' C ' HD23 ' A' ' 50' ' ' LEU . 1.3 pt-20 -139.01 -179.27 5.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.073 -162.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.491 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -66.44 169.08 7.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.365 -165.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 49' ' ' THR . 0.3 OUTLIER 61.08 13.17 4.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.344 -167.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -168.6 30.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.57 -174.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.719 HD23 ' C ' ' A' ' 46' ' ' GLU . 4.0 pp -153.03 175.11 13.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.498 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.67 107.97 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.3 -169.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.753 ' CB ' HG22 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -90.63 161.13 15.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.418 176.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.501 ' HD2' ' CE1' ' A' ' 58' ' ' TYR . 8.4 ptmm? -166.29 109.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.429 -171.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 60.78 18.36 8.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.471 164.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.4 -28.16 8.86 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -104.93 168.58 8.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.753 HG22 ' CB ' ' A' ' 52' ' ' ASP . 32.3 pt -150.11 131.22 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.443 -158.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.517 ' H ' ' HD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -124.71 -175.27 3.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.747 161.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.689 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.2 p -111.11 157.39 20.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.327 0.584 . . . . 0.0 110.927 -153.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 49' ' ' THR . 6.2 ttmm -71.89 -13.86 61.78 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.824 169.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.22 -10.41 41.1 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.151 165.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.15 -46.86 2.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -164.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -17.1 41.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.364 165.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.13 -58.31 2.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.289 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -20.52 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.401 -167.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.309 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.525 0.717 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 t -125.01 108.66 27.82 Favored Pre-proline 0 C--O 1.244 0.799 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -164.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 30' ' ' SER . 7.7 Cg_exo -57.56 -16.4 23.94 Favored 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 122.854 2.369 . . . . 0.0 113.578 166.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.82 -68.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.392 -167.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.1 p -90.1 -13.16 36.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.5 -175.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.75 18.74 67.3 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 175.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.89 164.44 13.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.378 168.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -120.32 143.2 48.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.089 167.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.781 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.5 t -108.14 140.6 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.864 -164.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -103.52 136.03 44.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.437 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.57 19.77 10.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.425 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.94 110.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.286 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.781 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -117.85 20.35 13.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.55 166.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -102.96 168.06 9.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.421 -158.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.982 HG21 ' CD2' ' A' ' 36' ' ' PHE . 1.2 m -115.51 -171.69 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.148 167.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -163.6 146.62 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.412 166.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.459 ' N ' HG13 ' A' ' 25' ' ' ILE . . . -171.44 141.07 6.2 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -170.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.38 -82.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.248 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.46 21.08 0.93 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 168.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -122.17 128.55 51.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.374 -169.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.435 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -96.48 144.14 26.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.34 167.469 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -139.51 -163.22 1.45 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.892 -177.122 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.623 ' NE2' HG22 ' A' ' 18' ' ' VAL . 18.6 m80 -103.9 163.55 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.136 164.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -73.92 -11.56 60.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.396 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -120.0 23.33 11.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.431 177.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 1.8 m -121.32 -20.35 6.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.457 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.982 ' CD2' HG21 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -61.42 104.62 0.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.298 -171.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 ptm85 -115.59 102.35 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.312 -164.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 29.8 t -62.53 116.35 5.05 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.477 163.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 41.99 1.1 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.371 168.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -129.93 -53.57 1.13 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.555 -178.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.6 p -92.63 -11.23 34.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.005 163.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.62 18.2 60.57 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.434 167.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -108.06 147.88 30.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.943 0.401 . . . . 0.0 110.34 -164.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.82 138.71 52.85 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.633 158.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -103.62 -163.51 0.99 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.919 -157.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.71 -159.26 0.68 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.095 168.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.0 p -92.52 -58.2 2.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.365 -168.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -110.62 41.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.453 -169.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 28.2 p -151.27 78.68 1.28 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.523 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.735 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 2.7 pp -151.96 167.18 29.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.496 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 58' ' ' TYR . . . -146.07 114.37 6.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.255 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.954 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.0 p30 -85.53 160.87 19.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.434 171.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.71 97.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.408 -169.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 61.03 17.82 8.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.464 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.9 -23.63 25.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 170.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -103.72 165.09 11.25 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 167.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.954 HG22 ' HA ' ' A' ' 52' ' ' ASP . 31.9 pt -147.98 137.6 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.376 -157.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 1.9 p90 -125.86 176.22 7.11 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.538 156.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.793 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.25 12.4 p -110.15 148.76 31.17 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.302 0.573 . . . . 0.0 111.814 -149.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -71.71 -9.63 58.56 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 120.587 -1.32 . . . . 0.0 109.873 168.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.02 -4.74 22.91 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.457 162.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.4 -49.26 2.16 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -166.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -13.6 12.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.367 163.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.48 -64.24 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.331 166.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -12.07 9.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.421 -166.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.478 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.526 0.732 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.9 t -129.65 102.42 18.1 Favored Pre-proline 0 C--O 1.242 0.692 0 CA-C-O 121.285 0.564 . . . . 0.0 109.5 -162.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 30' ' ' SER . 2.6 Cg_endo -58.36 -15.06 22.6 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.79 2.327 . . . . 0.0 113.504 170.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -63.76 1.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.463 -167.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -89.04 -34.85 16.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.554 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.7 -31.15 3.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.47 168.99 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.373 -169.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -126.56 145.87 50.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.215 168.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.885 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.8 t -109.15 148.91 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.907 -165.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -125.56 -45.46 1.79 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.516 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.95 -11.0 6.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.355 170.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.6 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 61.76 93.1 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.347 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.885 ' H ' HG11 ' A' ' 18' ' ' VAL . 4.0 mm-40 -107.68 34.36 3.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.764 164.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.7 124.1 31.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.345 -162.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.883 HG21 ' CD2' ' A' ' 36' ' ' PHE . 2.6 m -97.15 176.33 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.889 160.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.589 ' N ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -145.94 143.49 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.364 167.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.91 127.56 1.23 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 169.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 36.78 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.385 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.21 -20.27 48.74 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -86.6 130.44 34.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.382 -173.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 32.4 t -103.82 117.25 33.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.209 166.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.561 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -113.1 -173.43 2.25 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.029 -167.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.66 ' NE2' HG22 ' A' ' 18' ' ' VAL . 19.2 m80 -96.07 157.17 16.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.039 163.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -15.98 30.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.603 168.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.8 p -106.9 -27.13 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.353 -171.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -88.03 -17.38 31.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.384 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.94 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -60.6 95.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.431 171.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 18.9 ptt85 -133.11 126.73 32.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.316 -169.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 14.3 t -60.26 111.78 1.67 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.125 163.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.0 41.01 1.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.406 167.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.57 -41.26 1.53 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.539 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.2 p -108.5 -27.35 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.485 166.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.49 18.61 25.4 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -98.07 145.98 26.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.377 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 3.9 m -80.77 145.14 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.396 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 59' ' ' CYS . 1.4 pp -168.53 179.11 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.151 167.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.47 -159.34 0.15 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.107 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.91 -86.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.594 167.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 49' ' ' THR . 15.0 t -138.15 42.0 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.367 -166.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.527 ' HA ' ' HB3' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -168.09 40.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.471 -177.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.94 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 1.9 pp -133.45 167.78 19.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.409 -174.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.57 103.53 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.262 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.849 ' HA ' HG22 ' A' ' 57' ' ' ILE . 6.6 p-10 -75.62 168.83 19.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.335 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.47 100.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.482 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 60.88 19.46 9.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.444 165.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.58 -32.0 5.36 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.92 164.55 11.62 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.849 HG22 ' HA ' ' A' ' 52' ' ' ASP . 32.9 pt -148.64 129.99 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.363 -157.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.67 -175.66 3.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.768 162.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.633 ' HB2' HD11 ' A' ' 45' ' ' LEU . 13.7 p -111.61 155.16 23.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 111.166 -153.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 49' ' ' THR . 17.8 tptp -71.16 -14.01 62.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.733 169.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.16 -8.63 31.1 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.111 164.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.56 -46.57 2.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -165.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -14.88 20.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.423 165.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.46 -68.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.398 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -61.11 -25.95 67.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.402 -166.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.469 -169.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.5 t -123.69 102.15 35.81 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -162.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 30' ' ' SER . 2.0 Cg_endo -60.18 -14.12 27.35 Favored 'Trans proline' 0 N--CA 1.485 1.015 0 C-N-CA 122.778 2.319 . . . . 0.0 113.486 167.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.51 ' HD3' ' CZ3' ' A' ' 31' ' ' TRP . 4.8 tpt180 -79.39 -63.26 1.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.341 -167.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.2 p -91.78 -24.11 19.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.512 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.12 -29.55 5.05 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -172.64 1.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.293 -0.454 . . . . 0.0 110.331 -172.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.544 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -146.86 152.23 38.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.189 166.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.791 HG11 ' H ' ' A' ' 22' ' ' GLU . 2.6 t -106.46 166.61 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.556 -166.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -101.39 68.41 1.2 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.467 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.14 16.75 7.46 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.524 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.758 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -91.81 -70.45 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.359 -165.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.791 ' H ' HG11 ' A' ' 18' ' ' VAL . 3.3 mm-40 -106.27 17.12 23.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.123 -167.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.09 106.07 16.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.342 -163.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 36' ' ' PHE . 15.7 m -86.84 -167.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.015 161.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 tt -154.68 150.54 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.428 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.1 -142.01 3.71 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 168.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.419 ' HB3' ' H ' ' A' ' 55' ' ' GLY . . . -71.1 87.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.274 -173.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.78 23.11 60.69 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -113.31 154.59 26.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.4 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.459 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -144.63 120.24 10.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.246 168.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.644 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -115.38 166.3 12.03 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.858 -164.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.727 ' NE2' HG22 ' A' ' 18' ' ' VAL . 39.5 m80 -80.45 156.23 26.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.004 162.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -60.85 -12.31 10.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.486 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.1 p -115.93 18.3 15.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.412 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.78 11.89 6.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.413 -171.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.757 ' CE1' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -89.38 89.4 7.86 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.268 177.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.11 108.62 19.36 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.456 -173.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 32.2 t -62.91 116.81 5.62 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.399 163.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.63 40.26 1.14 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.387 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -129.27 -49.21 1.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.462 -176.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -96.07 -12.19 25.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.081 162.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.81 18.38 56.44 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.378 168.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -106.5 145.14 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.341 -163.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.8 m -69.61 126.28 29.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.668 159.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -90.55 -164.64 1.2 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.736 -158.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.45 88.59 2.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.173 -166.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 64.95 -86.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.483 165.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 p -146.61 67.37 1.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.405 -168.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 2.4 p -152.7 75.02 1.08 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.354 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.757 HD13 ' CE1' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -145.43 -177.35 5.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.376 -166.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.48 104.61 2.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.259 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.584 ' HA ' HG22 ' A' ' 57' ' ' ILE . 2.3 p30 -87.54 154.35 20.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.363 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER 178.81 140.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.425 168.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.34 18.34 9.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.394 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 27' ' ' ALA . . . 106.87 -29.31 10.98 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 168.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -113.11 177.95 4.45 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.93 -0.635 . . . . 0.0 109.966 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 52' ' ' ASP . 35.5 pt -148.25 141.06 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.323 -159.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.508 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 4.2 p90 -130.5 173.7 10.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.333 156.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.792 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.252 11.8 p -109.62 148.22 31.69 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.283 0.563 . . . . 0.0 111.86 -149.257 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.536 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 14.2 tttt -72.49 -9.03 58.04 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 120.387 -1.445 . . . . 0.0 109.853 167.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.7 -4.45 19.54 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.457 161.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.89 -51.51 2.02 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -166.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -14.21 16.92 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.479 166.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.86 -66.0 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.322 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -11.68 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.508 -166.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 . . . . . 0 C--N 1.331 -0.202 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.378 179.49 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.6 t -128.68 104.18 19.18 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -164.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' A' ' 30' ' ' SER . 5.8 Cg_exo -60.97 -12.32 22.03 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.792 2.328 . . . . 0.0 113.629 171.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.47 ' CB ' ' HB3' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -85.26 -65.58 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.368 -167.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -85.46 -27.66 25.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.481 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.72 -31.34 5.77 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.3 150.78 38.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.376 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.537 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -115.49 140.62 48.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.114 166.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.884 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.6 t -102.3 140.17 21.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.942 -162.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -121.07 -39.07 2.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.435 175.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -11.47 8.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.376 168.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.555 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 61.56 95.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.307 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.884 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -117.67 27.72 8.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.613 165.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 130.1 36.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.355 -160.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.803 HG23 ' CD1' ' A' ' 31' ' ' TRP . 11.1 m -95.93 -176.31 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.546 158.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.536 ' N ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -144.52 152.41 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.44 167.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.65 137.78 3.91 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . . . 61.55 14.37 5.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.296 174.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.58 -32.93 6.54 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.516 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -61.87 165.66 5.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.245 -0.477 . . . . 0.0 110.422 -170.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.451 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -137.88 124.37 20.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.228 165.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.803 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -117.69 159.64 22.64 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.658 -166.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.686 ' NE2' HG22 ' A' ' 18' ' ' VAL . 36.6 m80 -80.54 156.66 26.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.497 154.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HD2' ' HG3' ' A' ' 22' ' ' GLU . 12.4 ptmt -60.15 -12.81 9.45 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.569 170.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 t -122.47 18.29 10.5 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.481 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.47 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 79.7 m -129.14 34.16 4.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.042 163.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.764 ' HD2' HG21 ' A' ' 24' ' ' VAL . 8.8 t80 -126.04 96.23 4.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.692 -164.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 21.6 ttp180 -127.98 126.63 41.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.228 -164.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 12.2 t -59.29 111.56 1.41 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.411 163.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.43 -24.14 65.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.216 -1.357 . . . . 0.0 110.708 171.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -75.02 0.13 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.308 -173.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p -86.94 -17.14 33.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.585 -170.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.83 19.75 50.05 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.33 129.07 45.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.449 -0.376 . . . . 0.0 110.407 171.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 53.9 p -78.65 121.79 25.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.262 167.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.686 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.1 pp -147.14 -174.18 4.44 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.475 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.04 71.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.778 167.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -95.02 -165.27 1.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.46 -171.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.477 HG23 ' OG1' ' A' ' 49' ' ' THR . 12.5 t -68.48 -12.84 61.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.635 -169.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.477 ' OG1' HG23 ' A' ' 48' ' ' THR . 0.2 OUTLIER -139.62 136.3 34.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.518 -173.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.592 HD22 ' HZ ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -138.41 163.32 32.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.193 162.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB3' ' HD1' ' A' ' 58' ' ' TYR . . . -128.3 75.58 1.63 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.294 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 2.0 p30 -69.04 151.15 46.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.387 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.57 135.41 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.415 168.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 p30 61.06 22.11 12.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.554 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.01 -37.99 3.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -103.91 -171.31 1.91 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.968 -0.616 . . . . 0.0 110.043 -177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.781 HD13 ' CH2' ' A' ' 31' ' ' TRP . 27.5 pt -149.62 165.19 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.181 -160.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HD1' ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -133.72 170.06 16.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.696 162.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.686 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.5 p -104.88 155.9 18.51 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.253 0.549 . . . . 0.0 111.097 -152.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 1.0 OUTLIER -61.42 -22.68 65.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.022 166.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.49 -5.89 38.79 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.538 174.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -118.43 -45.4 2.62 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -165.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.5 -15.0 22.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.309 165.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.7 -70.49 0.71 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.387 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -61.05 -12.58 12.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.338 -165.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.379 177.503 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.2 t -123.95 100.55 36.75 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -167.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 30' ' ' SER . 2.8 Cg_exo -60.3 -13.27 23.58 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.82 2.347 . . . . 0.0 113.539 171.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.54 ' HD3' ' HB3' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -83.79 -63.24 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.444 -165.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -85.0 -26.08 27.32 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.504 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.41 -23.43 6.78 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 172.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.39 176.34 9.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.361 -171.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -130.67 155.55 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.227 167.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.839 HG11 ' H ' ' A' ' 22' ' ' GLU . 6.9 t -110.16 142.13 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.226 -167.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.56 -30.91 3.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.417 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.52 17.94 10.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.456 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' N ' HG12 ' A' ' 18' ' ' VAL . . . 61.19 94.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.301 165.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.839 ' H ' HG11 ' A' ' 18' ' ' VAL . 2.8 mt-10 -122.68 26.93 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.712 163.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.88 112.56 24.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.285 -162.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.875 HG21 ' CD2' ' A' ' 36' ' ' PHE . 10.8 m -80.95 -172.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.862 160.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -142.22 144.45 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.5 171.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.4 ' N ' HG13 ' A' ' 25' ' ' ILE . . . -136.55 96.33 0.25 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 -82.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.982 -0.609 . . . . 0.0 110.379 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.63 39.52 1.78 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 168.47 13.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.384 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.456 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -145.97 131.77 19.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.293 168.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.595 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -129.05 159.45 35.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.061 -165.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.734 ' NE2' HG22 ' A' ' 18' ' ' VAL . 25.9 m80 -71.55 147.66 47.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.05 165.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HG3' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.53 69.05 1.2 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.659 159.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.3 -42.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.913 -171.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.54 ' HB3' ' HD3' ' A' ' 13' ' ' ARG . 61.3 m -94.38 17.07 13.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.269 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.946 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -100.68 72.55 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.096 -164.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 16.1 mtt180 -93.28 117.04 29.6 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.376 -171.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 13.4 t -60.21 109.43 0.98 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.192 165.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.83 -22.64 65.14 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.424 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HD3' ' HB3' ' A' ' 58' ' ' TYR . 1.3 ttpp -71.25 -66.18 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.562 -167.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.7 p -89.77 -29.33 18.75 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.682 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.18 -25.5 6.68 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.8 129.36 39.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.354 -169.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 77.7 p -87.17 105.88 17.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.367 169.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.688 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -126.09 -171.14 2.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.263 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -131.45 -173.47 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.051 -161.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.856 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -64.25 170.29 3.88 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.281 -172.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 49' ' ' THR . 15.8 p 59.07 13.43 2.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.972 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 48' ' ' THR . 10.4 p -155.29 43.13 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.48 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.946 HD22 ' CE2' ' A' ' 36' ' ' PHE . 2.5 pp -129.98 174.21 9.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.332 -173.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.51 119.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.313 169.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -98.68 169.07 9.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.326 -172.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? 178.39 131.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.45 167.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 60.78 19.72 9.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.39 164.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.01 -19.94 52.83 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -105.06 168.09 9.29 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 169.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.583 HD12 ' CD1' ' A' ' 36' ' ' PHE . 29.7 pt -141.93 142.33 28.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.521 -158.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.524 ' HB3' ' HD3' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -133.18 -175.26 3.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.56 158.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.688 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.1 p -111.01 162.04 15.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.175 0.512 . . . . 0.0 110.727 -153.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -77.21 -12.71 59.98 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.927 169.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.89 -10.14 37.48 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.15 164.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.26 -50.52 2.56 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -164.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -59.88 -17.67 38.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.543 166.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.24 -66.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.289 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -60.85 -12.65 11.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.438 -166.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.425 -178.252 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.525 0.707 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 7.1 t -130.0 109.01 16.77 Favored Pre-proline 0 C--O 1.246 0.897 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -160.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 7.2 Cg_endo -58.13 -19.29 40.64 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.975 2.45 . . . . 0.0 113.598 165.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.437 ' HD2' ' HA ' ' A' ' 13' ' ' ARG . 11.5 tpt180 -80.51 -73.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.403 -170.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.21 -11.76 48.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.601 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.6 18.17 76.15 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.36 -169.99 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.181 166.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -152.55 146.57 25.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.212 165.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.842 HG22 ' HE2' ' A' ' 32' ' ' HIS . 2.4 t -101.47 178.11 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.295 -164.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.667 ' H ' HG12 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -91.7 46.79 1.31 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.551 172.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 19' ' ' TYR . . . 61.62 29.97 18.41 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.291 -174.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.841 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -93.99 -70.84 0.69 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.377 -159.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.838 ' CD ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -94.32 -9.75 34.92 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.907 -151.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.52 ' H ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -58.89 124.77 20.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.495 -146.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.86 HG21 ' CD2' ' A' ' 36' ' ' PHE . 10.0 m -93.08 175.03 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.721 158.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 29' ' ' LYS . 4.4 mp -142.3 153.15 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.382 166.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.02 135.58 4.84 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 169.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.57 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.99 -0.605 . . . . 0.0 110.291 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.61 20.43 1.84 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.624 ' O ' HG23 ' A' ' 25' ' ' ILE . 25.8 mmtm -103.65 168.31 9.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.392 -171.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.406 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 39.0 t -143.52 149.99 38.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.229 167.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.67 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -143.88 176.3 9.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.906 -168.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.842 ' HE2' HG22 ' A' ' 18' ' ' VAL . 67.3 m80 -90.57 164.21 14.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.507 160.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -30.12 63.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.429 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -81.44 -18.31 45.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.428 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.49 -15.2 43.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.446 -170.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.903 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -68.85 110.11 4.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.327 -171.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.63 99.79 7.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.344 -170.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 29.7 t -63.35 116.48 5.55 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.381 165.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.84 42.76 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.341 168.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.468 ' HD3' ' CB ' ' A' ' 58' ' ' TYR . 20.9 tttm -129.22 -46.95 1.21 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.491 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.3 p -96.57 -13.32 23.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.893 161.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.89 18.24 54.71 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.498 167.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.33 148.76 30.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.005 0.431 . . . . 0.0 110.404 -164.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -68.98 138.24 54.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.636 158.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.779 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -102.37 -164.88 1.13 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.776 -158.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -123.27 170.7 10.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.077 -170.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.2 p -60.89 -13.31 14.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.397 167.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.8 p -60.89 -177.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.486 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.629 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -83.54 -174.12 5.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.441 -168.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.903 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -154.45 -171.06 3.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.397 -170.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.06 104.12 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.225 170.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.513 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.1 p30 -79.38 157.24 27.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.371 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -179.94 112.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.517 -171.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 p30 61.27 20.45 11.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.615 170.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.73 -24.62 30.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 168.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 11.4 pt-20 -99.04 -174.75 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 168.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.788 HD12 ' CD1' ' A' ' 36' ' ' PHE . 16.9 pt -157.1 139.68 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.255 -160.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CB ' ' HD3' ' A' ' 40' ' ' LYS . 25.1 p90 -130.68 176.48 8.15 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.817 159.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.779 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.251 11.9 p -110.76 148.2 32.82 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 111.795 -150.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 4.4 tttm -72.0 -9.38 58.3 Favored 'General case' 0 C--N 1.345 0.375 0 O-C-N 120.403 -1.436 . . . . 0.0 109.883 167.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.26 -3.54 18.96 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.501 161.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -122.42 -49.93 2.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -167.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -59.96 -12.36 7.75 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.339 165.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.76 -61.22 1.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.369 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -60.95 -14.56 23.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.318 -166.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.444 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.527 0.793 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -136.31 112.03 10.08 Favored Pre-proline 0 C--O 1.245 0.848 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -158.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 30' ' ' SER . 8.8 Cg_exo -55.67 -17.2 16.96 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 C-N-CA 122.99 2.46 . . . . 0.0 113.53 164.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HD3' ' CE3' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -89.27 -70.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.466 -166.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 p -88.57 -26.06 22.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.577 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.7 44.83 4.76 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -124.7 144.01 50.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.985 -0.607 . . . . 0.0 110.29 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.536 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -96.23 142.05 28.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.183 167.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.883 HG11 ' H ' ' A' ' 22' ' ' GLU . 6.1 t -108.22 135.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.144 -164.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -61.48 -76.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.405 -166.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.03 -83.18 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.168 168.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.4 126.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.155 166.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.883 ' H ' HG11 ' A' ' 18' ' ' VAL . 1.5 mm-40 -114.41 17.67 17.31 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.455 164.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.54 ' HD2' ' H ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -97.41 170.59 8.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.091 -159.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 31' ' ' TRP . 1.1 p -164.33 156.6 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.608 -148.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 25' ' ' ILE . 3.0 tp -139.8 118.28 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.442 -168.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.46 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -99.09 171.3 24.42 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 160.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.647 ' HB3' ' H ' ' A' ' 55' ' ' GLY . . . -61.37 -13.31 18.78 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.001 0.429 . . . . 0.0 110.619 -167.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.449 ' N ' ' HA2' ' A' ' 55' ' ' GLY . . . -128.04 -18.7 1.87 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -140.59 158.41 44.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.378 -162.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.421 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -121.78 146.38 47.12 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.026 164.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.784 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -146.6 177.47 9.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.915 -163.501 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.564 ' NE2' HG22 ' A' ' 18' ' ' VAL . 13.7 m80 -85.84 158.35 19.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.898 161.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -60.33 -26.51 66.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.474 165.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.487 ' H ' ' HB3' ' A' ' 32' ' ' HIS . 59.8 p -116.71 18.44 14.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.469 -171.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.7 m -120.23 14.33 12.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.184 163.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CD1' HD22 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -92.71 108.19 19.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.276 -166.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -126.78 125.62 42.03 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.231 -165.065 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.5 t -57.52 107.6 0.46 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.755 162.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.11 -24.77 68.05 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.546 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.533 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -79.26 -76.38 0.21 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.522 -175.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.9 p -79.21 -18.0 53.77 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.431 -163.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.07 13.84 58.43 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -90.34 108.46 19.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.243 -0.478 . . . . 0.0 110.401 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 47.1 m -74.33 107.44 6.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.227 167.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.662 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -138.22 -172.86 3.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.306 -177.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.648 ' C ' HD23 ' A' ' 50' ' ' LEU . 1.7 mp0 -119.54 -177.37 3.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.068 -160.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.511 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 2.0 m -61.11 -46.36 90.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.457 -168.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.4 m -60.9 -13.64 17.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.457 -171.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 60' ' ' LYS . 6.9 m -145.12 41.49 1.27 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.374 -175.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.771 HD12 ' N ' ' A' ' 51' ' ' ALA . 2.0 pp -137.8 -175.46 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.375 170.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.771 ' N ' HD12 ' A' ' 50' ' ' LEU . . . -159.16 146.38 17.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.268 168.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.46 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 10.2 p-10 -89.55 143.8 26.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.383 169.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.48 99.83 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.392 -168.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 60.99 26.63 16.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.4 165.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.647 ' H ' ' HB3' ' A' ' 27' ' ' ALA . . . 103.75 -26.86 21.97 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 170.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -104.88 172.2 6.91 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.726 HD13 ' CH2' ' A' ' 31' ' ' TRP . 30.1 pt -130.71 158.82 43.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.307 -159.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.533 ' CE2' ' HG3' ' A' ' 40' ' ' LYS . 1.9 t80 -179.15 144.34 0.23 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.97 -159.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.662 ' SG ' HD21 ' A' ' 45' ' ' LEU 0.252 9.6 p -101.46 157.15 17.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.314 0.578 . . . . 0.0 111.283 -148.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.514 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -74.83 -14.77 60.72 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.703 169.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.18 -9.43 29.29 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.072 166.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -118.22 -46.79 2.59 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -165.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.94 -10.03 3.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.486 167.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.43 -66.33 0.93 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.52 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -59.83 -31.9 70.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.056 -158.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.393 175.55 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.595 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 t -123.84 101.51 36.01 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -167.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' A' ' 30' ' ' SER . 3.5 Cg_exo -59.95 -14.1 26.18 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 122.885 2.39 . . . . 0.0 113.47 167.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -80.07 -62.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.436 -167.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -91.26 -25.53 19.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.499 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.8 18.62 17.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -101.23 171.33 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.323 168.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -130.21 147.67 51.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.171 167.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.855 HG11 ' H ' ' A' ' 22' ' ' GLU . 4.5 t -106.04 141.51 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.136 -165.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -124.86 -31.97 3.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.374 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.95 18.81 9.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.33 170.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.17 97.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.286 166.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.855 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -125.74 23.79 7.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.623 163.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.25 117.75 30.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.316 -161.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.847 HG21 ' CE2' ' A' ' 36' ' ' PHE . 9.2 m -81.97 -176.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.707 159.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 pt -142.98 138.22 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.485 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 52' ' ' ASP . . . -126.5 -139.27 5.01 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 168.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.79 83.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.271 -169.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.57 19.4 54.13 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -170.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.77 167.89 9.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.932 0.396 . . . . 0.0 110.338 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -148.9 147.73 29.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.131 166.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.723 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -143.82 158.06 43.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.833 -164.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.713 ' NE2' HG22 ' A' ' 18' ' ' VAL . 44.1 m80 -78.41 154.96 30.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.988 161.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -23.05 64.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.505 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -84.45 -29.19 26.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.347 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.1 m -95.14 15.95 17.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.453 -167.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.913 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -100.59 101.7 12.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.412 -166.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.623 ' O ' HD11 ' A' ' 57' ' ' ILE . 8.1 mtp180 -124.94 125.03 43.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.295 -168.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.9 t -64.44 109.77 2.06 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.502 170.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.94 67.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.448 171.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -74.5 -74.27 0.2 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.332 -170.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -87.3 -11.13 50.45 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.645 -169.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.69 17.19 79.19 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.426 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -92.74 113.8 26.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.315 167.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 54.3 p -83.6 115.25 22.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.074 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.654 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -129.63 -171.18 2.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.86 -171.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -172.88 176.46 3.07 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 112.672 -2.058 . . . . 0.0 109.946 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.1 t 66.73 -61.98 0.3 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.458 170.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -177.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.368 166.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -92.17 -177.51 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.475 -164.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.913 HD22 ' CE2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -148.77 -166.24 2.5 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.334 -171.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.38 94.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.327 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.542 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 8.7 p-10 -65.37 161.95 18.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.442 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 tttt 179.92 124.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.358 168.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 70.34 -92.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.395 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.83 18.34 3.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.16 -171.53 3.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.263 -0.469 . . . . 0.0 109.884 -170.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.788 HD12 ' CD1' ' A' ' 36' ' ' PHE . 32.6 pt -150.46 157.64 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.243 -160.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -141.72 170.03 16.49 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.388 161.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.654 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.5 p -104.5 168.61 8.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.196 0.522 . . . . 0.0 110.84 -151.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 2.5 tptp -80.67 -14.82 57.81 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.086 168.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.37 -9.75 32.04 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.999 166.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.1 m -118.6 -48.83 2.47 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -164.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -59.6 -17.11 30.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.513 164.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.63 -57.64 3.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.336 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -11.32 10.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.491 -173.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.433 173.826 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.3 t -127.66 109.25 20.66 Favored Pre-proline 0 C--O 1.246 0.9 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -164.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 30' ' ' SER . 7.3 Cg_exo -65.06 -15.72 51.81 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.701 2.267 . . . . 0.0 113.707 171.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HD2' ' CE3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -77.0 -76.21 0.18 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.411 -178.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 p -85.63 -15.81 41.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.498 -166.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.12 22.67 31.86 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 171.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.42 156.04 19.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.983 -0.609 . . . . 0.0 110.399 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.533 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -113.51 142.99 45.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.191 167.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.892 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.5 t -105.22 136.31 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.932 -164.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.47 121.51 45.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.059 168.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.73 98.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.844 -160.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.625 ' HB1' ' HG3' ' A' ' 23' ' ' LYS . . . -60.04 123.85 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.4 -160.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.892 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -98.54 15.95 23.39 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.444 165.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HG3' ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -100.02 -178.27 3.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.126 -160.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 25' ' ' ILE . 3.7 p -164.91 179.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.973 -147.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.578 ' H ' HG22 ' A' ' 24' ' ' VAL . 12.5 pt -140.05 142.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.404 -172.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.51 117.3 0.78 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 167.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.896 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . . . 61.89 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.395 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.39 -18.93 1.25 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -88.76 149.35 23.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.433 -0.383 . . . . 0.0 110.338 -168.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.435 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 39.8 m -105.71 144.76 32.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.168 166.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.531 ' CE3' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -144.64 -170.91 3.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.818 -168.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.644 ' NE2' HG22 ' A' ' 18' ' ' VAL . 41.5 m80 -102.51 161.83 13.4 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.652 163.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HG2' ' HB3' ' A' ' 47' ' ' SER . 0.1 OUTLIER -62.64 129.72 41.82 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.671 154.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.6 p 69.11 13.06 8.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.475 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 1.1 m -99.79 -20.87 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.537 156.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.762 ' CE1' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -61.9 104.45 0.45 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.307 174.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.506 ' HG3' ' NH1' ' A' ' 13' ' ' ARG . 4.3 mmt180 -113.03 100.43 8.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.371 -167.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 27.0 t -62.91 116.28 5.14 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.499 164.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.11 42.8 1.08 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.413 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -130.74 -51.55 1.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.49 -177.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.5 p -93.18 -13.02 28.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.04 161.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.92 18.18 56.6 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.408 167.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -109.05 148.93 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.024 0.44 . . . . 0.0 110.446 -164.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.5 p -70.13 139.11 52.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.631 159.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.795 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -103.46 -163.65 1.0 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.027 -157.371 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -104.78 -162.24 0.87 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.126 169.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -94.34 -35.44 12.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.362 -168.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.5 t -139.67 37.71 2.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.4 -168.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.472 ' CB ' ' HB3' ' A' ' 60' ' ' LYS . 1.2 p -142.08 83.53 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.549 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.762 HD13 ' CE1' ' A' ' 36' ' ' PHE . 2.8 pp -153.22 165.06 36.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.386 -171.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 58' ' ' TYR . . . -146.61 115.97 7.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.314 -177.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.896 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -94.06 161.05 14.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.416 -178.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.79 115.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.34 -174.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.18 14.74 6.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.511 169.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.06 -18.36 56.83 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -104.62 171.55 7.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.725 HD12 ' HD1' ' A' ' 36' ' ' PHE . 17.3 pt -148.97 137.42 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.349 -158.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 3.5 p90 -126.21 172.81 9.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.478 156.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.795 ' HB2' HD11 ' A' ' 45' ' ' LEU . 12.5 p -108.77 147.17 32.44 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.339 0.59 . . . . 0.0 111.759 -148.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.487 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -69.61 -9.84 55.74 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.319 -1.488 . . . . 0.0 109.803 167.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.11 -2.47 25.21 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.59 163.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -122.59 -50.06 1.99 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -167.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -60.21 -12.45 8.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.376 165.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.56 -65.64 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.376 169.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -25.85 67.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.439 -165.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.624 -179.716 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 N--CA 1.465 0.607 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 t -125.89 99.7 31.7 Favored Pre-proline 0 C--O 1.244 0.781 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -162.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' O ' ' A' ' 30' ' ' SER . 1.1 Cg_endo -59.95 -13.78 24.63 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 122.864 2.376 . . . . 0.0 113.443 164.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -59.33 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.462 -165.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.5 p -93.0 -39.97 10.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.503 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.23 -45.23 0.87 Allowed Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.512 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -171.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.321 -167.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -151.03 149.55 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.231 165.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.796 HG11 ' H ' ' A' ' 22' ' ' GLU . 2.1 t -123.17 142.97 37.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.019 -165.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -125.26 12.87 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.518 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.44 ' H ' HG12 ' A' ' 18' ' ' VAL . . . -175.14 -38.89 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.407 176.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.776 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -60.75 -79.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.368 -158.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.796 ' H ' HG11 ' A' ' 18' ' ' VAL . 13.4 mm-40 -135.97 11.78 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.484 -157.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -79.78 155.23 28.0 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.118 -164.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -154.47 175.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.551 -151.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.566 ' N ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -149.0 141.89 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.539 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.4 ' CA ' ' HB3' ' A' ' 52' ' ' ASP . . . -147.39 107.76 0.4 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 165.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.75 -82.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.173 -0.513 . . . . 0.0 110.32 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.03 21.56 3.15 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -168.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.27 154.34 37.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.255 -0.473 . . . . 0.0 110.41 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 4.1 p -119.71 139.26 52.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.397 168.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.755 ' CH2' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -145.68 160.43 41.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.791 -170.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.651 ' CD2' HG21 ' A' ' 18' ' ' VAL . 51.2 m80 -80.49 161.44 24.85 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.361 158.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.597 ' CG ' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.73 133.39 43.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.784 154.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 72.33 9.52 5.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.583 -160.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 3.4 m -113.78 -29.59 7.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 155.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.941 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -60.04 110.47 1.21 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.611 174.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.57 ' O ' HD11 ' A' ' 57' ' ' ILE . 1.6 mtt180 -124.93 125.12 43.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.216 -169.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 8.5 t -61.51 112.81 2.36 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.632 166.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.11 18.95 7.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.541 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HB2' ' CD2' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -96.2 -76.3 0.51 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.286 161.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -85.04 -22.65 28.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.576 -165.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.06 32.34 6.49 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.38 122.05 46.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.417 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.463 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 24.9 p -78.89 112.14 15.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.394 165.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.672 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.7 OUTLIER -149.62 -168.81 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.554 -174.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -170.29 -82.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.907 162.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.6 p 67.23 -67.11 0.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.069 169.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.2 -87.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.404 -167.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.469 ' CB ' ' HB3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -87.17 117.63 26.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.458 -166.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.941 HD22 ' CE2' ' A' ' 36' ' ' PHE . 3.5 pp -125.22 154.53 41.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.143 173.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -142.87 97.9 3.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.331 -164.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HB3' ' CA ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER -89.3 153.07 21.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.313 -176.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.61 136.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.342 168.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.84 35.6 13.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.385 171.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.97 -18.33 57.55 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.75 -170.81 2.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -167.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.922 HD12 ' CD1' ' A' ' 36' ' ' PHE . 15.6 pt -149.82 158.82 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.093 -158.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -139.46 173.46 11.52 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.166 164.149 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.672 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.4 p -107.67 158.07 17.57 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.14 0.495 . . . . 0.0 111.134 -154.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -60.11 -26.96 66.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.295 164.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.431 ' N ' ' CD ' ' A' ' 60' ' ' LYS . . . -65.92 -5.75 27.38 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.331 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -118.79 -45.04 2.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -165.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.48 -18.8 53.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.368 163.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.75 -45.53 7.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.282 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . 3.9 tmmm? -61.21 -29.35 69.77 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.452 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.402 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.533 1.2 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.524 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 6.6 t -142.35 106.37 5.58 Favored Pre-proline 0 C--O 1.248 0.977 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -150.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.18 -14.32 23.43 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 C-N-CA 122.959 2.439 . . . . 0.0 113.403 165.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.51 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -82.69 -64.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.449 -167.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.59 -27.76 18.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.672 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.31 18.51 35.96 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -95.86 -168.97 1.85 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.203 167.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.523 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -164.72 147.63 8.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.167 164.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.861 HG11 ' H ' ' A' ' 22' ' ' GLU . 62.8 t -146.35 141.02 21.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 -156.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.31 -18.59 10.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.448 168.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.75 39.37 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.111 -162.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.575 ' H ' ' CG1' ' A' ' 18' ' ' VAL . . . -137.19 -78.95 0.39 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.418 162.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.861 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -126.96 6.65 6.6 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.869 -165.028 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 124.89 22.33 Favored 'General case' 0 C--O 1.231 0.093 0 O-C-N 121.228 -0.92 . . . . 0.0 110.443 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.709 HG21 ' CD2' ' A' ' 36' ' ' PHE . 2.7 m -109.56 -179.8 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.971 161.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 tt -148.77 144.6 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.355 164.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.18 107.56 0.32 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.22 30.16 19.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.348 -0.426 . . . . 0.0 110.319 168.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.08 -37.24 3.81 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -72.91 160.77 31.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.301 -0.45 . . . . 0.0 110.32 -170.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -132.44 134.26 44.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.373 168.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.714 ' CZ3' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -133.27 179.22 6.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.551 -169.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.661 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 39.5 m80 -118.81 160.75 21.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.296 156.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HB3' ' HG2' ' A' ' 46' ' ' GLU . 17.5 mtmt -61.53 -45.77 92.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.424 -172.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.429 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -61.08 -35.43 76.96 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.512 176.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.51 ' HB3' ' HG2' ' A' ' 13' ' ' ARG . 76.9 m -77.66 -16.62 58.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.639 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.884 ' CD1' HD12 ' A' ' 57' ' ' ILE . 1.9 t80 -67.11 104.34 1.4 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.365 -168.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.583 ' O ' HD11 ' A' ' 57' ' ' ILE . 9.6 mtp180 -116.79 121.63 42.11 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.307 -166.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.2 t -58.44 118.17 5.28 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.768 168.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.21 28.89 2.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.451 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -114.15 -73.82 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.258 159.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 22.5 p -79.28 -7.43 58.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.656 -168.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.2 17.71 68.41 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.456 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.809 ' HD2' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -85.56 110.45 19.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.278 166.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.507 ' HB2' ' HG2' ' A' ' 37' ' ' ARG . 40.4 t -79.41 103.03 9.06 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.181 171.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.809 HD23 ' HD2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -116.87 -168.39 1.45 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.562 -175.363 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.58 ' HG2' ' HB3' ' A' ' 33' ' ' LYS . 1.7 tt0 -172.23 156.52 3.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 113.146 -1.843 . . . . 0.0 110.098 -161.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.46 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 21.9 p 60.66 10.81 2.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.492 166.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 p -138.85 163.68 31.62 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.216 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.468 ' CA ' ' HB2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -62.36 172.21 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.514 -165.027 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.869 HD22 ' CE2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -153.54 -163.51 1.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.299 -172.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -174.36 97.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.25 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 3.6 p30 -85.94 131.98 34.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.363 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -153.76 147.51 25.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.325 166.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 61.12 30.04 19.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.302 168.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.99 -25.06 29.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -120.35 -171.76 2.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.245 -0.477 . . . . 0.0 109.972 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.884 HD12 ' CD1' ' A' ' 36' ' ' PHE . 35.2 pt -142.86 178.7 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.465 -157.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 62' ' ' CYS . 87.8 t80 -170.05 143.76 2.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.21 -174.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.661 ' SG ' HD21 ' A' ' 45' ' ' LEU . 13.8 p -97.49 167.15 11.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.149 0.5 . . . . 0.0 111.023 -146.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.468 ' HB2' ' CA ' ' A' ' 49' ' ' THR . 1.6 tttp -77.69 -16.98 58.12 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.025 168.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.22 -9.1 40.31 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.324 170.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 58' ' ' TYR . 1.2 m -119.03 -49.35 2.41 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -165.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -60.02 -13.81 13.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.366 166.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.08 -70.19 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.416 168.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -32.69 72.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.418 -165.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.2 t30 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.406 -169.455 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.524 0.633 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.1 t -124.56 108.98 28.7 Favored Pre-proline 0 C--O 1.246 0.887 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -167.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 30' ' ' SER . 8.1 Cg_exo -59.14 -15.35 27.9 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 122.808 2.338 . . . . 0.0 113.592 168.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -84.8 -69.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.469 -168.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -89.8 -16.14 30.83 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.547 -173.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.82 18.15 70.92 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -96.97 138.92 33.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 110.245 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -102.63 142.84 33.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.25 175.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.917 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.3 t -105.77 136.14 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.967 -164.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -99.09 -72.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.183 172.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 18' ' ' VAL . . . -61.8 97.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.978 162.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 113.27 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.451 -160.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.917 ' H ' HG11 ' A' ' 18' ' ' VAL . 3.9 tp10 -112.99 26.53 10.41 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.607 174.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.687 ' HD2' ' H ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -100.05 164.38 12.01 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.034 -161.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 31' ' ' TRP . 1.1 p -156.08 172.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.7 -148.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 mt -145.96 145.16 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.631 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.87 111.89 0.5 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . . . 61.97 -82.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.35 -170.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.45 13.61 1.4 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -170.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -106.77 148.22 28.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.365 176.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.424 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -110.91 142.18 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.317 169.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.746 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -150.45 -176.7 5.59 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.686 -168.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.676 ' NE2' HG22 ' A' ' 18' ' ' VAL . 18.8 m80 -93.17 163.84 13.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.121 169.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.527 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 1.4 mmtp -62.86 -16.18 57.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.557 170.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -126.97 23.14 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.424 -172.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.425 ' HB2' ' H ' ' A' ' 32' ' ' HIS . 8.3 m -120.68 -11.96 8.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.515 175.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.564 ' CD1' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -61.18 108.63 0.93 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.313 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -111.7 103.26 11.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.378 -167.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 31.8 t -63.14 116.66 5.6 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.389 163.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.93 42.65 1.08 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.462 168.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.54 -52.72 1.08 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.517 -177.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.7 p -91.87 -11.13 37.25 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.985 161.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.32 18.65 62.05 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.479 167.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.25 149.53 30.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.127 0.489 . . . . 0.0 110.436 -164.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -68.15 138.88 56.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.736 160.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.784 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -102.83 -164.89 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.711 -159.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -144.95 -165.42 2.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.031 -168.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.2 p -76.64 -17.81 58.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.394 -170.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 p -61.06 143.6 55.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.362 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.67 -164.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.458 -170.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.511 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -155.9 -170.55 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.333 -173.523 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.31 79.18 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.325 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.594 ' CB ' HG22 ' A' ' 57' ' ' ILE . 4.6 p30 -73.6 156.39 38.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.401 174.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 179.67 136.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.445 168.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.1 t70 61.57 19.96 10.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.367 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.97 17.91 60.48 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 171.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.1 178.05 7.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 166.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.594 HG22 ' CB ' ' A' ' 52' ' ' ASP . 33.8 pt -154.13 135.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.426 -159.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -130.19 175.48 8.88 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.741 160.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.784 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.254 11.7 p -110.34 147.88 33.05 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.381 0.61 . . . . 0.0 111.857 -149.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.29 -9.76 58.65 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 120.441 -1.412 . . . . 0.0 109.856 168.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.86 -4.92 22.67 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.468 162.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.46 -48.07 2.2 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -166.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -60.09 -10.37 4.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.461 165.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.01 -45.13 5.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.491 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.8 20.28 6.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.462 -172.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.3 165.578 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.527 0.793 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.5 t -132.38 101.71 14.52 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -160.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 30' ' ' SER . 1.4 Cg_endo -59.93 -14.12 26.15 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 122.697 2.265 . . . . 0.0 113.483 167.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -81.22 -62.25 1.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.412 -166.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -88.8 -17.76 29.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.484 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.37 -13.83 54.69 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -79.45 175.51 10.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.396 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.518 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -131.84 172.92 11.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.987 163.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.882 HG11 ' H ' ' A' ' 22' ' ' GLU . 2.6 t -119.67 158.74 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.811 -172.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.433 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.5 m-85 -94.96 38.33 1.13 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.428 177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.51 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . . . 61.88 68.05 0.72 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.079 -167.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.844 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -129.13 -63.72 0.94 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.444 -174.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.882 ' H ' HG11 ' A' ' 18' ' ' VAL . 16.9 mm-40 -117.9 27.61 8.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.081 -173.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -87.32 112.92 22.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.297 -167.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.944 HG21 ' CD2' ' A' ' 36' ' ' PHE . 15.5 m -97.99 -178.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.154 165.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 pp -139.87 159.96 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.481 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.84 87.1 0.16 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.252 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.05 -18.91 10.66 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.524 ' HB3' ' NE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -72.42 159.6 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.431 -0.384 . . . . 0.0 110.349 -169.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 98.8 p -147.86 123.53 10.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.157 167.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.799 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -122.66 178.48 4.99 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.799 -165.414 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.79 ' NE2' HG22 ' A' ' 18' ' ' VAL . 20.0 m80 -94.04 162.15 14.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.875 160.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.8 mttp -60.38 -42.45 95.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.449 167.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -95.78 21.14 8.84 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.69 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 16.6 m -120.68 -19.55 7.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.382 167.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.944 ' CD2' HG21 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -60.57 113.02 2.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.329 175.018 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.802 ' CZ ' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -138.67 127.03 22.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.282 -172.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 14.0 t -58.56 112.81 1.73 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.631 165.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.802 ' HB2' ' CZ ' ' A' ' 37' ' ' ARG . . . -91.2 23.01 3.49 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.631 171.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.97 -75.7 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.491 170.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.1 p -75.67 -21.54 57.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.562 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.15 -17.82 40.35 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.459 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.85 128.91 36.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.162 0.506 . . . . 0.0 110.388 -170.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -64.94 140.02 58.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.08 164.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.821 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.8 OUTLIER -163.62 -176.25 4.57 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.16 165.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.566 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -172.32 -157.63 0.11 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.381 -160.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.71 -87.29 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.74 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.38 15.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.241 -174.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.723 HG22 ' C ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -118.19 45.19 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.331 -171.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 46' ' ' GLU . 3.9 pp -142.8 168.79 18.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.452 -177.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.71 125.97 12.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.357 173.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.708 ' CB ' HG22 ' A' ' 57' ' ' ILE . 3.6 p-10 -124.64 146.65 48.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.427 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.66 156.32 0.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.449 167.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 61.27 19.76 10.42 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.554 172.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.83 -27.4 20.38 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 166.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.443 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -117.23 178.62 4.3 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.044 -0.578 . . . . 0.0 109.899 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.708 HG22 ' CB ' ' A' ' 52' ' ' ASP . 35.0 pt -156.2 135.83 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.446 -160.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -134.02 177.73 7.51 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 156.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.821 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.258 12.4 p -113.92 152.29 31.01 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.992 0.901 . . . . 0.0 113.17 -143.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.723 ' C ' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -84.91 -0.29 53.66 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 119.476 -2.015 . . . . 0.0 110.352 166.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.525 ' N ' HG22 ' A' ' 49' ' ' THR . . . -58.09 -15.25 20.94 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 151.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 -51.78 2.43 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -157.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -60.08 -14.85 18.76 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.474 167.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.5 -66.12 0.95 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.39 167.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -41.23 94.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.493 -164.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.352 -175.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 t -124.41 113.34 27.63 Favored Pre-proline 0 C--O 1.244 0.789 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -157.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.429 ' HG2' ' O ' ' A' ' 30' ' ' SER . 6.8 Cg_endo -63.4 -7.04 11.35 Favored 'Trans proline' 0 N--CA 1.484 0.916 0 C-N-CA 122.686 2.258 . . . . 0.0 113.696 171.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.512 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -92.09 -70.27 0.7 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.407 -174.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.4 p -91.22 -29.99 16.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.63 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 48.35 2.72 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.52 157.42 33.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.399 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -113.88 137.74 51.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.171 168.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.909 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.2 t -113.41 134.48 56.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.865 -163.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -94.2 -69.44 0.75 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.382 -167.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 -10.33 5.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.4 167.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.74 111.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.329 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.909 ' H ' HG11 ' A' ' 18' ' ' VAL . 9.0 tt0 -114.4 31.55 6.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.535 172.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.52 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 4.5 mtpm? -106.48 -175.14 2.71 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.171 -160.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 31' ' ' TRP . 2.1 p -169.05 161.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.768 -148.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -141.21 144.74 25.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.45 -171.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.512 ' HA3' ' HB3' ' A' ' 52' ' ' ASP . . . -163.99 135.65 3.88 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 167.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 53' ' ' LYS . . . 61.55 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.334 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.89 16.87 0.82 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -173.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.12 140.33 52.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.375 -168.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.51 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -104.67 145.59 30.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.305 168.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.771 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -149.71 163.94 36.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.595 -170.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 35' ' ' CYS . 17.9 m80 -74.26 144.66 44.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.734 158.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 4.1 mttm -60.27 -21.54 62.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.487 169.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -111.21 18.16 19.59 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.51 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 21.3 m -119.79 16.38 12.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.215 166.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.957 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -98.11 110.64 23.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.263 -163.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.529 ' O ' HD11 ' A' ' 57' ' ' ILE . 7.7 ttp-105 -122.61 120.62 34.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.278 -164.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.1 t -58.42 111.83 1.37 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.728 164.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.47 -24.6 67.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.681 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.551 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -75.99 -78.82 0.11 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.26 -176.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.7 p -84.75 -9.12 58.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.783 -163.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.78 15.69 74.8 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.929 ' HG2' HD23 ' A' ' 45' ' ' LEU . 8.6 tptm -88.78 103.07 15.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.415 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 14.3 t -71.15 92.38 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.105 166.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.929 HD23 ' HG2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -128.12 -175.17 3.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.555 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -171.64 -45.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.789 -163.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -60.94 -61.29 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.369 -173.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.8 p -65.63 133.05 50.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.124 163.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.58 HG22 ' HG2' ' A' ' 60' ' ' LYS . 6.3 t -62.6 -176.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.335 -166.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.957 HD22 ' CE2' ' A' ' 36' ' ' PHE . 2.3 pp -119.81 177.42 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.335 -167.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -163.41 108.84 1.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.292 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.512 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 4.4 p-10 -94.99 145.34 25.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.3 -168.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -130.49 -174.49 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.394 165.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.63 92.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.424 -169.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.04 -22.95 37.88 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.34 -174.08 3.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.046 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.873 HD12 ' CD1' ' A' ' 36' ' ' PHE . 35.6 pt -148.37 175.8 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.333 -161.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.551 ' CE2' ' HG3' ' A' ' 40' ' ' LYS . 13.6 t80 -178.29 141.45 0.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.162 -160.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.721 ' HB2' HD11 ' A' ' 45' ' ' LEU . 10.1 p -100.67 168.97 9.35 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.898 -148.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.58 ' HG2' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -85.23 -12.84 51.62 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.123 169.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.75 -10.35 37.62 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.038 166.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.526 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 1.3 m -119.0 -46.85 2.52 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -164.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -60.19 -16.4 32.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.444 163.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 -43.41 12.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.287 168.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -60.79 -11.72 8.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.523 177.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.307 -178.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.527 0.818 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 t -136.16 111.33 10.07 Favored Pre-proline 0 C--O 1.247 0.94 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -158.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 30' ' ' SER . 15.1 Cg_exo -53.9 -20.24 17.38 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.99 2.46 . . . . 0.0 113.642 166.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.23 -72.44 0.51 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.429 -167.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 p -86.62 -18.15 32.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.61 -172.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.87 18.75 64.74 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.77 168.09 11.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.328 170.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -122.49 145.03 48.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.168 168.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.92 HG11 ' H ' ' A' ' 22' ' ' GLU . 4.8 t -101.56 135.2 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.19 -164.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -73.83 -77.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.423 -166.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.61 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.135 167.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -176.86 133.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.091 165.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.92 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -129.0 17.51 6.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.389 161.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.45 ' CD ' ' N ' ' A' ' 24' ' ' VAL . 0.1 OUTLIER -103.49 160.59 14.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.91 -159.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 31' ' ' TRP . 2.3 p -150.97 178.02 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.575 -147.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.468 ' H ' HG22 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -144.91 147.58 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.541 -175.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.3 139.36 5.63 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.64 -82.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.046 -0.577 . . . . 0.0 110.397 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -153.74 27.95 0.75 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 170.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.62 153.85 31.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.399 -0.401 . . . . 0.0 110.359 -170.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.408 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 14.9 t -110.43 143.42 40.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.2 168.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.779 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -148.38 170.98 16.78 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.952 -172.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.725 ' NE2' HG22 ' A' ' 18' ' ' VAL . 15.2 m80 -86.31 147.38 26.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.519 -1.218 . . . . 0.0 110.084 162.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -60.67 -13.31 13.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.489 171.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -101.55 -36.08 8.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.417 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 39.8 m -72.93 -17.29 61.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.453 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.619 ' CE1' HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -61.19 85.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.267 177.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 17.5 mtm180 -121.65 127.12 50.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.196 -167.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 12.4 t -59.33 107.08 0.51 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.477 164.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.51 -20.99 66.07 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.573 170.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -67.37 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.541 -165.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p -88.55 -27.16 21.59 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.65 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.95 22.37 6.96 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.6 tppp? -110.03 110.7 21.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.265 -0.468 . . . . 0.0 110.401 -168.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -65.15 112.43 3.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.358 167.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.692 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.2 pp -147.19 176.64 9.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.399 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.36 -32.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.917 -173.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -67.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.54 -165.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -61.44 -75.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.358 -173.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.673 HG23 ' HB2' ' A' ' 60' ' ' LYS . 14.8 t -178.77 -169.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.366 164.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.619 HD13 ' CE1' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -168.66 -171.52 1.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.236 -169.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.34 82.64 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.368 -167.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.907 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.0 p30 -69.6 147.35 50.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.356 170.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.33 149.31 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.42 169.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.19 -96.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.459 -170.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.24 23.59 0.98 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.29 173.82 12.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 171.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.907 HG22 ' HA ' ' A' ' 52' ' ' ASP . 39.3 pt -141.3 152.74 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.194 -158.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -134.13 174.58 10.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.679 157.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.692 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.2 p -106.79 159.14 16.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.179 0.514 . . . . 0.0 110.847 -152.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.673 ' HB2' HG23 ' A' ' 49' ' ' THR . 11.8 tptt -72.33 -14.7 61.8 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.848 168.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.7 -10.26 43.49 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.196 166.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.43 -48.54 2.7 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -164.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -60.38 -13.62 14.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.258 165.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.57 -65.37 1.02 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.522 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -61.26 -16.53 46.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.567 -165.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.256 167.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . . . . . . 0 CA--C 1.533 1.179 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 8.1 t -140.32 107.02 6.64 Favored Pre-proline 0 C--O 1.249 1.049 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -149.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.74 -16.98 33.63 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 C-N-CA 122.762 2.308 . . . . 0.0 113.625 171.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -84.08 -67.03 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.593 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 p -87.94 -29.96 20.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.602 -170.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.09 18.62 36.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -93.64 -169.03 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 164.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -165.59 145.26 6.55 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.262 164.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.874 HG11 ' H ' ' A' ' 22' ' ' GLU . 64.7 t -143.57 137.77 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.444 -155.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -109.32 -19.04 13.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.446 169.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.57 -56.57 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.257 -167.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.801 ' HB1' ' OE2' ' A' ' 22' ' ' GLU . . . -61.38 -74.54 0.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.412 -162.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.874 ' H ' HG11 ' A' ' 18' ' ' VAL . 4.2 mm-40 -117.34 7.64 12.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.792 -164.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -60.9 122.11 14.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -161.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.637 HG21 ' CD2' ' A' ' 36' ' ' PHE . 3.5 m -122.13 169.27 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.249 167.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.7 mt -145.94 139.99 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.424 168.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.46 120.27 0.93 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -170.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.68 16.31 7.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.332 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.62 -22.92 25.39 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -79.64 134.64 36.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.437 -172.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.7 m -102.33 119.35 38.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.396 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.486 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -124.31 174.58 7.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.602 -172.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.532 ' CE1' ' HB2' ' A' ' 11' ' ' CYS . 44.2 m80 -105.29 153.99 20.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.1 157.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HD3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -61.11 -27.12 68.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.4 178.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 t -84.52 -23.77 29.64 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.486 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.3 m -95.81 25.09 4.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.347 171.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.884 ' HZ ' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -113.14 89.31 3.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.269 -171.066 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.892 ' NH1' ' HB2' ' A' ' 39' ' ' ALA . 1.1 ppt_? -112.02 130.39 55.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.282 -166.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.9 t -65.28 110.92 2.77 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.446 168.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.892 ' HB2' ' NH1' ' A' ' 37' ' ' ARG . . . -92.51 18.62 8.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.616 170.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.498 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.73 -75.34 0.48 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.379 165.195 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.5 p -83.4 -22.65 32.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.494 -173.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.35 -28.35 6.31 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 165.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HD2' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -82.61 145.22 29.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.307 -0.447 . . . . 0.0 110.385 -168.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 15.0 m -92.14 137.35 32.43 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.328 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.656 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -140.88 -168.47 2.6 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.841 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.506 ' HB2' ' HD3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -171.88 -69.73 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.946 -1.934 . . . . 0.0 110.254 -171.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.5 p -61.84 -22.06 65.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.391 -166.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -96.02 156.97 16.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.412 170.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.683 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -60.91 -173.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.355 -168.081 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.884 HD13 ' HZ ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -148.34 -175.89 5.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.419 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.46 77.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.312 -169.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.615 ' HA ' HG22 ' A' ' 57' ' ' ILE . 4.9 p-10 -67.45 90.91 0.25 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.361 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.25 169.66 17.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.368 170.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -61.07 89.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.434 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.74 -19.19 14.32 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -155.33 -171.73 3.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.003 -169.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.783 HD12 ' CE1' ' A' ' 36' ' ' PHE . 38.1 pt -148.77 140.15 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.381 -161.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.498 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 1.5 m-85 -132.93 -175.94 3.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.938 163.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.6 p -110.54 159.85 17.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.466 0.65 . . . . 0.0 111.185 -153.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 6.7 tmtt? -74.46 -13.32 60.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.866 169.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.66 -9.64 39.72 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.21 164.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.91 -45.34 2.77 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -164.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -60.51 -13.25 12.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.224 162.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.67 -51.1 5.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.393 172.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.02 -13.58 17.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.375 -168.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 . . . . . 0 N--CA 1.455 -0.18 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.458 -178.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ptt? . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 121.107 0.48 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.31 154.26 22.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.304 171.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 64.55 146.86 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.347 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.495 ' O ' HG12 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -127.11 149.37 49.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.411 -169.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 4' ' ' LYS . 5.5 p 60.12 39.41 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.045 174.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.26 143.0 6.95 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.451 -1.059 . . . . 0.0 110.451 170.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.95 97.56 2.41 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.8 t 65.81 116.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.437 -0.382 . . . . 0.0 110.3 -168.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.97 117.71 3.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.295 -168.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -108.35 170.66 15.15 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -164.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 t -122.42 103.2 38.64 Favored Pre-proline 0 C--O 1.244 0.769 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -167.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 30' ' ' SER . 10.3 Cg_endo -59.13 -15.2 27.16 Favored 'Trans proline' 0 N--CA 1.485 1.025 0 C-N-CA 122.704 2.269 . . . . 0.0 113.557 171.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -82.3 -65.87 0.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.459 -167.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.7 p -87.49 -14.57 40.02 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.517 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.94 18.41 61.3 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.534 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.51 161.17 13.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 110.272 167.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -119.81 148.61 43.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.277 169.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.892 HG11 ' H ' ' A' ' 22' ' ' GLU . 4.4 t -109.81 144.1 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.025 -166.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.73 -45.44 2.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.66 -1.154 . . . . 0.0 110.445 176.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.02 -11.69 9.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.315 171.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.595 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 61.73 92.54 0.05 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.31 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.892 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.7 OUTLIER -106.18 27.81 8.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.702 164.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.17 130.2 37.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.29 -162.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.636 HG21 ' CD2' ' A' ' 36' ' ' PHE . 2.3 m -107.04 -168.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.003 161.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 pp -154.56 155.55 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.435 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.502 ' HA3' ' HB3' ' A' ' 52' ' ' ASP . . . -161.57 128.67 1.95 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 168.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.54 -82.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.289 -172.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -152.39 21.13 0.83 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 169.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -85.29 168.63 14.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.359 -0.42 . . . . 0.0 110.395 170.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -141.99 142.33 32.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.295 168.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.793 ' CH2' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -135.39 176.47 8.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.091 -169.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.647 ' NE2' HG22 ' A' ' 18' ' ' VAL . 16.9 m80 -84.63 164.58 18.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.083 165.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.452 ' H ' ' HG2' ' A' ' 22' ' ' GLU . 16.0 tttp -60.95 -24.88 66.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.508 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.5 t -129.42 31.21 4.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.33 -169.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.1 m -119.5 -10.35 9.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.823 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.733 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -61.67 107.19 0.77 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.333 -172.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.46 100.54 7.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.366 -166.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 25.2 t -62.82 117.37 6.25 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.532 167.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.66 41.77 1.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.39 169.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -131.47 -48.35 0.98 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.436 -176.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.2 p -97.12 -11.85 23.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.099 162.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.3 17.68 58.54 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.372 167.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -107.96 147.03 31.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.069 0.462 . . . . 0.0 110.353 -164.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.9 m -68.77 136.59 53.02 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.53 159.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.764 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -100.84 -163.63 1.04 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.913 -158.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.818 ' HB2' HG22 ' A' ' 49' ' ' THR . 7.3 mt-10 -117.16 -178.17 3.38 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.926 165.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.69 -57.17 5.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.343 -166.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.8 t -118.82 44.48 2.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.405 -168.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.818 HG22 ' HB2' ' A' ' 46' ' ' GLU . 11.8 t -141.68 68.39 1.33 Allowed 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.324 176.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.733 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 2.2 pp -149.11 170.5 18.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.37 -164.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -158.14 115.22 2.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.35 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.672 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.0 p30 -91.82 162.08 14.59 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.353 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 53' ' ' LYS . 13.0 tptt -169.14 135.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.323 168.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 60.86 -95.49 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.477 175.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.29 16.57 1.69 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -127.58 -177.98 4.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 167.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.793 HD13 ' CH2' ' A' ' 31' ' ' TRP . 27.2 pt -157.27 136.8 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.538 -159.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.561 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 3.6 p90 -126.57 177.94 6.2 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 155.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.764 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.255 12.2 p -110.74 148.09 33.03 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.099 0.476 . . . . 0.0 111.793 -150.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -73.58 -6.47 46.82 Favored 'General case' 0 C--N 1.347 0.466 0 O-C-N 120.162 -1.586 . . . . 0.0 109.993 167.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.81 -3.02 26.16 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.609 159.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -122.8 -48.69 2.01 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -167.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -59.91 -12.87 8.66 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 113.943 -1.481 . . . . 0.0 110.334 162.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.67 -69.25 0.7 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.347 166.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.78 -32.53 71.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.447 -165.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -117.85 62.27 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.414 170.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -61.82 -22.29 65.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.313 -176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -152.7 87.84 0.13 Allowed Glycine 0 CA--C 1.543 1.802 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -173.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -54.44 146.72 50.7 Favored 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 122.514 2.143 . . . . 0.0 113.443 171.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 tptp 179.98 -76.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.442 170.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.04 153.57 11.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -168.21 124.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.371 -0.414 . . . . 0.0 110.345 170.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 169.2 44.72 0.03 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 170.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 70.02 -78.44 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.424 -0.388 . . . . 0.0 110.384 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.53 158.22 50.14 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -85.66 -63.57 1.3 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.113 -0.543 . . . . 0.0 110.363 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 130.99 -39.25 1.81 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -170.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -103.93 94.71 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.236 169.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -113.51 -79.77 0.93 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -169.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -166.09 35.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.363 -0.418 . . . . 0.0 110.259 -169.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.431 ' C ' HG22 ' A' ' 82' ' ' ILE . 1.4 pp -77.14 -43.06 35.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.497 169.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.431 HG22 ' C ' ' A' ' 81' ' ' LEU . 9.0 tp 58.54 61.06 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.608 171.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 m80 69.68 -80.58 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.432 170.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.66 -28.03 36.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.381 -168.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 . . . . . 0 C--O 1.241 0.616 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.393 -169.682 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 121.137 0.494 . . . . 0.0 109.846 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.94 157.16 23.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.234 172.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -85.82 151.16 24.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.303 169.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 128.6 36.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.381 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 m -111.23 142.78 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.377 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.19 162.7 22.59 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 169.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.94 -111.92 2.97 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -170.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.67 ' OG ' ' HB2' ' A' ' 20' ' ' ALA . 44.9 t -139.94 -72.73 0.37 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.418 -169.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.512 ' HB3' ' HD3' ' A' ' 23' ' ' LYS . 7.3 t0 -153.75 124.79 7.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.121 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -111.43 -179.36 20.12 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -158.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 9.3 t -123.29 106.68 32.98 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -162.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 30' ' ' SER . 8.6 Cg_endo -58.47 -15.3 24.24 Favored 'Trans proline' 0 N--CA 1.483 0.877 0 C-N-CA 122.917 2.411 . . . . 0.0 113.61 167.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.8 -67.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.377 -166.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.7 p -88.73 -22.75 23.18 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.618 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.6 -18.26 38.22 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -66.42 171.6 4.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.405 -0.397 . . . . 0.0 110.295 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -143.59 143.37 31.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.191 169.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.852 ' CG1' ' HB3' ' A' ' 21' ' ' ALA . 2.4 t -96.01 158.64 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.451 -162.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 9.9 t80 -94.55 38.89 1.1 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.475 177.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.67 ' HB2' ' OG ' ' A' ' 8' ' ' SER . . . 61.84 67.87 0.73 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.077 -167.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.852 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -129.12 -64.41 0.91 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.483 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.82 ' H ' HG11 ' A' ' 18' ' ' VAL . 3.0 mt-10 -129.38 16.71 6.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.185 -166.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' HD3' ' HB3' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -93.58 158.68 15.58 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.018 -166.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.757 HG12 ' O ' ' A' ' 31' ' ' TRP . 0.9 OUTLIER -158.92 173.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.724 -147.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -144.43 140.79 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.51 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.8 134.83 4.18 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 167.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.75 -83.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.275 -0.462 . . . . 0.0 110.459 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.14 48.18 0.52 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 172.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.89 148.66 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.4 -170.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.42 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -108.09 144.28 35.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.27 168.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.757 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -147.93 172.6 13.94 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.782 -170.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.821 ' NE2' HG22 ' A' ' 18' ' ' VAL . 43.3 m80 -92.96 156.18 17.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.855 162.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.544 ' CD ' ' HB3' ' A' ' 22' ' ' GLU . 13.7 ptmt -62.59 -14.18 39.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.456 169.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.49 17.73 18.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.547 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.1 m -125.73 23.51 7.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.243 167.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.581 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -118.3 82.97 1.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.177 -168.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -119.91 129.25 54.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.255 -166.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 13.0 t -60.01 105.59 0.41 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.271 163.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.46 -19.48 64.76 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.571 170.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.11 -65.08 1.04 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.59 -164.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.3 p -88.0 -24.92 23.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.615 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.96 18.76 30.86 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -99.03 132.19 44.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.396 169.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER -81.72 134.98 35.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.332 168.115 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.689 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.1 pp -157.78 -173.07 4.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.361 177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.719 ' C ' HD23 ' A' ' 50' ' ' LEU . 1.3 pt-20 -139.01 -179.27 5.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.073 -162.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.491 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -66.44 169.08 7.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.365 -165.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 49' ' ' THR . 0.3 OUTLIER 61.08 13.17 4.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.344 -167.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -168.6 30.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.57 -174.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.719 HD23 ' C ' ' A' ' 46' ' ' GLU . 4.0 pp -153.03 175.11 13.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.498 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.67 107.97 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.3 -169.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.753 ' CB ' HG22 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -90.63 161.13 15.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.418 176.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.501 ' HD2' ' CE1' ' A' ' 58' ' ' TYR . 8.4 ptmm? -166.29 109.98 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.429 -171.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 60.78 18.36 8.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.471 164.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.4 -28.16 8.86 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -104.93 168.58 8.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.753 HG22 ' CB ' ' A' ' 52' ' ' ASP . 32.3 pt -150.11 131.22 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.443 -158.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.517 ' H ' ' HD1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -124.71 -175.27 3.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.747 161.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.689 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.2 p -111.11 157.39 20.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.327 0.584 . . . . 0.0 110.927 -153.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 49' ' ' THR . 6.2 ttmm -71.89 -13.86 61.78 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.824 169.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.22 -10.41 41.1 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.151 165.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.15 -46.86 2.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -164.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -17.1 41.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.364 165.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -95.13 -58.31 2.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.289 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -20.52 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.401 -167.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.07 38.05 3.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.309 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.451 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -86.88 -42.11 13.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.335 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.9 102.24 2.4 Favored Glycine 0 CA--C 1.542 1.772 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -171.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 67' ' ' PHE . 8.0 Cg_exo -58.79 91.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.605 2.203 . . . . 0.0 113.517 -173.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.38 -169.12 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.461 169.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -110.03 -99.47 2.56 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -168.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -96.68 175.89 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.426 -168.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.84 174.79 28.21 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 169.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -128.83 -22.45 3.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.411 -0.394 . . . . 0.0 110.313 -169.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.22 -38.58 3.1 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -166.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 69.9 -76.0 0.07 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.33 167.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 121.19 177.21 15.55 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -167.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.41 -162.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.425 -0.388 . . . . 0.0 110.221 -168.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.21 -166.39 39.66 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 169.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.12 155.87 44.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.353 -0.424 . . . . 0.0 110.29 -170.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mt 60.16 -79.88 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.626 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.9 -32.44 6.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.441 -169.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 21.1 m170 71.58 -80.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.451 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 80.8 p 61.22 96.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.617 173.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.522 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.396 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.601 ' HE1' ' HB1' ' A' ' 17' ' ' ALA . 92.5 mtp . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.29 -82.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.408 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.7 27.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.358 -169.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.488 ' O ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -114.36 -174.48 2.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.398 -178.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 4' ' ' LYS . 10.0 m 59.61 40.38 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.224 174.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.31 -179.22 37.57 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.97 85.19 1.21 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 169.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.09 -163.65 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.069 0.461 . . . . 0.0 110.375 -168.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.402 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -147.0 -171.53 3.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.133 169.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -153.15 170.04 32.07 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -170.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.7 t -125.01 108.66 27.82 Favored Pre-proline 0 C--O 1.244 0.799 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -164.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 30' ' ' SER . 7.7 Cg_exo -57.56 -16.4 23.94 Favored 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 122.854 2.369 . . . . 0.0 113.578 166.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.82 -68.54 0.71 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.392 -167.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.1 p -90.1 -13.16 36.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.5 -175.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.75 18.74 67.3 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 175.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.89 164.44 13.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.378 168.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.601 ' HB1' ' HE1' ' A' ' 1' ' ' MET . . . -120.32 143.2 48.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.089 167.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.781 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.5 t -108.14 140.6 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.864 -164.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -103.52 136.03 44.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.437 171.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.57 19.77 10.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.425 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.94 110.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.286 168.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.781 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -117.85 20.35 13.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.55 166.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -102.96 168.06 9.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.421 -158.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.982 HG21 ' CD2' ' A' ' 36' ' ' PHE . 1.2 m -115.51 -171.69 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.148 167.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 26' ' ' GLY . 0.5 OUTLIER -163.6 146.62 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.412 166.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.459 ' N ' HG13 ' A' ' 25' ' ' ILE . . . -171.44 141.07 6.2 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -170.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.38 -82.44 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.015 -0.592 . . . . 0.0 110.248 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.46 21.08 0.93 Allowed Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 168.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -122.17 128.55 51.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.374 -169.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.435 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -96.48 144.14 26.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.34 167.469 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -139.51 -163.22 1.45 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.892 -177.122 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.664 ' HE2' HG22 ' A' ' 18' ' ' VAL . 18.6 m80 -103.9 163.55 12.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.136 164.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -73.92 -11.56 60.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.396 170.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -120.0 23.33 11.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.431 177.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 1.8 m -121.32 -20.35 6.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.457 174.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.982 ' CD2' HG21 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -61.42 104.62 0.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.298 -171.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.9 ptm85 -115.59 102.35 9.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.312 -164.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 29.8 t -62.53 116.35 5.05 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.477 163.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.0 41.99 1.1 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.371 168.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -129.93 -53.57 1.13 Allowed 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.555 -178.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.6 p -92.63 -11.23 34.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.005 163.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.62 18.2 60.57 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.434 167.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -108.06 147.88 30.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.943 0.401 . . . . 0.0 110.34 -164.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.82 138.71 52.85 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.633 158.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -103.62 -163.51 0.99 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.919 -157.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.71 -159.26 0.68 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.095 168.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.0 p -92.52 -58.2 2.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.365 -168.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.4 p -110.62 41.24 1.82 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.453 -169.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 28.2 p -151.27 78.68 1.28 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.523 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.735 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 2.7 pp -151.96 167.18 29.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.496 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 58' ' ' TYR . . . -146.07 114.37 6.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.255 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.954 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.0 p30 -85.53 160.87 19.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.434 171.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -175.71 97.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.408 -169.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 61.03 17.82 8.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.464 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.9 -23.63 25.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 170.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -103.72 165.09 11.25 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 167.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.954 HG22 ' HA ' ' A' ' 52' ' ' ASP . 31.9 pt -147.98 137.6 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.376 -157.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 1.9 p90 -125.86 176.22 7.11 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.538 156.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.793 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.25 12.4 p -110.15 148.76 31.17 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.302 0.573 . . . . 0.0 111.814 -149.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.52 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -71.71 -9.63 58.56 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 120.587 -1.32 . . . . 0.0 109.873 168.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.02 -4.74 22.91 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.457 162.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.4 -49.26 2.16 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -166.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -59.99 -13.6 12.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.367 163.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.48 -64.24 1.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.331 166.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -12.07 9.95 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.421 -166.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.97 -20.19 59.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.478 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -156.16 111.24 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.408 -175.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.44 ' N ' ' CD ' ' A' ' 69' ' ' PRO . . . 165.78 -54.43 0.26 Allowed Glycine 0 CA--C 1.543 1.831 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -173.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 68' ' ' GLY . 15.5 Cg_exo -52.38 91.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.532 2.155 . . . . 0.0 113.583 -171.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.22 -77.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.512 171.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.14 153.77 6.12 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -169.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.3 130.22 23.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.317 -0.441 . . . . 0.0 110.328 170.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -163.88 -103.34 0.17 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -170.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.26 -175.95 3.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.332 170.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.26 -71.58 0.27 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 170.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.37 -176.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.448 170.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.35 158.78 46.07 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.499 -1.041 . . . . 0.0 110.499 -170.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.75 133.01 10.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.395 -0.402 . . . . 0.0 110.235 169.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -146.21 -44.71 0.04 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -169.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 62.23 -82.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.187 -0.507 . . . . 0.0 110.329 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.36 99.84 8.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.388 -169.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 tp -97.95 -15.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.46 170.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 72.05 -80.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.433 171.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.27 -166.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.43 -170.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.241 0.655 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.324 170.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ptm . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.139 0.495 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.44 -171.37 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.311 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.4 126.94 10.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.312 169.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.95 -45.97 2.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.399 -170.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 m -90.9 -48.75 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.426 -170.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.27 177.16 15.93 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -170.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.0 -64.97 0.36 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 84.2 p -138.66 175.28 9.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.405 -0.398 . . . . 0.0 110.398 -169.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.52 ' HB3' ' HD2' ' A' ' 23' ' ' LYS . 7.8 t0 -130.97 123.57 29.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.169 169.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -117.92 177.36 16.52 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -161.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.9 t -129.65 102.42 18.1 Favored Pre-proline 0 C--O 1.242 0.692 0 CA-C-O 121.285 0.564 . . . . 0.0 109.5 -162.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 30' ' ' SER . 2.6 Cg_endo -58.36 -15.06 22.6 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.79 2.327 . . . . 0.0 113.504 170.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -63.76 1.32 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.463 -167.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -89.04 -34.85 16.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.554 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.7 -31.15 3.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.47 168.99 8.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.373 -169.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.519 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -126.56 145.87 50.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.215 168.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.885 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.8 t -109.15 148.91 12.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.907 -165.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -125.56 -45.46 1.79 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.516 176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.95 -11.0 6.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.355 170.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.6 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 61.76 93.1 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.347 177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.885 ' H ' HG11 ' A' ' 18' ' ' VAL . 4.0 mm-40 -107.68 34.36 3.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.764 164.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.52 ' HD2' ' HB3' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -85.7 124.1 31.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.345 -162.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.883 HG21 ' CD2' ' A' ' 36' ' ' PHE . 2.6 m -97.15 176.33 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.889 160.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.589 ' N ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -145.94 143.49 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.364 167.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -176.91 127.56 1.23 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 169.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 36.78 16.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.385 176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.21 -20.27 48.74 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -86.6 130.44 34.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.382 -173.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 32.4 t -103.82 117.25 33.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.209 166.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.561 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -113.1 -173.43 2.25 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.029 -167.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.735 ' HE2' HG22 ' A' ' 18' ' ' VAL . 19.2 m80 -96.07 157.17 16.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.039 163.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -15.98 30.78 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.603 168.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.8 p -106.9 -27.13 10.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.353 -171.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.8 m -88.03 -17.38 31.29 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.384 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.94 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -60.6 95.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.431 171.306 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 18.9 ptt85 -133.11 126.73 32.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.316 -169.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 14.3 t -60.26 111.78 1.67 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.125 163.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.0 41.01 1.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.406 167.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.57 -41.26 1.53 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.539 -177.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.2 p -108.5 -27.35 9.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.485 166.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.49 18.61 25.4 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -98.07 145.98 26.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.377 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 3.9 m -80.77 145.14 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.396 169.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.633 HD11 ' HB2' ' A' ' 59' ' ' CYS . 1.4 pp -168.53 179.11 4.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.151 167.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -171.47 -159.34 0.15 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.107 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.91 -86.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.594 167.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 49' ' ' THR . 15.0 t -138.15 42.0 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.367 -166.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.527 ' HA ' ' HB3' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -168.09 40.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.471 -177.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.94 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 1.9 pp -133.45 167.78 19.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.409 -174.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -161.57 103.53 1.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.262 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.849 ' HA ' HG22 ' A' ' 57' ' ' ILE . 6.6 p-10 -75.62 168.83 19.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.335 169.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.47 100.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.482 -177.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 60.88 19.46 9.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.444 165.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.58 -32.0 5.36 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 170.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.92 164.55 11.62 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.849 HG22 ' HA ' ' A' ' 52' ' ' ASP . 32.9 pt -148.64 129.99 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.363 -157.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.67 -175.66 3.4 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.768 162.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.633 ' HB2' HD11 ' A' ' 45' ' ' LEU . 13.7 p -111.61 155.16 23.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 111.166 -153.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 49' ' ' THR . 17.8 tptp -71.16 -14.01 62.13 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.733 169.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.16 -8.63 31.1 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.59 -1.187 . . . . 0.0 111.111 164.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -117.56 -46.57 2.66 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -165.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.27 -14.88 20.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.423 165.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.46 -68.17 0.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.398 172.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -61.11 -25.95 67.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.402 -166.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -92.08 -19.16 22.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.469 -169.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -115.13 29.62 7.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.279 -169.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -122.89 67.51 0.48 Allowed Glycine 0 CA--C 1.543 1.843 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.32 106.31 0.18 Allowed 'Trans proline' 0 N--CA 1.485 0.98 0 C-N-CA 122.522 2.148 . . . . 0.0 113.537 171.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 86.82 5.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.469 -167.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.74 -127.85 41.98 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 171.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.52 141.27 20.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.26 -0.47 . . . . 0.0 110.337 175.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.33 50.26 1.87 Allowed Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -169.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -132.44 98.7 4.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.33 -0.435 . . . . 0.0 110.365 169.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.27 -154.19 7.96 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 69.3 98.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.343 170.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -162.89 19.9 0.16 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -170.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -113.06 -46.97 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.416 -0.392 . . . . 0.0 110.276 169.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.97 120.75 6.29 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 169.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.75 154.84 41.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.194 -169.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.51 -18.48 28.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.515 169.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.0 pt 57.69 51.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.864 168.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -86.87 -73.64 0.46 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.398 168.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.69 -83.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.37 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 . . . . . 0 C--O 1.24 0.567 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.316 -170.622 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 N--CA 1.474 0.74 0 CA-C-O 121.222 0.534 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.18 -162.75 0.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.239 172.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.89 120.83 26.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.462 169.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.03 -169.95 2.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.372 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 p -101.23 30.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.349 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.27 87.79 1.1 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -137.66 -173.93 13.14 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.445 -1.062 . . . . 0.0 110.445 -170.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -123.72 -56.89 1.66 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.452 -169.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.88 122.72 5.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.147 176.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -109.26 177.4 20.18 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -160.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.5 t -123.69 102.15 35.81 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -162.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 30' ' ' SER . 2.0 Cg_endo -60.18 -14.12 27.35 Favored 'Trans proline' 0 N--CA 1.485 1.015 0 C-N-CA 122.778 2.319 . . . . 0.0 113.486 167.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.51 ' HD3' ' CZ3' ' A' ' 31' ' ' TRP . 4.8 tpt180 -79.39 -63.26 1.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.341 -167.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.2 p -91.78 -24.11 19.52 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.512 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.12 -29.55 5.05 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -172.64 1.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.293 -0.454 . . . . 0.0 110.331 -172.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.544 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -146.86 152.23 38.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.189 166.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.791 HG11 ' H ' ' A' ' 22' ' ' GLU . 2.6 t -106.46 166.61 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.556 -166.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -101.39 68.41 1.2 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.467 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.492 ' HB2' ' OG ' ' A' ' 8' ' ' SER . . . 61.14 16.75 7.46 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.524 174.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.758 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -91.81 -70.45 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.359 -165.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.791 ' H ' HG11 ' A' ' 18' ' ' VAL . 3.3 mm-40 -106.27 17.12 23.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.123 -167.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.09 106.07 16.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.342 -163.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 36' ' ' PHE . 15.7 m -86.84 -167.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.015 161.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.1 tt -154.68 150.54 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.428 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.1 -142.01 3.71 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 168.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.419 ' HB3' ' H ' ' A' ' 55' ' ' GLY . . . -71.1 87.11 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.274 -173.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.78 23.11 60.69 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -172.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -113.31 154.59 26.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.4 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.459 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -144.63 120.24 10.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.246 168.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.644 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -115.38 166.3 12.03 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.858 -164.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.727 ' NE2' HG22 ' A' ' 18' ' ' VAL . 39.5 m80 -80.45 156.23 26.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.004 162.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -60.85 -12.31 10.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.486 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.1 p -115.93 18.3 15.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.412 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.78 11.89 6.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.413 -171.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.757 ' CE1' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -89.38 89.4 7.86 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.268 177.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.11 108.62 19.36 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.456 -173.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 32.2 t -62.91 116.81 5.62 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.399 163.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.63 40.26 1.14 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.387 169.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -129.27 -49.21 1.19 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.462 -176.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.4 p -96.07 -12.19 25.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.081 162.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.81 18.38 56.44 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.378 168.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -106.5 145.14 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 110.341 -163.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.8 m -69.61 126.28 29.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.668 159.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -90.55 -164.64 1.2 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.736 -158.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -130.45 88.59 2.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 113.888 -1.505 . . . . 0.0 110.173 -166.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 64.95 -86.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.483 165.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 p -146.61 67.37 1.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.405 -168.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 2.4 p -152.7 75.02 1.08 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.354 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.757 HD13 ' CE1' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -145.43 -177.35 5.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.376 -166.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.48 104.61 2.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.259 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.584 ' HA ' HG22 ' A' ' 57' ' ' ILE . 2.3 p30 -87.54 154.35 20.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.363 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 0.2 OUTLIER 178.81 140.96 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.425 168.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.34 18.34 9.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.394 169.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 27' ' ' ALA . . . 106.87 -29.31 10.98 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 168.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -113.11 177.95 4.45 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.93 -0.635 . . . . 0.0 109.966 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 52' ' ' ASP . 35.5 pt -148.25 141.06 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.323 -159.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.508 ' HB3' ' HB2' ' A' ' 40' ' ' LYS . 4.2 p90 -130.5 173.7 10.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.333 156.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.792 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.252 11.8 p -109.62 148.22 31.69 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.283 0.563 . . . . 0.0 111.86 -149.257 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.536 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 14.2 tttt -72.49 -9.03 58.04 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 120.387 -1.445 . . . . 0.0 109.853 167.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.7 -4.45 19.54 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.457 161.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.89 -51.51 2.02 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -166.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.29 -14.21 16.92 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.479 166.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -89.86 -66.0 0.96 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.322 166.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 -11.68 8.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.508 -166.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -146.08 51.49 1.15 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.378 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -87.9 -45.67 10.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.325 167.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.482 ' H ' ' HD2' ' A' ' 69' ' ' PRO . . . -114.45 -65.7 0.43 Allowed Glycine 0 CA--C 1.542 1.78 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -174.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.482 ' HD2' ' H ' ' A' ' 68' ' ' GLY . 1.6 Cg_endo -57.31 141.99 94.77 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 122.353 2.035 . . . . 0.0 113.542 -178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -117.44 155.53 29.52 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.435 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.46 138.55 15.0 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 169.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -74.9 -79.92 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.334 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 174.73 166.04 32.03 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -113.62 -172.74 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.284 170.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.7 -145.06 0.14 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -170.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -174.37 -66.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.412 -170.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.3 149.43 5.66 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -174.54 168.47 3.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.225 -169.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 113.92 62.18 0.41 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -172.01 100.42 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.338 -0.431 . . . . 0.0 110.257 169.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.57 169.53 6.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.428 169.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.28 116.52 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.332 170.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -162.59 152.68 16.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.463 169.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.8 m -86.87 -77.84 0.31 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.398 177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.579 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.339 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 121.208 0.527 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.44 173.46 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.297 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -76.7 98.07 4.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.423 -169.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.65 ' HB3' HG23 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -178.63 162.91 1.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.434 169.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.65 HG23 ' HB3' ' A' ' 4' ' ' LYS . 11.4 t 65.51 19.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.295 170.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.43 -176.88 25.52 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 170.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 60.96 -102.83 0.44 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -169.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 p -63.41 157.17 23.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.954 0.407 . . . . 0.0 110.318 167.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.86 154.69 18.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.179 175.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -122.27 173.44 15.93 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -160.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.6 t -128.68 104.18 19.18 Favored Pre-proline 0 C--O 1.244 0.787 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -164.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' A' ' 30' ' ' SER . 5.8 Cg_exo -60.97 -12.32 22.03 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.792 2.328 . . . . 0.0 113.629 171.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.47 ' CB ' ' HB3' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -85.26 -65.58 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.368 -167.272 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -85.46 -27.66 25.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.481 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.72 -31.34 5.77 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.3 150.78 38.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.179 -0.51 . . . . 0.0 110.376 -174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.537 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -115.49 140.62 48.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.114 166.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.884 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.6 t -102.3 140.17 21.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.942 -162.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -121.07 -39.07 2.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.435 175.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.91 -11.47 8.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.376 168.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.555 ' H ' HG12 ' A' ' 18' ' ' VAL . . . 61.56 95.05 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.307 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.884 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -117.67 27.72 8.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.613 165.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 130.1 36.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.355 -160.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.803 HG23 ' CD1' ' A' ' 31' ' ' TRP . 11.1 m -95.93 -176.31 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 115.613 -0.722 . . . . 0.0 109.546 158.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.536 ' N ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -144.52 152.41 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.44 167.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -175.65 137.78 3.91 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 169.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . . . 61.55 14.37 5.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.359 -0.421 . . . . 0.0 110.296 174.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.58 -32.93 6.54 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.516 -174.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -61.87 165.66 5.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.245 -0.477 . . . . 0.0 110.422 -170.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.451 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -137.88 124.37 20.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.228 165.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.803 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -117.69 159.64 22.64 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.658 -166.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.696 ' HE2' HG22 ' A' ' 18' ' ' VAL . 36.6 m80 -80.54 156.66 26.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.497 154.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.526 ' HD2' ' HG3' ' A' ' 22' ' ' GLU . 12.4 ptmt -60.15 -12.81 9.45 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.569 170.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.1 t -122.47 18.29 10.5 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.481 -174.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.47 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 79.7 m -129.14 34.16 4.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.042 163.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.764 ' HD2' HG21 ' A' ' 24' ' ' VAL . 8.8 t80 -126.04 96.23 4.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.692 -164.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.512 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 21.6 ttp180 -127.98 126.63 41.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.228 -164.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 12.2 t -59.29 111.56 1.41 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.411 163.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.43 -24.14 65.61 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.216 -1.357 . . . . 0.0 110.708 171.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.49 -75.02 0.13 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.308 -173.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p -86.94 -17.14 33.86 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.585 -170.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.83 19.75 50.05 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.484 -1.047 . . . . 0.0 110.484 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.33 129.07 45.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.449 -0.376 . . . . 0.0 110.407 171.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 53.9 p -78.65 121.79 25.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.262 167.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.686 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.1 pp -147.14 -174.18 4.44 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.475 176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.04 71.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.778 167.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -95.02 -165.27 1.27 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.46 -171.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.477 HG23 ' OG1' ' A' ' 49' ' ' THR . 12.5 t -68.48 -12.84 61.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.635 -169.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.477 ' OG1' HG23 ' A' ' 48' ' ' THR . 0.2 OUTLIER -139.62 136.3 34.21 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.518 -173.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.592 HD22 ' HZ ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -138.41 163.32 32.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.193 162.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HB3' ' HD1' ' A' ' 58' ' ' TYR . . . -128.3 75.58 1.63 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.294 -173.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 2.0 p30 -69.04 151.15 46.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.387 -175.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.57 135.41 0.1 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.415 168.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.8 p30 61.06 22.11 12.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.554 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.01 -37.99 3.41 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.4 pm0 -103.91 -171.31 1.91 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.968 -0.616 . . . . 0.0 110.043 -177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.781 HD13 ' CH2' ' A' ' 31' ' ' TRP . 27.5 pt -149.62 165.19 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.181 -160.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HD1' ' HB3' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -133.72 170.06 16.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.696 162.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.686 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.5 p -104.88 155.9 18.51 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.253 0.549 . . . . 0.0 111.097 -152.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 1.0 OUTLIER -61.42 -22.68 65.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.022 166.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.49 -5.89 38.79 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.538 174.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -118.43 -45.4 2.62 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -165.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -60.5 -15.0 22.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.309 165.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.7 -70.49 0.71 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.387 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -61.05 -12.58 12.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.338 -165.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 31.8 t-20 -61.2 -52.09 66.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.379 177.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 64.86 -80.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.388 171.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.87 68.84 0.01 OUTLIER Glycine 0 CA--C 1.543 1.834 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 66' ' ' ASN . 9.6 Cg_endo -60.78 -41.02 49.33 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 C-N-CA 122.596 2.198 . . . . 0.0 113.605 -171.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.56 140.94 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.311 -167.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.1 176.35 19.9 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -169.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -146.39 -44.6 0.19 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.356 -0.422 . . . . 0.0 110.39 -169.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.53 136.99 9.59 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -113.23 29.53 7.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.343 170.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.85 80.56 0.45 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 69.82 132.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.377 -0.411 . . . . 0.0 110.339 170.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 124.72 135.54 4.42 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -170.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.78 96.22 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.358 -0.421 . . . . 0.0 110.224 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -128.69 170.46 19.91 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 169.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.08 -162.87 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.253 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 mt -134.46 -91.68 0.33 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.407 169.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.4 mm -139.8 -60.29 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.378 -169.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -132.9 -76.91 0.49 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.379 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.57 156.98 16.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.406 -169.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 . . . . . 0 C--O 1.24 0.559 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.392 177.778 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptt? . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.155 0.503 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.22 -162.91 0.82 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.253 171.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.87 177.06 3.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.372 169.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.9 tttp 64.38 103.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.357 -170.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.0 p -128.96 138.72 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.32 -170.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.26 -122.34 3.85 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -169.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.08 -30.0 29.68 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -169.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.2 t -61.03 156.73 17.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.341 -0.43 . . . . 0.0 110.354 -169.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.536 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -156.46 128.87 7.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.225 169.107 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -109.81 171.56 15.11 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -162.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.2 t -123.95 100.55 36.75 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -167.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 30' ' ' SER . 2.8 Cg_exo -60.3 -13.27 23.58 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 122.82 2.347 . . . . 0.0 113.539 171.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.54 ' HD3' ' HB3' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -83.79 -63.24 1.39 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.444 -165.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.0 p -85.0 -26.08 27.32 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.504 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.41 -23.43 6.78 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 172.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.39 176.34 9.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.302 -0.449 . . . . 0.0 110.361 -171.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -130.67 155.55 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.227 167.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.839 HG11 ' H ' ' A' ' 22' ' ' GLU . 6.9 t -110.16 142.13 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.226 -167.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.56 -30.91 3.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.417 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.52 17.94 10.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.456 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' N ' HG12 ' A' ' 18' ' ' VAL . . . 61.19 94.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.301 165.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.839 ' H ' HG11 ' A' ' 18' ' ' VAL . 2.8 mt-10 -122.68 26.93 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.712 163.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HG2' ' HB2' ' A' ' 9' ' ' ASP . 0.2 OUTLIER -93.88 112.56 24.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.285 -162.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.875 HG21 ' CD2' ' A' ' 36' ' ' PHE . 10.8 m -80.95 -172.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.862 160.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 26' ' ' GLY . 0.8 OUTLIER -142.22 144.45 25.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.5 171.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.4 ' N ' HG13 ' A' ' 25' ' ' ILE . . . -136.55 96.33 0.25 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 -82.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.982 -0.609 . . . . 0.0 110.379 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -130.63 39.52 1.78 Allowed Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 171.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 168.47 13.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.384 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.456 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -145.97 131.77 19.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.293 168.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.595 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -129.05 159.45 35.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.061 -165.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.734 ' NE2' HG22 ' A' ' 18' ' ' VAL . 25.9 m80 -71.55 147.66 47.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.05 165.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.452 ' HG3' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.53 69.05 1.2 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.659 159.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.3 -42.05 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.913 -171.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.54 ' HB3' ' HD3' ' A' ' 13' ' ' ARG . 61.3 m -94.38 17.07 13.61 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.269 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.946 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -100.68 72.55 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.096 -164.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 16.1 mtt180 -93.28 117.04 29.6 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.376 -171.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 13.4 t -60.21 109.43 0.98 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.192 165.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.83 -22.64 65.14 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 114.382 -1.281 . . . . 0.0 110.424 171.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HD3' ' HB3' ' A' ' 58' ' ' TYR . 1.3 ttpp -71.25 -66.18 0.65 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.562 -167.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.7 p -89.77 -29.33 18.75 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.682 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.18 -25.5 6.68 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 174.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.8 129.36 39.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.354 -169.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 77.7 p -87.17 105.88 17.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.367 169.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.688 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -126.09 -171.14 2.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.263 -179.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -131.45 -173.47 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.051 -161.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.856 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -64.25 170.29 3.88 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.281 -172.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 49' ' ' THR . 15.8 p 59.07 13.43 2.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.972 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 48' ' ' THR . 10.4 p -155.29 43.13 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.48 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.946 HD22 ' CE2' ' A' ' 36' ' ' PHE . 2.5 pp -129.98 174.21 9.98 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.332 -173.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.51 119.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.313 169.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -98.68 169.07 9.75 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.326 -172.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? 178.39 131.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.45 167.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 60.78 19.72 9.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.39 164.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.01 -19.94 52.83 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 170.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -105.06 168.09 9.29 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 169.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.583 HD12 ' CD1' ' A' ' 36' ' ' PHE . 29.7 pt -141.93 142.33 28.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.521 -158.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.524 ' HB3' ' HD3' ' A' ' 40' ' ' LYS . 0.6 OUTLIER -133.18 -175.26 3.73 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.56 158.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.688 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.1 p -111.01 162.04 15.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.175 0.512 . . . . 0.0 110.727 -153.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -77.21 -12.71 59.98 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.927 169.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.89 -10.14 37.48 Favored Glycine 0 CA--C 1.521 0.461 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.15 164.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.26 -50.52 2.56 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -164.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -59.88 -17.67 38.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.543 166.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -88.24 -66.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.289 169.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -60.85 -12.65 11.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.438 -166.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -141.65 47.32 1.66 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.425 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -81.28 124.62 29.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.361 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 61.06 100.65 0.01 OUTLIER Glycine 0 CA--C 1.544 1.846 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.82 167.32 2.31 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.473 2.115 . . . . 0.0 113.517 171.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -122.5 153.97 38.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.289 -0.868 . . . . 0.0 110.404 169.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.34 -80.11 1.02 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -170.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -113.08 158.71 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.335 -0.432 . . . . 0.0 110.37 169.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -120.08 -134.08 4.68 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.1 OUTLIER -148.61 131.46 16.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.375 -0.412 . . . . 0.0 110.372 170.09 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.34 102.68 0.22 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 170.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -98.24 129.94 44.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.382 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 145.9 69.17 0.01 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -169.75 128.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.355 -0.423 . . . . 0.0 110.269 169.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.8 150.4 10.77 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -169.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -88.6 -163.01 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.977 -0.611 . . . . 0.0 110.284 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 tt 60.1 107.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.52 -170.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -127.74 134.21 65.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.412 170.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -96.94 -43.12 7.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.394 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.94 152.01 35.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.376 169.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.564 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.349 170.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.187 0.517 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.46 -19.72 62.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.28 171.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.94 -84.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.38 -169.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -162.67 123.98 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.351 170.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -126.7 153.48 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.327 169.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.31 -107.94 1.39 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 125.77 -170.27 17.66 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -176.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -73.98 -65.42 0.84 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.004 -0.598 . . . . 0.0 110.401 179.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . 68.7 m-20 -138.45 108.64 6.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.007 165.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -112.29 -179.64 19.68 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -159.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 7.1 t -130.0 109.01 16.77 Favored Pre-proline 0 C--O 1.246 0.897 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -160.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 11' ' ' CYS . 7.2 Cg_endo -58.13 -19.29 40.64 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.975 2.45 . . . . 0.0 113.598 165.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.437 ' HD2' ' HA ' ' A' ' 13' ' ' ARG . 11.5 tpt180 -80.51 -73.01 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.403 -170.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 p -87.21 -11.76 48.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.601 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.6 18.17 76.15 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.36 -169.99 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.471 -0.365 . . . . 0.0 110.181 166.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -152.55 146.57 25.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.212 165.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.842 HG22 ' HE2' ' A' ' 32' ' ' HIS . 2.4 t -101.47 178.11 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.295 -164.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.667 ' H ' HG12 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -91.7 46.79 1.31 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.551 172.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.646 ' HB2' ' HB3' ' A' ' 8' ' ' SER . . . 61.62 29.97 18.41 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.291 -174.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.841 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -93.99 -70.84 0.69 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.377 -159.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.838 ' CD ' HG21 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -94.32 -9.75 34.92 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.907 -151.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.52 ' H ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -58.89 124.77 20.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.495 -146.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.86 HG21 ' CD2' ' A' ' 36' ' ' PHE . 10.0 m -93.08 175.03 0.76 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.721 158.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 29' ' ' LYS . 4.4 mp -142.3 153.15 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.382 166.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.02 135.58 4.84 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 169.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.57 -81.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.99 -0.605 . . . . 0.0 110.291 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -145.61 20.43 1.84 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 171.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.624 ' O ' HG23 ' A' ' 25' ' ' ILE . 25.8 mmtm -103.65 168.31 9.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.392 -171.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.406 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 39.0 t -143.52 149.99 38.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.229 167.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.67 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -143.88 176.3 9.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.906 -168.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.842 ' HE2' HG22 ' A' ' 18' ' ' VAL . 67.3 m80 -90.57 164.21 14.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.507 160.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -30.12 63.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.429 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 m -81.44 -18.31 45.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.428 176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -85.49 -15.2 43.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.446 -170.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.903 ' CZ ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -68.85 110.11 4.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.327 -171.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.63 99.79 7.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.344 -170.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 29.7 t -63.35 116.48 5.55 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.381 165.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.84 42.76 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.341 168.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.468 ' HD3' ' CB ' ' A' ' 58' ' ' TYR . 20.9 tttm -129.22 -46.95 1.21 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.491 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.3 p -96.57 -13.32 23.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.893 161.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.89 18.24 54.71 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.498 167.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.33 148.76 30.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.005 0.431 . . . . 0.0 110.404 -164.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -68.98 138.24 54.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.636 158.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.779 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -102.37 -164.88 1.13 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.776 -158.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -123.27 170.7 10.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.077 -170.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.2 p -60.89 -13.31 14.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.397 167.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.8 p -60.89 -177.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.486 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.629 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -83.54 -174.12 5.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.441 -168.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.903 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -154.45 -171.06 3.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.397 -170.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.06 104.12 2.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.225 170.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.1 p30 -79.38 157.24 27.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.371 171.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -179.94 112.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.517 -171.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 p30 61.27 20.45 11.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.615 170.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.73 -24.62 30.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.412 -1.075 . . . . 0.0 110.412 168.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 11.4 pt-20 -99.04 -174.75 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 168.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.788 HD12 ' CD1' ' A' ' 36' ' ' PHE . 16.9 pt -157.1 139.68 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.255 -160.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CB ' ' HD3' ' A' ' 40' ' ' LYS . 25.1 p90 -130.68 176.48 8.15 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.817 159.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.779 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.251 11.9 p -110.76 148.2 32.82 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 111.795 -150.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.431 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 4.4 tttm -72.0 -9.38 58.3 Favored 'General case' 0 C--N 1.345 0.375 0 O-C-N 120.403 -1.436 . . . . 0.0 109.883 167.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.26 -3.54 18.96 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.501 161.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -122.42 -49.93 2.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -167.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -59.96 -12.36 7.75 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 114.006 -1.452 . . . . 0.0 110.339 165.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.76 -61.22 1.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.369 167.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.2 tptm -60.95 -14.56 23.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.318 -166.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.53 60.89 1.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.444 169.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -72.1 172.69 9.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.441 171.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.46 141.35 15.47 Favored Glycine 0 CA--C 1.541 1.7 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -170.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -61.75 -24.11 77.06 Favored 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 122.608 2.205 . . . . 0.0 113.675 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.54 26.82 13.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.429 173.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.14 60.57 0.23 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 169.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -122.88 -53.57 1.86 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.305 169.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 60.99 18.91 55.84 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 169.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 66.43 167.29 0.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.198 -0.501 . . . . 0.0 110.396 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.94 28.42 4.38 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -170.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -137.37 87.53 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.306 -0.447 . . . . 0.0 110.376 170.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -143.23 154.04 25.18 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -123.94 139.71 53.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.317 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -150.22 23.47 1.11 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -117.91 -82.3 0.63 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.395 -0.403 . . . . 0.0 110.243 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.758 HD23 HG22 ' A' ' 82' ' ' ILE . 1.3 tt -124.6 -60.63 1.38 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.335 169.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.758 HG22 HD23 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -171.94 106.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.365 169.013 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -159.26 121.53 3.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.261 -169.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.52 103.17 12.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.356 -170.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 . . . . . 0 C--O 1.241 0.626 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.401 170.218 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 ptt? . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 121.134 0.493 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.44 -173.76 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.268 171.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -86.99 150.8 23.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.38 169.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.68 122.99 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.38 -170.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 p -159.74 115.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.386 169.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.03 88.68 0.07 OUTLIER Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.47 -77.32 0.23 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 170.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.31 -176.5 2.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.37 -0.415 . . . . 0.0 110.372 170.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.539 ' OD2' ' HB1' ' A' ' 21' ' ' ALA . 25.3 m-20 -102.89 -168.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.168 167.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -174.81 173.74 46.32 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 166.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t -136.31 112.03 10.08 Favored Pre-proline 0 C--O 1.245 0.848 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -158.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 30' ' ' SER . 8.8 Cg_exo -55.67 -17.2 16.96 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 C-N-CA 122.99 2.46 . . . . 0.0 113.53 164.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.449 ' HD3' ' CE3' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -89.27 -70.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.466 -166.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.5 p -88.57 -26.06 22.16 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.577 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.7 44.83 4.76 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -124.7 144.01 50.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 114.985 -0.607 . . . . 0.0 110.29 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.536 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -96.23 142.05 28.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.183 167.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.883 HG11 ' H ' ' A' ' 22' ' ' GLU . 6.1 t -108.22 135.32 47.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.144 -164.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -61.48 -76.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.405 -166.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.03 -83.18 0.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.168 168.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HB1' ' OD2' ' A' ' 9' ' ' ASP . . . -176.4 126.22 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.155 166.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.883 ' H ' HG11 ' A' ' 18' ' ' VAL . 1.5 mm-40 -114.41 17.67 17.31 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.455 164.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.54 ' HD2' ' H ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -97.41 170.59 8.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.091 -159.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 31' ' ' TRP . 1.1 p -164.33 156.6 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.608 -148.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 25' ' ' ILE . 3.0 tp -139.8 118.28 11.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.442 -168.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.46 ' HA2' ' CB ' ' A' ' 52' ' ' ASP . . . -99.09 171.3 24.42 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 160.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.647 ' HB3' ' H ' ' A' ' 55' ' ' GLY . . . -61.37 -13.31 18.78 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.001 0.429 . . . . 0.0 110.619 -167.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.449 ' N ' ' HA2' ' A' ' 55' ' ' GLY . . . -128.04 -18.7 1.87 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -140.59 158.41 44.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.742 0.306 . . . . 0.0 110.378 -162.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.421 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -121.78 146.38 47.12 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.026 164.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.784 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -146.6 177.47 9.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.915 -163.501 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.784 ' HE2' HG22 ' A' ' 18' ' ' VAL . 13.7 m80 -85.84 158.35 19.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.898 161.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -60.33 -26.51 66.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.474 165.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.487 ' H ' ' HB3' ' A' ' 32' ' ' HIS . 59.8 p -116.71 18.44 14.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.469 -171.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 80.7 m -120.23 14.33 12.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.184 163.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.578 ' CD1' HD22 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -92.71 108.19 19.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.276 -166.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.506 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER -126.78 125.62 42.03 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.231 -165.065 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.5 t -57.52 107.6 0.46 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.755 162.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.11 -24.77 68.05 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.546 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.533 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -79.26 -76.38 0.21 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.522 -175.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.9 p -79.21 -18.0 53.77 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.431 -163.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.07 13.84 58.43 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.8 mmtm -90.34 108.46 19.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.243 -0.478 . . . . 0.0 110.401 175.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.506 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 47.1 m -74.33 107.44 6.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.227 167.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.662 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.0 OUTLIER -138.22 -172.86 3.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.306 -177.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.648 ' C ' HD23 ' A' ' 50' ' ' LEU . 1.7 mp0 -119.54 -177.37 3.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.068 -160.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.511 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 2.0 m -61.11 -46.36 90.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.457 -168.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.4 m -60.9 -13.64 17.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.457 -171.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 60' ' ' LYS . 6.9 m -145.12 41.49 1.27 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.374 -175.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.771 HD12 ' N ' ' A' ' 51' ' ' ALA . 2.0 pp -137.8 -175.46 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.375 170.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.771 ' N ' HD12 ' A' ' 50' ' ' LEU . . . -159.16 146.38 17.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.268 168.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' CB ' ' HA2' ' A' ' 26' ' ' GLY . 10.2 p-10 -89.55 143.8 26.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.383 169.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.48 99.83 2.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.392 -168.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 60.99 26.63 16.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.4 165.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.647 ' H ' ' HB3' ' A' ' 27' ' ' ALA . . . 103.75 -26.86 21.97 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 170.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -104.88 172.2 6.91 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.726 HD13 ' CH2' ' A' ' 31' ' ' TRP . 30.1 pt -130.71 158.82 43.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.307 -159.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.533 ' CE2' ' HG3' ' A' ' 40' ' ' LYS . 1.9 t80 -179.15 144.34 0.23 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.97 -159.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.662 ' SG ' HD21 ' A' ' 45' ' ' LEU 0.252 9.6 p -101.46 157.15 17.02 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.314 0.578 . . . . 0.0 111.283 -148.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.514 ' H ' ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -74.83 -14.77 60.72 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.703 169.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.18 -9.43 29.29 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.072 166.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -118.22 -46.79 2.59 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -165.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.94 -10.03 3.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.486 167.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.43 -66.33 0.93 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.52 171.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -59.83 -31.9 70.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.056 -158.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -144.59 16.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.393 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.77 12.23 3.64 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.506 -1.224 . . . . 0.0 110.423 -172.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 173.6 -144.65 7.81 Favored Glycine 0 CA--C 1.544 1.879 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -172.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -62.16 149.28 91.11 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 122.611 2.208 . . . . 0.0 113.573 -169.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.82 105.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.352 167.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -149.68 135.7 5.42 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -166.93 -38.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.325 -0.438 . . . . 0.0 110.309 -171.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.73 -74.12 0.05 OUTLIER Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.13 -57.49 0.86 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.109 -0.545 . . . . 0.0 110.361 -177.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.98 70.79 0.01 OUTLIER Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 -103.32 116.23 32.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.394 169.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 137.15 -65.25 0.56 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -169.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.75 109.12 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.341 169.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.76 158.15 8.02 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 169.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.768 ' C ' HD22 ' A' ' 81' ' ' LEU . . . 61.8 27.46 16.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.369 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.768 HD22 ' C ' ' A' ' 80' ' ' ALA . 3.4 mm? -131.61 61.4 1.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.404 167.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 82' ' ' ILE . 0.7 OUTLIER -71.94 84.34 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.364 -169.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -130.11 106.43 8.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.36 169.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.2 m -98.16 -165.44 1.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.368 -169.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.626 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.347 -170.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 CA-C-O 121.13 0.49 . . . . 0.0 109.831 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.46 174.39 6.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.268 172.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -61.57 93.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.417 169.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -61.87 -42.9 99.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.341 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.93 18.38 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.417 -170.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.94 17.28 50.7 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 168.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.74 36.21 0.19 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -169.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.53 162.78 38.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.362 -0.419 . . . . 0.0 110.383 169.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.534 ' HB2' ' HG2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -156.69 136.85 12.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.203 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -116.42 171.31 13.71 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -162.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 t -123.84 101.51 36.01 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -167.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' A' ' 30' ' ' SER . 3.5 Cg_exo -59.95 -14.1 26.18 Favored 'Trans proline' 0 N--CA 1.485 1.022 0 C-N-CA 122.885 2.39 . . . . 0.0 113.47 167.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -80.07 -62.47 1.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.436 -167.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -91.26 -25.53 19.44 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.499 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.8 18.62 17.52 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -101.23 171.33 7.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.388 -0.406 . . . . 0.0 110.323 168.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -130.21 147.67 51.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.171 167.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.855 HG11 ' H ' ' A' ' 22' ' ' GLU . 4.5 t -106.04 141.51 21.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.136 -165.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -124.86 -31.97 3.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.374 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.95 18.81 9.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.33 170.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.17 97.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.286 166.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.855 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -125.74 23.79 7.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.623 163.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' HG2' ' HB2' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -94.25 117.75 30.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.316 -161.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.847 HG21 ' CE2' ' A' ' 36' ' ' PHE . 9.2 m -81.97 -176.79 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.707 159.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.8 pt -142.98 138.22 27.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.485 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.542 ' HA2' ' HB3' ' A' ' 52' ' ' ASP . . . -126.5 -139.27 5.01 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.449 -1.061 . . . . 0.0 110.449 168.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.79 83.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.271 -169.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.57 19.4 54.13 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -170.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.77 167.89 9.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.932 0.396 . . . . 0.0 110.338 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.455 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -148.9 147.73 29.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.131 166.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.723 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -143.82 158.06 43.95 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.833 -164.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.764 ' HE2' HG22 ' A' ' 18' ' ' VAL . 44.1 m80 -78.41 154.96 30.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.988 161.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -23.05 64.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.505 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.2 t -84.45 -29.19 26.28 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.347 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.1 m -95.14 15.95 17.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.453 -167.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.913 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -100.59 101.7 12.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.412 -166.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.623 ' O ' HD11 ' A' ' 57' ' ' ILE . 8.1 mtp180 -124.94 125.03 43.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.295 -168.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.9 t -64.44 109.77 2.06 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.502 170.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.53 -24.94 67.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.448 171.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -74.5 -74.27 0.2 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.332 -170.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -87.3 -11.13 50.45 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.645 -169.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.69 17.19 79.19 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 114.724 -1.126 . . . . 0.0 110.426 177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -92.74 113.8 26.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.039 0.447 . . . . 0.0 110.315 167.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 54.3 p -83.6 115.25 22.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.074 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.654 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -129.63 -171.18 2.45 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.86 -171.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -172.88 176.46 3.07 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 112.672 -2.058 . . . . 0.0 109.946 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.1 t 66.73 -61.98 0.3 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.458 170.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -177.29 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.368 166.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -92.17 -177.51 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.475 -164.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.913 HD22 ' CE2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -148.77 -166.24 2.5 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.334 -171.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.38 94.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.327 -177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.542 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 8.7 p-10 -65.37 161.95 18.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.442 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 tttt 179.92 124.51 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.358 168.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.4 t70 70.34 -92.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.395 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.83 18.34 3.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 176.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.16 -171.53 3.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.263 -0.469 . . . . 0.0 109.884 -170.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.788 HD12 ' CD1' ' A' ' 36' ' ' PHE . 32.6 pt -150.46 157.64 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.243 -160.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -141.72 170.03 16.49 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.388 161.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.654 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.5 p -104.5 168.61 8.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.196 0.522 . . . . 0.0 110.84 -151.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 2.5 tptp -80.67 -14.82 57.81 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.086 168.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.37 -9.75 32.04 Favored Glycine 0 CA--C 1.521 0.469 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.999 166.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.1 m -118.6 -48.83 2.47 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -164.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 67' ' ' PHE . 10.3 t80 -59.6 -17.11 30.4 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.513 164.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.63 -57.64 3.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.336 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -11.32 10.54 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.491 -173.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -153.46 65.78 0.75 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.433 173.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -61.72 104.75 0.47 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.396 177.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.87 93.13 0.05 OUTLIER Glycine 0 CA--C 1.543 1.816 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -50.36 113.5 1.05 Allowed 'Trans proline' 0 N--CA 1.484 0.949 0 C-N-CA 122.537 2.158 . . . . 0.0 113.611 -173.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.9 101.43 0.15 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.499 172.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.85 167.47 12.83 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 67.54 104.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.293 -0.453 . . . . 0.0 110.439 -169.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.42 -177.37 47.14 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -170.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -102.55 98.41 8.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.337 -0.431 . . . . 0.0 110.356 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.03 -81.09 0.45 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 170.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -133.2 115.78 15.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.121 -0.539 . . . . 0.0 110.382 177.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.01 -160.67 2.97 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 170.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.47 -81.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.183 -0.509 . . . . 0.0 110.372 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -161.69 -164.37 16.47 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -169.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -129.21 -48.04 1.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.378 -0.411 . . . . 0.0 110.273 -169.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.4 mt -95.48 16.09 17.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.393 -169.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.51 124.67 24.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.439 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.5 m170 62.03 19.36 10.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.388 177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.75 77.01 1.24 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.319 169.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 . . . . . 0 C--O 1.24 0.562 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.364 -169.22 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 121.17 0.509 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.38 -39.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.26 -171.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -84.3 -165.44 1.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.344 -169.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.34 148.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.376 -169.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.15 153.07 5.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.311 -169.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.2 -41.12 0.31 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.436 -1.065 . . . . 0.0 110.436 -170.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.18 -111.04 2.87 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 p 67.94 104.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.393 0.616 . . . . 0.0 110.848 172.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB3' ' HD3' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -174.6 151.83 1.56 Allowed 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.266 -177.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -122.39 170.96 15.27 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -162.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.3 t -127.66 109.25 20.66 Favored Pre-proline 0 C--O 1.246 0.9 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -164.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 30' ' ' SER . 7.3 Cg_exo -65.06 -15.72 51.81 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.701 2.267 . . . . 0.0 113.707 171.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' HD2' ' CE3' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -77.0 -76.21 0.18 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.411 -178.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 p -85.63 -15.81 41.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.498 -166.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.12 22.67 31.86 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 171.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.42 156.04 19.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.983 -0.609 . . . . 0.0 110.399 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.533 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -113.51 142.99 45.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.191 167.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.892 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.5 t -105.22 136.31 39.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.932 -164.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.47 121.51 45.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.059 168.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 61.73 98.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.844 -160.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.625 ' HB1' ' HG3' ' A' ' 23' ' ' LYS . . . -60.04 123.85 18.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.4 -160.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.892 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.6 OUTLIER -98.54 15.95 23.39 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.444 165.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.625 ' HG3' ' HB1' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -100.02 -178.27 3.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.126 -160.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.578 HG22 ' H ' ' A' ' 25' ' ' ILE . 3.7 p -164.91 179.05 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.973 -147.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.578 ' H ' HG22 ' A' ' 24' ' ' VAL . 12.5 pt -140.05 142.3 32.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.404 -172.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.51 117.3 0.78 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 167.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.896 ' HB2' ' HB2' ' A' ' 52' ' ' ASP . . . 61.89 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.024 -0.588 . . . . 0.0 110.395 177.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.39 -18.93 1.25 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -88.76 149.35 23.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.433 -0.383 . . . . 0.0 110.338 -168.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.435 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 39.8 m -105.71 144.76 32.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.168 166.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.531 ' CE3' ' HD2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -144.64 -170.91 3.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.818 -168.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.792 ' HE2' HG22 ' A' ' 18' ' ' VAL . 41.5 m80 -102.51 161.83 13.4 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.652 163.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.522 ' HG2' ' HB3' ' A' ' 47' ' ' SER . 0.1 OUTLIER -62.64 129.72 41.82 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.671 154.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.6 p 69.11 13.06 8.68 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.475 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 1.1 m -99.79 -20.87 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.537 156.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.762 ' CE1' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -61.9 104.45 0.45 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.307 174.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.506 ' HG3' ' NH1' ' A' ' 13' ' ' ARG . 4.3 mmt180 -113.03 100.43 8.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.371 -167.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 27.0 t -62.91 116.28 5.14 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.499 164.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.11 42.8 1.08 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.413 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -130.74 -51.55 1.06 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.49 -177.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.5 p -93.18 -13.02 28.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.04 161.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.92 18.18 56.6 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.408 167.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -109.05 148.93 30.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.024 0.44 . . . . 0.0 110.446 -164.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 60.5 p -70.13 139.11 52.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.631 159.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.795 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -103.46 -163.65 1.0 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.027 -157.371 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -104.78 -162.24 0.87 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 113.815 -1.539 . . . . 0.0 110.126 169.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -94.34 -35.44 12.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.362 -168.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.5 t -139.67 37.71 2.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.4 -168.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.472 ' CB ' ' HB3' ' A' ' 60' ' ' LYS . 1.2 p -142.08 83.53 1.84 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.549 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.762 HD13 ' CE1' ' A' ' 36' ' ' PHE . 2.8 pp -153.22 165.06 36.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.386 -171.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 58' ' ' TYR . . . -146.61 115.97 7.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.314 -177.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.896 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -94.06 161.05 14.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.416 -178.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 178.79 115.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.34 -174.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.18 14.74 6.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.511 169.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.06 -18.36 56.83 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -104.62 171.55 7.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 166.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.725 HD12 ' HD1' ' A' ' 36' ' ' PHE . 17.3 pt -148.97 137.42 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.349 -158.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 3.5 p90 -126.21 172.81 9.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.478 156.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.795 ' HB2' HD11 ' A' ' 45' ' ' LEU . 12.5 p -108.77 147.17 32.44 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.339 0.59 . . . . 0.0 111.759 -148.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.487 ' HB2' ' N ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -69.61 -9.84 55.74 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.319 -1.488 . . . . 0.0 109.803 167.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.11 -2.47 25.21 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.59 163.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -122.59 -50.06 1.99 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -167.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.507 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 7.2 t80 -60.21 -12.45 8.8 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.376 165.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.56 -65.64 0.97 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.376 169.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -25.85 67.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.439 -165.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -122.16 17.54 10.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.624 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 60.81 18.56 8.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.497 167.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 63' ' ' TYR . . . 110.24 -72.91 0.21 Allowed Glycine 0 CA--C 1.543 1.787 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 173.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -53.77 172.45 0.25 Allowed 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 122.632 2.222 . . . . 0.0 113.557 -171.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.79 -54.72 3.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.339 -169.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.67 169.68 13.05 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -170.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.71 163.06 15.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.344 -0.428 . . . . 0.0 110.325 170.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -116.38 -114.99 2.85 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 170.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -89.44 -13.73 36.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.376 -0.412 . . . . 0.0 110.406 169.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.84 -126.14 1.67 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -100.26 96.41 7.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.3 -0.45 . . . . 0.0 110.363 170.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.57 -121.2 0.56 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -170.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.66 28.68 17.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.349 -0.425 . . . . 0.0 110.315 -169.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.71 129.1 0.06 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -174.25 39.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.324 -0.438 . . . . 0.0 110.276 169.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.1 pp -112.71 -178.56 3.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.39 -178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 82' ' ' ILE . 0.6 OUTLIER -165.04 69.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.444 169.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -136.62 -61.66 0.67 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.343 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 85.1 p -139.87 -164.23 1.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.299 170.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 C--O 1.241 0.632 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.362 170.077 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mmm . . . . . 0 N--CA 1.473 0.675 0 CA-C-O 121.19 0.519 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.31 113.4 19.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.209 -172.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -110.45 14.32 22.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.401 -169.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.68 101.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.351 176.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.71 136.81 43.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.366 168.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.87 -179.68 26.35 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 174.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.78 172.47 36.02 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -169.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.608 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER 63.02 -165.78 0.23 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.969 -0.616 . . . . 0.0 110.216 179.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 76.79 170.22 0.24 Allowed 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.344 171.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -109.62 -177.74 21.2 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -153.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 t -125.89 99.7 31.7 Favored Pre-proline 0 C--O 1.244 0.781 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -162.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' O ' ' A' ' 30' ' ' SER . 1.1 Cg_endo -59.95 -13.78 24.63 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 122.864 2.376 . . . . 0.0 113.443 164.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.1 -59.33 2.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.462 -165.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.5 p -93.0 -39.97 10.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.503 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 144.23 -45.23 0.87 Allowed Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.512 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -171.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.321 -167.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -151.03 149.55 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.231 165.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.796 HG11 ' H ' ' A' ' 22' ' ' GLU . 2.1 t -123.17 142.97 37.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.019 -165.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -125.26 12.87 8.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.518 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.44 ' H ' HG12 ' A' ' 18' ' ' VAL . . . -175.14 -38.89 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.407 176.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.776 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -60.75 -79.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.368 -158.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.796 ' H ' HG11 ' A' ' 18' ' ' VAL . 13.4 mm-40 -135.97 11.78 3.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.484 -157.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.608 ' HD3' ' H ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -79.78 155.23 28.0 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.118 -164.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.602 HG12 ' O ' ' A' ' 31' ' ' TRP . 0.3 OUTLIER -154.47 175.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.551 -151.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.566 ' N ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -149.0 141.89 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.539 -179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.4 ' CA ' ' HB3' ' A' ' 52' ' ' ASP . . . -147.39 107.76 0.4 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.464 -1.055 . . . . 0.0 110.464 165.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.75 -82.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.173 -0.513 . . . . 0.0 110.32 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.03 21.56 3.15 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -168.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.27 154.34 37.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.255 -0.473 . . . . 0.0 110.41 -177.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.464 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 4.1 p -119.71 139.26 52.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.397 168.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.755 ' CH2' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -145.68 160.43 41.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.791 -170.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.651 ' CD2' HG21 ' A' ' 18' ' ' VAL . 51.2 m80 -80.49 161.44 24.85 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.361 158.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.597 ' CG ' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.73 133.39 43.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.784 154.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 72.33 9.52 5.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.583 -160.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 3.4 m -113.78 -29.59 7.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 155.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.941 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -60.04 110.47 1.21 Allowed 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.611 174.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.57 ' O ' HD11 ' A' ' 57' ' ' ILE . 1.6 mtt180 -124.93 125.12 43.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.216 -169.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.525 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 8.5 t -61.51 112.81 2.36 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.632 166.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.11 18.95 7.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.541 172.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.405 ' HB2' ' CD2' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -96.2 -76.3 0.51 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.286 161.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -85.04 -22.65 28.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.576 -165.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.06 32.34 6.49 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.38 122.05 46.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.417 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.463 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 24.9 p -78.89 112.14 15.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.394 165.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.672 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.7 OUTLIER -149.62 -168.81 3.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.554 -174.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -170.29 -82.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.907 162.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.6 p 67.23 -67.11 0.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.069 169.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.2 -87.85 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.404 -167.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.469 ' CB ' ' HB3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -87.17 117.63 26.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.458 -166.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.941 HD22 ' CE2' ' A' ' 36' ' ' PHE . 3.5 pp -125.22 154.53 41.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.143 173.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -142.87 97.9 3.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.331 -164.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HB3' ' CA ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER -89.3 153.07 21.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.313 -176.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 178.61 136.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.342 168.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.84 35.6 13.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.385 171.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.97 -18.33 57.55 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.75 -170.81 2.3 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -167.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.922 HD12 ' CD1' ' A' ' 36' ' ' PHE . 15.6 pt -149.82 158.82 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.093 -158.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -139.46 173.46 11.52 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.166 164.149 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.672 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.4 p -107.67 158.07 17.57 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.14 0.495 . . . . 0.0 111.134 -154.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -60.11 -26.96 66.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.295 164.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.431 ' N ' ' CD ' ' A' ' 60' ' ' LYS . . . -65.92 -5.75 27.38 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.331 177.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -118.79 -45.04 2.6 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -165.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -60.48 -18.8 53.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.368 163.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.75 -45.53 7.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.282 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . 3.9 tmmm? -61.21 -29.35 69.77 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.452 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.01 32.36 3.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.402 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.76 115.25 0.86 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.428 169.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.441 ' N ' ' CD ' ' A' ' 69' ' ' PRO . . . 138.54 -54.02 0.7 Allowed Glycine 0 CA--C 1.543 1.811 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 68' ' ' GLY . 14.9 Cg_exo -52.06 151.08 17.22 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.572 2.181 . . . . 0.0 113.609 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -65.8 175.91 1.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.37 -169.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.9 156.52 51.72 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -170.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.519 ' H ' ' HD1' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -61.82 -179.12 0.18 Allowed 'General case' 0 N--CA 1.46 0.045 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.418 -175.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.13 -86.04 1.75 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.481 -1.047 . . . . 0.0 110.481 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 74' ' ' PHE . 0.2 OUTLIER -158.7 92.1 1.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.015 -0.593 . . . . 0.0 110.361 -178.416 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.55 44.6 1.73 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -169.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 179.64 92.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.345 -0.427 . . . . 0.0 110.351 170.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.14 -108.31 2.46 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 170.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -102.63 143.31 32.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.379 -0.41 . . . . 0.0 110.258 -169.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.94 -107.55 3.07 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 169.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.23 86.56 4.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.439 -0.381 . . . . 0.0 110.264 169.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 82' ' ' ILE . 0.2 OUTLIER -108.22 161.15 15.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.419 -176.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.458 ' H ' HD13 ' A' ' 81' ' ' LEU . 2.6 tt -90.31 129.7 40.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.384 169.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -61.11 -52.37 65.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.377 -169.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.9 p -84.97 179.07 7.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.359 -170.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 . . . . . 0 C--O 1.241 0.635 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.284 -170.047 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 mtp . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 121.132 0.491 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.38 142.93 0.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.281 -171.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -66.65 -19.1 65.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.419 169.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.4 tttt 64.0 142.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.357 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.6 t 61.85 37.57 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.32 -170.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.69 -64.82 1.59 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -170.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.25 -101.45 0.17 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -170.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.508 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 0.6 OUTLIER -65.72 -163.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.398 -0.401 . . . . 0.0 110.411 -169.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.15 107.44 18.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.022 167.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -114.05 -167.91 16.26 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -162.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.524 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 6.6 t -142.35 106.37 5.58 Favored Pre-proline 0 C--O 1.248 0.977 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -150.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.18 -14.32 23.43 Favored 'Trans proline' 0 N--CA 1.487 1.112 0 C-N-CA 122.959 2.439 . . . . 0.0 113.403 165.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.51 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -82.69 -64.93 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.449 -167.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.59 -27.76 18.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.672 -177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.31 18.51 35.96 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.419 -1.073 . . . . 0.0 110.419 178.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -95.86 -168.97 1.85 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.203 167.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.523 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -164.72 147.63 8.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.167 164.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.861 HG11 ' H ' ' A' ' 22' ' ' GLU . 62.8 t -146.35 141.02 21.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 -156.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.508 ' CD1' ' HA ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -116.31 -18.59 10.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.448 168.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -153.75 39.37 0.48 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.111 -162.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.575 ' H ' ' CG1' ' A' ' 18' ' ' VAL . . . -137.19 -78.95 0.39 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.418 162.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.861 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -126.96 6.65 6.6 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.869 -165.028 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 124.89 22.33 Favored 'General case' 0 C--O 1.231 0.093 0 O-C-N 121.228 -0.92 . . . . 0.0 110.443 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.709 HG21 ' CD2' ' A' ' 36' ' ' PHE . 2.7 m -109.56 -179.8 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.971 161.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.6 tt -148.77 144.6 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.355 164.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.18 107.56 0.32 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.22 30.16 19.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.348 -0.426 . . . . 0.0 110.319 168.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.08 -37.24 3.81 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.4 mttt -72.91 160.77 31.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.301 -0.45 . . . . 0.0 110.32 -170.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -132.44 134.26 44.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.373 168.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.714 ' CZ3' HD13 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -133.27 179.22 6.33 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.551 -169.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.661 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 39.5 m80 -118.81 160.75 21.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.296 156.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HB3' ' HG2' ' A' ' 46' ' ' GLU . 17.5 mtmt -61.53 -45.77 92.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.424 -172.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.429 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 0.8 OUTLIER -61.08 -35.43 76.96 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.512 176.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.51 ' HB3' ' HG2' ' A' ' 13' ' ' ARG . 76.9 m -77.66 -16.62 58.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.639 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.884 ' CD1' HD12 ' A' ' 57' ' ' ILE . 1.9 t80 -67.11 104.34 1.4 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.365 -168.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.583 ' O ' HD11 ' A' ' 57' ' ' ILE . 9.6 mtp180 -116.79 121.63 42.11 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.307 -166.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.2 t -58.44 118.17 5.28 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.768 168.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.21 28.89 2.65 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 113.69 -1.595 . . . . 0.0 110.451 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -114.15 -73.82 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.258 159.348 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 22.5 p -79.28 -7.43 58.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.656 -168.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.2 17.71 68.41 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.456 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.809 ' HD2' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -85.56 110.45 19.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.278 166.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.507 ' HB2' ' HG2' ' A' ' 37' ' ' ARG . 40.4 t -79.41 103.03 9.06 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.181 171.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.809 HD23 ' HD2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -116.87 -168.39 1.45 Allowed 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.562 -175.363 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.58 ' HG2' ' HB3' ' A' ' 33' ' ' LYS . 1.7 tt0 -172.23 156.52 3.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 113.146 -1.843 . . . . 0.0 110.098 -161.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.46 ' N ' ' HG2' ' A' ' 46' ' ' GLU . 21.9 p 60.66 10.81 2.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.492 166.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 p -138.85 163.68 31.62 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.216 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.468 ' CA ' ' HB2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -62.36 172.21 1.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.514 -165.027 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.869 HD22 ' CE2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -153.54 -163.51 1.68 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.299 -172.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -174.36 97.32 0.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.25 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 3.6 p30 -85.94 131.98 34.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.363 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -153.76 147.51 25.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.325 166.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 61.12 30.04 19.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.302 168.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.99 -25.06 29.11 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -120.35 -171.76 2.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.245 -0.477 . . . . 0.0 109.972 -172.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.884 HD12 ' CD1' ' A' ' 36' ' ' PHE . 35.2 pt -142.86 178.7 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.465 -157.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 62' ' ' CYS . 87.8 t80 -170.05 143.76 2.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.21 -174.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.661 ' SG ' HD21 ' A' ' 45' ' ' LEU . 13.8 p -97.49 167.15 11.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.149 0.5 . . . . 0.0 111.023 -146.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.468 ' HB2' ' CA ' ' A' ' 49' ' ' THR . 1.6 tttp -77.69 -16.98 58.12 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.025 168.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.22 -9.1 40.31 Favored Glycine 0 CA--C 1.521 0.458 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.324 170.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 58' ' ' TYR . 1.2 m -119.03 -49.35 2.41 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -165.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -60.02 -13.81 13.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.366 166.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.08 -70.19 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.416 168.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -32.69 72.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.418 -165.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -60.85 -17.89 52.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.406 -169.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -61.17 101.79 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.367 -169.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.11 169.06 13.26 Favored Glycine 0 CA--C 1.542 1.739 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 176.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -52.11 149.33 21.8 Favored 'Trans proline' 0 N--CA 1.485 0.984 0 C-N-CA 122.467 2.112 . . . . 0.0 113.575 176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.39 103.22 13.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.361 169.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -148.77 -89.51 0.08 OUTLIER Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 170.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.433 ' HB3' ' CD2' ' A' ' 74' ' ' PHE . 2.4 m-85 -70.42 140.22 51.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.41 169.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.03 25.88 17.19 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 72' ' ' PHE . 10.6 m-85 -98.11 -25.21 15.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.083 -0.559 . . . . 0.0 110.34 -177.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.93 48.08 83.59 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -169.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.94 -176.19 0.1 Allowed 'General case' 0 N--CA 1.455 -0.223 0 O-C-N 122.122 -0.634 . . . . 0.0 110.899 177.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.73 175.96 15.91 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -169.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.28 -18.07 56.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.403 -0.399 . . . . 0.0 110.197 169.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.67 75.26 1.16 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 169.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -175.64 -82.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.282 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 mt -88.54 -157.97 0.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.356 -169.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 82' ' ' ILE . 5.3 mm -129.34 44.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.39 -169.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -112.34 19.62 17.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.426 169.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.67 119.88 11.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.336 -171.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 C--O 1.239 0.552 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.324 170.084 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 tpt . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.093 0.473 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.12 -43.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.329 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 52.17 -91.17 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.731 0.812 . . . . 0.0 112.159 167.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.03 -169.28 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.481 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.3 p -101.07 -19.22 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.312 167.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.53 107.26 0.2 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 169.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -113.81 54.62 0.55 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -169.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.61 -80.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.413 -0.393 . . . . 0.0 110.401 -172.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.452 ' CB ' ' HE2' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -174.08 -171.39 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.261 167.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -152.99 172.25 31.99 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -169.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.1 t -124.56 108.98 28.7 Favored Pre-proline 0 C--O 1.246 0.887 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -167.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 30' ' ' SER . 8.1 Cg_exo -59.14 -15.35 27.9 Favored 'Trans proline' 0 N--CA 1.485 0.976 0 C-N-CA 122.808 2.338 . . . . 0.0 113.592 168.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -84.8 -69.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.469 -168.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -89.8 -16.14 30.83 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.547 -173.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.82 18.15 70.92 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -96.97 138.92 33.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.932 0.396 . . . . 0.0 110.245 166.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -102.63 142.84 33.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.25 175.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.917 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.3 t -105.77 136.14 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.967 -164.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -99.09 -72.68 0.65 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.183 172.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 18' ' ' VAL . . . -61.8 97.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.978 162.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.09 113.27 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.451 -160.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.917 ' H ' HG11 ' A' ' 18' ' ' VAL . 3.9 tp10 -112.99 26.53 10.41 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.607 174.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.687 ' HD2' ' H ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -100.05 164.38 12.01 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.034 -161.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 31' ' ' TRP . 1.1 p -156.08 172.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.7 -148.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 mt -145.96 145.16 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.631 -175.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -156.87 111.89 0.5 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 169.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.427 ' HB2' ' OD2' ' A' ' 52' ' ' ASP . . . 61.97 -82.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.393 -0.403 . . . . 0.0 110.35 -170.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.45 13.61 1.4 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -170.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -106.77 148.22 28.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.213 -0.493 . . . . 0.0 110.365 176.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.424 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -110.91 142.18 43.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.317 169.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.746 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -150.45 -176.7 5.59 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.686 -168.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.762 ' HE2' HG22 ' A' ' 18' ' ' VAL . 18.8 m80 -93.17 163.84 13.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.121 169.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.527 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 1.4 mmtp -62.86 -16.18 57.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.557 170.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -126.97 23.14 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.424 -172.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' HB2' ' H ' ' A' ' 32' ' ' HIS . 8.3 m -120.68 -11.96 8.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.515 175.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.564 ' CD1' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -61.18 108.63 0.93 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.313 179.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -111.7 103.26 11.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.378 -167.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 31.8 t -63.14 116.66 5.6 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.389 163.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.93 42.65 1.08 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.462 168.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.54 -52.72 1.08 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.517 -177.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.7 p -91.87 -11.13 37.25 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.985 161.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.32 18.65 62.05 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.479 167.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.25 149.53 30.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.127 0.489 . . . . 0.0 110.436 -164.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -68.15 138.88 56.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.736 160.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.784 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -102.83 -164.89 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.711 -159.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -144.95 -165.42 2.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.031 -168.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 67.2 p -76.64 -17.81 58.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.394 -170.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 p -61.06 143.6 55.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.362 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -62.67 -164.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.458 -170.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.511 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -155.9 -170.55 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.333 -173.523 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.31 79.18 1.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.325 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.594 ' CB ' HG22 ' A' ' 57' ' ' ILE . 4.6 p30 -73.6 156.39 38.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.401 174.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 179.67 136.77 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.445 168.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.1 t70 61.57 19.96 10.84 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.367 176.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.97 17.91 60.48 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 171.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -135.1 178.05 7.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 166.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.594 HG22 ' CB ' ' A' ' 52' ' ' ASP . 33.8 pt -154.13 135.36 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.426 -159.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -130.19 175.48 8.88 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.741 160.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.784 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.254 11.7 p -110.34 147.88 33.05 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-O 121.381 0.61 . . . . 0.0 111.857 -149.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.29 -9.76 58.65 Favored 'General case' 0 C--N 1.344 0.341 0 O-C-N 120.441 -1.412 . . . . 0.0 109.856 168.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.86 -4.92 22.67 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.468 162.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -121.46 -48.07 2.2 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -166.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -60.09 -10.37 4.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 113.917 -1.492 . . . . 0.0 110.461 165.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.01 -45.13 5.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.491 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.8 20.28 6.7 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.462 -172.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -103.76 -22.15 13.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.3 165.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 61.71 -80.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.377 176.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -155.38 97.15 0.16 Allowed Glycine 0 CA--C 1.543 1.839 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -173.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -54.98 -40.36 86.21 Favored 'Trans proline' 0 N--CA 1.486 1.079 0 C-N-CA 122.454 2.103 . . . . 0.0 113.468 -171.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.87 173.9 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.391 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.8 131.16 2.76 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 170.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -158.66 149.91 20.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.29 -0.455 . . . . 0.0 110.353 170.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.53 -18.94 13.06 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -118.62 114.92 23.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.41 -0.395 . . . . 0.0 110.313 -169.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.44 56.03 0.51 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 68.9 127.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.311 168.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.69 147.3 0.18 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 168.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -175.59 128.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.282 169.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.65 -34.35 0.41 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -81.38 139.7 35.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.394 . . . . 0.0 110.28 -169.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 mp 60.05 19.07 8.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.599 -170.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.8 mm -105.8 80.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.353 169.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.13 122.91 16.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.352 -168.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -175.32 134.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.32 170.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--O 1.24 0.6 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.387 -170.041 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 tpt . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 121.146 0.498 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.34 -44.17 0.93 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.219 -172.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 70.02 -77.48 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.354 169.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.583 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -124.87 -77.22 0.59 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.49 170.058 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.583 HG13 ' O ' ' A' ' 4' ' ' LYS . 1.3 m -163.75 80.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.324 -174.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.29 -69.86 0.09 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.87 -87.06 0.55 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -169.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -61.17 -167.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.392 -0.404 . . . . 0.0 110.292 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.458 ' HB2' ' CB ' ' A' ' 23' ' ' LYS . 2.8 m-20 -132.26 99.71 4.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.104 167.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -108.21 -179.52 21.85 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -163.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.5 t -132.38 101.71 14.52 Favored Pre-proline 0 C--O 1.242 0.687 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -160.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 30' ' ' SER . 1.4 Cg_endo -59.93 -14.12 26.15 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 122.697 2.265 . . . . 0.0 113.483 167.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -81.22 -62.25 1.71 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.412 -166.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -88.8 -17.76 29.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.484 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.37 -13.83 54.69 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -79.45 175.51 10.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.09 -0.555 . . . . 0.0 110.396 175.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.518 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -131.84 172.92 11.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.987 163.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.882 HG11 ' H ' ' A' ' 22' ' ' GLU . 2.6 t -119.67 158.74 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.811 -172.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.433 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 1.5 m-85 -94.96 38.33 1.13 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.428 177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.51 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . . . 61.88 68.05 0.72 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.079 -167.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.844 ' HB3' ' CG1' ' A' ' 18' ' ' VAL . . . -129.13 -63.72 0.94 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.444 -174.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.882 ' H ' HG11 ' A' ' 18' ' ' VAL . 16.9 mm-40 -117.9 27.61 8.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.081 -173.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -87.32 112.92 22.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.297 -167.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.944 HG21 ' CD2' ' A' ' 36' ' ' PHE . 15.5 m -97.99 -178.71 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.154 165.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 pp -139.87 159.96 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.481 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.84 87.1 0.16 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.49 -81.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.252 -170.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.05 -18.91 10.66 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.524 ' HB3' ' NE1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -72.42 159.6 33.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.431 -0.384 . . . . 0.0 110.349 -169.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.448 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 98.8 p -147.86 123.53 10.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.157 167.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.799 ' CD1' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -122.66 178.48 4.99 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.799 -165.414 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.79 ' NE2' HG22 ' A' ' 18' ' ' VAL . 20.0 m80 -94.04 162.15 14.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.875 160.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.8 mttp -60.38 -42.45 95.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.449 167.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.5 t -95.78 21.14 8.84 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.69 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 16.6 m -120.68 -19.55 7.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.382 167.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.944 ' CD2' HG21 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -60.57 113.02 2.22 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.329 175.018 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.802 ' CZ ' ' HB2' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -138.67 127.03 22.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.282 -172.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 14.0 t -58.56 112.81 1.73 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.631 165.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.802 ' HB2' ' CZ ' ' A' ' 37' ' ' ARG . . . -91.2 23.01 3.49 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.289 -1.323 . . . . 0.0 110.631 171.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.97 -75.7 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.491 170.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.1 p -75.67 -21.54 57.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.562 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.15 -17.82 40.35 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.459 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.85 128.91 36.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.162 0.506 . . . . 0.0 110.388 -170.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -64.94 140.02 58.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.08 164.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.821 HD11 ' HB2' ' A' ' 59' ' ' CYS . 0.8 OUTLIER -163.62 -176.25 4.57 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.16 165.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.566 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -172.32 -157.63 0.11 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.381 -160.749 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.71 -87.29 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.74 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.38 15.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.241 -174.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.723 HG22 ' C ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -118.19 45.19 2.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.331 -171.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 46' ' ' GLU . 3.9 pp -142.8 168.79 18.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.452 -177.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.71 125.97 12.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.357 173.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.708 ' CB ' HG22 ' A' ' 57' ' ' ILE . 3.6 p-10 -124.64 146.65 48.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.427 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.66 156.32 0.45 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.449 167.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 p30 61.27 19.76 10.42 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.554 172.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.83 -27.4 20.38 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 166.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.443 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -117.23 178.62 4.3 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.044 -0.578 . . . . 0.0 109.899 178.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.708 HG22 ' CB ' ' A' ' 52' ' ' ASP . 35.0 pt -156.2 135.83 3.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.446 -160.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -134.02 177.73 7.51 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 156.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.821 ' HB2' HD11 ' A' ' 45' ' ' LEU 0.258 12.4 p -113.92 152.29 31.01 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-O 121.992 0.901 . . . . 0.0 113.17 -143.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.723 ' C ' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -84.91 -0.29 53.66 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 119.476 -2.015 . . . . 0.0 110.352 166.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.525 ' N ' HG22 ' A' ' 49' ' ' THR . . . -58.09 -15.25 20.94 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 151.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 -51.78 2.43 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -157.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -60.08 -14.85 18.76 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.474 167.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.5 -66.12 0.95 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.39 167.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -41.23 94.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.493 -164.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.12 28.83 3.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.352 -175.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -125.46 80.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.346 167.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.66 -83.37 0.18 Allowed Glycine 0 CA--C 1.543 1.784 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -53.96 -179.14 0.05 OUTLIER 'Trans proline' 0 N--CA 1.486 1.051 0 C-N-CA 122.403 2.069 . . . . 0.0 113.474 -171.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 71' ' ' GLY . 8.4 tttt -105.86 163.83 12.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.332 170.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.522 ' N ' ' HG2' ' A' ' 70' ' ' LYS . . . -137.05 -179.62 16.98 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 169.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -64.73 -76.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.345 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 135.94 -117.31 1.63 Allowed Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -169.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -114.41 -37.93 4.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.106 -0.547 . . . . 0.0 110.364 -176.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.01 -175.75 23.7 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -170.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -119.78 107.96 13.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.343 -0.429 . . . . 0.0 110.322 -170.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.76 167.36 42.9 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 170.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -93.94 -65.34 1.0 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.34 -0.43 . . . . 0.0 110.299 -169.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 161.31 168.7 23.56 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.53 106.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.135 -0.533 . . . . 0.0 110.363 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.6 tp -146.42 -82.13 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.398 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.1 pt 57.6 42.2 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.91 173.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 71.32 -79.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.312 -172.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.36 169.13 11.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.315 -170.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 . . . . . 0 C--O 1.24 0.595 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.308 -170.036 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtt . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 121.05 0.452 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.66 -46.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.224 172.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.31 135.68 49.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.351 -169.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.713 ' HG3' HG13 ' A' ' 5' ' ' VAL . 39.5 tptt 65.01 -77.38 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.452 172.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.713 HG13 ' HG3' ' A' ' 4' ' ' LYS . 11.4 m -104.49 100.27 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.315 -170.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.19 -49.58 0.04 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -169.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.75 73.62 0.27 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 173.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 m 65.9 173.67 0.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.434 -0.383 . . . . 0.0 110.338 166.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 31.7 p30 -116.48 132.52 56.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.0 167.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -120.7 174.41 15.73 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -160.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 13.5 t -124.41 113.34 27.63 Favored Pre-proline 0 C--O 1.244 0.789 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -157.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.429 ' HG2' ' O ' ' A' ' 30' ' ' SER . 6.8 Cg_endo -63.4 -7.04 11.35 Favored 'Trans proline' 0 N--CA 1.484 0.916 0 C-N-CA 122.686 2.258 . . . . 0.0 113.696 171.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.512 ' HG2' ' HB3' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -92.09 -70.27 0.7 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.407 -174.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.4 p -91.22 -29.99 16.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.63 -171.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 48.35 2.72 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.52 157.42 33.63 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.932 -0.634 . . . . 0.0 110.399 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.527 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -113.88 137.74 51.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.171 168.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.909 HG11 ' H ' ' A' ' 22' ' ' GLU . 3.2 t -113.41 134.48 56.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.865 -163.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -94.2 -69.44 0.75 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.382 -167.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.76 -10.33 5.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.4 167.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.74 111.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.329 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.909 ' H ' HG11 ' A' ' 18' ' ' VAL . 9.0 tt0 -114.4 31.55 6.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.535 172.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.52 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 4.5 mtpm? -106.48 -175.14 2.71 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.171 -160.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.771 HG12 ' O ' ' A' ' 31' ' ' TRP . 2.1 p -169.05 161.42 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.768 -148.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 tt -141.21 144.74 25.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.45 -171.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.512 ' HA3' ' HB3' ' A' ' 52' ' ' ASP . . . -163.99 135.65 3.88 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 167.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.623 ' HB2' ' O ' ' A' ' 53' ' ' LYS . . . 61.55 -82.12 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.032 -0.584 . . . . 0.0 110.334 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.89 16.87 0.82 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -173.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.12 140.33 52.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.375 -168.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.51 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -104.67 145.59 30.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.305 168.675 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.771 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -149.71 163.94 36.58 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.595 -170.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.635 ' HE2' HG22 ' A' ' 18' ' ' VAL . 17.9 m80 -74.26 144.66 44.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.734 158.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 46' ' ' GLU . 4.1 mttm -60.27 -21.54 62.03 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.487 169.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -111.21 18.16 19.59 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.51 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 21.3 m -119.79 16.38 12.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.215 166.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.957 ' CE2' HD22 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -98.11 110.64 23.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.263 -163.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.529 ' O ' HD11 ' A' ' 57' ' ' ILE . 7.7 ttp-105 -122.61 120.62 34.3 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.278 -164.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.1 t -58.42 111.83 1.37 Allowed 'General case' 0 C--O 1.239 0.508 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.728 164.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.47 -24.6 67.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.681 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.551 ' HG3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -75.99 -78.82 0.11 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.26 -176.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.7 p -84.75 -9.12 58.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.783 -163.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.78 15.69 74.8 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.929 ' HG2' HD23 ' A' ' 45' ' ' LEU . 8.6 tptm -88.78 103.07 15.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.415 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 14.3 t -71.15 92.38 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.105 166.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.929 HD23 ' HG2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -128.12 -175.17 3.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.555 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -171.64 -45.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.789 -163.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -60.94 -61.29 2.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.369 -173.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.8 p -65.63 133.05 50.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.124 163.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.58 HG22 ' HG2' ' A' ' 60' ' ' LYS . 6.3 t -62.6 -176.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.335 -166.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.957 HD22 ' CE2' ' A' ' 36' ' ' PHE . 2.3 pp -119.81 177.42 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.335 -167.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -163.41 108.84 1.09 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.292 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.512 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . 4.4 p-10 -94.99 145.34 25.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.3 -168.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -130.49 -174.49 3.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.394 165.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.63 92.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.424 -169.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 100.04 -22.95 37.88 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.34 -174.08 3.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.046 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.873 HD12 ' CD1' ' A' ' 36' ' ' PHE . 35.6 pt -148.37 175.8 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.333 -161.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.551 ' CE2' ' HG3' ' A' ' 40' ' ' LYS . 13.6 t80 -178.29 141.45 0.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.162 -160.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.721 ' HB2' HD11 ' A' ' 45' ' ' LEU . 10.1 p -100.67 168.97 9.35 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.898 -148.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.58 ' HG2' HG22 ' A' ' 49' ' ' THR . 0.0 OUTLIER -85.23 -12.84 51.62 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.123 169.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.75 -10.35 37.62 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.038 166.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.526 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 1.3 m -119.0 -46.85 2.52 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -164.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -60.19 -16.4 32.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.444 163.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -87.09 -43.41 12.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.287 168.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -60.79 -11.72 8.53 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.523 177.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.9 37.82 1.77 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.307 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -79.06 -27.4 43.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.398 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.87 89.75 2.06 Favored Glycine 0 CA--C 1.543 1.795 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 171.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.69 119.02 5.87 Favored 'Trans proline' 0 N--CA 1.486 1.033 0 C-N-CA 122.493 2.129 . . . . 0.0 113.466 171.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.11 -19.38 15.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.395 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.44 80.67 1.05 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -170.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.51 105.19 9.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.389 -0.405 . . . . 0.0 110.346 -169.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.48 -101.62 2.79 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -100.9 135.53 42.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.447 -0.376 . . . . 0.0 110.338 -170.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.46 61.18 2.83 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 170.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -70.98 -23.84 62.29 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.082 -0.559 . . . . 0.0 110.427 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -168.53 165.09 38.58 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.68 163.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.23 169.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.16 174.29 33.85 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -170.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -119.16 99.94 7.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.408 -0.396 . . . . 0.0 110.283 -169.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.685 HD22 ' N ' ' A' ' 81' ' ' LEU . 2.0 mm? -84.27 67.93 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.323 169.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 83' ' ' HIS . 42.1 mt 66.12 166.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.355 -169.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.43 ' N ' HG22 ' A' ' 82' ' ' ILE . 3.0 m80 -61.06 93.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.338 -169.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.9 t -112.45 -79.81 0.58 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.379 -170.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 . . . . . 0 C--O 1.24 0.568 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.367 170.079 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.0 ttm . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 121.137 0.494 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.46 -82.02 0.31 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.298 -172.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 57.53 96.87 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.481 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HE2' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -61.34 -26.31 67.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.42 -177.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.428 HG13 ' HE2' ' A' ' 4' ' ' LYS . 35.0 m -152.71 -35.43 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.424 177.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 121.29 -116.9 3.28 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -128.71 -89.48 0.6 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -172.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -61.11 -171.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.386 -0.407 . . . . 0.0 110.313 167.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' CB ' ' HB3' ' A' ' 23' ' ' LYS . 18.5 m-20 -125.48 -162.16 1.09 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.221 166.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -174.31 178.73 46.03 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 165.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.3 t -136.16 111.33 10.07 Favored Pre-proline 0 C--O 1.247 0.94 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -158.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 30' ' ' SER . 15.1 Cg_exo -53.9 -20.24 17.38 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.99 2.46 . . . . 0.0 113.642 166.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.23 -72.44 0.51 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.429 -167.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.6 p -86.62 -18.15 32.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.61 -172.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.87 18.75 64.74 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.77 168.09 11.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.423 -0.389 . . . . 0.0 110.328 170.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.529 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -122.49 145.03 48.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.168 168.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.92 HG11 ' H ' ' A' ' 22' ' ' GLU . 4.8 t -101.56 135.2 39.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.19 -164.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -73.83 -77.01 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.423 -166.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.61 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.135 167.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.406 ' HB1' ' OD2' ' A' ' 9' ' ' ASP . . . -176.86 133.81 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.091 165.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.92 ' H ' HG11 ' A' ' 18' ' ' VAL . 0.5 OUTLIER -129.0 17.51 6.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.389 161.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . 0.1 OUTLIER -103.49 160.59 14.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.91 -159.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 31' ' ' TRP . 2.3 p -150.97 178.02 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.575 -147.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.468 ' H ' HG22 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -144.91 147.58 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.541 -175.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.3 139.36 5.63 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.439 -1.065 . . . . 0.0 110.439 168.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.64 -82.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.046 -0.577 . . . . 0.0 110.397 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -153.74 27.95 0.75 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 170.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.62 153.85 31.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.399 -0.401 . . . . 0.0 110.359 -170.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.408 ' O ' ' HD2' ' A' ' 12' ' ' PRO . 14.9 t -110.43 143.42 40.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.2 168.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.779 ' O ' HG12 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -148.38 170.98 16.78 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.952 -172.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.863 ' HE2' HG22 ' A' ' 18' ' ' VAL . 15.2 m80 -86.31 147.38 26.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.519 -1.218 . . . . 0.0 110.084 162.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -60.67 -13.31 13.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.489 171.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 m -101.55 -36.08 8.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.417 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 32' ' ' HIS . 39.8 m -72.93 -17.29 61.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.453 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.619 ' CE1' HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -61.19 85.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.267 177.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 44' ' ' SER . 17.5 mtm180 -121.65 127.12 50.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.196 -167.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 12.4 t -59.33 107.08 0.51 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.477 164.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.51 -20.99 66.07 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.573 170.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.45 -67.37 0.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.541 -165.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 30.3 p -88.55 -27.16 21.59 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.65 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.95 22.37 6.96 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.433 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.6 tppp? -110.03 110.7 21.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.265 -0.468 . . . . 0.0 110.401 -168.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER -65.15 112.43 3.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.358 167.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.692 HD21 ' SG ' ' A' ' 59' ' ' CYS . 1.2 pp -147.19 176.64 9.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.399 177.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.36 -32.63 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.917 -173.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -67.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.54 -165.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -61.44 -75.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.358 -173.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.673 HG23 ' HB2' ' A' ' 60' ' ' LYS . 14.8 t -178.77 -169.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.366 164.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.619 HD13 ' CE1' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -168.66 -171.52 1.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.236 -169.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.34 82.64 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.368 -167.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.907 ' HA ' HG22 ' A' ' 57' ' ' ILE . 3.0 p30 -69.6 147.35 50.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.356 170.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.33 149.31 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.42 169.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 61.19 -96.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.459 -170.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -151.24 23.59 0.98 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.29 173.82 12.22 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 171.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.907 HG22 ' HA ' ' A' ' 52' ' ' ASP . 39.3 pt -141.3 152.74 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.194 -158.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -134.13 174.58 10.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.679 157.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.692 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.2 p -106.79 159.14 16.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.179 0.514 . . . . 0.0 110.847 -152.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.673 ' HB2' HG23 ' A' ' 49' ' ' THR . 11.8 tptt -72.33 -14.7 61.8 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.848 168.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.7 -10.26 43.49 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.196 166.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.43 -48.54 2.7 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -164.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -60.38 -13.62 14.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.258 165.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -90.57 -65.37 1.02 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.522 173.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -61.26 -16.53 46.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.567 -165.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.04 -56.59 3.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.256 167.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 t80 60.77 13.93 4.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.508 -175.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -150.85 -142.8 3.6 Favored Glycine 0 CA--C 1.544 1.889 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -168.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.98 -88.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.058 0 C-N-CA 122.612 2.208 . . . . 0.0 113.511 -167.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.68 -34.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.394 -167.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.47 96.9 0.1 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -164.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.5 t80 179.28 110.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.403 -0.398 . . . . 0.0 110.288 166.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.43 130.6 3.02 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 -169.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.3 t80 68.18 156.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.435 -0.382 . . . . 0.0 110.364 168.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 132.23 159.14 9.22 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 70.24 -71.36 0.13 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.439 169.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.96 -86.36 0.04 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 61.68 110.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.372 -0.414 . . . . 0.0 110.35 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 64.3 128.64 0.01 OUTLIER Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -161.61 -70.11 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.37 -0.415 . . . . 0.0 110.286 -169.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.8 mt -64.93 -91.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.437 -168.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.499 HG22 ' H ' ' A' ' 83' ' ' HIS . 14.6 mm -100.23 168.41 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.457 -169.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.499 ' H ' HG22 ' A' ' 82' ' ' ILE . 4.9 m-70 -122.03 103.78 9.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.337 -169.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.0 t 66.05 119.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.36 169.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.418 HE22 ' HB ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.534 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.408 169.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtt . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 121.106 0.479 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.53 -78.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.266 172.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 62.9 77.7 0.32 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.473 -169.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -104.93 102.16 11.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.362 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 t -102.99 109.51 27.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.335 -169.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.42 98.75 0.26 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.66 118.77 6.26 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 19' ' ' TYR . 1.9 m -96.32 -164.42 1.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.281 -0.459 . . . . 0.0 110.406 170.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' HB2' ' CG ' ' A' ' 23' ' ' LYS . 45.7 m-20 -85.04 104.72 15.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.013 170.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 17' ' ' ALA . . . -110.93 -168.13 19.05 Favored Glycine 0 CA--C 1.533 1.179 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -162.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 32' ' ' HIS . 8.1 t -140.32 107.02 6.64 Favored Pre-proline 0 C--O 1.249 1.049 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -149.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.74 -16.98 33.63 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 C-N-CA 122.762 2.308 . . . . 0.0 113.625 171.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -84.08 -67.03 0.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.593 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 p -87.94 -29.96 20.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.602 -170.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.09 18.62 36.18 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -93.64 -169.03 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 164.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.531 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . . . -165.59 145.26 6.55 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.262 164.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.874 HG11 ' H ' ' A' ' 22' ' ' GLU . 64.7 t -143.57 137.77 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.444 -155.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.462 ' HB2' ' HB3' ' A' ' 8' ' ' SER . 50.5 t80 -109.32 -19.04 13.43 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.446 169.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.57 -56.57 1.96 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.257 -167.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.801 ' HB1' ' OE2' ' A' ' 22' ' ' GLU . . . -61.38 -74.54 0.08 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.412 -162.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.874 ' H ' HG11 ' A' ' 18' ' ' VAL . 4.2 mm-40 -117.34 7.64 12.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.792 -164.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' CG ' ' HB2' ' A' ' 9' ' ' ASP . 3.4 ttpt -60.9 122.11 14.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.435 -161.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.637 HG21 ' CD2' ' A' ' 36' ' ' PHE . 3.5 m -122.13 169.27 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.249 167.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 55.7 mt -145.94 139.99 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.424 168.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.46 120.27 0.93 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -170.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.68 16.31 7.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.311 -0.444 . . . . 0.0 110.332 169.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.62 -22.92 25.39 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -79.64 134.64 36.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.437 -172.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.7 m -102.33 119.35 38.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.396 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.486 ' CD1' ' N ' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -124.31 174.58 7.63 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.602 -172.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.532 ' CE1' ' HB2' ' A' ' 11' ' ' CYS . 44.2 m80 -105.29 153.99 20.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.1 157.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HD3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -61.11 -27.12 68.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.4 178.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 t -84.52 -23.77 29.64 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.486 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.3 m -95.81 25.09 4.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.347 171.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.884 ' HZ ' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -113.14 89.31 3.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.269 -171.066 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.892 ' NH1' ' HB2' ' A' ' 39' ' ' ALA . 1.1 ppt_? -112.02 130.39 55.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.282 -166.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 59' ' ' CYS . 11.9 t -65.28 110.92 2.77 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.446 168.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.892 ' HB2' ' NH1' ' A' ' 37' ' ' ARG . . . -92.51 18.62 8.3 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.616 170.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -91.73 -75.34 0.48 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.379 165.195 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.5 p -83.4 -22.65 32.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.494 -173.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.35 -28.35 6.31 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 165.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HD2' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -82.61 145.22 29.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.307 -0.447 . . . . 0.0 110.385 -168.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 37' ' ' ARG . 15.0 m -92.14 137.35 32.43 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.328 177.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.656 HD21 ' SG ' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -140.88 -168.47 2.6 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.841 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.506 ' HB2' ' HD3' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -171.88 -69.73 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 112.946 -1.934 . . . . 0.0 110.254 -171.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.5 p -61.84 -22.06 65.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.391 -166.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -96.02 156.97 16.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.412 170.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.683 HG22 ' H ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -60.91 -173.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.355 -168.081 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.884 HD13 ' HZ ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -148.34 -175.89 5.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.419 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -155.46 77.8 1.0 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.312 -169.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.615 ' HA ' HG22 ' A' ' 57' ' ' ILE . 4.9 p-10 -67.45 90.91 0.25 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.361 177.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.25 169.66 17.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.368 170.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -61.07 89.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.434 -170.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.74 -19.19 14.32 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.446 -1.061 . . . . 0.0 110.446 171.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -155.33 -171.73 3.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.43 -0.385 . . . . 0.0 110.003 -169.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.783 HD12 ' CE1' ' A' ' 36' ' ' PHE . 38.1 pt -148.77 140.15 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.381 -161.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.498 ' CD1' ' HB2' ' A' ' 40' ' ' LYS . 1.5 m-85 -132.93 -175.94 3.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.938 163.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.656 ' SG ' HD21 ' A' ' 45' ' ' LEU . 14.6 p -110.54 159.85 17.17 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.466 0.65 . . . . 0.0 111.185 -153.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HB2' ' HB ' ' A' ' 49' ' ' THR . 6.7 tmtt? -74.46 -13.32 60.68 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.866 169.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.66 -9.64 39.72 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.21 164.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.91 -45.34 2.77 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -164.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -60.51 -13.25 12.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.224 162.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -92.67 -51.1 5.26 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.393 172.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.02 -13.58 17.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.375 -168.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -61.51 -18.52 59.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.458 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -75.47 -33.68 60.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.332 -169.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -118.37 105.79 1.25 Allowed Glycine 0 CA--C 1.542 1.762 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -170.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -51.82 -34.85 56.85 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.651 2.234 . . . . 0.0 113.515 173.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -63.91 147.67 51.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.358 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 163.17 -114.99 0.63 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -170.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -95.82 177.74 5.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.436 -0.382 . . . . 0.0 110.34 169.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -136.16 132.48 6.13 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 170.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -92.02 101.86 14.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.413 -0.393 . . . . 0.0 110.311 169.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.74 72.31 0.33 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -170.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -144.34 18.14 1.71 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.262 -0.469 . . . . 0.0 110.382 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.04 179.67 30.08 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -170.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -175.25 -60.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.423 -0.388 . . . . 0.0 110.273 169.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.62 100.32 1.54 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 169.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -161.96 107.24 1.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.026 -0.587 . . . . 0.0 110.356 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 mt 60.04 96.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.59 170.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 83' ' ' HIS . 18.5 mm -74.23 167.93 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.353 -170.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.432 ' N ' HG22 ' A' ' 82' ' ' ILE . 7.0 t60 -87.12 121.33 29.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.386 170.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 p -159.13 -77.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.402 170.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.24 0.594 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.289 -170.07 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_